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Abstract
An evidence synthesis of qualitative and quantitative 
research on component intervention techniques, 
effectiveness, cost-effectiveness, equity and 
acceptability of different versions of health-related 
lifestyle advisor role in improving health
SM Carr,1* M Lhussier,1 N Forster,1 L Geddes,1 K Deane,2,3 
M Pennington,2 S Visram,1 M White,2 S Michie,4 C Donaldson2 
and A Hildreth1
1Northumbria University, Newcastle upon Tyne, UK
2Newcastle University, Newcastle upon Tyne, UK
3University of East Anglia, Norwich, UK
4University College London, London, UK
*Corresponding author
Background: There is a need to identify and analyse the range of models developed to 
date for delivering health-related lifestyle advice (HRLA), or training, for effectiveness and 
cost-effectiveness in improving the health and well-being of individuals and communities in 
the UK, with particular reference to the reduction of inequalities.
Objectives: To identify the component intervention techniques of lifestyle advisors (LAs) in 
the UK and similar contexts, and the outcomes of HRLA interventions.
Data sources: Stakeholder views, secondary analysis of the National Survey of Health 
Trainer Activity, telephone survey of health trainer leads/coordinators. A search of a range 
of electronic databases was undertaken [including the Applied Social Sciences Index and 
Abstracts (ASSIA), EMBASE, NHS Economic Evaluation Database (NHS EED), MEDLINE, 
Psyc INFO, etc.], as well searching relevant journals and reference lists, conducted from 
inception to September 2008.
Review methods: Identified studies were scanned by two reviewers and those meeting the 
following criteria were included: studies carrying out an evaluation of HRLA; those taking 
place in developed countries similar to the UK context; those looking at adult groups; 
interventions with the explicit aim of health improvement; interventions that involved paid 
or voluntary work with an individual or group of peers acting in an advisory role; advice 
delivered by post, online or electronically; training, support or counselling delivered to 
patients, communities or members of the public. After quality assessment, studies were 
selected for inclusion in the review. Data were abstracted from each study according to 
an agreed procedure and narrative, and realist and economic approaches were used to 
synthesise the data. Cost-effectiveness analysis of interventions was undertaken.
Results: In total, 269 studies were identified but 243 were excluded. The 26 included 
studies addressing chronic care, mental health, breastfeeding, smoking, diet and physical 
activity, screening and human immunodeficiency virus (HIV) infection prevention. Overall, 
there was insufficient evidence to either support or refute the use of LAs to promote 
iv Abstract
health and improve quality of life (QoL), and thus uncertainty about the interventions’ 
cost-effectiveness. However, the economic analysis showed that LA interventions were 
cost-effective in chronic care and smoking cessation, inconclusive for breastfeeding and 
mental health and not cost-effective for screening uptake and diet/physical activity. LA 
interventions for HIV prevention were cost-effective, but not in a UK context.
Limitations: The wide variety of LA models, delivery settings and target populations 
prevented the reviewers from establishing firm causal relationships between intervention 
mode and study outcomes.
Conclusions: Evidence was variable, giving only limited support to LAs having a positive 
impact on health knowledge, behaviours and outcomes. Levels of acceptability appeared 
to be high. LAs acted as translational agents, sometimes removing barriers to prescribed 
behaviour or helping to create facilitative social environments. Reporting of processes of 
accessing or capitalising on indigenous knowledge was limited. Ambiguity was apparent 
with respect to the role and impact of lay and peer characteristics of the interventions. 
A future programme of research on HRLA could benefit from further emphasis on 
identification of needs, the broadening of population focus and intervention aims, the 
measurement of outcomes and the reviewing of evidence.
Funding: This study was funded by the Health Technology Assessment programme of the 
National Institute for Health Research.
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Executive summary
Review question and objectives
This research aims to identify, describe, classify and analyse the range of models developed 
to date for delivering health-related lifestyle advice (HRLA), or training, for effectiveness, 
mechanism of effect, cost-effectiveness, equity and acceptability in improving the health and well-
being of individuals and communities, with particular reference to the reduction of inequalities 
in the UK.
Typical of the complexity of public health issues, the question addressed in this review is broad 
and multifaceted. The overall question was therefore broken down and grouped under two broad 
groupings:
1. What are the component intervention techniques of lifestyle advisors (LAs) in the UK and 
similar contexts?
2. What are the outcomes of HRLA interventions?
Methods
Data sources
In preparation to undertake the evidence synthesis, a process of problem definition and 
intervention modelling to facilitate development of classification of the various intervention 
dimensions was undertaken: eliciting stakeholder views, secondary analysis of the National 
Survey of Health Trainer Activity, telephone survey of health trainer leads/co-ordinators. An 
extensive search of electronic databases [including the Applied Social Sciences Index and 
Abstracts (ASSIA), EMBASE, NHS Economic Evaluation Database (NHS EED), MEDLINE, 
PsycINFO, etc.], relevant journals and reference lists was undertaken. Searches were conducted 
from inception to September 2008.
Study selection
Studies with the following criteria were included:
 ■ those carrying out an evaluation (quantitative, qualitative or economic) of HRLA
 ■ those taking place in developed countries similar to the UK context, i.e. Western Europe, 
North America, Australia and New Zealand
 ■ those looking at adult groups
 ■ interventions with the explicit aim of health improvement, including community-based 
secondary prevention for chronic disease
 ■ interventions that involved paid or voluntary work with an individual or group of peers 
acting in an advisory role, offering support in person, over the telephone or online
 ■ advice delivered by post, online or electronically (only if this involved an iterative process of 
interaction between individual and advisor)
 ■ training, support or counselling delivered to patients, communities or members of the public.
After quality assessment, using standardised quality checklists, 26 studies were identified for 
inclusion in the review.
x Executive summary
Data abstraction
Data were abstracted from each study according to an agreed procedure.
Data analysis and synthesis
Multiple approaches were required to synthesis the data in this review: narrative, realist and 
economic. The narrative synthesis provided a detailed description of the included studies 
(qualitative and quantitative) and treated them as exemplar cases of LA interventions. The realist 
synthesis builds on this emerging theory to refine and elaborate the knowledge of how, why, and 
in which circumstances, LA interventions are likely to produce successful outcomes. The analysis 
of cost-effectiveness provided as comprehensive an answer as possible to the second group of 
review questions.
Results
In total, 269 studies that evaluated HRLA were identified but 243 were excluded owing to a range 
of methodological factors that made them unsuitable for inclusion in a systematic review. The 
26 included studies addressing chronic care, mental health, breastfeeding, smoking, diet and 
physical activity, screening and human immunodeficiency virus (HIV) infection prevention.
Overall, the evidence was not sufficient to support or refute the use of LAs to promote health 
and improve quality of life (QoL). Although there is likely to be considerable uncertainty 
about statements of interventions’ cost-effectiveness because of the sparse evidence base for 
effectiveness, lessons can be drawn from the realist analysis of the included studies.
 ■ LA interventions in chronic care are cost-effective. The success of interventions to improve 
the management of chronic conditions is linked to their largely already engaged target group 
and to their aim, which differs from that of some of the other HRLA, in that they help people 
live with a condition rather than necessarily aiming at behaviour change.
 ■ LA interventions for smoking cessation are cost-effective because of the important health 
gains that derive from cessation. The economic analysis excluded studies when effectiveness 
did not reach statistical significance. However, the buddy schemes explored in these studies 
have much to offer to an analysis of intervention components and may still offer potential as 
a practice model.
 ■ From the evidence that could be accessed, the cost-effectiveness of LA interventions 
for breastfeeding is inconclusive. Intervention mechanisms details suggest that these 
interventions tended to use peers with common experience, and aimed at enhancing, rather 
than changing, behaviour.
 ■ Included studies did not allow the production of a conclusive cost-effectiveness estimate for 
LA interventions for mental health. This intervention presented a mechanism in common 
with the smoking cessation ‘buddy’ system, in that it paired people with a similar experience 
(that of being the parent of a child with a chronic condition). LA interventions for screening 
uptake are not cost-effective. These interventions did reach, however, a large number of 
people, they presented, on the whole, high degrees of acceptability, and targeted population 
groups, which tended to be disengaged from mainstream service provision.
 ■ LA interventions for diet and physical activity are not cost-effective. Highlighted by the 
realist analysis was an alternative intervention mechanism, in that one study targeted whole 
family groupings rather than individuals. This was a unique intervention characteristic 
within this review.
 ■ LA interventions for HIV infection prevention were cost-effective, but not in a UK context. 
Realist analysis highlights that they did succeed, however, in reaching hard-to-reach 
communities and build on social capital – two aims of the health trainer scheme in the UK.
© Queen’s Printer and Controller of HMSO 2011. All rights reserved.
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Conclusions
The wide variety of LA models, delivery settings and target populations prevented the reviewers 
from establishing firm causal relationships between intervention mode and study outcomes. 
Evidence is variable and can only give limited support to LAs having a positive impact on health 
knowledge, behaviours and outcomes. Levels of acceptability appear to be high. LAs acted as 
translational agents, sometimes removing barriers to prescribed behaviour or helping to create 
facilitative social environments. Reporting of processes of accessing or capitalising on indigenous 
knowledge (IK) is limited. Ambiguity continues with respect to the role and impact of lay and 
peer characteristics of the interventions.
Recommendations for practice
 ■ Interventions that are low cost and have some effect are recommended.
 ■ Further recognition of the IK base of the LA may be required.
 ■ Training of LAs may be worthy of particular attention, as a balance needs to be reached 
between provider and LA-identified learning needs.
 ■ The process of message tailoring and the effectiveness of inclusion of different aspects of 
community allegiance and IK require further exploration.
 ■ There is a need for clearer definitions of target groups, their characteristics and particular 
needs.
 ■ Intervention approaches need to be made more explicit.
 ■ Peership and layness need to be considered and defined for particular settings.
 ■ Short-, medium- and long-term intervention outcomes need to be clearly identified and 
measured.
Recommendations for a future programme of research
The following recommendations carry particular relevance to the UK context, but may also 
be of international relevance. They are designed to form a programme of research on HRLA, 
around the identification of needs, the broadening of population focus and intervention aims, the 
measurement of outcomes and the reviewing of evidence.
 ■ Identifying need:
 – A concept mapping approach may be an appropriate strategy to use in order to identify 
what people believe helps them adhere to healthy lifestyle advice, and to triangulate this 
to views of public health professionals and community leaders.
 ■ Target groups:
 – Interventions in groups not addressed in the review (men, transient populations, 
homeless people, etc.), broader interventions in groups with specific issues (e.g. physical 
health in mental health population groups), and prevention in general health promotion 
(such as stop smoking plus diet, exercise and screening) need further development.
 – Research on alternative target groups that may be of broader focus than health 
related, such as, for example, faith groups, youth groups, community centres, 
gangs, playschemes, etc.; within each group, existing leaders could be identified and 
collaborative relationships nurtured to identify, assess and address local needs. Such 
schemes are likely to lead to community development activities but would require 
longitudinal funding schemes.
xii Executive summary
 ■ Intervention aim:
 – Research is needed on the building of social capital or community development through 
LA schemes. This would entail a focus on social and structural, rather than individual, 
determinants of health inequalities.
 – A development of research led by, or conducted in collaboration with, community 
guides would help to develop ways for health-care providers to maximise the potential of 
pre-existing ‘unofficial’ health improvement activities.
 ■ Outcome identification and measurement:
 – This review endorses the need for a strategic movement along the Medical Research 
Council continuum of evidence so that research evolves from scoping practice to 
evaluating outcomes.
 – HRLA schemes would benefit from a development of current methodological 
advancements to help identify and assess short-, medium- and long-term intervention 
outcomes. In the long term, this would encourage the publication of promising outcomes 
and thus strengthen the HRLA evidence base.
 – There is a need to establish equity of outcomes between groups of different 
socioeconomic profiles.
 – There is a need to identify what enables long-term effects, i.e. regular low-cost ‘top-up’ 
interventions or multidimensional interventions with changes in approach over time.
 ■ Systematic reviewing in public health:
 – A greater engagement with realistic review or synthesis principles would allow exposure 
of contexts and mechanism components that influence a range of outcomes in HRLA 
interventions.
 – This review supports previously published commentaries on the necessity for the 
development of quality assessment tools that could allow increased methodological 
flexibility.
Funding
This study was funded by the Health Technology Assessment programme of the National 
Institute for Health Research.
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Chapter 1  
Introduction
This chapter discusses the background to the review and presents a brief history and scoping of the lay health advisor (LHA) role. It is complemented by a review of existing reviews in 
the field of health-related lifestyle advice (HRLA), presented in Appendix 1.
Background
Behaviour is recognised as a key determinant of health, with modifiable lifestyle behaviours, such 
as smoking, physical activity, unhealthy eating and excessive alcohol use, resulting in significant 
morbidity and mortality.1 There is a substantial knowledge base with respect to effective lifestyle 
intervention approaches. However, the successful translation of this into practice is a continuing 
challenge.2 The consequent individual and societal costs are considerable. These major health 
risks tend to be more prevalent among lower socioeconomic groups and, consequently, large 
sociodemographic differences exist in both experiences and expectations of health.3–6 With 
respect to the UK context, the Public Health White Paper Choosing health: making healthy choices 
easier sought to address this issue by taking action to encourage and enable individuals to make 
healthier choices, with a particular focus on those living in disadvantaged communities.7 It 
recognises the central importance of changing behaviour to improve population health and also 
builds on the vision of a ‘fully engaged scenario’, in which people take control of their own health 
and the wider determinants of ill health are addressed.8
Approaches to health-care provision are therefore changing in recognition that clinical and 
curative foci are unsustainable, inappropriate or insufficiently effective.9,10 Many Western health-
care systems are currently undergoing a shift from paternalistic to partnership models of care, 
with policy-makers, clinicians and consumers all seeking ways to promote increased involvement 
of patients and the wider public.11 There is therefore a movement in public health approaches 
‘from advice from on high to support from next door’ (p. 13).7 These shifts in policy require an 
expanded portfolio of public health interventions, including an expanded workforce continuum, 
in order to effectively address the health needs of both the general population and the most 
vulnerable groups in society.
The introduction of new roles or the expansion of existing roles to deliver HRLA or training 
represents one response to these developments. In the UK, NHS health trainers were introduced 
in the Public Health White Paper Choosing health,7 as one element of a wider workforce, offering 
a range of approaches to helping people change their behaviour in relation to their health. They 
are described as ‘people who are in touch with the realities of the lives of the people with whom 
they work and connected through a shared stake in improving the health of the communities that 
they live in’(p. 106)7 and ‘Offering practical support instead of preaching, and good connections 
into the advice and support available locally’ (p. 106).7 It is also recognised that a one-size-fits-all 
approach will not be appropriate, noting that ‘different neighbourhoods will need different types 
of health trainers’ (p. 106) and that different models of provision will be required to achieve best 
outcomes for different individuals and communities.
Versions of the health-related lifestyle advisor (LA) role represent a strategy that has been 
widely used to promote behaviour change and self-care across diverse conditions and 
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population groups.12,13 It is becoming increasingly important in health-care environments that 
are challenged by limited financial and human resources, enduring inequalities issues and 
expanding populations with chronic diseases.8,14,15 Much of the formal literature describing 
peer-based models comes from North America, where health promotion and disease prevention 
programmes that rely on LHAs have proliferated since the 1970s.16 Research has shown that 
people are more likely to hear and personalise messages, and thus to change their attitudes 
and behaviours, if they believe the messenger is similar to them.17 In addition, peer-based 
interventions can often be implemented economically, allow for direct involvement of clients and 
can result in long-term benefits for the peer educators themselves.18 Preliminary work conducted 
in relation to the implementation of health trainers in the NHS identified a range of models 
varying by degree of targeting and mode of delivery.19,20 However, it is not currently known what 
the effects of these various models are on health outcomes. It is therefore timely to bring together 
the available data on the impacts of HRLA or training to determine how effective the various 
approaches are. Drawing on both qualitative and quantitative research, this report synthesises 
the evidence on the component intervention techniques, effectiveness, cost-effectiveness, equity 
and acceptability of different versions of the health-related LA role in improving health and well-
being in the UK.
Terminology
The term ‘LHA’ belongs to a group of roles that have been given, over time, a range of titles, but 
which have some common principle of recruitment, purpose or operation. These include ‘natural 
helpers’,21 ‘peer educators’,22,23 ‘lay health advisors’,16 ‘lay volunteers’,24 ‘community health advisor’,2 
‘community health aides’,25 ‘peer counsellors’,26 ‘lay health volunteers’,27 ‘navigators’,24 ‘community 
health workers’,12 ‘health trainers’,7 ‘community guides’,28 ‘indigenous encouragers’,29 ‘buddy’30 
and ‘telecarer’.9 There does appear to be a consistent term ‘promotora’, used in Spanish-speaking 
communities. Summarising this diversity, Devilly et al.23 suggest that peer education constitutes 
an umbrella term covering a ‘range of different approaches including peer training, peer 
facilitation, peer counselling, peer modelling or peer helping’ (p. 221).23
The variety of language has been highlighted as an issue of note.12 There are, for example, 
consequences for clarity of role and expectations of impact. Opportunities for comparability of 
impact and effectiveness are also inhibited. With respect to this review the search strategy had to 
be particularly broad, utilising complex search strings. For clarity in this report, the intervention 
will be referred to as HRLA and the person delivering it as an LA.
History of the LA role
Accepting the LHA as an umbrella term, the role has a considerable history, more so in other 
parts of the world than in the UK, and with particular focus on certain health needs. For 
example, Earp and Flax16 report a 30-year history of the development and increased utilisation 
of the role in the USA with respect to health promotion and disease prevention programmes. 
Similarly, Bishop et al.21 report an increase during the 1990s in the development of links between 
communities and service providers through the training of indigenous community members.
The role of LA is more established in some fields, for example breastfeeding, sexual health, 
screening, chronic conditions/Expert Patients Programmes. Emerging roles are appearing, for 
example as exemplified in the development of the role for health improvement activities with 
offenders.23
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The development of the role has not been unproblematic and reference to the World Health 
Organization (WHO) report on community health workers (CHWs)12 provides an eight-item list 
of areas of potential weakness:
1. minimal policy and organisational commitment – vertical programmes, implemented with 
little professional interest, structural, political and economic factors neglected, lessons not 
learned from other sectors
2. poorly defined functions
3. poor selection
4. deficiencies in training and continuing education
5. lack of support and supervision
6. uncertain working conditions
7. undetermined cost and sources of finance
8. lack of monitoring and evaluation.
It seems reasonable to assume these issues may potentially apply to the LA role.
This brief review highlights that the LA role has had a precarious history and diversity of 
development that has not always benefited from rigorous evaluation.
Definitions and distinguishing features
As with role titles, there is also ambiguity with respect to role definitions. Significant debate has 
been devoted to attempting to clarify the role and what distinguishes it from other intervention 
approaches. Some definitions are offered here to both assist the process of distinguishing the role 
boundaries and characteristics and highlight the inherent challenges: ‘community members who 
work almost exclusively in community settings and who serve as connectors between health care 
consumers and providers to promote health among groups that have traditionally lacked access 
to adequate care’ (p. 1055);31 ‘members of the communities where they work, should be selected 
by the communities, should be answerable to the communities for their activities, should be 
supported by the health system but not necessarily a part of its organisation, and have a shorter 
training than professionals’ (p. 6);32 ‘CHW must be of the people they serve. They must live with 
them, work with them, rejoice with them, suffer with them, grieve with them and decide with 
them’ (p. 6).32
Being ‘of the community’ is recognised, however, as a complex issue. The WHO Study Group 
on strengthening CHW performance recognises that:12 ‘Community is not a homogeneous 
group – its members can have strong conflicts of interest. In this report, the word community is 
therefore used in the geographical sense of the population potentially served by a CHW; there is 
no assumption that such social groupings cooperate harmoniously in everyday affairs’ (p. 16).
Walt33 identifies that traditional definitions of the role are being challenged as new derivations 
emerge. She reports that until the 1980s CHWs were ‘people who were selected by the community, 
resident in the community and from the community’ (p. 3). These foundations are seen to be 
challenged, for example, when the degree of the relationship and the affiliations of the worker 
with the health-care system are strengthened or formalised, by issues of volunteer or financially 
remunerated worker, selection by the service provider rather than the service recipients. 
Transition from ‘community’ member to paid employee, as is the case for some LHAs, is an issue 
worthy of scrutiny. If, and how, this changes the individual’s and /or the communities’ perception 
of and relationship with the individual is open to debate.34 Braithwaite et al.,35 when exploring the 
experiences of community members who were involved in action research, found the transition 
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from community member or voluntary worker to a paid researcher to change the way that LHAs 
were perceived by community members.
In summary, the distinguishing features of belonging to a community are highly complex.36 At 
any one point in time, one LA individual may belong to several ‘communities’, such as gender, 
age, geography, religion and occupation, and the challenge arises with respect to which affiliation 
to prioritise, or which results in the most effective health improvement intervention.
As an alternative to a community affiliation as a distinguisher, it may helpful to refer to Ungar et 
al.’s37 discussion on the drivers for such role development in social care, which they identify as 
increased recognition of the value of indigenous knowledge (IK).
Indigenous knowledge can be broadly defined as the knowledge that an indigenous (local) 
community accumulates over generations of living in a particular environment.38 This definition 
encompasses all forms of knowledge – technologies, know-how skills, practices and beliefs – 
that enable the community to achieve stable livelihoods in their environment.38 A number of 
terms are used interchangeably to refer to the concept of IK, including ‘traditional knowledge’, 
‘indigenous technical knowledge’, ‘local knowledge’ and ‘indigenous knowledge system’.38
Indigenous knowledge is unique to every culture and society, and it is embedded in community 
practices, institutions, relationships and rituals.38
Indigenous knowledge is based on, and is deeply embedded in, local experience and historic 
reality, and is therefore unique to that specific culture; it also plays an important role in defining 
the identity of the community.38
Rationale for role/intervention
The LA role is generally used to achieve three broad aims: (1) access to communities or 
individuals who are in some way marginalised from the mainstream; (2) access from 
marginalised communities into the health and social care systems; and (3) alternative delivery 
mechanisms to professional provider. Varying degrees of detail and distinction on each of these 
aims have been reported, with the level of sophistication developing over time and role history.
Referring to the role of ‘indigenous helpers’, Reiff and Reissman39 identify two distinct role 
intentions: one they describe as ‘expediters or service agents’ and the other as ‘care aides or 
therapeutic agents’. Witmer et al.31 differentiate role rationale under four headings: increasing 
access to health care; improving quality of care; reducing costs of care; and broader social 
contributions.
With respect to the use of peer education as a health promotion intervention, Turner and 
Shepherd40 provide a list of 10 rationales:
1. More cost-effective.
2. Peers are credible.
3. Peer education is empowering.
4. Uses already established means of communication/information transfer.
5. People identify with peers and so peers are more successful than professionals.
6. Can act as positive role model.
7. Beneficial to those involved in providing it.
8. May be more acceptable than other education provider.
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9. Reaches those hard to reach through conventional methods.
10. Reinforcement of learning through ongoing contact.
In summary, the purpose and aims of the LA role are broad and varied.
Theoretical basis of health-related lifestyle advisor
The theoretical basis of LA interventions is another debated issue, and one for which there is 
inconsistent reference in the literature on the topic. Although potentially only a dimension 
of HRLA, Turner and Shepherd40 describe peer education as ‘a method in search of a theory 
rather than the application of theory to practice … Although located broadly within the field of 
social psychology, peer education does not appear to have its roots within a particular school of 
thought’ (p. 235).
Drawing on Turner and Shepherd’s40 work and a general review of the LA-type role, this report 
highlights a range of possible theoretical underpinnings: social network theory, social learning 
theory, self-efficacy theory, social inoculation theory, role theory, differential association theory, 
subcultures theories and communication of innovations theory.
Mechanism and models of intervention
As distinct from a theoretical basis, most reports of LA activity do make reference, even 
minimally, to mechanisms of intervention.
With respect to the lay health worker as a distinct intervention provider, the mechanisms may be 
grouped into three broad categories. One category is mechanisms that address embellishment of 
standard care, such as the provision of a ‘bridge’ between communities and service providers,33 a 
‘complement’ to formal systems,16 a ‘link’ between communities and organisations.41 Another is 
the provision of social network support for behaviour change messages and activity.42 Schulz et 
al.40 further differentiate support into affective support (caring, trust, love), informational support 
(advice, suggestions, information) and instrumental support (tangible aid and services). The 
third mechanism is style of information transmission, which can range from repeated message 
provision in several social contexts to individual one-to-one tailored message giving.42
With respect to models of provision, working alone or in partnership with another provider 
are two clear distinctions. For example, Nunez et al.43 report an approach that combines the 
knowledge of a nurse with an advocate’s understanding of the social reality of the community as a 
‘package’ of provision.
Challenges of evaluating public health interventions
The WHO12 endorses the effectiveness of CHWs by reporting: ‘They have achieved much in 
many countries at different times, but shortcomings of CHW programmes are often imputed to 
the CHWs themselves. However, this debate is a sterile one: there is no longer any question of 
whether CHWs can be key agents in improving health; the question is how their potential can be 
realized’ (p. 9).
These comments can potentially be applied to the more generic LA role. Evidence of effectiveness 
is not readily available and is hindered by acknowledged evaluation challenges for this type 
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of service provision. Twenty years ago, Walt33 described the methodological difficulties as 
‘enormous, further hindered by the financial resources required to conduct rigour evaluation 
designs and a limited service provision history’. This comment still applies, as the practical 
difficulties in measuring the impact of public health interventions remain unchanged. Indeed, 
public health interventions may need to adapt to local circumstances and needs, preventing 
tight control of the intervention:44 randomisation of community-based trials can be difficult45 
– possible contamination may preclude individual randomisation, and randomisation at 
community level may be beyond the resources of the trial46 – and measurement of lifestyle 
changes inevitably relies on self-reported data, as observation of health improvements at 
community level is rarely feasible given the size and duration of a typical study.47
The impact of lifestyle and behaviour changes in terms of health gains is often not manifest 
until old age.48 A measure of effectiveness almost inevitably necessitates extrapolation of health 
benefits from surrogate markers and measures of lifestyle changes. These benefits are dependent 
on the maintenance of lifestyle changes.49 Considerable literature is available in certain disease 
areas allowing estimates of the health gains from changes in behaviour. However, little evidence 
is available on the long-term maintenance of lifestyle/behaviour changes.50 Most of the available 
evidence comes from the smoking cessation literature, which suggests that 65%–75% of quitters 
at 1 month will relapse at 12 months.51,52 A further 35%–54% of those abstaining at 12 months 
will subsequently relapse.53,54
Further challenges in evaluating public health interventions arise from the complex nature of 
these interventions. Interventions aimed at changing lifestyles inevitably interact with the social 
environment in which they are delivered.55 The environment shapes and modifies the effect of the 
intervention.56 Subtle differences in social environment may have a significant modifying effect 
on the impact of the intervention.57 The intervention may also modify the social environment in 
terms of attitude towards health improvement and empowerment to make changes. While the 
impact of the intervention can be captured within the social environment studied, generalising 
the effects of the interventions to other contexts may not be possible. A thorough understanding 
of how the intervention works might be necessary before a judgement can be made on whether 
that intervention can be transferred to another context.58
The impact of the intervention on the social environment brings additional and unique 
challenges to public health evaluations. It requires consideration of the possibility of benefits (or 
harms) that extend well beyond the recipients. The impact of any particular intervention on the 
social values may be too small to detect.59 Nevertheless, it is clear that social norms and lifestyles 
can and do change. The decline in cardiovascular disease (CVD) across the Western world over 
the last 30–40 years60 is only partly a product of medical intervention – significant changes in 
diet have taken place.61,62 However, the impacts of health-promotion programmes on changes in 
attitudes to diet are difficult to quantify.
Unsurprisingly, then, ‘many LHA programmes are only minimally evaluated, if at all, and little 
published information is available about LHA evaluation strategies’ (p. 443).63 This situation is 
a consequence of the need for evaluation activities to not disturb the spontaneous and informal 
processes of natural helping, the difficulty in intermediate outcome measurement of unstructured 
roles and the generally modest evaluation budgets available to such interventions. Despite 
recent methodological developments in the public health and health improvement fields, these 
comments remain highly pertinent.
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Chapter 2  
Methods
Research question
This research aims to identify, describe, classify and analyse the range of models developed to 
date for delivering HRLA or training for effectiveness, mechanism of effect, cost-effectiveness, 
equity and acceptability in improving the health and well-being of individuals and communities, 
with particular reference to the reduction of inequalities in the UK. The proposed protocol is 
presented in Appendix 2.
Review question(s)
Typical of the complexity of public health issues, the question addressed in this systematic review 
is broad and multifaceted.64,65 The overall question was therefore broken down and grouped 
under two broad groupings:
1. What are the component intervention techniques of health-related LAs in the UK or similar 
contexts?
This includes content and mediation aspects, and reference to Davidson et al.66 provides detail of 
useful minimal intervention description.
 ■ Content What is the content of the intervention and how was it delivered? (e.g. oral 
communication, written material, etc.)
 ■ Provider The detailed role of the intervention deliverer.
 ■ Format What were the methods of intervention administration (e.g. self-help, telephone, 
individual, group, etc.)
 ■ Setting Where and when was the intervention delivered.
 ■ Intensity How many different patient contacts and how much oral contact time was 
involved?
 ■ Duration Over what time period were the intervention contacts conducted and how were 
they spaced?
 ■ Fidelity Was the intervention delivered as intended?
2. What are the outcomes of LA interventions? This includes moderation issues of for whom, and in 
what setting, effectiveness was achieved.
 ■ Are health-related LAs effective in improving health and well-being in the UK?
 ■ Are health-related LAs cost-effective in improving health and well-being in the UK?
 ■ Are health-related LAs equitable in improving health and well-being in the UK?
 ■ Are health-related LAs acceptable in improving health and well-being in the UK?
The concept of health-related LAs is multifaceted and, as such, represents a complex public 
health intervention. Hence, any assessment of the effectiveness and cost-effectiveness of the 
models identified needs to take into consideration the nature of this type of intervention and 
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FIGURE 1 Medical Research Council framework for the evaluation of complex interventions. RCT, randomised 
controlled trial.
requires multiple methods of enquiry. The review was therefore framed by a staged approach 
to intervention development, evaluation and implementation, as exemplified by the Medical 
Research Council (MRC) framework for the evaluation of complex interventions67 (Figure 1). The 
first phase of this review was therefore focused on problem definition and intervention modelling 
to facilitate development of classification of the various intervention dimensions developed by the 
research team (Appendix 3). There were three aspects to this phase: eliciting stakeholder views; 
secondary analysis of the National Survey of Health Trainer Activity;68 and a telephone survey of 
health trainer leads/coordinators.
1.  Eliciting stakeholder views The Project Advisory Group (PAG) (Appendix 4), recruited from 
different geographical locations, service, user and academic backgrounds and disciplines, 
was consulted on the key issues surrounding the role of health-related LAs to be taken into 
account when shaping, planning and executing the systematic review. The PAG membership 
was influenced by the Centre for Reviews and Dissemination (CRD)69 guidance to ensure 
breadth of representation to attempt to make certain that ‘the questions addressed are those 
of importance to decision makers’ (p. 159). Considerable debate was generated with respect 
to inclusion of health trainers as members of the PAG. The desirability was not in question, 
but rather the appropriateness of the request at such an early point in the establishment 
of the services. Advice was sought from local health trainer leads and co-ordinators, who 
consulted with health trainers. The consensus was that the relevant PAG members would 
liaise with the health trainers in their areas regarding project issues and be the conduit for 
bringing that information to the PAG meetings. This also allowed a wider representation 
of health trainer views than inviting a small number to join the PAG. As a result of the 
consultation with PAG members, the researchers were able to elicit perceptions of key issues 
relating to the LA role to help set the parameters for the systematic review phase of the study. 
This added depth of detail to the knowledge already held by the reviewers.
Theory
Pre-clinical
Explore relevant
theory to ensure
best choice of
intervention and
hypothesis and to
predict major
confounders and
strategic design
issues
Modelling
Phase I
Identify the
components of the
intervention, and the
underlying
mechanisms by
which they will
influence outcomes,
to provide evidence
that you can predict
how they relate to
and interact with
each other
Exploratory
trial
Phase II
Continuum of increasing evidence
Describe the
constant and
variable
components of
a replicable
intervention 
and a
feasible protocol for
comparing the
intervention with an
appropriate
alternative
Definitive
RCT
Phase III
Compare a
fully defined
intervention with
an appropriate
alternative using
a protocol that is
theoretically
defensible,
reproducible
and adequately
controlled, in a study
with appropriate
statistical power
Long-term
implementation
Phase IV
Determine whether
others can reliably
replicate your
intervention and
results in
uncontrolled
settings over the
long term
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2.  A secondary analysis of the National Audit of Health Trainer Activity Undertaken 
by Professor Susan Michie and colleagues at the Centre for Outcomes Research and 
Effectiveness (CORE), University College London (UCL). Data from the UCL audit were 
recoded, and questions were mapped against the primary classification sampling frame 
developed by the research team. These data were then analysed to identify key areas of 
importance for future discussion and sampling. However, owing to the limited number of 
data (many respondents to the original audit did not provide answers to each question – it 
was unclear in which instances missing data suggested the question was unanswered or the 
response was zero or not applicable) and the differences between the original audit data 
and the project’s sampling frame, there were too many missing data to progress with this 
approach. Accordingly, services were mapped on to the sampling frame in the three key areas 
in which the audit data were the strongest. These were:
i.  theoretical basis (how does the intervention work?) 48%–66% response rates
ii.  level of delivery (population, group/individual intervention) 65%–69% response rates
iii.  setting delivery (where the intervention takes place) 62% response rates.
These issues were agreed to be capable of providing an accurate sample of services through 
the country. Although data levels were not high enough to be mapped against each other 
to provide a complete picture of delivery, they were able to provide enough depth to select 
services reflecting a range of models for interview. These results, along with the PAG 
consultation, helped to shape the development of the analytical framework (found in 
Appendix 3) to be used in the evidence synthesis.
3.  Semi-structured telephone interviews with local health trainer leads/co-ordinators in 
England Conducted in order to refine the classification of intervention dimensions as 
identified in the analytical framework. Review of the literature, consultation with the PAG 
and reference to the national audit identified three key dimensions for mapping diversity of 
models of provision:
i.  setting of delivery community/health-care setting/client’s home
ii.  level of delivery formal to individual/closed group/general advice/support to members of 
the local community
iii.  techniques used use of formal behaviour change techniques.
Using a purposive sampling approach, the 113 respondents to the national health trainer 
audit67 were plotted against these dimensions and by region to enhance sample geographical 
diversity. Interviews (n = 18) were conducted with local project leads/co-ordinators (largely 
those with some involvement in local health trainer projects), until information saturation 
point was reached (an interview schedule is presented in Appendix 5). Although invitations 
to participate were positively received, recruitment was significantly hindered by multiple 
changes: in personnel change, organisation mergers and restructuring. Interviews were 
audio-recorded, with participants’ consent, and later transcribed verbatim. Analysis of 
transcripts was undertaken using the framework analysis method to verify the classification 
and modify it according to the findings. No additional keywords were identified to refine the 
search strategy for Phase II.
Therefore, at the conclusion of Phase I, original search terms defined were confirmed and the 
series of continuums used within the analytical framework developed were refined for use in 
Phase II of the study.
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Review protocol
The PICOS (Population, Interventions, Comparators, Outcomes and Study Designs) framework 
was used to break down the research question into search terms. The CRD69 identified a number 
of ways in which this framework may need to be adapted for use with public health interventions. 
A decision was made to focus the ‘P’ on the different versions of LA roles and the ‘I’ on their 
intervention modes. This was done to best answer the first group of the review questions, as 
detailed (p. 25). Petticrew and Roberts70 suggest that inclusion of a sixth criterion of context 
may be appropriate. Consideration of context is important to better understand if context is a 
contributor to outcome. However, as there were no contexts that would be excluded, context was 
not included in the review protocol at this stage, although context of delivery was noted in the 
data abstraction processes.
Population
The population dimension is shown in Table 1.
Reference to the literature identifies a wide variety of terms and roles that could potentially 
be regarded as a LA. For example, Eng et al.24 refer to ‘a continuum from natural helping to 
paraprofessional helping’. This breadth of role created considerable debate for the review team in 
defining the boundaries of the roles to be accepted under the LA title. The outcome was to adopt 
a wide and inclusive approach.
The population mediators of socioeconomic position, ethnicity, age and gender were taken into 
consideration to allow monitoring of any size or direction of any effects.
Interventions
The interventions dimension is shown in Table 2.
Again, the breadth of intervention activity coming under the umbrella title of LHA was 
the source of considerable debate for the review team. They are distinguished from clinical 
interventions, which are intended to prevent or treat illness in individuals.
TABLE 1 Population dimension of the PICOS framework
Include Exclude
Workplace advisors
Health champions
Health activists
LAs
Age Concern
Lifestyle coaches
Citizens Advice Bureau
Badged/rebadged health trainers
Expert patient trainers
Healthlink workers
Community parents
Community health educators
Countries: Western Europe, North America, Australia, New Zealand
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There is a wide continuum from very specific disease-focused, protocol-guided instruction at 
one end, to social support being available for use as determined by individual users. Again, the 
decision was taken to adopt a wide and inclusive approach. This did generate some consequences 
that are detailed further in the results section of this report, which hinge on distinguishing 
disease management from health improvement interventions.
Comparators
The comparators dimension is shown in Table 3.
Comparator issues are complicated by the fact that public health interventions tend not to be 
single, isolated interventions, but rather multifaceted interventions. Another complication, 
especially when focusing on interventions that are attempting to address health inequalities, is 
that the populations may also be simultaneously exposed to a range of area-based initiatives and 
complex packages of interventions. Comparators were relevant only in the context of a controlled 
study design.
Outcomes
The outcomes dimension is shown in Table 4.
Study designs
The study designs dimension is shown in Table 5.
As highlighted by Rychetnik et al.71 ‘public health interventions tend to be complex, 
programmatic and context dependent’. It follows therefore that ‘the evidence base for their 
effectiveness must be sufficiently comprehensive to encompass that complexity’ (p. 119). 
Although the traditional hierarchy of evidence is applicable to public health reviews, the CRD 
guidance69 recommends that a range of study designs may need to be included. Skewing of 
findings towards certain intervention types may result if only randomised controlled trials 
(RCTs) and controlled trials were included. A particularly pertinent issue in view of the limited 
number of RCT designs conducted in public health and, in particular, the field of the LA.
Review methods
A systematic review was carried out in accordance with the methods outlined in guidance 
issued by the CRD.69 Searches were performed to identify a broad range of literature on the 
health-related LA roles in improving health. Citations were downloaded into an endnote 
(version X.0.2) library. Two reviewers independently screened all titles and abstracts. Full paper 
manuscripts of any titles/abstracts that were considered relevant were obtained where possible. 
The relevance of each paper was assessed independently by two reviewers according to the 
inclusion criteria below. Any discrepancies were resolved by consensus and if necessary a third 
reviewer was consulted. The quality assessors were not masked.
TABLE 2 Interventions dimension of the PICOS framework
Include Exclude
HRLA or training delivered to patients or public in the UK or a sufficiently 
similar setting
Individual or groups of peers acting in advisory role, offering training, 
support or counselling (in person, telephone, online) focuses on 
delivering HRLA or training in terms of health improvement
Advice provided electronically or by mail, if iterative interaction
Advice/training interventions without explicit aim of health improvement
Advice/training related to acute care only
One-off advice-giving
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TABLE 5 Study design dimension of the PICOS framework
Include Exclude
RCT
Non-RCTs
Cohort studies
Case–study control
Interrupted time series
Ethnographic
Phenomenological
In-depth qualitative evaluations
Combined designs
Descriptions
Reviews
TABLE 3 Comparators dimension of the PICOS framework
Include Exclude
Standard care
Types of LA
TABLE 4 Outcomes dimension of the PICOS framework
Include Exclude
Physiological measures of general health:
 BP levels
 Cholesterol levels
Other measures of general health
Health behaviour:
 Smoking rates
 Breastfeeding rates
Health-care beliefs and knowledge:
 Self-efficacy to improve health
 Knowledge acquisition
 Self-reported competence
 Communication with health-care professionals
Health-care use:
 Uptake
 Rates of referral
Participation:
 Social role/activities
Cost-effectiveness
Other outcomes:
 Effects on relatives /carers
Adverse outcome (e.g. complaints)
BP, blood pressure.
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Seven search activities were undertaken:
1. searches of electronic databases
2. searches of the internet
3. suggestions from experts and those working in the field
4. searches of specific websites
5. reference lists of relevant studies
6. searches of the Science Citation Index (SCI) and Social Sciences Citation Index (SSCI)
7. hand searches of relevant journals.
Search strategy
Electronic databases
A range of electronic databases (Box 1) were searched for published and grey literature on the 
effectiveness and role of the health-related LA in improving health. These databases were chosen 
in order to reflect a broad social definition of health and the link to health inequalities. Obviously 
there is a wide range of other databases available to search that have not been included in this 
study due to the limitations of resources, which future similar studies may wish to consider. 
These include databases such as the Cochrane Database of Systematic Reviews (CDSR), The 
Campbell Library, Database of Promoting Health Effectiveness Reviews, Cochrane Controlled 
Trials Reports (CCTR) and Trials Register of Promoting Health Interventions.
Applied Social Sciences Index and Abstracts (ASSIA)
Article 1st
British Humanities Index
Cumulative Index to Nursing and Allied Health Literature (CINAHL)
EMBASE
Database of Abstracts and Reviews of Effects (DARE)
FRANCIS
NHS Economic Evaluation Database (NHS EED)
International Bibliography of the Social Sciences (IBSS)
MEDLINE
Public Affairs Information Services (PAIS)
PsycINFO
Science Citation Index (SCI)
SIRS Researcher
Social Sciences Citation Index (SSCI)
Social Services Abstracts
Sociological Abstracts
Web of Knowledge
WorldCat
Zetoc
BOX 1 Electronic databases searched
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Preliminary search strategy
Potential search terms were circulated among the team and the advisory group to develop a 
potential search string. Initial terms were derived from preliminary searches of the literature and 
previous research carried out in this area by members of the review team. They were limited to 
the following:
 ■ list one role label
 ■ list two study method
 ■ list three health improvement areas (based on the Choosing health priority areas7).
Following feedback, a string was confirmed and preliminary searches were carried out within the 
databases listed in Box 1:
(Health train$ OR lifestyle advi$ OR lifestyle train$ OR lay health worker OR lay health advis*r 
OR peer educ$ OR peer counsel$ OR peer support$ OR health activ$ OR health aide OR health 
advoc$ OR link worker OR community champion OR community health educ$ OR outreach 
worker)
and
(Evaluation OR effectiveness OR cost-effectiveness OR equity OR acceptability OR behaviour 
change OR health promotion OR health improvement OR disease prevention)
and
(Smoking OR physical activity OR diet OR overweight OR obesity OR alcohol OR breastfeeding 
OR sexual health)
Search strategy enhancement
Via access to the database host Ovid, the preliminary search strategy was used to identify a 
number of medical subject heading terms and Cumulative Index to Nursing and Allied Health 
Literature (CINAHL) headings that could develop the string further. These terms, along with 
others identified by the project team and advisory group (including those relating to health 
economics) and additional literature searches were then integrated into the preliminary search 
strategy when considered to be relevant. This created a more detailed search string that could 
be utilised more effectively on a variety of hosts. Also, to improve the accuracy of the results, an 
additional list of exclusions was added to the string as follows:
 ■ list one role label
 ■ list two health improvement areas/terms
 ■ list three study method/health economics terms
 ■ list four exclusions.
The string detailed in Box 2 was utilised to undertake the search.
Where multiple options were available, hosts that supported advanced Boolean operators were 
selected, and in each case the string was modified to best suit the functions available on the 
hosts. Individual search strategies were developed, where applicable, for each electronic database. 
Detailed search logs were maintained throughout. Searches were conducted from inception to 
September 2008, and no language restrictions were applied. The full search strategies for each 
database searched are presented in Appendix 6.
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Differences in terminology and definitions of terms made refinement of the strategy difficult. For 
example, lay health worker and CHW have similar meanings in different cultures. As discussed 
in the introduction, the term LHA belongs to a group of roles that, over time, have been given a 
range of titles, but which have some common principle of recruitment, purpose or operation. The 
problem of defining role and value, and translating these into a finite list of searchable keywords 
meant that a very broad strategy was required.
The following databases were searched for relevant studies: MEDLINE (via Ovid 1950 to week 4 
May 2008, 9 September 2008); CINAHL (via Ovid 1982 to September week 1 2008, 9 September 
2008); EMBASE (via Ovid 1980 to week 36 2008, 9 September 2008); ISI Web Of Knowledge 
[via Thomas Reuters (formerly ISI web of knowledge) no date restriction, 25 September 2008]; 
Applied Social Sciences Index and Abstracts (ASSIA) (via CSA Illumina no date restriction, 9 
September 2008); Social Services Abstracts (via CSA Illumina no date restriction, 9 September 
2008); Sociological Abstracts (via CSA Illumina no date restriction, 9 September 2008); British 
Humanities Index (via CSA Illumina no date restriction, 9 September 2008); PsycINFO 
[American Psychological Association (APA) PsychNet no date restriction, 12 September 2008]; 
FRANCIS (via OCLC FirstSearch no date restriction, 14 September 2008); SIRS Researcher (via 
OCLC FirstSearch no date restriction, 14 September 2008); WorldCat (via OCLC FirstSearch 
no date restriction, 14 September 2008); Article 1st (via OCLC FirstSearch no date restriction, 
14 September 2008); International Bibliography of the Social Sciences (IBSS) (via EBSCO no 
date restriction, 16 September 2008); Zetoc (via Mimas no date restriction, 16 September 2008); 
Web of Knowledge (via ISI no date restriction, 25 September 2008); NHS Economic Evaluation 
Database (NHS EED) (12 October 2008).
The number of results obtained for the various databases searched can be found in Table 6. Please 
note that two databases [MDX Health Digest (MDXHD) and Public Affairs Information Services 
(PAIS)] were unavailable to both Northumbria and Newcastle Universities and, therefore, were 
omitted from the final strategy. On completion of the database searches there were 19,203 
references, and the final total was 17,673 after duplicates were removed.
Searches of the internet
Searches were made by means of the Google search engine (www.google.com) using the search 
terms listed in Appendix 7. It is acknowledged that other Google search options, such as date, 
geographic location and file type, could have been used to narrow the results, but this was felt to 
be too exclusive, as it was important to capture as broad a range of results as possible.
The first 100 results returned by each search strategy were scanned for relevance and those judged 
to be potentially relevant were followed up. As only the first 100 results were to be examined, it 
was decided to break down the list of search terms into smaller search strings to avoid the danger 
that a long string would result in the first 100 results being relevant to only the first search term. 
(Health trainer OR lifestyle advi$/ train$ OR lay health worker/adviser OR peer educ$/counsel$/support$ OR 
health activator/activist OR health aide OR health advocate OR link worker OR community champion OR 
community health educator OR outreach worker) AND (evaluation OR effectiveness OR cost-effectiveness OR 
equity OR acceptability OR behaviour change OR health promotion/improvement OR disease prevention) OR 
searches for specific health-related behaviours: (smoking OR physical activity OR diet OR overweight/obesity 
OR alcohol OR breastfeeding OR sexual health)
BOX 2 Search string
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These were then combined with search terms on study methods or general outcome. The number 
of results returned for each search string can be found in Appendix 8.
Where health-related advice or training programmes were identified but no information on 
evaluation was available on the internet, attempts were made to contact programme organisers 
by e-mail in order to access any evaluation that has been performed. Where reference lists or 
bibliographies were identified through the searches, these were also examined for their relevance. 
A total of 15 documents/articles were identified through searches of the internet, included in the 
endnote database, and entered into the full text assessment stage
Suggestions from experts and those working in the field
Requests for assistance with accessing relevant literature were posted on the NHS Health Trainers’ 
Network discussion forum (www.networks.nhs.uk/forums/showthread.php?p=11#post11) and 
sent to relevant mailbases detailed in Box 3.
‘Experts’ – identified as such either by responses to postings, frequent publication in the area, or 
through personal contacts of the research team – were also contacted directly and asked for help 
with identifying relevant literature or providing further contacts. A total of 12 studies/documents 
were identified in this way.
TABLE 6 Results obtained for the databases searched
Databases searched Number of results
ASSIA 910
Article 1st 217
British Humanities Index 501
CINAHL 4823
EMBASE 4863
FRANCIS 101
NHS EED 181
IBSS 0
MDXHD N/A
MEDLINE 10,222
PAIS N/A
PsycINFO 617
SCI (part of Web of Science) 613
SIRS Researcher 2
SSCI (part of Web of Science) See above
Social Services Abstracts 768
Sociological Abstracts 501
Web of Knowledge 1359
WorldCat 745
Zetoc 232
Total (with duplicates removed by endnote) = 17,673 results
N/A, not available.
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Searches of specific websites
The websites below were searched on the dates shown, using the onsite search engines with single 
search terms: ‘health trainer’, ‘lay health worker’, ‘health trainer evaluation’, ‘lay health worker 
evaluation’, ‘health trainer effectiveness’, ‘lay health worker effectiveness’, ‘health improvement’, 
‘lay health worker health improvement’ and ‘health trainer health improvement’:
 ■ National Audit Office [www.nao.org.uk (accessed 16 October 2008)]
 ■ Home Office [www.homeoffice.gov.uk (accessed 16 October 2008)]
 ■ Office of the Deputy Prime Minister [www.odpm.gov.uk, now www.communities.gov.uk 
(accessed 16 October 2008)]
 ■ International Standard Randomised Controlled Trial Number (ISRCTN) Register [www.
controlled-trials.com/isrctn (accessed 16 October 2008)]
 ■ Joseph Rowntree Foundation [www.jrf.org.uk (accessed 16 October 2008)]
 ■ Department of Health [www.dh.gov.uk (accessed 16 October 2008)]
 ■ American Institutes for Research [www.air.org (accessed 17 October 2008)]
 ■ Office of Policy [www.ssa.gov/policy (accessed 17 October 2008)]
 ■ MRC [www.mrc.ac.uk (accessed 17 October 2008)]
 ■ Urban Institute [www.urban.org (accessed 17 October 2008)]
 ■ Wellcome Trust [www.wellcome.ac.uk (accessed 17 October 2008)].
Results of these searches produced a total of 5225 references. A breakdown of the search results 
for each website can be found in Appendix 9.
HEALTH-EQUITY-NETWORK@JISCMAIL.AC.UK
COMMUNITY-HEALTH@JISCMAIL.AC.UK
GP-UK@JISCMAIL.AC.UK
GPRD-RESEARCH@JISCMAIL.AC.UK
HEALTH-FOR-ALL@JISCMAIL.AC.UK
HEALTH-PROMOTION@JISCMAIL.AC.UK
HEALTH-SERVICES-RESEARCH@JISCMAIL.AC.UK
PUBLIC-HEALTH@JISCMAIL.AC.UK
PUBLIC-HEALTH-IN-TRUSTS@JISCMAIL.AC.UK
SOCIALWORK-HEALTHINEQUALITIES@JISCMAIL.AC.UK
EVIDENCE-BASED-HEALTH@JISCMAIL.AC.UK
HEALTH-SECTOR-DEVELOPMENT@JISCMAIL.AC.UK
HEALTHFUTURESUK@JISCMAIL.AC.UK
APIG@JISCMAIL.AC.UK
LEEDSPEERSUPERVISION@JISCMAIL.AC.UK
primarycarenursingresearchnetwork@yahoogroups.com
evidencenetwork.com
click4HP@yorku.ca
address_healthcare_disparities@list.ahrq.gov
health-disparities@lis.ahrq.gov
public-health@latrobe.edu.au
SDOH@yorku.ca
BOX 3 Relevant mailbases
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Reference lists of relevant studies
The reference lists of all studies assessed to be relevant were hand searched to identify additional 
studies that may be of relevance. Reference lists of previous reviews were also searched to ensure 
thoroughness. In total, five articles were identified as relevant studies and were included in the 
endnote database.
Searches of the SCI and SSCI
Citation searches of the SCI and SSCI were made in order to identify all citations of studies 
identified as relevant, and therefore to identify any further possible relevant studies. This was 
carried out as part of the above electronic database searches.
Hand searches of relevant journals
The contents pages of journals considered to be highly relevant (i.e. found to contain a significant 
number of relevant articles using the above methods) were scanned to identify additional relevant 
publications by a member of the research team. Any relevant articles were checked against the 
endnote database, and if not a duplicate they were included.
Search outcome summary
A total of two databases (MDXHD and PAIS) were unavailable to both Northumbria and 
Newcastle University and were therefore omitted from the final strategy, as the existing searches 
were deemed to have met an appropriate saturation point (i.e. many resources are duplicated 
within multiple hosts). All search results were merged and de-duplicated via endnote. The 
remaining duplicates were then removed manually by members of the project team and 
administrative staff. At this stage, the final database contained 22,898 references.
Study selection criteria and procedures
At the initial screening stage, titles and abstracts (where available) of studies that were identified 
using the above search strategies were scanned by two reviewers to make an initial assessment of 
relevance. If doubt concerning relevance remained at this stage, or no abstract was available, full 
reports were retrieved for review.
Abstracts and relevant articles were reviewed independently by two reviewers, based on the 
inclusion criteria and the specified outcomes of interest detailed in Box 4.
After reviewing abstracts or full reports, studies were excluded, based on the following criteria:
 ■ not based in Western Europe, North America, Australia and New Zealand
 ■ not an evaluative design
 ■ not solely health-related LAs
 ■ not adult health focused
 ■ poor methodological quality
 ■ not translatable.
Full details of excluded studies can be found in Appendix 10.
In cases when both an internal report and peer-reviewed paper on the same study were retrieved 
then both documents were scrutinised. If there were any discrepancies in results then those 
reported in peer-reviewed journals were favoured.
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Study quality assessment checklists and procedures
The quality of each paper was assessed independently by two reviewers, using the tools described 
below. Any discrepancies were resolved by consensus and, if necessary, a third reviewer was 
consulted.
With respect to quantitative studies, quality was assessed using the Quality Assessment Tool for 
Quantitative Studies, developed by the Effective Public Health Practice Project, ON, Canada72. 
The tool assesses the following quality criteria: selection bias, study design, confounders, 
blinding, data collection methods, withdrawals and dropouts, intervention integrity and 
statistical analyses. It is suitable to be used in systematic reviews of effectiveness, and can be used 
for RCTs, quasi-experimental studies and uncontrolled studies.73
Quality appraisal is a much discussed issue in relation to the role of qualitative research in 
systematic reviews.74 With respect to qualitative studies, the Critical Appraisal Skills Programme 
(CASP)75 checklist for qualitative research was used, a tool which is recommended for reviewers 
by the Cochrane Qualitative Research Methods Group.76 The checklist comprises 10 questions 
that are designed to help the reviewer to appraise the report of qualitative research by thinking 
systematically about the key issues of rigour, credibility and relevance.
Include
1. Those studies carrying out an evaluation of HRLA
2. Studies conducted in developed countries similar to the UK context, i.e. Western Europe, North America, 
Australia and New Zealand
3. Those looking at adult groups
4. Interventions with the explicit aim of health improvement, including community-based secondary prevention 
for chronic disease
5. Interventions that involve paid or voluntary work with an individual or group of peers acting in an advisory 
role, offering support in person, over the telephone or online
6. Advice delivered by post, online or electronically (only if this involves an iterative process of interaction 
between individual and advisor)
7. Training, support or counselling delivered to patients, communities or members of the public
Exclude
8. Purely descriptive material
9. Studies conducted outside of the specified areas
10. Those focusing solely on advice or training delivered to children or adolescents
11. Training, support or lifestyle advice that does not have health improvement as its primary aim
12. Services that do not involve some form of contact with a trained interventionist, e.g. self-care or the 
provision of information and advice via leaflets and audiovisual materials
13. Simple web-based information sources or online peer support groups
14. Training on HRLA delivered to professionals or service providers
BOX 4 Study selection criteria
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Data abstraction
A project-specific data abstraction tool modified from a tool developed by Adams et al.77 was 
used. The following information was extracted from studies investigating the health-related LA 
roles in improving health: bibliographic details, study characteristics, participant characteristics, 
intervention and setting, outcome and data results, time period, study design, methods of 
analysis, factors considered in the analysis, other contextual factors, role, costs and any other 
outcomes of interest. Data abstraction forms were piloted using a sample of included studies to 
ensure that all of the relevant information was captured and that resources were not wasted on 
extracting data that were not required. The consistency of the data extracted was also assessed 
to make sure that those extracting the data were interpreting in the same way the forms, draft 
instructions and decision rules about coding data. Data were extracted by one reviewer into 
an access database and checked by a second reviewer. Any disagreements were resolved by 
consensus by the researchers or, if required, a third member of the team was consulted. A record 
of corrections or amendments to data extraction forms was kept for future reference.
Data synthesis
Synthesis involves the collation, combination and summary of the findings of individual studies 
included in the systematic review. The synthesis of qualitative findings in systematic reviews 
is still a new and developing discipline. The Cochrane Qualitative Research Methods Group76 
acknowledges a need for methodological work on combining studies using different qualitative 
methods and data types. These were anticipated challenges to this review.
Less anticipated was the wide variety of LA models delivered in a wide variety of settings, 
targeting a variety of population groups, and assessed through disparate outcomes. This 
prevented the reviewers from engaging in establishing firm causal relationships between 
intervention mode and study outcomes (as would have been allowed through a meta-analysis). 
The options thus available to the reviewers were to conduct a narrative synthesis only (providing 
a descriptive of the interventions), and be confronted with the inconclusiveness of the evidence, 
or use elements of a realist model to produce a new, and more informative, assemblage of 
evidence.
Pawson78 makes the distinction between the causality models used in different synthesis 
approaches. Meta-analysis assumes a successionist causality, with comparison of net effects. 
Narrative reviews assume a configurational approach to causality, in which interventions 
components and strategies are aligned to produce the most favourable outcomes. Realist 
synthesis delves deeper into the intervention components and contexts, and assumes a generative 
approach to causation. This takes the stand that it is not interventions per se that bring about 
positive outcomes, but underlying mechanisms of action. Thus, while narrative synthesis 
identifies groups of programmes, realist synthesis examines groups of underlying mechanisms 
that might be common across a wide variety of interventions. In order to illustrate this, Figure 2 
represents an adaptation of the MRC framework for the evaluation of complex intervention to 
the synthesis of data for the same kind of interventions.
Pawson78 exposes the relative approaches of meta-analysis, narrative review and realist synthesis, 
and makes a case for theoretical development through realist synthesis. The protocol originally 
developed for this systematic review assumed the existence of a strength of evidence that would 
allow for a meta-analysis, complemented by exemplar development of successful interventions, 
through narrative synthesis.
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By convention, meta-analysis is designed to utilise results from several related studies (in terms of 
research hypotheses) by identifying a common measure of effect size that is modelled via meta-
regression. The resulting inferences are thus more credible than those obtained via individual 
studies. The only common factor of the studies included in this review, however, is the fact that 
they focus on interventions delivered by non-health professionals, and neither the outcomes 
under investigation nor the methods used are constant. While most of the studies reviewed 
adopted a quantitative methodology, primary outcome measures were of either the parametric or 
frequency variety, thereby rendering direct comparisons impossible. Thus it became apparent that 
the synthesis could not be fulfilled as originally proposed. The statistical treatment of the data 
available is explained below, before the final synthesis strategy is exposed.
Given the difficulties outlined above, the following strategies were undertaken when synthesising 
the data. Parametric data, for which effect sizes based on the means and standard deviations 
(SDs) have been supplied by the authors, are reproduced in the report. Where no effect sizes are 
given, and the authors have supplied baseline and follow-up mean scores for groups together with 
variances and sample sizes, approximate effect sizes have been calculated via differences in the 
means (baseline to follow-up), and by estimating the common SDs. Wherever possible, estimates 
for 95% confidence intervals (CIs) for effect size have also been calculated. Where variances 
are not provided by authors, effect sizes have not been calculated. In the case of frequency data, 
where odds ratios (ORs) [or relative risk (RR) estimates] are supplied then these are simply cited 
in the report, otherwise they are calculated (together with 95% CIs) from the stated proportions 
and sample sizes.
In some studies authors have applied multivariate methods to their data, usually resulting in ORs 
being supplied in terms of the relative effect on outcome of different covariates. Where this is the 
case, these are cited in the report together with 95% CIs (where provided).Where CIs based on 
multivariate models are not provided then these have not been estimated. In some cases authors 
have included baseline values in the model as covariates, either together with likely confounders 
FIGURE 2 Adaptation of the MRC framework to systematic reviews.
Theory
Pre-synthetic
Continuum of increasing evidence synthesis potential
Lack of
consensual
theoretical
underpinning,
interventions
strategies and
assessment
Modelling
Realist synthesis
Interrogation
of
intervention
components
and contextual
characteristics;
generates a
transferrable
theory
Evidence
building
Narrative synthesis
Preliminary
synthesis of
data from
qualitative and
quantitative
studies,
comparing
studies and
developing a
theory of how
the interventions
work, why and
for whom
Evidence
generation
Meta-analysis
Establishment of
evidence of
effectiveness
from quantitative
data from
theoretically
defensible and
reproducible
interventions,
tested in
adequately
controlled RCTs
with appropriate
statistical power
22 Methods
or individually. Unfortunately, resulting statistics are not always comprehensive, nor are effect 
sizes included.
Additional approaches drawing on the philosophical stance of realist synthesis71,79 were used, 
with the emphasis thus shifted from focusing solely on effectiveness and cost-effectiveness to 
providing a rich description of intervention environments, mechanisms of interventions and 
outcomes measured. Realist synthesis acknowledges that outcomes are the consequence of 
‘individuals, interpersonal relationships, institutions and infrastructures through which and 
in which the intervention is delivered’79 (p. 3). The relevance of this approach is supported 
with reference to Rychetnik et al.,71 who highlight that ‘public health interventions are rarely a 
standard package’ and ‘to assess transferability, information is needed on multiple components of 
an intervention’ (p. 120). This was supported by economic analysis and modelling.
Pawson78 makes the case for realist synthesis by exposing how it fills the gap between a firm 
establishment of causality generated by meta-analysis and the ‘configurational’ exploration of 
causality achieved by narrative synthesis. Using realist principles for the synthesis of studies 
selected through a stringent conventional process of quality assessment enables the surfacing 
of interventions contexts and mechanisms that would be likely to go unnoticed through other 
methods. Realist synthesis is much broader in its approach to selection of studies, and in that 
respect this synthesis falls short of adopting a ‘true’ realist approach. Realist synthesis indeed 
enables the identification of ‘families of mechanisms’,78 rather than ‘families of programmes’. 
This enables the present review to test out the LA idea in a variety of intervention formats 
(mechanisms) and settings (contexts) in order to build on existing theories of lay interventions 
developed in Phase I of this project. The integration of economic, narrative and realist approaches 
to synthesis, and how this strategy has been used to answer the review questions, is represented 
in Figure 3.
FIGURE 3 Integration of narrative, economic and realist synthesis strategies.
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As exposed earlier, the review question has been subdivided into two distinct foci: intervention 
components on one side and on their outcomes on the other. While the combination of narrative 
synthesis and economic analysis does answer both strands of the review questions to an extent, 
many of the intervention details would remain unexplored without an additional approach. 
The concurrent use of the three review strategies enables the production of a review with a 
clear and explicit audit trail of the different steps included. The narrative synthesis provides a 
detailed description of the included studies (qualitative and quantitative), and treats them as 
exemplar cases of LA interventions, with their outcomes classified rather conventionally by 
intervention focus and following the series of continuums developed in Phase I and presented 
in Appendix 3. The realist synthesis builds on this emerging theory, by delving into the 
inconsistencies presented by the studies included to refine and elaborate the theory of how, why 
and in which circumstances LA interventions are likely to produce successful outcomes. The 
two qualitative studies included in this review provided a richness of detail that was crucial in 
theory development. Within the limits of available evidence and methodological constraints 
further elaborated on p. 109, the combination of the three synthetic approaches enables the most 
efficient and meaningful management of data, in a way that both answers the review question and 
maximises the potential of the studies included.

© Queen’s Printer and Controller of HMSO 2011. All rights reserved.
25 Health Technology Assessment 2011; Vol. 15: No. 9DOI: 10.3310/hta15090
Chapter 3  
Results of the review
The results of the review are provided in three sections:
 ■ Section 1 Studies described by intervention focus.
 ■ Section 2 Studies described by their intervention’s context, mechanisms and measured 
outcomes.
 ■ Section 3 Cost-effectiveness analysis and modelling.
A flowchart showing the study selection process is shown in Figure 4.
Studies included in the review are listed in Table 7.
Each included study has been scanned for associated publications (i.e. same population, same 
intervention, different evaluation subset, for example).  For ease of reading in the rest of the 
report, included studies are referred to by the study ID, as presented in the first column. Thus, for 
example, Andersen 2000 refers to the three studies referenced in the second column of Table 7.
26 Results of the review
Titles identified and screened
n = 22,898
Full copies retrieved and
accessed for eligibility
n = 381
Publication meeting the
inclusion criteria
n = 269
Publication quality assessed
as strong/included in review
n = 26
Publication quality assessed
as weak/moderate
n = 243
Foreign language n = 2
Excluded n = 22,517 
Grey literature
n = 209
Google searches
(including online
reference lists)
n = 15
Studies identified from
contact with expert
n = 12
Relevant studies from
included review
n = 182
Unable to obtain/further
information required to
make assessment
n = 37
Excluded n = 282
Studies design/descriptive
material n = 113 (40.1%)
Review n = 24 (8.5%)
Age group (i.e. under 18 years
old) n = 25 (8.9%)
No health improvement as
primary aim n = 48 (17.0%)
Lack of trained interventionist
n = 7 (2.5%)
Basic information (i.e. online
support groups) n = 3 (1.1%)
Delivered by professional staff
n = 62 (22.0%)
FIGURE 4 Study selection process.
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TABLE 7 Included studies
Study ID and main 
publication reference Full referencesa
Anand 200780 Anand SS, Davis DA, Rashid A, Jacobs R, Xie C, Hill A, et al. A family-based intervention to promote healthy 
lifestyles in an aboriginal community in Canada. Can J Public Health 2007;98:447–5280
Andersen 200042,81,82 Andersen MR, Yasui Y, Meischke H, Kuniyuki A, Etzioni R, Urban N. The effectiveness of mammography 
promotion by volunteers in rural communities. Am J Prev Med 2000;18:199–20781
Andersen MR, Hager M, Su M, Urban N Analysis of the cost-effectiveness of mammography promotion by volunteers in 
rural communities. Health Educ Behav 2002;29:755–7082
Andersen MR, Hager M, Meischke H, Shaw C, Yasui Y, Urban N. Recruitment, retention, and activity of volunteers 
promoting mammography use in rural communities. Health Promot Prac 2000;1:341–5042
Barlow 200083 Barlow JH, Turner AP, Wright CC. A randomized controlled study of the Arthritis Management Programme in the 
UK Health Educ Res 2000;15:665–8083
Bird 199884–87 Bird JA, McPhee SJ, Ha NT, Le B, Davis T, Jenkins CNH. Opening pathways to cancer screening for Vietnamese-
American women: lay health workers hold a key. Prev Med 1998;27:821–984
McPhee SJ, Bird JA, Ha NT, Jenkins CNH, Fordham D, Le B. Pathways to early cancer detection for Vietnamese: Suc Khoe 
La Vang! (Health is Gold!). Health Educ Q 1996;23:S60–7585
McPhee SJ, Bird JA, Davis T, Ha NT, Jenkins CNH, Le B. Barriers to breast and cervical cancer screening among 
Vietnamese-American Women. Am J Prev Med 1997;13:205–1386
Bird JA, Otero-Sabogal R, Ha NT, McPhee SJ. Tailoring lay health worker interventions for diverse cultures: lessons 
learned from Vietnamese and Latina communities. Health Educ Q 1996;23:S104–2187
Dennis 200288 Dennis CL, Hodnett E, Gallop R, Chalmers B. The effect of peer support on breast- feeding duration among 
primiparous women: a randomised controlled trial. CMAJ 2002;166:21–888
Dickson-Gomez 
200389,90
Dickson-Gomez J, Knowlton A, Latkin C Hoppers and Oldheads: Qualitative Evaluation of a Volunteer AIDS 
Outreach Intervention. AIDS Behav 2003;7:303–1589
Latkin CA, Sherman S, Knowlton A. HIV prevention among drug users: outcome of a network-oriented peer outreach 
intervention. Health Psychol 2003;22:332–990
Dickson-Gomez 
200691,92
Dickson-Gomez J, Weeks M, Martinez M, Convey M. Times and places: process evaluation of a peer led HIV 
prevention intervention. Subst Use Misuse 2006;41:669–9091
Weeks MR, Dickson-Gomez J, Mosack Ke, Convey M, Martinez M, Clair S. The Risk Avoidance Partnership: training active 
drug users as peer health advocates. J Drug Issues 2006;36:541–7092
Earp 200216,63,93,94 Earp JA, Eng E, O’Malley M, Alpeter M, Rauscher G, Mayne L, et al. Increasing use of mammography among 
older, rural African-American women: results from a community trial. Am J Public Health 2002;92:432–5163
Earp JA, Viadro C, Vincus A, Alpeter M, Flax V, Mayne L, et al. Lay health advisors: a strategy for getting the word out 
about breast cancer. Health Educ Behav 1997;24:432–5193
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Section 1: StudieS deScribed by intervention focuS
In this section, studies are grouped by their intervention focus in chronic care, mental health, 
breastfeeding, smoking, diet and physical activity, screening and human immunodeficiency virus 
(HIV) infection prevention. The section begins with a summary table (Table 8) of studies’ design, 
setting and outcomes, as well as a brief statement about their intended aim.
For each intervention grouping, the series of intervention dimensions developed in the first phase 
of this review (see Appendix 3) was populated, and placed within a context-mechanism-outcome 
framework (see Box 5).
Description of studies
Study design
Context of intervention
Population focus
Location
Referral/recruitment
Mechanism of intervention
Intervention components
Theoretical underpinning
Aims
Origin
Approach
Topic focus
Main activities
Mode of delivery
Role/training
Practitioner type
Level of training
Skill level
Nature of role
Hours
Level of formality
Intensity of intervention
Frequency/hours/duration
Results from studies (outcomes)
Health status
Health behaviours
Participation
Health-care beliefs and knowledge
Health-care use
Costs
Discussion
BOX 5 Series of intervention dimensions
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Chronic care
 ■ Barlow 2000,83 Gary 2003,98–100 Griffiths 2005,101,102 Kennedy 2007,104–107 Lorig 1999,110 Lorig 
2003,111 Lujan 2007112 and Young 2005.121–123
Description of studies
Five of the studies reviewed here83,101,102,104–107,110,111 describe application of lay-led disease 
management programmes based on the chronic disease self-management programme developed 
by Kate Lorig in CA, USA.110 Two of the studies were undertaken by Lorig and coworkers in the 
USA, and the remaining three studies were UK based. Griffiths 2005101,102 specifically adapted the 
intervention to be culturally appropriate to the Bangladeshi community. Both Kennedy 2007104–107 
and Griffiths 2005101,102 are essentially pragmatic, with few recruitment restrictions. Barlow 
200083 describes a large trial of a programme specifically limited to arthritis. Lujan 2007112 targets 
Mexican Americans, most of whom speak Spanish as a first language.
Study design
Four high-quality RCTs examined a self-management programme targeting people with 
chronic conditions.101,102,104–107,110,111 One study focused on a disease-specific management 
programme (arthritis).83 Three studies examined the impact of LAs on the management of 
diabetes.98–100,112,121–123 The control group received no intervention and were placed on a waiting 
list for 4 months83,101,102,111 or 6 months.104–107,110 The control groups received usual care without a 
LA in Gary 2003,98–100 Lujan 2007112 and Young 2005.121–123 Gary 200398–100 had additional arms in 
their trial that examined usual care plus nurse case manager, which is not relevant to our review, 
and usual care plus nurse case manager plus LA, where the impact of the LA alone could not be 
determined. Patients were the unit of randomisation in all eight studies.
Only Barlow 200083 and Lorig 2003111 applied outcome measurements after the control group 
received the intervention, and only to the first intervention group in Barlow 2000.83 Lorig 2003111 
does not explicitly report the impact of the intervention on the control group, hence it is unclear 
whether the improvements in the intervention group were replicated in the controls when they 
received the intervention.
Context of intervention
Population focus
Four studies were UK based: three within the general population83,103–106,121–123 and one with the 
Bangladeshi community;101,102 four were US-based, with a population of people over 40,110 a 
Hispanic population,111 Catholic Mexican-American112 and African-American98–100 communities. 
In Gary 200398–100 the study took place in East Baltimore, a particularly deprived inner city 
community. A total of 629 people with any chronic condition were recruited in Kennedy 
2007;104–107 476 Bangladeshis with diabetes, CVD, respiratory disease or arthritis were recruited 
in Griffiths 2005;101,102 and 602 people with arthritis in Barlow 2000;83 1140 over-40s with a 
diagnosis of heart disease, lung disease, stroke or arthritis were recruited in Lorig 1999;110 and 
551 Hispanics in the northern California area, with heart disease, lung disease or type 2 diabetes 
(other diagnoses were allowed) were recruited in Lorig 2003.111 The three diabetes studies 
recruited 150,112 18698–100 and 591121–123 people with diabetes.
Location
The intervention was generally delivered in non-NHS community settings,104–107 in general 
practices or community centres,101,102 in community-based setting,83 such as churches, 
neighbourhood centres and clinics,110 in a faith-based community clinic with telephone 
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follow-up111 or in participants’ homes with additional telephone contact98–100 or by telephone 
alone.121–123
Referral/recruitment
Participants were recruited via general practitioner (GP) registers101,102 or people with self-
defined long-term conditions were recruited within Strategic Health Authorities (SHAs), 
using community-based recruitment strategies, including posters in GP surgeries and media 
advertisements.104–107 In Griffiths 2005,100,101 a further 14 volunteered after hearing about the 
programme by word of mouth or local media. Barlow 200083 recruited through Arthritis Care’s 
trainers, via the Arthritis Care Branch Network, information was placed in GP practices and 
rheumatology departments, and public service announcements were made in the local media. 
In Lorig 1999,110 subjects had to have a physician-confirmed diagnosis and were refereed using 
public service announcements in the mass media, flyers left in physicians’ offices, community 
clinics, posters at senior citizen centres, announcements in patient newsletters and from 
government employees. In Lorig 2003,111 community outreach to churches, community centres 
and clinics were used. Participants for the three diabetes studies were recruited via care providers: 
these were GP registers121–123 and a faith-based community clinic112 or medical chart review from 
two outpatient medical centres.98–100
Mechanism
Intervention components
Theoretical underpinning
Although three of the interventions are based on the same programme (Expert Patients 
Programme), the theoretical model underpinning it was described as incorporating or based on 
the Bandura’s theoretical model of self-efficacy, a sociocognitive theory124,125 in Griffiths 2005,100,101 
Lorig 1999,110 Lorig 2003111 and Barlow 2000,83 and social learning in Kennedy.104–107 Young 
2005121–123 based their intervention on the Stages of Change model. Lujan 2007112 used the middle 
range theory of community empowerment.126 Gary 200398–100 used the Precede–Proceed model.127 
The model incorporates critical constructs from adult learning, social support and behaviour 
modification theories, and takes account of predisposing, reinforcing and enabling factors.
Aims
Interventions in Kennedy 2007104–207 and Griffiths 2005101,102 aimed to increase self-efficacy in 
the participant’s management of their chronic conditions. In addition, Barlow 200083 sought to 
determine the effectiveness of a US-developed programme for a UK population. Lorig 1999110 
aimed to use a self-management programme to improve health behaviours and health status 
in a heterogeneous group of patients with chronic disease. Lorig 2003111 aimed to impact of 
self-management behaviours, symptoms, health status, health utilisation and self-efficacy. Gary 
2003,98–100 Lujan 2007112 and Young 2005121–123 aimed to improve glycaemic control in people 
with type 2 diabetes. This was done by improving knowledge of diabetes and promoting lifestyle 
management, treatment adherence and self-efficacy.
Origin
The original programme was developed by researchers at Stanford University, CA, USA, in 
collaboration with people with chronic conditions.110 The content was culturally adapted for 
the Bangladeshi community.101,102 Barlow 200083 draws on the Arthritis Self-Management 
Programme.128 In Lorig 2003111 the intervention was based on the English Chronic Disease 
Self-Management (CDSM125) programme and the Spanish Arthritis Self-Management Program, 
adapted for the Hispanic community. The intervention in Young 2005121–123 was based on local 
guidelines for the management of people with type 2 diabetes; these local guidelines were 
modelled on the National Institute for Health and Clinical Excellence (NICE) guidelines.129 The 
culturally specific 6-month intervention used in Lujan 2007112 was developed in collaboration 
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with clinic promotores and patients, and adhered to the American Diabetes Association 
curriculum guidelines (collaborative). The origin of the intervention in Gary 200398–100 was not 
specified; it is therefore reasonable to presume that it was developed by the authors.
Approach
Trainers act as role models and impart information on chronic condition management, as well 
as goal setting. All three diabetes interventions had information giving components, which were 
culturally adapted in Gary 200398–100 and Lujan 2007.112 The CHW in Gary 200398–100 offered 
appointment and visit scheduling, monitored behaviours, reinforced adherence to treatment 
recommendations, mobilised social support and provided physician feedback. Participants were 
also asked to prioritise their needs from a pre-established list of areas related to diabetes control, 
so that intervention could be tailored. Lujan 2007112 promoted health change through the use of 
linguistically and culturally adapted messages. In particular, the promotores were acknowledging 
and integrating the Mexican-American belief in divine fatalism and familialism into relevant 
interactions to improve health. In Young 2005121–123 the intervention consisted of a Pro-Active 
Call Centre treatment support, with regular telephone calls to patients, which aimed to support 
and guide them towards the best possible management of their diabetes. It also allowed referral 
to a diabetes nurse specialist if supplementary lifestyle counselling or medication adjustment was 
required.
Topic focus
In Barlow 2000,83 Griffiths 2005,101,102 Kennedy 2007,104–107 Lorig 1999110 and Lorig 2003111 the 
focus of the interventions was on management of chronic conditions. However, within this, 
general health topics, such as communication with health professionals, diet and exercise, were 
also addressed. In Gary 2003,98–100 Lujan 2007112  and Young 2005121–123 the primary focus was the 
management of diabetes. This included advice on drug treatments and lifestyle advice, such as 
exercise and diet. Depending on participants’ chosen priorities, other foci could include foot care, 
appointments or smoking cessation in Gary 2003.98–100
Main activities
The intervention included sessions on relaxation, diet, exercise, fatigue, breaking the ‘symptom 
cycle’, managing pain and medication, decision-making, communication, problem-solving and 
role-playing. In Lujan 2007112 great emphasis was put on using participants’ faith as a means to 
convey health-improving messages, and to reinforce the relationships between faith and diabetes 
self-management. The promotores also developed strong, family-like bonds with participants. 
In Young 2005,121–123 the call centre application covered four domains: gaps in knowledge (this 
included weight management, healthy eating, physical activity, stress management and smoking), 
readiness to change, medication adherence and blood glucose control.
Mode of delivery
The intervention was delivered to groups supported with videos101,102 course participant text 
book,83,110 illustrated leaflet and audiotape111 or with telephone follow-up.112 In Lujan 2007112 
participants were also mailed regular inspirational faith-based health behaviour change 
postcards. In Kennedy 2007104–107 the sessions were run using a ‘tightly scripted format’, and in 
Lorig 1999110 the lay leaders had a detailed teaching manual. Young 2005121–123 provided their 
intervention on a one-to-one basis solely by telephone. Gary 200398–100 provided the intervention 
on a one-to-one basis in participant’s homes in addition to telephone contact.
Role/training
Practitioner type
Barlow 2000,83 Griffiths 2005101,102 and Kennedy 2007104–107 used peers with common personal 
experience, i.e. they had a chronic condition, and in the case of Griffiths 2005101,102 these peers 
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were from a shared community, i.e. the Bangladeshi community. In Lorig 1999110 the lay leaders 
were volunteers, some of whom also had a chronic condition (71%): they ranged in age from 21 
to 80 years. In Lorig 2003111 most leaders had one or more chronic conditions. Lujan 2007112 used 
peers from a shared community, i.e. they were bilingual clinic employees. Gary 200398–100 and 
Young 2005121–123 used practitioners with no specific relationship with the community that they 
served (though the health advisor was described as ‘local’ in Gary 200398–100 it was not specified 
whether he or she is also of African-American origin). All the LAs in Young 2005120–122 were call 
centre operatives who were selected for their professional telephone manners.
Level of training
There was intensive technical training in Griffiths 2005.101,102 In Kennedy,104–107 the training was 
intensive and involved attendance at a standardised event, assessment of the delivery of two 
training courses in order to obtain accreditation, followed by observed practice at least once 
every 12–18 months and attendance at group supervision once a year. Barlow 200083 reports that 
the leaders are trained by Arthritis Care, but no details on content or duration are provided. In 
Lorig 1999,110 20 hours’ training with a detailed teaching manual was received. In Lorig 2003111 
lay leaders received 4 days’ training in the use of the programme protocol, including two practice 
teaching sessions, the final session being evaluated to allow progress to course teaching. Lujan 
2007112 and Young121–123 used intensive training for their practitioners: two promotores in Lujan et 
al.112 received 60 hours of training each, and the telecarers in Young 2005121–123 received 3 months 
of training. The level of training of the health advisor was not specified in Gary 2003.98–100
Skill level
Gary 2003,98–100 Griffiths 2005,101,102 Kennedy 2007,104–107 Lujan 2007112 and Young 2005121–123 used 
unqualified lay advisors. In Gary 200398–100 the health advisor was a local high school graduate 
with no formal training in health care before the study. Lorig 1999110 used volunteers with little 
previous experience in health education: 23% were health professionals and 15% were students. 
Lorig 2003111 and Barlow 200083 do not give details.
Nature of role
The tutors were paid £587.10 each to facilitate the 6-week course in Griffiths 2005.101,102 However, 
it was unclear whether the tutors were paid in Kennedy 2007104–107 as they were described as ‘lay 
trainers or volunteer tutors’. Barlow 200083 reports only that LAs delivered the programme in 
pairs, under the auspices of a voluntary organisation, Arthritis Care. In Lorig 1999110 volunteer 
lay leaders delivered courses in pairs, acted more as facilitators than as lecturers, and received 
a stipend of US$100 per leader per course of 15 participants. In Lorig 2003111 the lay leaders 
modelled for participants. All of the LAs were stated (or strongly implied) to be employed by the 
studies in Gary 2003,98–100 Lujan 2007112 and Young 2005.121–123
Hours
It was unclear in most studies whether the hours were full- or part-time. The health advisors 
worked part-time in Young 2005.121–123 It was implied that the advisor worked part-time in Gary 
200398–100 (was enrolled part-time at college).
Level of formality
The LAs in Griffiths 2005101,102 are stated to be accredited lay tutors, and those in Kennedy 
2007104–107 and Richardson et al.107 are stated to be subject to quality assurance. Barlow 200083 
reports that training was provided and the course delivered using a manual. Lorig 1999110 
documented their intervention in a detailed protocol in a ‘leaders’ manual’, and the content of the 
course has been published as Living a healthy life with chronic conditions.130 Lorig 2003111 does not 
provide details. None of the health advisor training schemes were accredited or examined in any 
way in Gary 2003,98–100 Lujan 2007112 and Young 2005.121–123
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Intensity of intervention
Frequency/hours/duration
Barlow 2000,83 Griffiths 2005,101,102 Kennedy 2007,104–107 Lorig 1999110 and Lorig 2003111 examined 
six sessions, which were delivered over 6 weeks. In Griffiths 2005101,102 the sessions lasted 3 hours 
(i.e. 18 hours over 6 weeks), in Kennedy 2007,104–107 they lasted 2.5 hours (i.e. 15 hours over 
6 weeks) and in Barlow 200083 approximately 2 hours (i.e. 12 hours over 6 weeks). In Lorig 2003111 
seven weekly 2.5-hour sessions were delivered (i.e. 17.5 over 7 weeks). Lujan 2007112 provided 
eight weekly 2-hour classes and telephone follow-up, so they provided approximately 16 hours 
over 8 weeks. In Young121–123 the intensity of the telephone contact was determined in relation 
to people’s blood sugar levels at baseline. These calls were performed once every 3 months if 
the glycated haemoglobin (HbA1c) level was ≤ 7%, every 7 weeks if HbA1c level was in the range 
7.1%–9%, and monthly if HbA1c level was > 9%. Each call lasted 20 minutes and was continued 
over 12 months. Thus they provided between 1 hour 10 minutes and 4 hours of telephone calls 
over 1 year. In Gary 200398–100 the health advisor conducted 45- to 60-minute home visits. Sixty-
two per cent of participants in the health advisor group received at least three visits and < 20% in 
the health advisor group received at least seven visits. Many participants (~50%) also received at 
least one telephone intervention (but the authors did not split this contact according to group). 
The intervention intensity was calculated on the basis of the number of visits that the authors 
were aiming to reach (six in 24 months) and was classified as low.
Results from studies
Unless stated otherwise, effect size is derived from Cohen’s d,131 which is defined as the difference 
between means divided by a common SD, and is in relation to between-group differences. Where 
feasible and appropriate, post hoc power has been calculated in relation to the studies reviewed, 
generally in relation to generic outcomes.
Health status
General health was measured by a single question in Kennedy 2007104–107 and did not change 
significantly. It was not measured in Griffiths 2005101,102 Neither study showed significant effect 
on health-related quality of life (HRQoL) as measured by the European Quality of Life-5 
Dimensions (EQ-5D) instrument.132,133 Psychological well-being was measured with five items 
in Kennedy 2007104–107 and improved significantly (effect size 0.25 cited by authors). The trial 
was powered to have a 90% probability of detecting a standardised effect size of 0.25, and, 
subsequently, the target sample size of n = 600 was exceeded by 4.8%. Depression and anxiety 
were measured using the Health Assessment Questionnaire [Hospital Anxiety and Depression 
Scale (HADS)]134 in Griffiths 2005,101,102 but neither changed significantly.
Pain was measured on a five-point Likert scale in Griffiths 2005101,102 and on a five-item 
questionnaire in Kennedy 2007.104–107 Neither measure changed significantly. In Gary 2003,98–100 
Lujan 2007112 and Young 2005121–123 energy significantly improved in the study group compared 
with controls (effect size 0.18, p = 0.004), but fatigue did not change significantly in Griffiths 
2005.101,102 Physiological measures and adverse events were not assessed in either study.
Gary 2003,98–100 Lujan 2007112 and Young 2005121–123 did not assess general health, QoL, 
psychological well-being, pain, fatigue or adverse events. However, in Young 2005121–123 > 90% of 
intervention participants agreed that the intervention improved their well-being.
Using self-administered mailed questionnaires, Lorig 1999110 reported significant improvement 
in treatment subjects compared with controls in five variables: self-rated health, disability, social/
role activities limitations, energy/fatigue and health distress (p < 0.02). Post-trial assessment of 
ability reveals 95% power to detect an effect size (Cohen’s d131) of 0.238, equivalent to detecting, 
for example, a difference in means between groups of 0.3 assuming a common SD of 1.26 and 
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a 0.05 (two-sided) significance level. No significant difference was demonstrated for pain or 
physical discomfort, shortness of breath or psychological well-being. Validated outcomes were 
used.135–140 Using the self-rated health item from the medical outcomes studies and visual numeric 
scales for pain and fatigue, Lorig 2003111 reported improvements in health status with usual care 
controls (p < 0.05). Post-trial power was 90% to detect a standardised mean difference of 0.279, 
implying an ability to detect a difference in means of, for example, 1.0, where the common SD is 
3.6 and a 0.05 (two-sided) significance level.
Barlow 200083 used validated measures, including Health Assessment Questionnaire141 HADS,134 
and Positive and Negative Affect Scale,142 and reported statistically significant mean decreases in 
fatigue (effect size 0.17), anxiety (effect size 0.21) and depression (effect size 0.27) and an increase 
in positive mood (effect size 0.29) when compared with the control group. No significant changes 
were reported in the control group. No statistically significant mean changes or between group 
differences were found on EQ-5D143 visual analogue scale measures. Power was predetermined at 
90% to detect an effect size (difference in means) of 0.35 between groups.
Gary 2003,98–100 Lujan 2007112 and Young 2005121–123 measured HbA1c levels, for which the 
reference range (that found in healthy persons) is about 4%–5.9%.144 Young 2005121–123 found a 
significant (p = 0.003) difference between groups of –0.31% HbA1c (95% CI –0.11 to 0.52) and 
effect size 0.25 (95% CI 0.07 to 0.43 with estimated pooled variance) at 1 year. The trial was 
powered to have a 90% probability of detecting a difference of 1% in HbA1c level, assuming a SD 
of 2% between groups. While there were no significant differences at the 3-month assessment, 
Lujan 2007111 found a significant difference of –0.25% HbA1c levels at 6 months (effect size 0.41, 
95% CI 0.08 to 0.73). However, there was a difference in the mean baseline HbA1c level between 
the intervention and control groups, the intervention mean being 0.45% higher. Levels of HbA1c 
increased markedly in the control group over 6 months (0.3%). It is generally accepted that HbA1c 
levels rise over time, but at a typical rate of 0.2% per year. Pretrial power was set at 90%, based on 
unspecified differences in HbA1c levels and Diabetes Knowledge Questionnaire scores.
Gary 200398–100 found a similar-sized difference between their groups at 2 years – –0.30% HbA1c 
(± 0.48%, insufficient information for an effect size calculation) – but this was not statistically 
significant. Gary 200398–100 measured other surrogate markers of cardiovascular health, such 
as low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol levels, 
triglycerides, systolic and diastolic blood pressure, and body mass index (BMI). Unfortunately, 
the absolute changes in outcomes are not reported in Gary 200398–100 only the difference between 
arms, making it difficult to assess whether the reported effects are due to decreases in the trial 
arms or increases in the controls. The reported changes in systolic and diastolic blood pressure, 
HDL and LDL cholesterol and triglycerides are mostly in a similar direction to the primary 
outcome measure, but are not significant. Neither a target difference nor a difference in power 
were specified; however, defining a clinically significant difference would seem to be the main 
issue in studies of this nature. That said, the authors claim that the observed difference of –0.8% 
between the collective treatment group and controls was clinically significant. Therefore, given 
the statistically non-significant p-value, one might conclude that the study may have been 
underpowered. Nonetheless, the study may prove useful and encouraging to anyone planning 
further work in this area.
Health behaviours
Self-care behaviour was assessed in Griffiths 2005101,102 using the Cognitive Symptom Self-
Management Scale from the Chronic Disease Self-Efficacy Scale145 and improved significantly 
(effect size 1.16, p = 0.047). The authors state that their study was 80% powered to detect 
‘... an effect size associated with improvements in behaviour, heath status and healthcare ...’ . 
Subsequent recruitment figures confirm that the trial was sufficiently powered to detect relatively 
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small effect sizes. Kennedy 2007104–107 measured exercise (six items) and diet (one item), neither 
of which changed significantly. Lorig 1999110 reported significant improvement in four behaviour 
variables (p < 0.01): number of minutes exercise per week of stretching/strengthening exercise 
and aerobic exercise, increased practice of cognitive symptom management and improved 
communication with physician. At 4-month comparison, Lorig 2003111 reported improvements in 
health behaviours compared with usual care controls (p < 0.05).
Barlow 200083 used scales developed by the Stanford Arthritis Centre145 and reported statistically 
significant mean increases in cognitive symptom management relative to controls (effect size 
0.46), communication with physician (effect size 0.24) and no mean change on dietary habit or 
fluid intake. No significant changes were found in the control group.
Gary 200398–100 measured dietary practices using a validated food frequency questionnaire 
designed to guide cholesterol reduction in low-income individuals;146 this did not change 
significantly between the groups. Physical activity was measured using a validated questionnaire 
about habitual physical activity during leisure time147 and this increased significantly in the CHW 
group and CHW/nurse case manager group compared with the control group, all p < 0.05 (mean 
change +0.26 ± 0.18 and +0.34 ± 0.18, respectively).
Participation
Kennedy 2007104–107 found that social role limitation (assessed with four items) improved 
significantly in the expert patient group (effect size 0.19). Griffiths 2005101,102 did not assess 
participation.
Health-care beliefs and knowledge
The primary outcome for Kennedy 2007104–107 was self-efficacy, which both studies claimed to 
improve significantly: and Griffiths 2005,101,102 effect size of 1.47; Kennedy 2007104–107 effect size 
of 0.44. Kennedy 2007104–107 found no significant differences in self-efficacy among groups with 
different chronic conditions. Griffiths 2005101,102 assessed communication with physicians using 
the communication strategies scale of the Chronic Disease Self-Efficacy Scale,144 but it did not 
change significantly. Kennedy 2007104–107 assessed partnership with clinicians (with four items), 
which improved significantly in the Expert Patients Programme group (effect size 0.25). Lorig 
2003111 assessed physician visits, which remained statistically unchanged. In Griffiths 2005,101,102 
51% of intervention participants attended three or more sessions, whereas 21% attended none. 
The attendance in Kennedy 2007104–107 was higher, with 60% attending four or more sessions. 
Neither Griffiths 2005101,102 nor Kennedy 2007104–107 measured any other aspects of health-
care beliefs and knowledge. At 4-month comparison, Lorig 2003111 reports improvements in 
self-efficacy compared with usual care controls (p < 0.05). Barlow 200083 used the Arthritis 
Self-Efficacy (ASE) Scale148 and reported statistically significant mean increases on ASE: other 
symptoms (effect size 0.43) and pain (effect size 0.41). Small, but statistically significant, increases 
in ASE pain score (effect size 0.14) were also found in the control group (unverified statistics).
Lujan 2007112 measured diabetes knowledge and health beliefs using validated questionnaires. 
The DKQ149 score mean change of the intervention group was significantly higher than that of 
the control group at the 6-month assessment, with effect size 0.63, 95% CI 0.29 to 0.97 (baselines 
of original adjusted for health insurance). With the diabetes health beliefs measure,150 a higher 
score indicates a higher belief in the ability to manage diabetes. The mean changes of the two 
groups decreased, without a significant difference at the 3-month assessment, the decrease 
was significantly less [F(1, 148) = 5.97, p < 0.01] for the intervention group than for the control 
group at the 6-month assessment. The consistent decrease in the diabetes health beliefs mean 
scores of both of the groups at the two points of assessment indicates that the participants did 
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not experience an increase in their belief about their ability to manage diabetes, although the 
intervention group demonstrated more knowledge.
In Gary 200398–100 it was expected that individuals would complete six intervention visits before 
the 2-year follow-up. Their actual participation fell far short of that goal, primarily because of 
insufficient staff support and participant non-compliance (although figures were not provided). 
Overall, more individuals were seen in the health advisor groups, which may be related to the 
fact that they saw the participants in the convenience of their homes. This may be a surrogate 
indicator of acceptability, which appears to be better in the health advisor group than in the usual 
care group.
In Lujan 2007112 96% of participants completed the classes (i.e. attended at least six of the eight 
classes) and the overall attrition rate was 6% (n = 9). Two of these nine participants also failed to 
complete the education phase of the intervention. One of the participants, who did not attend 
either the 3- or 6-month assessment interview, died from pneumonia, two moved to another 
city, and six reported that they were unable to attend the assessment interviews because of a 
lack of time. The very high attendance rate of the classes suggests that it was acceptable to most 
participants.
Young 2005121–123 noted that withdrawal from the study occurred in 10.7% of usual care subjects 
and 15.7% of telephone-support patients. This suggests that there may have been some negative 
issues regarding acceptability in the telephone-support group. They assessed satisfaction with 
treatment using the validated Diabetes Satisfaction and Treatment Questionnaire,151 and 
acceptability of the approach with a purposely designed self-completion questionnaire. Over 90% 
of participants found the intervention acceptable and agreed that it improved their knowledge 
and control of diabetes. However, only 50% of intervention participants would rather have this 
approach than seeing a health professional face to face. Participants generally described the 
development of strong bonds with the LAs, and liked the personalised format of the intervention. 
A total of 33% thought it had enhanced their self-knowledge and helped with changes in attitudes 
and behaviours.
Health-care use
There was no significant difference in health-care visits over 6 months in Kennedy 2007104–107 
or in primary care visits over the previous 3 months in Griffiths 2005.101,102 Kennedy 2007104–107 
also measured the number of counsellor visits, outpatient appointments, day-case appointments 
and inpatient days, none of which differed significantly between the two groups. Lorig 1999110 
reported that the treatment group had fewer hospitalisations (p < 0.05) and spent, on average, 0.8 
fewer nights in hospital (p = 0.01). There were no significant differences in visits to physicians 
(p = 0.11). At 4-month comparison, Lorig 2003111 reports no difference in days of hospitalisation, 
but the treatment group did show a trend to fewer physician visits. Barlow 200083 reports 
on number of physician visits where arthritis was discussed, but did not find any difference 
at 4 months between intervention and control groups. However, at 12 months they found 
significantly fewer mean number of visits to the GP, though these data were uncontrolled.
Costs
The delivery of the Expert Patients Programme cost £123 per participant in Griffiths 2005,101,102 
and £250 per participant in Kennedy 2007.104–107 Kennedy 2007104–107 found lower overall costs 
in the intervention arm that more than compensated for the estimated cost of the intervention 
(£250). This difference was driven by a marked (but not statistically significant) reduction in 
inpatient length of stay. The difference, 0.8 days, has a large impact on overall costs owing to the 
high cost of inpatient stays (cost of £203–486 applied). It is possible that this difference has arisen 
from a few patients with extended hospital stays.
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In Lorig 1999110 the treatment group reduced visits to physicians slightly more than control 
group but the difference was not significant. The decreases in the number of hospitalisations 
and in the number of nights of hospitalisation were significant (p < 0.05). Assuming a cost of 
US$1000 per day of hospitalisation, the 6-month health-care costs for each control participating 
were > US$820 for each treatment subject. The costs of providing the programme for treatment 
subjects who completed the 6 months were calculated to be US$70 per participant. This includes 
US$26 for training leaders. No costs are reported in Lorig 2003111 and Barlow 2000.83
Discussion
Five large, well-described and well-conducted studies evaluated the efficacy of lay-led disease 
management programme based on the Chronic Disease Self-Management Programme developed 
by Kate Lorig110 in California, USA. The studies did not affect general health or QoL, our review’s 
primary outcomes. However, three studies claimed a change in self-efficacy, as their primary 
outcome did change significantly in the groups in receipt of the programme. It is possible that 
in the longer term the impact of increased self-efficacy may have been to have a positive effect 
on general health and QoL at periods > 4–6 months’ follow-up. Lorig 1999110 and Barlow 200083 
also reported significant improvements in fatigue. Only 51% of the Bangladeshi participants in 
Griffiths 2005101,102 attended three or more sessions, compared with 60% of the general population 
in Kennedy 2007104–107 who attended four or more sessions. The relatively low rate of attendance 
in the Bangladeshi community may be suggested to be a surrogate marker of the intervention’s 
acceptability to this community. Although the intervention had been adapted for the Bangladeshi 
community there were social and spiritual barriers to attendance. Both studies were relatively 
cheap to implement (£123–£250 per participant). Barlow 2000,82 Lorig 1999110 and Lorig 2003111 
present relatively high completion rates, although the Lorig studies are particularly high, with 
68% completed at 4 months in Barlow 2000,83 83% at 6 months in Lorig 1999110 and 68% at 1 year 
in Lorig 2003.111 This may reflect the high acceptability of the interventions.
Gary 2003,98–100 Lujan 2007112 and Young 2005121–123 evaluated the effect of LAs without explicitly 
stated common experience on chronic care management in people with diabetes in the US or 
UK. The two US studies examined Mexican-American or African-American communities, but 
only in the Mexican-American study were the health advisors specified to be of that community. 
The three interventions all appeared to come from a biomedical perspective, and emphasised 
disease-specific knowledge as a way to improve condition management. However, because in the 
Gary 200398–100 study the participants were encouraged to set their own priorities (all being from 
a predetermined list), 77% of visits by the health advisor addressed needs outside the diabetes-
specific focus, such as social (family responsibilities), health insurance and non-diabetic health 
issues. None of the studies measured general health or QoL.
The three studies showed small reductions in overall blood sugar levels, which were significant 
in two of the three studies. However, it can be suggested that HbA1c level is a relatively easy 
outcome to measure, whereas outcomes that may have greater significance to patients, such as 
activity and participation, are harder to measure and, it can be suggested, harder to change. In 
the one study98–100 that assessed other physiological measures that act as surrogate markers of 
cardiovascular health or BMI none of the measures changed significantly in the health advisor 
group.
The health-care knowledge and belief findings in Lujan 2007112 highlight the danger in the 
assumption that a better level of knowledge will necessarily improve health-care beliefs. However, 
in this case participants in the intervention group did improve their blood sugar control as well 
as their knowledge, despite their beliefs score getting worse. There might be a particular message 
here about how health improvement messages can be delivered to populations for which divine 
fatalism is core to their faith.
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Smoking
 ■ Emmons 2005,26,97 May 2006,113 West 199830 and Woodruff 2002.120
Description of studies
Four studies were identified that examined the impact of LAs in smoking cessation. May 2006113 
was conducted following the positive results from West 199830 It was written up by the same 
authors, and describes the same intervention strategy, but in two different populations using 
different control strategies and in a larger and longer-scale study. Emmons 200526,97 examined a 
smoking cessation intervention for childhood cancer survivors. Woodruff 2002120 examined a 
culturally appropriate smoking intervention for Latinos.
Study design
Four high-quality RCTs examined the impact of LAs on smoking cessation. The control 
groups received no community health advisor input. The control groups’ interventions varied 
and included attendance at a nurse-led smokers’ clinic or group-based smoking cessation 
intervention, but without the additional buddy support,30,113 referral to a Spanish-language 
telephone helpline via two postcards mailed during the study,120 and a self-help intervention.26,97 
The smokers were the unit of randomisation.
Context of intervention
Population focus
Two studies26,97,120 were based in the USA, and two in the UK.30,113 West 199830 recruited 172 
smokers based in the general population; May 2006112 recruited 564 smokers from three sites 
across London, UK. Woodruff 2002120 recruited 313 smokers in the Latino community, and 
Emmons 200526,97 recruited 796 smokers who were childhood cancer survivors.
Location
The intervention was delivered in people’s homes via visits and telephone calls120 or telephone 
calls alone.26,30,97,113
Referral/recruitment
West 199830 recruited smokers from their GP records in south-east London. Participants in May 
2006112 were a subset of those participating in a larger RCT of glucose as an aid for smoking 
cessation. In this study, smokers were recruited through advertisements in local papers, word 
of mouth and GP referrals. Emmons 200526,97 recruited smokers from the Childhood Cancer 
Survivors Study152,153 register, and Woodruff 2002120 used 11 trained recruiters, who worked 
at community events, popular neighbourhood shopping centres, and within their own social 
networks, to identify Latino smokers.
Mechanism
Intervention components
Theoretical underpinning
West 199830 and May 2006113 did not describe any theoretical underpinning. Woodruff ’s 
intervention154 was based on social cognitive principles, including positive reinforcement, 
stimulus control, modelling, social support, problem-solving, and practical skills and techniques 
for quitting. Emmons’ 2005 intervention26,97 was based on theories of behaviour change, in 
particular, Social Cognitive Theory,154 the Transtheoretical Model,155 the Social–Ecological 
Model156 and on principles of motivational interviewing.157
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Aims
West 1998,30 May 2006113 and Woodruff 2002120 aimed to improve rates of smoking cessation. 
Emmons 200526,97 aimed to get cancer survivors to stop smoking, enhance self-efficacy and social 
support, increase knowledge about the health risks of smoking, reduce barriers to quitting, help 
participants to set goals and provide feedback regarding behaviour change.
Origin
Emmons 200526,97 followed recommendations in the clinical practice guidelines for Treating 
tobacco use and dependence.158 West 199830 based their intervention on a study that established 
the link between smoking cessation and social support.159 May 2006113 provides an evidence base 
as rationale for their study (West 199830 is one of the studies, as well as May et al.,113 May and 
West160 and Park et al.161). Woodruff 2002120 did not state the origins of their intervention.
Approach
West 199830 and May 2006113 used a buddy system where people attempting to stop smoking 
were paired up to support each other. Woodruff 2002120 and Emmons 200526,97 were mainly 
information-giving approaches with some support.
Topic focus
The focus of West 1998,30 May 2006113 and Emmons 200526,97 was solely smoking cessation. 
Woodruff 2002120 focused mainly on smoking cessation but the final home visit included a talk 
about overall lifestyle change (e.g. exercise).
Main activities
In West 1998,30 smokers allocated to the intervention group were organised into buddy pairs, 
introduced to each other a week before stopping smoking and encouraged to exchange telephone 
numbers. In addition, it was proposed that they hand in some money that would be given to 
charity if either they or their partner failed to last a week of abstinence, and would be returned 
to them otherwise. It was stressed that this was voluntary. They were invited to telephone or 
otherwise contact each other at least once a day over the next week and at any time that they 
needed support. They were scheduled to attend all further sessions together. The content of the 
buddy’s conversation was not specified in any way. Intervention components were the same in 
May 2006,113 with the exception that buddies were introduced to each other on their smoking 
cessation day, that money was left with the researcher, and that buddy pairs attended smoking 
cessation groups for a period of 6 weeks. Woodruff 2002120 provided culturally appropriate 
approaches to set the stage for maximising success of quitting. The promotora and participant 
reviewed past quit attempts, discussed the pros and cons of smoking and quitting, discussed 
self-monitoring to identify smoking patterns, identified potential reinforcements and substitute 
behaviours and discussed appropriate coping strategies, set a quit date, discussed experiences 
while quitting and relapse prevention, and talked about overall lifestyle change. In Emmons 
2005 26,97 the intervention emphasised the smoker’s choice, personal responsibility for change and 
enhancement of self-efficacy. The calls were tailored to the participants’ stage of readiness to quit 
smoking and interest in other health topics and goals. Nicotine replacement therapy (NRT) was 
discussed, and was made available without cost to the intervention group’s participants and their 
spouses/partners who indicated in the counselling calls that they were ready to make a serious 
quit attempt.
Mode of delivery
All of the interventions were delivered on a one-to-one basis. The support was delivered via 
telephone26,97 or face-to-face meetings in addition to telephone calls.30,113,120 The contacts were 
supported with videos and pamphlets120 and access to free NRT.26,97
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Role/training
Practitioner type
West 199830 and May 2006113 used peers with common personal experience (fellow smokers 
attempting to quit). Emmons 200526,97 also used peers with a common personal experience, but in 
this case the common experience was having survived childhood cancer, not smoking. Woodruff 
2002120 used peers from a shared community (Latino community).
Level of training
West 199830 and May 2006113 did not train the smoking buddies, but they received smoking 
cessation advice at the clinic (as did the control group). The level of training of the peers in 
Emmons 200526,97 was not stated. The Woodruff 2002120 promotores were trained for 25 hours in 
nine lessons over 5 weeks, but were not examined (intensive training).
Skill level
West 1998,30 May 2006113 and Woodruff 2002120 used unqualified lay trainers. The level of 
qualification of the counsellors in Emmons 200526,97 was not stated.
Nature of role
The smoking buddies in West 199830 and May 2006113 were unpaid, whereas the promotores in 
Woodruff 2002120 were paid a modest stipend and the peer counsellors in Emmons 200526,97 were 
salaried.
Hours
The smoking buddies in West 199830 and May 2006113 used their time freely, as and when they felt 
a telephone call was needed. It was unclear in Emmons 200526,97 whether the peer supporters were 
full- or part-time, and in Woodruff 2002120 advisors had different caseloads, depending on their 
availability.
Level of formality
West 199830 and May 2006113 were very informal (untrained peers), Emmons 200526,97 did not 
describe if training was provided, and Woodruff 2002120 provided training but competency 
afterwards was not assessed.
Intensity of intervention
Frequency/hours/duration
West 199829 had one 10-minute face-to-face meeting initially, and 85% of buddy smokers 
attending after 1 week’s abstinence reported speaking to their buddies at least once between 
clinic sessions (mean 2.5 times). At 4 weeks after quit date, 65% had spoken to their buddy 
since the last session (mean 2.4 times). The overall intensity was unclear but estimated as low. 
In May 2006,113 participants made an average of 2.7 telephone calls in the first week after the 
quit date. This dropped to 1.2, 1.1 and 0.7 over the following weeks, which was estimated as low 
intensity. Woodruff120 provided four home visits, each 1–2 hours long, as well as three telephone 
calls, typically 15–30 minutes long, over 78 days. So, between 4 hours 45 minutes and 9 hours 
30 minutes of support was provided over 3 months.
Emmons 200526,97 provided up to six counselling calls of unknown time over 7 months. Both 
authors report a mean of 3.5 contacts per participant.
Results from studies
Health status
No measures of health status were assessed in any of the studies.
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Health behaviours
Woodruff 2002120 found that attrition rates were significantly different by condition, with 4.5% 
of comparison group participants dropping out versus 15.4% of the intervention participants 
(χ2[1] = 10.47, p < 0.001) (effect size 0.18). Participation in the intervention varied from zero to 
seven sessions with an average of 3.44 sessions. In total, 24% of the control group reported using 
the smoking cessation helpline.
Emmons 200526,97 uses self-reported smoking status at 8 and 12 months; both West 199830 
and Woodruff 2002120 use expired air CO2 monitoring to verify self-reported abstinence, at 
1 month and 3 months, respectively. Significantly more remained abstinent from smoking in 
the buddy support group after 4 weeks [15% difference, effect size 2.79 (95% CI 1.26 to 6.22)] in 
West 199830 but not in May 2006113 (adjusted OR 1.16, 95% CI 0.76 to 1.78). Woodruff 2002120 
reports that 20.3% of the intervention group had quit at 3 months compared with 8.7% of the 
comparison group, the comparison group being a statistically significant 2.5 times more likely 
than the intervention group to be smoking at the 3-month assessment after adjusting for gender 
and amount smoked per day at baseline. However, these results are based on a per-protocol 
analysis that ignores differential attrition in the intervention arm. Applying a more conservative 
intention-to-treat analysis, and assuming that all of those lost to follow-up have relapsed, gives 
a quit rate of 17.3% in the intervention group and 8.3% in the control group. Emmons 200526,97 
reported that the quit rate was significantly higher in the peer counselling group than the control 
group (16.8% vs 8.5%, p < 0.0003) at 8 months. This difference was maintained at the 12-month 
follow-up (15% vs 9%, p < 0.01). Controlling for baseline self-efficacy and depression, the peer 
counselling group was more likely to quit smoking by the 12-month follow-up compared with the 
control group (12-month OR 1.99, 95% CI 1.27 to 3.14). Post hoc power for this trial was around 
87% for a difference of 8.5% (quit rate) between groups, albeit that power to detect differences in 
proportions was dependent on the location of the difference.
Participation
None of the studies assessed any measures of participation.
Health-care beliefs and knowledge
Emmons 200526,97 reported that 74% of the control participants responded that they had 
indeed received the self-help smoking cessation materials. Of that group, 67% reported having 
read either a lot, or all, of the materials sent; 56% of participants reported that they found the 
materials to be somewhat useful, and 21% reported that they were very useful. As expected, recall 
of receipt and rates of use of the materials were higher among the peer-counselled intervention 
group participants (95% reported receiving the materials, 79% reported reading a lot or all of the 
materials).
None of the studies reported any other measures of health-care beliefs and knowledge.
Health-care use
West 199830 and Emmons 200526,97 reported the rates of use of NRT. There was no significant 
difference in the use of NRT in the two groups in West 1998,29 with about 50% of both groups 
using it. Emmons 200526,97 reported that at the 8-month follow-up, 33% of participants in 
the peer-support condition reported that they had used NRT during the previous 6 months, 
compared with 8% of the control (self-help) participants. At the 12-month follow-up, 16% of the 
provider counselling participants indicated that they had used NRT in the previous 4 months 
compared with 6% of self-help participants. No significance values were given. A total of 14% of 
those in the self-help group who used NRT reported that they had quit compared with 26% of 
the peer counselling group, although this difference did not reach significance using intention-to-
treat analyses.
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Emmons 200526,97 does not appear to have recorded NRT use in the control group for the first 
2 months of the trial, and this oversight may explain why there is no attempt to adjust for it in the 
results. NRT has well-established effectiveness data with an OR for the patches of 1.67. There is 
no mention of NRT in Woodruff 2002,120 and it does not appear to form a planned constituent of 
the intervention.
None of the studies showed any other data for health-care use.
Costs
No costs were given in West 1998,30 May 2006113 or Woodruff 2002.120 Emmons 200526,97 stated 
that the total intervention delivery cost per person was US$298.17 for the peer counselling 
group and US$1.25 for the self-help group. Therefore, the incremental cost-effectiveness of the 
peer counsellor (PC) condition compared with the self-help (SH) control [(costpc – costsh)/(quit 
ratePC – quit rateSH)] was US$5371 per additional quit at 12 months.
Discussion
These well-described and -conducted studies evaluated the efficacy of the community LAs for 
smoking cessation in two communities in the USA (Latinos and childhood cancer survivors) and 
two studies in the UK (general population). The studies did not measure if LHAs had any effect 
in general health or QoL, our review’s primary outcomes. Three studies claimed an improved rate 
on smoking cessation as their primary outcome, which did change significantly in the groups 
in receipt of the LA intervention.26,29,96,119 May 2006113 reported no such intervention effect. The 
authors suggest that this may be due to the fact that the level of social support provided by the 
smoking cessation groups may have limited the possibility for any additional effect to be observed 
in the buddy intervention arm. No assessments of improvements in knowledge of the effect of 
smoking on health or smoking cessation strategies were measured, despite these being the main 
component of the information given in the interventions. However, Emmons 200526,97 reported 
that most participants found the written material useful or very useful. Rates of participation 
and attrition can be used as surrogate markers for the acceptability of a programme. Woodruff120 
showed that attrition from the study was three times higher in the peer support group. NRT was 
used in West 199830 and Emmons 2005,26,97 but West 199830 found no differences in the rate of 
use between the groups, and Emmons 200526,97 did not report the statistical significance of the 
difference they found. NRT was used with a proportion of participants in May 2006113 but the 
authors do not report on any differential outcome.
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Breastfeeding
 ■ Dennis 2002,88 and Morrow 1999.114,115
Description of studies
Two studies were identified which examined interventions to promote breastfeeding. Morrow 
1999114,115 examined the effect on exclusive breastfeeding and Dennis 200288 on breastfeeding 
duration.
Study design
Two high-quality RCTs examined the efficacy of peer support on exclusive breastfeeding and 
breastfeeding duration.88,114,115 Morrow 1999114,115 examined differing counselling frequencies: 
three and six visits. The control groups received conventional care, i.e. no peer support. Both 
groups followed the mothers for 3 months87 or 6 months post partum.113,114 Patients were the unit 
of randomisation in both studies.
Context of the intervention
Population focus
The studies were based in semiurban settings in North America: Mexico City, Mexico114,115 and 
Toronto, ON, Canada.88 Morrow 1999114,115 recruited 130 pregnant women, whereas Dennis 200288 
recruited 258 primiparous breastfeeding mothers.
Location
The interventions were delivered in mothers’ homes by home visits 114,115 or via telephone.88
Referral/recruitment
Study mothers were identified in Morrow 1999114,115 by a semiannual door-to-door census and 
continuous reporting of new pregnancies in the community by study staff and mothers. Eligible 
mothers were identified within two community hospitals for the Dennis 200288 study.
Mechanism
Intervention components
Theoretical underpinning
None stated in either study.
Aims
The studies aimed to promote exclusive breastfeeding114,115 and to increase breastfeeding duration 
and increase satisfaction with the breastfeeding experience.88
Origin
The interventions used were culturally-adapted materials from the La Leche League, a mother-
to-mother support organisation,114,115 and a 43-page handbook developed in conjunction with 
an existing volunteer breastfeeding organisation.88 This organisation was established in 1993, 
originally in conjunction with the local regional health department.
Approach
Peers imparted information on breastfeeding and supported mothers.
Topic focus
Unsurprisingly, the focus of these two studies was exclusively breastfeeding.
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Main activities
Both the interventions emphasised the benefits of breastfeeding, provided general breastfeeding 
information and dispelled myths. Morrow 1999114,115 also provided information on preparation for 
birth and emphasised the importance of exclusive breastfeeding. They also included counselling 
to key family members to support the mothers.
Mode of delivery
Morrow 1999114,115 delivered the intervention face to face in the mother’s home supported by a 
culturally adapted set of visual aids. Dennis 200288 provided the intervention via telephone.
Role/training
Practitioner type
Morrow 1999114,115 used peers from a shared community, some of whom had the common 
personal experience of breastfeeding. Dennis 200288 exclusively used peers with common 
personal experience of breastfeeding.
Level of training
The level of training varied significantly between the two studies. Morrow 1999114,115 trained their 
advisors for over 2 months, whereas Dennis 200288 trained their advisors for just 2.5 hours.
Skill level
Both studies used unqualified lay tutors.
Nature of role
The advisors in Morrow 1999114,115 had previously worked as field data collectors, so it is implied 
that they were paid. The advisors in Dennis 200288 were volunteers, i.e. unpaid.
Hours
It is unclear in Morrow 1999114,115 whether the lay advisors were full- or part-time, and in Dennis 
200288 they were part-time (i.e. involved for the duration of the phone calls).
Intensity of intervention
Frequency/hours/duration
The lay advisors in Morrow 1999114,115 delivered three sessions (one late pregnancy and two by 
2 weeks post partum) or six sessions (two in mid to late pregnancy and four by 8 weeks post 
partum). The length of time of these sessions was not stated, so the overall intensity cannot be 
calculated. Lay advisors in Dennis 200288 were able to provide as much contact as they deemed 
necessary to support the mother, and logs were kept of this contact, which was on average five 
16.2-minute telephone calls to the mother, i.e. 81 minutes over the 3 months of the intervention.
Results from studies
Health status
Neither study assessed any measure of health status of the mothers. Morrow 1999114,115 measured 
rates of diarrhoea in infants 0–3 months of age, which was reduced significantly in the supported 
group (RR = 0.47, i.e. the probability of a baby in the intervention group having diarrhoea is 0.47 
that of the control group, or less than a half.)
Health behaviours
Dennis 200288 and Morrow 1999114,115 reported that their intervention groups were significantly 
more likely to be breastfeeding at 3 months [Morrow 1999114,115 exclusive breastfeeding only 
(RR = 1.11); Dennis 200288 all breastfeeding, (p = 0.01) RR = 1.21] but this effect was not observed 
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at 3 months when it was measured in Morrow 1999.114,115 Dennis 200288 also noted that the rates 
of exclusive breastfeeding were significantly higher in the intervention group up to 3 months 
post partum (p = 0.01, RR = 1.21). Morrow 1999114,115 also provides details of the differential 
responses in breastfeeding outcomes to peer counselling, finding that multiparous women and 
those with uncertainty about infant feeding plans were more likely to respond to peer counselling 
by initiating breastfeeding. It was also demonstrated that peer counselling had the ability to 
counteract the negative effects of early supplementation on breastfeeding among the subgroup of 
breastfeeding mothers who have introduced formula within the first day post partum. The study 
by Morrow 1999114,115 was powered on a hypothesised difference between a combined intervention 
group (three and six visits) and a control group; however, results are also reported in relation 
to differences between the three groups. Post hoc power was 95% in relation to the observed 
difference of 20% between the combined study group and controls. Dennis 200287 powered their 
study at 90% to detect a difference of 20% located at 60% and 80%; post hoc recruitment figures 
confirmed power at 90%.
Neither study assessed any other measure of health behaviour.
Participation
Neither study assessed any measure of participation.
Health-care beliefs and knowledge
Dennis 200288 found no significant difference in mean satisfaction scores between the two groups 
on maternal satisfaction, but significantly fewer mothers in the intervention group reported 
dissatisfaction [RR (intervention vs control) = 0.63, 1.5% vs 10.5%, p = 0.02]. Significantly fewer 
mothers in the peer support group in Dennis 200288 indicated that they would breastfeed their 
next infant differently (RR = 0.68, 23% vs 34%, p = 0.05). Morrow 1999114,115 stated that nearly all 
(98%) intervention group mothers reported that the peer counsellor was helpful and supportive. 
In Dennis 200288 three mothers indicated dissatisfaction with the peer support, most indicating 
a preference for a higher frequency of contact. However, a few mothers responded that they 
did not like a specific aspect of their peer volunteer. For example, only one mother requested 
to discontinue her participation in the intervention, stating that the peer volunteer frightened 
her about the potential hazards of not breastfeeding. The peer volunteer’s comments made her 
anxious and diminished her feelings of confidence, despite the fact that breastfeeding was going 
well. Another mother felt her right to confidentiality was violated when her peer volunteer 
contacted the public health department without her consent. Although this mother did require 
professional assistance, the peer volunteer should have discussed the referral with the new 
mother. Neither study assessed any other measure of health-care beliefs or knowledge.
Health-care use
Morrow 1999114,115 noted the number of visits to the doctor due to infant diarrhoea but did not 
compare between the two groups. Dennis 200288 reported on health service utilisation but in a 
format inaccessible to the reviewers in the timescale available.
Costs
Neither study assessed any measure of costs.
Discussion
These medium-sized, well-described and well-conducted studies evaluated the efficacy of HRLA 
for breastfeeding in two semiurban communities in North America (Mexico City, Mexico and 
Toronto, ON, Canada). The studies did not assess measures of general health or QoL, our review’s 
primary outcomes. However, both studies claimed a change in rates of breastfeeding as their 
primary outcome that did change significantly in the groups in receipt of peer support. The 
© Queen’s Printer and Controller of HMSO 2011. All rights reserved.
49 Health Technology Assessment 2011; Vol. 15: No. 9DOI: 10.3310/hta15090
positive effects on mother’s health of breastfeeding are very long term and so would be hard to 
measure in these sorts of studies. However, Morrow et al.114,115 did measure the rates of diarrhoea 
in the baby’s first 3 months and found significantly lowered rates in the children of mothers in 
the peer support group. Both studies showed high rates of satisfaction with the programmes, but 
some complaints reported in Dennis 200288 show that appropriate training of peer counsellors is 
essential. Neither study gave any indication of the costs of the interventions.
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Mental health
 ■ Ireys 2001.103
Description of study
Only one study was identified that addressed mental health issues, in mothers of children with 
chronic conditions.
Study design
One high-quality RCT examined the impact of a support intervention for families of children 
with selected chronic diseases.103 The control group received a ‘low dose’ of the intervention, as 
they were given a telephone number through which they could reach an experienced parent, who 
had received no training and who did not initiate any telephone calls. Fewer than 3% of mothers 
in the control group called the number. Families were the unit of randomisation.
Context of intervention
Population focus
The study was based in the USA and recruited 161 mothers whose children aged 7–11 years had 
been diagnosed as having diabetes, sickle cell anaemia, cystic fibrosis or moderate-to-severe 
asthma, living within a 80-km range of Baltimore, MD, USA.
Location
The intervention for this study was delivered in participants’ homes or in nearby coffee shops if 
requested, as well as in the community (for events organised, such as bowling parties or small 
group lunches).
Referral/ recruitment
Participants were identified by 11 specialty clinics and five general paediatric clinics.
Mechanism of intervention
Intervention components
Theoretical underpinning
The theoretical underpinning is not stated.
Aims
The intervention aimed to enhance the mental health of mothers of children with selected 
chronic diseases.
Origin
The programme described in Ireys 2001103 incorporated elements from previous studies.162–165
Approach
Lifestyle advisors provided informational support, linking families with existing health and 
community resources, and gave information on child behaviour, parenting; and coping; 
affirmational support by enhancing a mother’s confidence in parenting; and emotional support 
through listening, and demonstrating interest and an empathic understanding.
Topic focus
The focus of the intervention was on mental health, particularly anxiety and depression.
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Main activities
Throughout, the intervention identified examples of naturally occurring sources of support, 
pointed out examples of effective parenting by the mother and discussed opportunities for 
strengthening these sources of support and existing parenting skills.
Mode of delivery
The intervention consisted of visits to the families’ homes, or coffee shops if requested, biweekly 
telephone contacts and the organisation of events, such as bowling parties or small group 
lunches, which would allow programme parents to meet one another.
Role/training
Practitioner type
The study used peers with a common personal experience, i.e. they were mothers who have 
children with chronic conditions. Where possible, they were also in close proximity to those 
participating in the intervention.
Level of training
Intensive training consisted initially of a 30-hour training programme focused on enhancing 
skills in listening, reflecting and ‘story swapping’, from which successful graduates were invited to 
work as LAs and took part in additional 20 hours of training to reinforce the team aspects of the 
programme and to review operational procedures.
Skill level
The study used unqualified lay trainers.
Nature of role
The health advisors were paid an hourly rate, although the amount is not clear.
Hours
It is not clear how many hours the health advisors worked; however, it is stated that each advisor 
was assigned one to seven families.
Formality
The graduation of advisors suggests formal training.
Intensity of intervention
Frequency/hours/duration
The intervention consisted of seven visits of 60–90 minutes, fortnightly telephone calls of at least 
5 minutes, and three special events over a 15-month period.
Results from studies
Health status
Levels of anxiety were measured using an 11-item anxiety subscale of the Psychiatric Symptom 
Index (PSI).166 Whereas participants in the control group reported higher levels of anxiety after 
baseline, participants in the experimental group reported lower levels of anxiety post intervention 
compared with baseline scores. The interventions’ effect (reduction in anxiety scores) was 
especially pronounced for mothers who were highly anxious at baseline, with mean anxiety 
scores for the highly anxious experimental group mothers decreasing from 33.3 at baseline to 
26.4 at 12 months post baseline, and those for the highly anxious mothers in the control group 
remaining unchanged. Maternal physical health was also an important factor in determining 
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effects of the intervention. The mean anxiety score for mothers in the experimental group who 
reported that they were in good, fair or poor health at baseline decreased from 26.4 to 23.9 
during the intervention period, whereas for those mothers in the control group who reported 
being in good, fair or poor health the mean anxiety score increased. Whereas mothers in the 
experimental group who reported being in very good or excellent health also showed a decrease 
in anxiety (from 13.4 to 11.5), those in the control group reporting very good or excellent health 
reported an increase in anxiety in this period (from 15.2 to 17.9). No relationship was found 
between the effects of the intervention and the number of reported stressful life events or the 
dose of the intervention. No effect was demonstrated on symptoms of depression as reported on 
the Beck Depression Inventory.167 The second step model (using baseline as a covariate) resulted 
in a standardised ‘B coefficient’ of 0.145 (p ≤ 0.05); however, this effect disappears when other 
covariates are included in the model. Specifically, the effect of each and all of the stage 3 factors 
make a substantial contribution to the regression coefficient (R2 = 0.51), suggesting that 51% of 
the variance in post-test PSI anxiety score is explained by the stage 3 model, i.e. it is the most 
predictive model. In other words, the intervention group was no longer a significant factor.
Health behaviours
Not measured.
Health-care beliefs and knowledge
Not measured.
Health-care use
Not measured.
Costs
No details given.
Discussion
This well-described and well-conducted study evaluated the efficacy of support to mothers of 
school-aged children with selected chronic illnesses, from mothers of older children with the 
same condition, for enhancing mental health. The study did not assess general health or QoL, our 
review’s primary outcomes. However, it did claim a change in anxiety – one of the study’s primary 
outcomes – but this did not change significantly in the groups in receipt of the intervention. The 
intervention effect was particularly pronounced for mothers who were highly anxious at baseline 
and for those who reported that they were in good, fair or poor health at baseline. There was 
found to be no relationship between the number of reported stressful life events or the dose of 
the intervention and the intervention effect. There was no demonstrated effect on symptoms of 
depression. Health behaviours, health-care beliefs and knowledge and health-care use were not 
assessed in Ireys 2001103 and no details of costs were given.
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Screening
 ■ Andersen 2000,42,81,82 Bird 1998,84–87 Earp 200216,63,93,94 and Paskett 2006.116,117
Description of studies
No screening interventions for men were identified. The four studies that were identified 
promoted the uptake of mammography screening for women;16,42,81,82,84–87,93,94,116,117 one also 
specifically promoted cervical cancer screening.84–87
Study design
Two high-quality RCTs,42,81,82,116,117 and two high-quality controlled trials16,63,84–87,93,94 were 
identified. Women were the unit of randomisation in Paskett 2006116,117 and participants were 
randomly assigned to LHAs or no advisor and followed up after 12–14 months. Communities 
(as defined by a zip code or group of adjacent zip codes) were the unit of randomisation to 
one of three intervention arms or to a non-intervention control arm in Andersen 200042,81,82 
The interventions were implemented by volunteer groups, and were ‘individual counselling’ 
(IC), ‘community activities’ (CA) and a combination of both (IC + CA). In the two controlled 
trials16,63,84–87,93,94 the intervention was delivered to one community, whereas the control 
community received no intervention. Samples of women from all of the communities were 
surveyed after 3 years.
Context of intervention
Population focus
All four studies were based in the USA. Bird 199884–87 surveyed 645 Vietnamese-American 
women in two urban communities (San Francisco, CA – intervention; Sacramento, CA – 
control). In Andersen 2000,42,81,82 a cohort of 352 women aged 50–80 years from each of the 
40 communities (giving a total of 14,080 participants) was randomly selected and surveyed to 
assess intervention effectiveness. The communities were located predominantly in rural areas of 
Washington state. Earp 2002,16,63,93,94 surveyed 993 rural African-American women in 10 counties 
in NC, USA; five counties were allocated to each group and they were also geographically 
separated by the Pamlico Sound. The studies of Bird 199884–87 and McPhee et al.,85,86 were 
conducted in the context of the Breast and Cervical Cancer Control Program (BCCCP), which 
covers screening fees for all age-eligible, low-income women. Paskett 2006116,117 assessed the 
impact of LHAs who were randomly assigned to 453 women individually, with a control group 
of 444 women receiving normal care. These 897 women were from a rural, low-income, triracial 
(white, Native American and African-American) population within a county ranked the eighth 
poorest of the 100 counties in North Carolina and in which one-half of the adults are high school 
graduates.
Location
The interventions were delivered in participants’ homes (Bird 1998,84–87 by telephone, Paskett 
2006116,117), in community settings (beauty parlours, churches, bingo halls, clubs, stores, libraries, 
golf courses)16,63,84–87,93,94 or in health settings within the community (health fairs, mobile 
mammography van days).16,63,93,94
Referral/recruitment
The LHAs spoke to any woman with whom they came into contact in their social group.16,63,84–
87,93,94 In Paskett 2006,116,117 women who had been clients of the clinic for at least 2 years and had 
not had a mammogram in the prior year were randomly selected from the health records of their 
health-care provider. Participants were randomly selected from a list of women purchased from a 
mailing list company in Andersen 200042,81,82
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Mechanism
Intervention components
Theoretical underpinning
In Andersen 200042,81,82 the IC consisted of barrier-specific telephone counselling (BSTC), which 
is based on theories of decision-making and is designed to help underusing women to overcome 
their barriers to obtaining a mammogram.168 The CA component of the intervention focused 
on developing social norms that were supportive of mammography. Earp’s intervention was 
based on a social–ecological model of behaviour, emphasising linked strategies at the individual 
social network of the organisational, community and policy levels.169 In addition, interventions 
on a one-to-one basis in Earp 200216,63,93,94 were informed by behavioural change theory. 
Paskett’s intervention was based on a number of theories: the Precede–Proceed model170,171 
provided a framework to identify screening barriers; social learning theory172,173 guided the 
educational programme; the communication/behaviour change model174 provided an organising 
framework for choosing specific culturally appropriate messages for delivery; the minority 
health communication model informed the culturally specific focus of the intervention; and the 
Transtheoretical Model175 was used to judge the women’s state of readiness.
Aims
All four studies aimed to increase the uptake of mammogram screening. Bird 199884–87 also 
aimed to increase the uptake of cervical smear tests (Pap smears). Paskett 2006116,117 also aimed to 
identify and address barriers to the uptake of mammograms.
Origin
In Bird 199884–87 the intervention was developed by the authors. Andersen 200042,81,82 based their 
IC component on BSTC, which was developed by other authors and adapted for use by volunteer 
peer counsellors from the included communities. Earp 2002,16,63,93,94 Earp and Flax,16 and Flax 
and Ear94 developed the intervention informed by focus groups from the relevant communities 
and which is also an outgrowth of a HRLA programme launched in 1990 in a semiurban eastern 
North Carolina county.176,177 In Earp 2002,16,63,93,94 community outreach specialists working out 
of local health agencies were hired to recruit, train and meet with LHAs and to co-ordinate the 
LHAs activities as well as creating and working with five community advisory groups to guide 
the lay health worker activities. Paskett 2006116,117 developed their intervention in several steps, 
informed by a previous study:178 community analysis, development of prototype materials, focus 
group review, pretesting and revision.
Approach
All three studies’ peers imparted information on screening, and Earp 2002,16,63,93,94 supported 
women’s attendance by providing transportation where needed and organising special screening 
days or raising funds for women who could not afford mammograms. In Paskett 2006116,117 LAs 
also helped to schedule mammography appointments. A specificity of Andersen 200042,81,82 and 
Paskett 2006116,117 was the focus on helping women to overcome their personal barriers to using 
mammography.
Topic focus
The focus of all four interventions was the promotion of screening.
Main activities
The interventions provided information on the importance of regular screening, breast cancer 
diagnosis, treatment and risk factors, general prevention and eligibility for screening payment 
programmes.
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Mode of delivery
The interventions were delivered face to face on a one-to-one basis16,42,63,81,82,93,94,116,117 or in 
small groups.84–87 Bird 199884–87 and Earp 2002,16,63,93,94 also made presentations to groups in the 
community, whereas Andersen 200042,81,82 and Paskett 2006116,117 also used telephone contact. 
Supportive written information pamphlets were used in all four interventions. CAs, such as video 
showings and mammography-themed bingo nights42,81,82 and health fairs,84–87 were also organised 
around the promotion of mammography.
Role/training
Practitioner type
All four studies selected women only as peer advisors (common personal experience), women 
who were indigenous to the communities they served (shared community).
Level of training
Paskett 2006116,117 provided intensive training, 1 week’s training with an examination at the end 
and additional follow-up sessions throughout the study. Earp 2002,16,63,93,94 provided moderate 
training (10–12 hours), mostly structured in three 3- to 4-hour sessions, but the length of time 
over which these were delivered is not stated. The level of training was unclear in Bird 1998,84–87 
or in Andersen 2000,42,81,82 though ‘a’ training session is mentioned in the latter, suggesting 
minimal training.
Skill level
Two studies used unqualified lay trainers,16,63,84–87,93,94 whereas Paskett 2006116,117 used a former 
nurse, social worker and a research study interviewer. Skill level is unspecified in Andersen 
2000.42,81,82
Nature of role
Bird 199884–87 paid their lay trainers on a sessional basis. Paskett 2006116,117 states that their LHAs 
were paid. The advisors in Earp 2002,16,63,93,94 were volunteers. In Andersen 2000,42,81,82 volunteers 
received modest incentives and tokens of appreciation but were not paid.
Hours
Bird 199884–87 paid their lay trainers on a sessional basis, which implies part-time working. The 
other three studies are unclear whether the advisors worked full- or part-time.
Level of formality
Paskett 2006116,117 conducted an examination after training but training was not externally 
accredited. The advisors in Earp 2002,16,63,93,94 had a graduation ceremony and received a 
certificate for their training. In the Andersen 200042,81,82 and Bird 199884–87 studies few details were 
reported about training.
Intensity of intervention
Frequency/hours/duration
In Bird 199884–87 the lay advisors provided 10- to 15-minute teaching sessions with discussion 
afterwards. The average number of these sessions was 232. They were provided over the 
30 months of the study. Earp 2002,16,63,93,94 did not state any parameters of intensity. Andersen 
200042,81,82 mentions that health advisors were asked to attempt to call at least 10 women monthly 
over the 3 years’ study duration but give no indication of a possible number of contacts or 
duration of contact per person. The Paskett 2006116,117 intervention lasted 9–12 months in total; 
lay trainers worked for 75–105 minutes for the first two sessions, with the second visit being 
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2–3 weeks after the first; they then provided two telephone calls (of unknown duration) following 
the second visit during months 2 and 6 of the intervention. Participants in Paskett 2006116,117 also 
received two postcard reminders at months 4 and 8, along with a last visit, of unknown duration, 
in months 10–12.
Results from studies
Health status
Not measured in Andersen 2000,42,81,82 Bird 1998,84–87 Earp 200216,63,93,94 or Paskett 2006.116,117
Health behaviours
Bird 199884–87 distinguishes regular users from those who have ever had a mammogram, defining 
regular users as those who have had at least two mammograms in the previous 5 years with the 
most recent within 18 months. Andersen 200042,81,82 defines regular users as those reporting at 
least two mammograms with one in the last 2 years (50% of sample), and all other women as 
underusers.
Bird 199884–87 reports the largest gain in regular mammography users. The unadjusted data show 
an increase of 18% in the intervention arm compared with a fall of 4% in the control. The rates of 
ever having had mammograms (intervention OR 2.2) and Pap smear (OR 4.5) were significantly 
raised in the intervention community.84–87 In addition, the rates of having had more than one 
screen in the last 5 years were, again, significantly raised in the intervention population for 
mammograms (OR 2.4) and cervical cancer screening (OR 2.4). The trial had in excess of 80% 
power to detect clinically significant differences for all primary and secondary outcomes.
Earp 2002,16,63,93,94 showed that self-reported mammography use in past 2 years increased in the 
intervention group compared with the controls by a statistically significant 7% (adjusted for 
age, medical visits, physician recommendation for mammography and perceived susceptibility 
to breast cancer). The difference between the two populations was even greater when just the 
low-income (< US$12,000 per year) women in each community were compared: 11% (adjusted, 
p = 0.02 – insufficient data reported to calculate effect size). The high-income women in the two 
communities did not differ significantly in their use of mammograms. Post hoc power was not 
assessed owing to the diversity of outcomes.
Paskett 2006116,117 showed that those in the LHA group were significantly more likely to have 
reported having a mammogram in the 12 months before the follow-up assessment (RR = 1.56, 
95% CI = 1.29 to 1.87, p < 0.001). When assessed by racial group (African-Americans, Native 
Americans and white people), all three groups improved rates of mammography use and there 
were no statistically significant differences in screening rates observed between racial groups 
or clinics. A total of n = 820 women completed the study resulting in > 80% power to detect a 
prespecified difference of 10% overall and 20% within racial groups.
Andersen 200042,81,82 studied the effect of IC and (IC + CA)/or CA on women who were 
underusers of mammography at baseline, and on the prevention of relapse for those women 
who had had mammograms at regular intervals at the baseline interview. Each intervention 
demonstrated increases in mammography use in both regular users (relapse prevention) and 
underusers relative to the control communities. The only statistically significant difference is 
observed among regular users in the CA arm, where 2.9% more women report a mammogram. 
Andersen 200042,81,82 combines the impact of the intervention among regular and underusers 
to obtain a percentage increase in the number of women using mammography of 2.5% in the 
CA arm. Given the similar costs for each intervention the authors conclude that CAs are the 
most cost-effective. This was a large-scale study (n = 6592), providing high power to detect small 
differences between three treatment groups and controls.
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Participation
Not measured in Andersen 2000,42,81,82 Bird 1998,84–87 Earp 200216,63,93,94 and Paskett 2006.116,117
Health-care beliefs and knowledge
Bird 199884–87 measured whether the women had ever heard of mammography (OR 7.0) or Pap 
smears (OR 52.7), both of which were significantly increased in the intervention population.
Earp 200216,63,93,94 measured increase in awareness of mammography-promoting interventions and 
materials over the period of the intervention (3 years), which did not differ significantly between 
the two groups. However, there was a difference between high- and low-income groups, in that 
although women with a high income had more exposure to the intervention the changes for this 
group were smaller.
Paskett 2006116,117 measured knowledge (12 items), barriers (12 items) and beliefs (four items) of 
mammograms and breast cancer with an unvalidated questionnaire developed for their study. 
The knowledge scores did not differ significantly between the groups. The barrier score was 
significantly smaller in the LHA group (insufficient data reported to calculate an effect size). 
The proportion of women reporting inaccurate beliefs was statistically significantly reduced 
(p = 0.034) in the LHA group (insufficient data reported to calculate an effect size).
Andersen 200042,81,82 did not measure health-care beliefs or knowledge.
Health-care use
Not measured in Andersen 2000,42,81,82 Bird 1998,84–87 Earp 200216,63,93,94 and Paskett 2006.116,117
Costs
Not measured in Bird 199884–87 and Paskett 2006.116,117 stated that the total cost of the intervention 
was US$329,054. The difference in mammography rates between the two groups was 15.2%, 
which translates into 66 additional mammograms in the LHA group; therefore, each additional 
mammogram in the advisor group cost US$4986.
Although no exact intervention costs were given in Earp 2002,16,63,93,94 the programme has entailed 
‘substantial direct costs’ due to staffing costs as a result of the large size of the LA network and the 
area that it covers (although the LAs volunteered their services, paid staff were involved in the 
stages of implementation, most intensively in the training phase); the materials for the training 
workshops and LA activities; consultant expenses, incentive payments, refreshments, tape 
recorders, tapes and transcription costs associated with the focus groups; and, finally, consultant 
expenses, development of mock-ups, photography costs and printing costs associated with 
brochure development.
Although no exact intervention costs were detailed in Bird 1998,84–87 it is mentioned that the free 
services that were available at the time of the study allowed the trial to be conducted in a cost-free 
environment, and therefore, if participants had been subject to fees for screening, increases in 
receipt and maintenance of tests might have been smaller.
Discussion
These four large, well-described and well-conducted studies evaluated the efficacy of HRLA 
for increasing attendance at screening in rural communities and one urban community in 
North America. One study promoted screening for breast and cervical cancers,84–87 whereas the 
other three promoted mammography uptake alone.16,42,63,81,82,93,94,116,117 The studies did not assess 
measures of general health or QoL, our review’s primary outcomes. However, all three studies 
claimed a change in rates of attendance at screening for breast cancer (mammography) as their 
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primary outcome, which did increase significantly in the groups in receipt of peer support. 
Bird 199884–87 also showed significant increases in the uptake of cervical cancer screening (Pap 
smears).
Bird 199884–87 and Earp 2002,16,63,93,94 increased knowledge of screening with LHAs. Paskett 
2006116,117 developed their own knowledge, barriers and beliefs scale, which did not show 
improvement in overall knowledge but did show a reduction in barriers and erroneous beliefs in 
the group with LHAs. In Andersen 200042,81,82 the IC was targeted at reducing women’s personal 
barriers to accessing mammography, but this was no more effective than CA or a combination of 
IC and CA at reducing relapses by regular users at baseline. Only the CA intervention arm made 
a statistically significant difference in mammography use.
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Diet and physical activity
 ■ Anand 2007,80 Elder 2006,95,96 Keyserling 2002,108,109 Staten 2004119 and Resnicow 2004.118
Description of studies
We identified five studies examining general health promotion interventions. Two examined 
healthy diet promotion alone,95,96,118 and three examined the promotion of healthy diet and greater 
levels of physical activity.80,108,109,120 No other studies examining other health promotion activities, 
such as improving mental well-being or combining health promotion with preventative messages 
(e.g. don’t start smoking), were identified
Study design
All of the identified studies were RCTs. The control group received no intervention/usual care 
in Resnicow 2004118 and Anand 2007.80 Keyserling 2002108,109 had two comparator groups: one 
received a clinic-based intervention with IC with a nutritionist and the other received minimal 
intervention consisting of mailed pamphlets only. Staten 2004119 had two comparator groups: one 
received provider counselling and the other received provider counselling and health education. 
Elder 200695,96 had two comparator groups; one received tailored mailed print materials and the 
other received targeted mailed ‘off-the-shelf ’ materials.
The unit of randomisation was the participants in three studies95,96,108,109,118 and cluster 
randomisation in two studies: households80 and church congregations.118
Context of intervention
Population focus
All five studies were conducted in North America: in a Canadian Aboriginal community;80 in 
uninsured women, over the age of 50 years, from a mainly Hispanic community;119 in a Latinas 
community;95,96 in African-American church communities;118 and in African-American women 
with type 2 diabetes108,109). In Anand 2007,80 57 households (174 individuals) were recruited; 357 
participants in Elder 2006;95,96 200 in Keyserling 2002;108,109 1022 participants in Resnicow 2004;118 
and 326 in Staten 2004.119 The rural or urban nature of the studies was not well defined in any of 
the studies but was probably rural in Anand 200780 (on the reservation) and probably urban in 
Staten 2004119 (clinics in Tucson). In Anand 200780 the household structure was chosen to build 
upon the strength of family ties and promote healthy lifestyle role modelling. Two of the studies 
restricted the age of their participants: over 40 years of age108,109 or over 50 years of age.119
Location
The interventions were delivered at home,80,95,96 home and clinic,108,109 home, clinic and 
community,118 and in church and the home.118
Referral/recruitment
Participants were recruited via clinics in two studies,108,109,119 by telephoning people in the region 
with Hispanic surnames,95,96 by recruiting within church communities on a first-come first-served 
basis,118 and by recruiting eligible households within the reservation.80 In Staten 2004119 the clinics 
from which participants were recruited were participating in the National Breast and Cervical 
Cancer Early Detection Program.
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Mechanism
Intervention components
Theoretical underpinning
Staten 2004119 did not state the theoretical underpinning of their interventions. Elder 200695,96 
states that the tailored materials were based on the person’s readiness to change, suggesting 
that the intervention is informed by the stages of change model.179,180 Keyserling’s intervention 
was based on the Transtheoretical Model,181 social cognitive theory154 and basic behaviour 
modification principles.182 Facilitators in the group session’s intervention used an active learning 
discovery approach183 and adult learning principles.184 Anand’s intervention80 was based on 
protection motivation theory, the social learning theory, normative influences and theories of 
persuasion.185–188 Resnicow 2004117 encompassed intervention components from two previous 
studies.189–192 They were based upon the social–ecological model,193 targeting activities at the 
individual, social network and community levels, and on motivational interviewing.157,194
Aims
Three studies examined interventions aimed at increasing activity and improving diet. There were 
small variations in the specific aims: Keyserling 2002108,109 aimed to increase moderate-intensity 
physical activity to 30 minutes per day, to decrease total and saturated fat intake and to improve 
control and distribution of carbohydrate intake, and to improve diabetes self-care; Staten 2004119 
aimed to increase moderate-to-vigorous activity to 150-plus minutes per week and to promote 
the consumption of five-plus servings of fruit and vegetables per day; and Anand 200780 aimed to 
reduce energy intake and increase physical activity. Two studies examined interventions aimed at 
improving diet: Resnicow 2004,118 by increasing fruit and vegetable intake, and Elder et al,95,96 by 
reducing dietary fat and increasing fibre intake.
Origin
The intervention was developed by the researchers in consultation with the community in Anand 
200780 and Elder 2006,95,96 and on the basis of formative data collection including focus groups 
with African-American people with diabetes195 and prior testing196 in Keyserling 2002.108,109 
The development of the intervention was based upon successful components of two similar 
studies189–192 in Resnicow 2004.118 The origin was not stated in Staten.119
Approach
The CHWs imparted information and counselled participants to improved health behaviours 
in all five studies. Resnicow 2004118 and Anand 200780 provided food preparation classes and 
recipes. In Staten 2004119 they also organised bimonthly walks.
Topic focus
The focus of the intervention was healthy diet promotion alone in two studies,95,96,118 
whereas three studies examined the promotion of healthy diet and greater levels of physical 
activity.80,108,109,119
Main activities
The dietary interventions included personalised dietary counselling.95,96 In Resnicow 2004118 
the intervention was made up of different elements, including church-wide activities, such as 
health fairs, serving fruit and vegetables after services or church programmes, sponsoring food 
demonstrations, and having pastor sermons related to health; the distribution of a cookbook 
with recipes and information about the health benefits of fruit and vegetables, tips for shopping 
and storing fruit and vegetables and cooking techniques; the distribution of an 18-minute video 
targeting fruit and vegetable intake using spiritual and secular motivational messages; and 
one-to-one lay counselling regarding fruit and vegetable intake. The diet and physical activity 
interventions included ‘A New Leaf … Choices for Healthy Living with Diabetes’ intervention 
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including individual, clinic-based counselling with a nutritionist, as well as telephone calls 
with a LA.108,109 Health counsellors assessed and set dietary and physical activity goals for each 
household member, and provided traditional recipes, grocery store tours and food preparation 
classes. A water cooler was provided per household, as well as two 18-l containers and 24 
bottles of spring water (which were provided per week per household), and an after-school 
activity programme for children was provided to the whole community (both intervention 
and control groups had access).80 Staten’s intervention included provision of counselling from 
nurse practitioners regarding the benefits of and barriers to increasing physical activity and 
consumption of fruit and vegetables, and gave an individualised behaviour change prescription, 
two health education seminars (one on nutrition and one on physical activity), and a monthly 
health newsletter, while CHWs provided information support and organised bimonthly walks.119
Mode of delivery
The interventions were delivered in a variety of modes. The participants in Elder 200695,96 
received weekly home visits or telephone calls over a 14-week period, alongside 12 mailed 
tailored newsletters with homework assignments. The participants in Resnicow 2004118 had 
access to church-wide health fairs, education sessions and cooking classes, and received one-to-
one lay counselling via two telephone calls. The participants in Staten 2004119 received provider 
counselling, along with an individualised behaviour change prescription, two health education 
seminars and a monthly newsletter, while CHWs provided fortnightly telephone calls and 
organised bimonthly walks. The participants in Keyserling 2002108,109 received one 60-minute 
and three 45-minute clinic-based counselling sessions with a nutritionist and 12 monthly 
telephone calls from a LA. The participants in Anand 200780 received home visits from the health 
counsellor, who provided individualised dietary and physical activity goals, traditional recipes, 
grocery store tours and food preparation classes. A water cooler and supplies of spring water were 
provided per household. An after-school activity programme for children was provided to the 
whole community (both intervention and control groups had access).
Role/training
Practitioner type
Three studies used peers from a shared community (aboriginal;80 African-American church-
goers;118 Spanish language-dominant role models within the community95,96). Two studies used 
peers with common personal experience from a shared community [African-American women 
with type 2 diabetes;108,109 Hispanic women most of whom (five of the six) were over 50 years of 
age119].
Level of training
Staten 2004119 gave no training to their CHWs, although four had been previously trained as 
CHWs to provide outreach, translation services and transportation. Two studies gave moderate 
levels of technical training80,118 and one study gave intensive technical training.108,109 In Elder 
2006,95,96 promotores received 12 weeks of training, during which a desirable interaction was 
modelled by staff followed by opportunities for promotores to develop skills through the 
opportunity to practice and seek feedback and develop solutions to problems that might occur 
through role-playing in a supportive environment.
Skill level
All the studies used unqualified lay trainers. However, the lay trainer intervention was provided 
in conjunction with training delivered by qualified nurse practitioners in Staten 2004119 and 
a nutritionist in Keyserling 2002.108,109 In Resnicow 2004,118 attempts were made to identify 
individuals with a college degree- or graduate-level education and a background in a helping 
profession (e.g. teacher, psychologist, nurse, social worker or counsellor).
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Nature of role
Four of the five studies did not specify whether the CHWs were paid. It is stated that advisors 
were volunteers in Resnicow 2004118
Hours
None of the five studies specified whether the CHWs were full- or part-time. Elder 2006,95,96 
however, states that the promotores were assigned an average of 28 participants over the course of 
the study (12 weeks), and advisors in Resnicow 2004118 were asked to make two telephone calls 
with a minimum of five participants.
Level of formality
The CHWs in Resnicow 2004118 received a day and a half of training, after which they got 
assessed for their competencies and were allowed to continue to provide the lay peer service only 
when they met a minimum standard. However, none of the five studies assessed their training 
against external standards or accreditation.
Intensity of intervention
Frequency/hours/duration
Three studies used medium-intensity intervention80,95,96,119 and two used a low-intensity 
approach.108,109,118
Specifically, Staten 2004119 provided an unspecified number of clinic visits, two seminars, 
12 monthly newsletters and fortnightly telephone calls for 12 months. Elder 200695,96 provided 
14 weekly visits/telephone calls plus 12 newsletters. Anand 200779 provided regular home visits 
over 6 months. Keyserling 2002108,109 provided three group sessions plus 12 monthly telephone 
calls. Resnicow 2004118 provided two telephone calls from CHWs in addition to interventions 
provided on a church-wide basis, for example health fairs.
Results from studies
Health status
None of the studies identified measured general health status, QoL, pain, fatigue or adverse 
events. One study measured psychological outcomes: Keyserling 2002108,109 measured mental well-
being on a validated scale,197 but this did not differ significantly between the groups. Three of the 
studies measured specific physiological measures: Staten 2004119 found no significant reductions 
between waist measurements in the CHW group versus the group that had provider counselling 
and health education (linear regression adjusted for BMI, ethnicity and age, – insufficient 
information to calculate effect size). There were significant reductions in systolic blood pressure 
(approximately 5.4 mmHg – insufficient information to calculate effect size) the CHW group 
versus both other groups (linear regression unadjusted). They also measured BMI, diastolic 
blood pressure, total cholesterol, glucose and triglycerides, but these physiological measures 
did not differ significantly between the groups. Keyserling 2002108,109 measured HbA1c levels, 
total cholesterol levels, HDL cholesterol levels and weight, but these physiological measures 
did not differ significantly between the groups. Anand 200780 found that, overall, there were no 
statistically significant changes in body weight, waist circumference, skinfold thickness or body 
fat percentage in the intervention versus the usual care group. Resnicow 2004118 did not assess 
any measures of health status. Elder 200695,96 measured BMI, but failed to report the results.
Health behaviours
Three studies assessed physical activity levels: Keyserling 2002108,109 measured exercise over a 
period of 1 week using Caltrac accelerometers – devices worn on the hip and designed to detect 
and record movement; Staten 2004119 and Anand 200780 rely on self-reported data. Keyserling 
2002108,109 determined that the CHW group was significantly more active at 12 months than the 
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minimal intervention group [effect size approximate (unadjusted 3.0) ~52 kcal/day], but not 
significantly different from the group that had access to the clinic intervention. Staten 2004119 and 
Anand 200780 found no significant difference between the groups’ physical activity levels.
Dietary changes were measured in all five studies:
 ■ Total food energy Elder 200695,96 showed a significant difference in energy immediately 
after the intervention. This effect did not last to the 6- and 12-month follow-up time points. 
Keyserling 2002108,109 and Anand 200780 showed no differences in total daily energy intake.
 ■ Fats Resnicow 2004118 found significant reductions in the amount of fat eaten (effect 
size = 0.26). Anand 200780 also found a significant reduction in trans fatty acid consumption 
[p = 0.02, mean difference (D) = 0.8, effect size (ES) = 0.34, 95% CI –0.65 to –0.02] and 
a reduced consumption of ‘fats, oils and sweets’ by approximately two servings per day 
(p = 0.006, D = 1.9, ES = 0.12, 95% CI –0.44 to 0.19, compared with the control). However, 
there were no differences in the percentage of daily calories from fats or in the consumption 
of ‘milk, yoghurt and cheese’. Elder 200695,96 found significant reductions in dietary total 
fat and total saturated fat consumption. These effects did not last to the 6- and 12-month 
follow-up time points. Keyserling 2002108,109 found no significant differences between the 
groups’ percentage of calories from saturated fat or dietary cholesterol.
 ■ Carbohydrates Elder 200695,96 showed a significant reduction in total carbohydrates, glucose 
and fructose immediately after the intervention, but this difference was not seen at 6 and 
12 months’ follow-up. Anand 200780 found no difference in percentage of calories from 
carbohydrates or the types of food served (such as ‘bread, cereal, rice, pasta’).
 ■ Proteins Anand 200780 found no difference in percentage of calories from protein or the 
types of food served (such as ‘meat, poultry, fish, dried beans, eggs, nuts’).
 ■ Fruit and vegetables Resnicow 2004118 found significant improvements in the levels of fruit 
and vegetables eaten (effect size of 0.39 for the two-item measure and 0.18 for the 17-item 
measure), but Staten 2004119 and Anand 200780 found no significant differences in the 
consumption of fruit and vegetables between their groups.
 ■ Drinks Only Anand 200780 measured consumption of drinks and they found that water 
consumption increased by ~0.4 of a serving per day (p = 0.04, D = 0.04, ES = 0.35, CI 0.03 
to 0.67), and carbonated drink consumption decreased by ~0.2 servings per day (p = –0.02, 
D = 0.02, ES = 0.16, 95% CI –0.15 to 0.48).
Participation
Resnicow 2004118 measured the levels of social support to eat more fruit and vegetables on a scale 
developed for this study and found it was significantly improved (effect size 0.39). Keyserling 
2002108,109 measured social well-being on a validated scale but this did not differ significantly 
between the groups.
Three studies80,95,96,119 did not measure participation.
Health-care beliefs and knowledge
One study measured health-care beliefs: Resnicow 2004118 measured autonomous/intrinsic 
motivation and controlled/extrinsic motivation with a validated outcome measure and self-
efficacy with a measure developed for this study and found that these all significantly improved in 
the intervention group (effect sizes of 0.21, 0.33 and 0.22, respectively).
One study measured health-care knowledge: Keyserling 2002108,109 measured diabetes knowledge 
with a validated scale (see Dunn et al.198). Although they stated that there was a significant overall 
group effect (p = 0.037) they did not conduct the analysis to determine which group(s) produced 
this effect and whether it was significant.
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The patient acceptability of the intervention was measured specifically in two studies.108,109,118 
Resnicow 2004118 measured satisfaction with the programme; 77% of participants reported 
being very satisfied with the cookbook and educational materials, and 72% of those receiving 
at least one call reported being very satisfied with their volunteer advisors. Keyserling 2002108,109 
measured programme acceptability. For clinic-based IC, 94% of 117 respondents reported 
being very satisfied with the amount of information and help the nutritionist gave about diet, 
and 88% were very satisfied with the counselling provided to enhance physical activity, whereas 
15% reported having some difficulty getting to the clinic for these visits. For the community 
diabetes advisor component, 85% of 59 respondents felt the number of telephone calls was 
appropriate, 86% felt the role of community diabetes advisors in the programme was important, 
and 83% strongly agreed that talking to someone else with diabetes was very helpful. One study 
measured attrition rates between the groups, which can be suggested to be a surrogate marker of 
acceptability: Elder 200695,96 found that the total attrition rate over 12 months was 21%: 23% in 
the promotora group, 24% in the tailored print group and 18% in the control group.
Two studies80,119 did not assess any measure of health-care knowledge or beliefs.
Health-care use
None of the studies identified assessed any measure of health-care use.
The studies by Keyserling 2002,108,109 Staten 2004119 and Elder 200695,96 were not powered to detect 
specific differences. Anand 200780 powered their trial at 80% to detect modest changes in total 
calories and increase in physical activity.
Costs
Elder 200695,96 detailed the costs to be US$9 per participant for the control condition, US$45 per 
participant for the tailored condition and US$135 per participant for the intervention group. 
In looking at simple costs per unit of pre–post change for the control, tailored and promotores 
groups, respectively, these costs were US$1.30, US$5.11 and US$8.28 per reduced gram of fat; 
US$3.21, US$17.31 and US$21.09 per reduced gram of saturated fat; and US$0.07, US$3.21 
and US$0.36 per reduced calorie.95,96 Resnicow 2004,118 although not detailing the costs of 
the intervention, do state that larger-scale dissemination of the intervention would require ‘a 
considerable cadre of trainers to implement the intervention, which would involve substantial 
costs’. The other studies did not identify any assessed costs.
Discussion
These well-described and well-conducted studies evaluated the efficacy of the community LHAs 
for general health promotion in five communities in North America which would have relatively 
poor access to preventive health-care services. Two of the studies examined the promotion of 
healthy diet alone95,96,118 and three promoted a healthy diet along with increased physical activity 
levels.80,108,109,119 Three of the studies examined the effect on particular populations,80,95,96,118 one 
examined women over 40 years of age only,119 and one examined diabetic women over 40 years of 
age only.108,109
The five studies identified did not measure if the LAs had any effect on general health or QoL, 
our review’s primary outcomes. Three of the studies assessed a variety of physiological measures, 
the majority of which did not differ significantly between the groups. However, Staten 2004119 
found small but statistically significant reductions in systolic blood pressure. Three studies 
assessed physical activity levels: Keyserling 2002108,109 found that they were significantly increased 
compared to a minimal intervention group but not when compared with the group with access 
to counselling sessions from the clinic. However, the size of the increase was small (~52 kcal/day) 
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and may well be within the range of measurement inaccuracy. Neither Staten 2004119 nor Anand 
200780 found any significant differences in physical activity levels.
Two studies assessed participation.108,109,118 Resnicow 2004118 found a significant increase in the 
levels of social support to eat more fruit and vegetables, but the scale was developed for this 
study and its reliability, sensitivity and validity were not assured. Keyserling 2002108,109 measured 
social well-being on a validated scale but this did not differ significantly between the groups. 
Resnicow 2004118 found significant improvements in intrinsic and extrinsic motivation, but it is 
unclear if this split of the scale has been validated. They also found significant improvements in 
self-efficacy. Acceptability was measured in two studies:108,109,118 both studies reported high levels 
of satisfaction with aspects of the interventions. Attrition rates, which can be suggested to be 
a surrogate for acceptability, were not much different between the promotora group (23%) and 
the tailored print group (24%), and not substantially higher than in the control group (18%).94,95 
None of the studies measured health-care use and only Elder 200695,96 measured the cost of the 
intervention.
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HIV infection prevention
 ■ Dickson-Gomez 200389,90 and Dickson-Gomez 2006.91,92
Description of studies
We identified two studies89–92 examining strategies to tackle HIV infection prevention in 
marginalised populations. They were by the same authors and focused on active drug users in 
Baltimore, MD, and Hartford, CT, USA. In the studies, participants were encouraged to conduct 
HIV infection prevention outreach, and it was hypothesised that participation in this activity 
would have an impact on their own HIV risk behaviours as well as that of their close networks.
Study design
The studies used ethnographic methods.89–92 Dickson-Gomez 200389,90 also conducted a network-
oriented intervention-controlled trial (n = 250), with the control group being designed to be 
equal to the intervention condition in the number of sessions, duration and interest level. In 
addition, the experimental group was encouraged to conduct HIV infection prevention outreach 
among their close social networks. It was hypothesised that outreach activity would reduce 
participants’ own HIV risk behaviours. Interviews were carried out with 30 participants, as well 
as ethnographers pairing with eight participants for between four and 10 outreach sessions in 
Dickson-Gomez 2003.89,90 In Dickson-Gomez 200691,92 project ethnographers completed 131 
observations, including 67 partnered field training sessions with 39 LAs. In total, the authors 
completed 50 in-depth interviews.
Context of intervention
Population focus
The studies were conducted in the USA but within different project settings. The two studies were 
conducted in an urban community of active drug users,89–92 in which the focus was work with 
these drug users as LAs. In Dickson-Gomez 200389,90 and 200691,92 some participants were also 
HIV sero-positive (20% in Dickson-Gomez 200691,92), or homeless or had a history of sexually 
transmitted disease (STD) or hepatitis.
Location
The interventions were delivered in the community,89,90 through outreach91,92 or in an unspecified 
training location (Dickson-Gomez 200389,90 for the training per se). Settings had a particular 
impact on intervention effectiveness and acceptability in Dickson-Gomez 200691,92 as interactions 
could take place in the streets or in other public or private places, which could be very transitory 
in nature.
Referral/recruitment
Participants were identified from a previous study and through street outreach and by direct 
invitation by the project staff,91,92 and through outreach, ethnographic observations, focus group 
and geographical coding of drug-related arrests.89,90
Mechanism
Intervention components
Theoretical underpinning
Dickson-Gomez 200389,90 used cognitive and affective process strategies from theories of 
behaviour change and added a social component derived from theories of social influence, 
social diffusion and social identity (this was particularly relevant, as in the training sessions 
emphasis was put on superordinate goals of protecting one’s community).199–203 Dickson-Gomez 
200691,92 used theories of peer modelling, dynamic social impact theory and diffusion theory 
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(which provides a framework for understanding the process by which innovations such as harm 
reduction practices are accepted, rejected or transformed by drug users).
Aims
 ■ To conduct a network-orientated HIV infection prevention and outreach intervention for 
HIV-positive and HIV-negative drug users.89,90
 ■ To reach the maximum number of drug users with HIV infection prevention messages and 
equipment.91,92
Origin
The intervention was developed by the researchers89,90 or developed by the researchers with 
knowledge developed from previous collaborative research.91,92
Approach
The LAs were encouraged to conduct HIV education and risk reduction in their community.89,90 
They also imparted information, demonstrated techniques (e.g. needle cleaning) and counselled 
participants.91,92
Topic focus
HIV transmission prevention within drug-users, via safe sex and clean-needle promotion.89–92
Main activities
In Dickson-Gomez 2003,89,90 and 200691,92 the peer educators conducted HIV education outreach 
with sex and drug partners, friends, family and other community members, with emphasis 
on drug and sex partners. This included passing out HIV infection prevention kits (including 
condoms, alcohol swabs, bleach, water, cotton and bottle tops for heating the water and drug 
solution), talking about HIV infection prevention, and providing information about drug 
treatment facilities, housing, shelters and other services. In Dickson-Gomez 200691,92 the peer 
educators received a backpack filled with intervention materials, such as bleach kits, crack kits, 
male and female condoms, and dental dams, a ‘flipbook’ containing descriptions of intervention 
materials and practices, and information about HIV/acquired immune deficiency syndrome 
(AIDS) and other infectious diseases, an identification badge, and colourful badges containing 
intervention slogans.
Mode of delivery
The intervention in Dickson-Gomez 200389,90 took place both in a training location and in private 
and public places in the community. In Dickson-Gomez 200691,92 outreach was delivered in small 
groups or one to one, as opportunities arose within the community.
Role/training
Practitioner type
Both of the studies used peers with shared experience and community,89–92 i.e. drug users 
educated their own community about fellow drug users; some of both were HIV sero-positive.
Level of training
In Dickson-Gomez 200389,90 the training consisted of 10 90-minute sessions, using a small-group 
highly scripted interactive format. In Dickson-Gomez 200691,92 the training consisted of 10 
2-hour sessions: five in the offices of a community-based research institute and five field training 
sessions, partnered with a staff member, to practise conducting HIV infection prevention 
interventions with their peers in community settings.
Skill level
Both of the studies used unqualified LAs.89–92
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Nature of role
The LAs in Dickson-Gomez 200389,90 were paid for their participation in the research (US$20 for 
baseline interviews, US$25 for follow-up interviews, US$15 for group sessions and US$20 for 
the time they spent with ethnographers in partnered sessions), but they were not paid for their 
outreach activities. The LAs in Dickson-Gomez 200691,92 were paid US$20 for outreach they did 
with staff partners; however, this accounted for only 54% of the reported encounters.
Hours
Dickson-Gomez 200389,90 and 200691,92 did not employ their peer health advisors.
Level of formality
Dickson-Gomez 200389,90 and 200691,92 did not formally assess the competencies of their LAs.
Intensity of intervention
Frequency/hours/duration
The interventions in Dickson-Gomez 200691,92 were opportunistic, and the frequency and 
duration of which were not specified. In Dickson-Gomez 200389,90 interventions were also 
opportunistic – the peer educators conducted a median of 20 contact forms (range 1–111).
Results from studies
Dickson-Gomez 200389,90 comprised both a qualitative and quantitative element (reported in two 
separate articles); the qualitative element is summarised here, whereas the quantitative element is 
reported below.
Outreach with adolescents: rapport or conflict Many adult outreach workers felt threatened in 
places where young people hung out and successful outreach with young people often happened 
in their homes rather than on the street. Despite this, the use of younger male outreach workers 
would potentially lead to more conflicts, as they would appear as a greater threat.
The line between respect and stigma Young drug dealers have more money and power than LAs. 
Attempts at outreach sometimes question this street hierarchy and may cause conflict. LAs take 
issue with the invasion of street culture (smoking marijuana and cocaine in public) in all public 
spaces where ‘decent’ codes were once dominant. Young people often have family members who 
are/were injecting drug users and feel stigmatised by that. Most LAs recognised that most young 
people did not inject drugs and would resent any implication that they were. Outreach methods 
were therefore focused on safer sex messages, which were also sometimes thought of as offensive 
because of the underlying assumption of promiscuity.
The business of selling drugs: the corner is hot In dealing drugs, young people discourage crowd 
gatherings as they attract the police. Outreach work is therefore sometimes seen as threatening 
to business. There were differences in reactions to male and female advisors, as male LAs are 
confronted to a struggle for recognition of masculine power, whereas women, particularly if 
older, may be seen as mother figures who are due some degree of respect.
Successful outreach: my children come first The most successful outreach workers were mothers 
who in the past had failed their parenting due to drug use and wanted to engage with young 
people.
Dickson-Gomez 200691,92 was a qualitative study and did not have results that could be 
categorised in the same way as those from quantitative studies. The results section focused on the 
challenges of conducting outreach in public or private drug use sites; the main challenge in public 
spaces was the drug users’ fear of attracting the police. Access to private spaces depended on the 
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familiarity of the LAs with the space (whether using it themselves regularly), its gatekeeper and 
the presence, or not, of the ethnographer (which could arouse suspicion). The discussion focused 
on understanding how or why peer-led interventions work and contrasted traditional outreach 
with the HRLA model. Some LAs were older, well known and well respected within the drug 
use community, which enabled them to have a large impact on the HIV infection prevention 
practices. The strength of the personal ties that LAs had with other drug users was the most 
important asset in conducting the prevention work. Many LAs incorporated work into their daily 
routine and carried their backpacks filled with condoms, bleach kits and crack kits with them as 
they hung out on the streets or in parks. Because a lot of LAs were homeless they were spending 
a lot of time on the street, which enabled them to reach otherwise hard to reach subpopulations 
of drug users. Some LAs emphasised the importance of conducting outreach while people were 
using drugs, so that they could correct misuse of the prevention materials, demonstrate proper 
needle cleaning and tailor the intervention to the observed needs. LAs had more up-to-date 
information about drug-using sites and were less likely to be greeted with suspicion or hostility 
than traditional outreach workers. Some LAs allowed other drug users to use their homes and 
conducted HIV infection prevention there, which was seen as highly efficient.
Health status
In Dickson-Gomez 200691,92 many LAs reported positive experiences related to their own health 
and well-being, including their knowledge about risk and prevention.
Health behaviours
Dickson-Gomez 200389,90 report significant differences between intervention and control 
participants in overall drug use and unsafe practices: reduction in injection drug use (48% 
intervention vs 25% control, p < 0.05); increase in cessation (44% intervention vs 22% control, 
p < 0.05); and reductions in unhygienic needle use (69% intervention vs 30% control, p < 0.10). 
Some success in reducing risky sexual behaviour is also reported: reduction in unprotected 
vaginal sex with casual partners (16% intervention vs 4% control, p < 0.05); reduction in number 
of casual partners (18% intervention vs 7% control, p = 0.05). There were no changes observed 
in condom use with regular partners. Regression modelling suggested that the intervention 
condition was almost three times more likely to result in a reduction in injection drug use than 
the control condition (OR 2.8) and a significant reduction in the use of unhygienic needles 
(χ2 = 3.57, p < 0.01) at follow-up. The experimental condition was found to be more than seven 
times as likely to result in the increased use of condoms with casual partners. However, these 
results were based on a regression model that ignored any reported increases in risky behaviour 
(those reporting the same level or increased levels of risky behaviour were coded 0).
Dickson-Gomez 200691,92 presents a comparison of pre- and postintervention self-reported data 
on risk behaviours. The experimental condition was found to report a greater decrease of the 
number of casual sexual partners (χ2 = 3.33, p = 0.05), and in multiple logistic regression analysis 
the experimental condition was found to be more than seven times as likely to report increase use 
of condoms with casual partners.
In Dickson-Gomez 200691,92 the programme had a positive impact on many LAs who sought 
to reduce their drug consumption or stop all together (p ≤ 0.001). Outreach work provided 
them with an alternative means of engaging with other drug-using community members. 
LAs also gained a greater sense of self in doing something useful for their community; many 
saw outreach work as a first step towards employment and a stable housing arrangement. LAs 
reported increased usage of condoms (p = 0.000), a reduction in the number of sex partners 
(p ≤ 0.001), increases in cooking of drug solutions (p = 0.007), use of rubber tips among crack 
users (p ≤ 0.001), and stopping sharing cookers/drug solutions (p = 0.35). A total of 21.3% of 
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LAs reported having entered a drug treatment programme in the 2 months prior to the closing 
interview.
Participation
In Dickson-Gomez 200389,90 participants’ attitudes towards outreach were examined; given that 
the intervention put emphasis on social belonging, responsibility and participation, engagement 
in outreach activities can be taken as an approximate of social participation. At 6 months’ 
follow-up, participants in the experimental condition were significantly more likely to report 
talking about HIV with family members (χ2 = 6.42, p < 0.05), sex partners (χ2 = 6.7, p < 0.05), 
non-drug users (χ2 = 3.92, p < 0.05), and drug users (χ2 = 5.32, p < 0.05). In Dickson-Gomez 
200389,90 there were no statistically significant differences between the experimental and control 
groups in the outreach self-efficacy score [t(219) = 1.10, p = 0.27). In Dickson-Gomez 200691,92 
many LAs reported in closing interviews that they had engaged in other activities – for example, 
independent community action, such as volunteering in homeless shelters or soup kitchens – and 
working with youth and pastors in their neighbourhood.
Health-care beliefs and knowledge
In Dickson-Gomez 2003,89,90 99% of experimental condition participants declared themselves 
proud to be LAs; 94% thought that they gained respect by doing outreach and were glad to show 
that they were doing something positive; and 95% and 94% of participants reported that their 
family and friends were supportive of their outreach respectively.
Health-care use
No study in this category assessed health-care use.
Costs
Although Dickson-Gomez 200389,90 and 200691,92 reported some of the costs incurred by the study 
(payment for training attendance, for example), neither of the two studies reported any costs for 
running an HIV infection prevention programme.89–92
Power calculations are not appropriate given the nature of the above two studies.
Discussion
The two qualitative studies89–92 examined the nature of the role and practices of peer health 
advisors, as they promoted HIV infection prevention within their drug and sexual networks and 
in their neighbourhood.
Neither Dickson-Gomez 200389,90 nor Dickson-Gomez 200691,92 assessed general health or QoL, 
our review’s primary outcomes. Dickson-Gomez 200389,90 reported significantly greater sex- and 
drug-related behavioural risk reduction; LAs were more likely to report talking about HIV to 
family members, sex partners and drug users at 6 months’ follow-up. However, the effect of the 
outreach activity was measured on the LAs themselves and it remains unclear whether their 
outreach activities had any impact on their communities.
Dickson-Gomez 200691,92 found that the project had had a profound impact on many LAs. 
Beyond attempts to become free of drugs, many LAs were taking very seriously their role to 
promote harm reduction practices among active drug users. This was further reinforced by 
positive feedback and support from community members, which suggests a high degree of 
acceptability of the intervention. However, Dickson-Gomez 200691,92 highlighted the fact that LAs 
have many competing needs, such as finding housing, food, money and drugs, which sometimes, 
in the short term, have to take priority over outreach work. In the long term, funding LAs would 
be key to the success and sustainability of the scheme.
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Section 2: interventionS context, mechaniSmS and outcomeS
In this section of the report the synthesis activity is further developed to continue to explore 
the LA as a health improvement intervention. The review data are interrogated in a number of 
ways to explore and consider multiple dimensions. In order to build on the programme theory 
established in Phase I, this analysis began by positioning the dimensions in Appendix 3 on to the 
context–mechanisms–outcome framework in order to tease out intervention components and 
characteristics.
Context
See Box 6.
Mechanisms
See Box 7.
Dimension
Informal Level of formality Formal
Generic, focus on overall health and 
well-being
Topic focus Targeted, focus on specific health 
topics or behaviours
Community outreach Referral Biomedical referral model
One-off contact Frequency Iterative, ongoing intervention
Peer or lay led Practitioner type Professionally driven
Unqualified, low/no skill Skill level Qualified, highly skilled
Unpaid volunteers Nature of role Paid employees
Part-time/sessional workers Hours Full-time advisors/trainers
Group or community work Mode of delivery One-to-one intervention
Community development and 
engagement
Main activities Evidence-based lifestyle advice,  
goal-setting
Nurturing and supporting Approach Information-giving and signposting
BOX 7 Mechanisms 
BOX 6 Context
Dimension
Whole population within a specified 
locality
Population focus Particular target groups or local 
communities
Bottom up, emergent Origins Top down, mandated
Community setting Context Health-care setting
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Outcomes
See Box 8.
In this section, the previous grouping of included studies by intervention focus will be 
disaggregated to one that enables a rich description of intervention characteristics. In order 
to attempt to establish potential links between intervention characteristics and achievements, 
this section is prefaced with an assessment of intervention success (Table 9). It is worth noting 
here that, in a realist perspective, the aim of a synthesis is to refine a programme theory. Thus 
the hierarchy of evidence applied in the quality assessment process does not apply here. The 
assessment of intervention success stands not as an equivalent metric to the pooled estimate 
obtained in standard meta-analyses, but rather as a crude indicator of the extent to which the 
combination of intervention and contextual components has achieved its intended aim. This is 
BOX 8 Outcomes 
Dimension
Enhanced capacity and social 
capital within communities
Key outcomes Health behaviour change within 
individual clients
TABLE 9 Degree of success
Degree of success Studies Intervention focus
Low Gary 200398–100 Chronic care
Griffiths 2005101,102
Kennedy 2007104–107
Lujan 2007112
Medium Dennis 200288 Breastfeeding
Morrow 1999114,115
Barlow 200083 Chronic care
Lorig 1999110
Young 2005121–123
Anand 200780 Diet/physical activity
Elder 200695,96
Keyserling 2002108,109
Dickson-Gomez 200691,92 HIV infection prevention
Ireys 2001103 Mental health
Paskett 2006116,117 Screening uptake
Andersen 200042,81,82
Emmons 200526,97 Smoking cessation
May 2006113
Woodruff 2002120
High Lorig 2003111 Chronic care
Staten 2004119 Diet/physical activity
Resnicow 2004118
Dickson-Gomez 200389,90 HIV infection prevention
Earp 200216,63,93,94 Screening uptake
Bird 199884–87
West 199830 Smoking cessation
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thus a broad assessment, defined as the greatest impact for the least cost, but with a weighting 
for hard-to-reach communities. It was developed collaboratively by the research team. This was 
determined by developing a calculation based on six criteria:
1. whether they measured general health or QoL (as the focus of this review)
2. whether their primary outcome changed significantly
3. the effect size and relevant contextual information – as missing data prevented the generation 
of sizes for all studies, in some cases contextual information was used, for example a 0.3% 
reduction in HbA1c level represents approximately a 3% drop in cardiovascular risks. 
Impact on health in hard-to-reach communities was also deemed of greater value than in 
communities with regular contact with health-care organisations.
4. health-related LA’s training intensity
5. intervention intensity (see Appendix 11)
6. cost consideration.
The first three criteria stand as an approximation of the effectiveness of the intervention in 
improving health, the area of effect and the size of effect. The next three criteria delineate the 
costs of the intervention in terms of training resources and the time to train the advisors, the 
time required to deliver the intervention (and by implication the size of its impact on ‘everyday’ 
life of both the advisors and the recipients) and, finally, a crude calculation of the monetary costs 
of intervention (where this was reported). Full detail of the calculation process for intervention 
success is provided in Appendix 12.
All of the included studies with a low degree of success were focused on chronic care. Young 
2005121–123 are the only exception to this – what distinguishes the study is its lower intervention 
intensity and the fact that the study primary outcome (HbA1c level) was significant, although the 
effect size (ES 0.25) was of limited relevance.
For screening, Paskett 2006116,117 and Andersen 200042,81,82 owe their medium success rating to 
the fact that they conducted an intensive training (thus more costly)116,117 and did not describe 
training intensity, compared with the Earp 200216,63,93,94 and Bird 199884–87 in which the training 
was of moderate intensity.42,81,82 In Andersen 200042,81,82 the participants were also easily accessible.
For smoking cessation, West 199830 was attributed a higher success rating owing to its particularly 
low cost: peers and participants were fellow smokers supporting each other in their cessation 
efforts. Peers were not trained but, nevertheless, delivered a high-intensity intervention. In these 
circumstances, the minimal cost of any cessation renders the intervention highly successful. On 
the other hand, May 2006113 which used the same intervention technique, could be classified as 
reaching only a medium degree of success because of the lack of significance in cessation rates, 
even after just 1 week.
Staten 2004119 differed from the other diet/physical activity studies in that the peers had no 
training and delivered a medium-intensity intervention. Resnicow 2004118 provided peers with a 
moderate training, but they delivered a low-intensity intervention, with a significant increase in 
fruit and vegetable consumption.
Dickson-Gomez 200389,90 was allocated a higher rating than Dickson-Gomez 200691,92 as a related 
quantitative study could be identified, which identified successful outcomes.
74 Results of the review
Context of intervention
See Box 9.
By context we are referring to the elements surrounding the intervention that may have 
influenced its development or execution. Rychetnik et al.71 define context as the ‘social, political 
and /or organisational setting in which an intervention was evaluated’. Pawson and Tilley204 
describe context as social and cultural conditions in which mechanisms or interventions 
take place. In this framework, contextual issues should include policy directives, population 
characteristics (in terms of socioeconomic status for example), available evidence, models of 
health care and an understanding of local needs, for example. However, the series of continuums 
developed in the early phases of this review was developed as part of an endeavour to characterise 
HRLA interventions, thus few of the dimensions identified apply here. The following section, 
however, includes a description of the population focus and location of delivery in the included 
studies. The origins characteristic identified initially could not be applied to published evidence, 
as all included studies were developed by the authors.
Population focus
See Box 10.
A detailed analysis of the included studies revealed that this continuum may be simplistic, as the 
study groups included could be characterised in multiple ways. By logistical necessity, all studies 
were within defined geographical areas, but all targeted specific groups. The necessity emerged, 
then, to develop a more detailed categorisation, in eight characteristics that could be used 
simultaneously:
1. people with a shared belief or cultural background
2. people living in a restricted geographical area
3. people with a shared illness experience
4. people at a similar stage of life
5. people engaging in risky behaviours
6. people seeking to engage with services
7. people with similar economic status
8. homeless people.
Whole population within a specified 
locality
Population focus Particular target groups or local 
communities
Bottom up, emergent Origins Top down, mandated
Community setting Context Health-care setting
BOX 9  Context of intervention
Whole population within a specified 
locality
Population focus Particular target groups or local 
communities
BOX 10  Population focus
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The data presentation format (Table 10) was selected to allow highlighting of the challenging 
issue of multiple community definition and allegiances manifested in this review. This emphasises 
what can sometimes be called a hidden complexity in the aim of recruiting LAs from the 
‘relevant’ community.
In Dickson-Gomez 2003,89,90 contextual issues had a major impact on intervention development 
and success. The study took place in Baltimore, MD, USA, where nearly 30% of African-
Americans live below the poverty line, and where drug dealing is the ‘biggest equal opportunities 
employer for bright, ambitious inner-city youth’ (p. 310). In this context, adolescents often have 
to manage their product and their finances, as well as keeping an eye on the police or others who 
could threaten the smooth-running of the business. Outreach could be one such thing.
In Dickson-Gomez 2006,91,92 50% of the LAs considered themselves homeless. This had a great 
impact on their ability to reach other drug users at times and in places where they would not 
otherwise be reached.
Targeting people with a shared belief or cultural background, people engaging in risky behaviours 
or people seeking to engage with services seems to lead to increased chances of achieving 
TABLE 10 Population focus
Study Intervention focus ISa 1 2 3 4 5 6 7 8
Dennis 200288 Breastfeeding M  
Morrow 1999114,115 M  
Barlow 200083 Chronic care M  
Gary 200398–100 L   
Griffiths 2005101,102 L    b
Kennedy 2007104–107 L 
Lorig 1999110 M  
Lorig 2003111 H  
Lujan 2007112 L     
Young 2005121–123 M   b
Anand 200780 Diet and physical 
activity
M   b
Elder 200695,96 M  
Keyserling 2002108,109 M   
Resnicow 2004118 H  
Staten 2004119 H    
Dickson-Gomez 200389,90 HIV infection prevention H   
Dickson-Gomez 200691,92 M   
Ireys 2001103 Mental health M 
Andersen 200042,81,82 Screening uptake M 
Bird 199884–87 H 
Earp 200216,63,93,94 H    
Paskett 2006116,117 M  
Emmons 200526,97 Smoking cessation M  
May 2006113 M  
West 199830 H   b
Woodruff 2002120 M     b
a Intervention success: H, high; M, medium; L, low.
b Study populations described as of low economic status; the assumption is made that the study sample was equally deprived.
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intervention success. On the other hand, targeting people with a shared illness experience or at 
a similar stage of life does not seem to, in itself, lead to successful interventions. Determining 
people’s participation by their place of living or by their socioeconomic status does not seem to 
bear any impact on intervention success.
Location of intervention delivery
See Box 11.
Few of the included interventions took place in a health-care setting, and quite a number of them 
were taking place in participants’ home (Table 11). This meant that, again, a two-dimensional 
continuum could not describe the breadth of interventions. Location of delivery may be an 
indicator of important contextual characteristics of level of formality, attendance and access 
issues. Location may also be determined by the fact that a LA is delivering the service and the 
location opportunities this provides in comparison with a standard care provider.
Griffiths 2005101,102 is the only study that described an intervention that took place in both 
general practices and community centres. Keyserling 2002108,109 describes an intervention that 
was both based in a clinic and made home telephone calls. Ireys 2001103 and Bird 199884–87 
describe an intervention that takes place in the home and which also involved organised activities 
in the community. Staten 2004119 described an intervention in the home and clinic, with the 
organisation of group walks in the local area, and Resnicow 2004118 describes an intervention that 
took place both in the home and in African-American churches. It has to be noted that although 
Keyserling 2002,108,109 Lujan 2007112 and Griffiths 2005101,102 conducted the intervention in a 
primary care clinic, this was with people with a chronic condition who were probably well used 
to being in health-care settings.
In Dickson-Gomez 200389,90 while most outreach activities took place in the community, the LAs 
(for whom the intervention was deemed to lead to risk reduction behaviour) were trained in 
small groups in an unspecified location. Sometimes, the community was not the most conducive 
location, as outreach on the street was following the same patterns as other street interactions 
and could become a struggle for power or be seen as an infringement on adolescents’ hard-
won territory. Conversely, in the home, the street code becomes less important than family 
relationships.
In Dickson-Gomez 200691,92 location was quite crucial, as the authors highlight that different 
types of outreach could be conducted in different locations. For example, conducting outreach 
where drug users were getting high enabled them to correct risky practices, and it would be 
difficult to demonstrate appropriate needle cleaning on the streets. Because LAs were active drug 
users, they had the most up-to-date knowledge about the sites most used, as public drug use sites 
frequently changed location.
In Dickson-Gomez 200691,92 50% of the LAs considered themselves homeless. This had a great 
impact on their ability to reach other drug users at times and in places where they would not 
otherwise be reached.
Community setting Context Health-care setting
BOX 11  Location of intervention delivery
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TABLE 11 Intervention location
Location Studies Intervention focus ISa
Home (visits/telephone/both) Dennis 200288 Breastfeeding M
Morrow 1999114,115 M
Gary 200398–100 Chronic care L
Young 2005121–123 M
Anand 200780 Diet/physical activity M
Elder 200695,96 M
Keyserling 2002108,109 M
Resnicow 2004118 H
Staten 2004119 H
Ireys 2001103 Mental health M
Andersen 200042,81,82 Screening uptake M
Bird 199884–87 H
Paskett 2006116,117 M
Emmons 200526,97 Smoking cessation M
West 199830 H
May 2006113 M
Woodruff 2002120 M
Health-care setting Griffiths 2005101,102 Chronic care L
Lujan 2007112 L
Keyserling 2002108,109 Diet/physical activity M
Community Barlow 200083 Chronic care M
Griffiths 2005101,102 L
Kennedy 2007104–107 L
Lorig 1999110 M
Lorig 2003111 H
Resnicow 2004118 Diet/physical activity H
Staten 2004119 H
Dickson-Gomez 200389,90 HIV infection prevention H
Dickson-Gomez 200691,92 M
Ireys 2001103 Mental health M
Andersen 200042,81,82 Screening uptake M
Bird 199884–87 H
Earp 200216,63,93,94 H
a Intervention success: H, high; M, medium; L, low.
Andersen 200042,81,82 described two intervention arms, one consisting of telephone counselling 
and the other one of an array of CAs. Although they compared the effectiveness of either 
approach or a combination of both, it seems that intervention effectiveness was linked more to 
the amount of time volunteers spent implementing the intervention than to the intervention 
setting per se.
Interventions that took place in the community tended to be more successful than those taking 
place in health-care settings.
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Mechanism
See Box 12.
Exploration of the mechanism aspect of the HRLA interventions is with the intent of enabling 
the surfacing of the detail of the intervention. In this section, studies are grouped according 
to the components of the interventions described and the characteristics of the LAs delivering 
the interventions, in order to facilitate an understanding of which components of the HRLA 
interventions contribute to, or hinder, an interventions’ effectiveness and acceptability. 
Components considered are the interventions’ aim, theoretical underpinning, approach, the 
practitioners’ type, level of training, the nature of their role, and the intervention intensity. The 
dimensions of referral route and hours of work, while important in practice, were not reflected in 
the studies included, as participants were invited to take part in a study (rather than referred to a 
service), and LAs were recruited to undertake the study, rather than being employed.
Intervention aim
See Box 13.
All of the interventions described were targeted to particular topic areas (Table 12). It thus 
became quickly evident that a classification of ‘generic versus targeted’ would not do justice to the 
breadth of interventions described, and the reviewers decided to place intervention activities on 
a continuum of health improvement, targeting groups of people considered at risk, well or with a 
diagnosed chronic condition.
Of note is the fact that no intervention tackled health maintenance, in any population. That is 
to say, studies on chronic conditions, for example, focused on the management of the chronic 
condition or on health issues directly related to it, rather than on other aspects of people’s health. 
An exception to this, however, is Kennedy 2007104–107 who examined exercise and diet. Similarly, 
for people identified at risk of a particular issue, interventions focused on preventing this from 
happening, rather than encouraging them to be otherwise healthy or to take up screening (e.g. in 
Anand 200780 participants had an average BMI of 34.8 at the onset of the study).
It is of note that with the exception of Gary 200398–100 and Keyserling 2002108,109 (although other 
issues such as social issues or smoking cessation, are said to be addressed, no outcomes have been 
measured for these) all of the studies targeting people with a shared illness experience focused on 
that illness in their intervention. This is also true of studies that targeted people engaging in risky 
Dimension
Community outreach Referral Biomedical referral model
Part-time/sessional workers Hours Full-time advisors/trainers
BOX 12 Mechanism
Generic, focus on overall health and 
well-being
Topic focus Targeted, focus on specific health 
topics or behaviours
BOX 13 Intervention aim
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behaviours: they all focused on these behaviours, rather than, for example, on diet and physical 
activity. The reverse is also true: studies that focused on diet/physical activity, breastfeeding or 
screening uptake did not identify engagement in risky behaviours (i.e. smoking).
Interventions that engaged in health promotion (regardless of the health status of participants) 
and screening participation tended to lead to successful outcomes. Interventions that aimed at 
disease prevention tended to be more successful when they targeted people at risk of disease 
(rather than people already diagnosed).
Theoretical underpinnings
Although not described in the original series of continuums, most studies described some 
theoretical underpinning. It was thus thought important to describe these (Table 13). The 
theoretical bases of studies were collated and grouped in three broad categories: those aiming at 
individual behaviour change, those building on social learning or influence, and those with an 
emphasis on communication or learning strategies.
Although Lorig 2003111 do not mention the theoretical basis of the intervention, it is based on the 
same theory as their previous study,110 so it seems reasonable to assume that it borrowed from 
TABLE 12 Intervention aim
Intervention activity Population Studies Intervention focus ISa
Health promotion At risk Anand 200780 Diet/physical activity M
Chronic condition Keyserling 2002108,109 Diet/physical activity M
Well Dennis 200288 Breastfeeding M
Morrow 1999114,115 M
Elder 200695,96 Diet/physical activity M
Resnicow 2004118 H
Staten 2004119 H
Ireys 2001103 Mental health M
Disease prevention At risk Dickson-Gomez 200389,90 HIV infection prevention H
Dickson-Gomez 200691,92 M
Emmons 200526,97 Smoking cessation M
May 2006113 M
West 199830 H
Woodruff 2002120 M
Chronic condition Barlow 200083 Chronic care M
Gary 200398–100 L
Griffiths 2005101,102 L
Kennedy 2007104–107 L
Lorig 1999110 M
Lorig 2003111 H
Lujan 2007112 L
Young 2005121–123 M
Screening 
participation
Well Andersen 200042,81,82 Screening uptake M
Bird 199884–87 H
Earp 200216,63,93,94 H
Paskett 200616,117 M
a Intervention success: H, high; M, medium; L, low.
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TABLE 13 Theoretical underpinnings
Aim Theoretical underpinning Studies ISa Intervention focus
Behaviour change Stages of Change Model Elder 200695,96 M Diet/physical activity
Transtheoretical model of change Keyserling 2002108,109 M Diet/physical activity
Paskett 2006116,117 M Screening uptake
Emmons 200526,97 M Smoking cessation
Motivational interviewing Resnicow 2004118 H Diet/physical activity
Emmons 200526,97 M Smoking cessation
Young 2005121–123 M Chronic care
Behaviour modification principles Keyserling 2002108,109 M Diet/physical activity
Gary 200398–100 L Chronic care
Cognitive and affective process 
strategies from theories of behaviour 
change
Dickson-Gomez 
200389,90
H HIV infection prevention
Behavioural change theory Earp 200216,63,93,94 H Screening uptake
The communication behaviour change 
model
Paskett 2006116,117 M Screening uptake
Theoretical model of self-efficacy Griffiths 2005101,102 L Chronic care
Lorig 1999110 M Chronic care
Self-efficacy theory Barlow 200083 M Chronic care
Social learning/social 
influence
Social learning theory Anand 200780 M Diet/physical activity
Paskett 2006116,117 M Screening uptake
Kennedy 2007104–107 L Chronic care 
Social Cognitive Theory/principles Keyserling 2002108,109 M Diet/physical activity
Emmons 200526,97 M Smoking cessation
Woodruff 2002120 M Smoking cessation
Theories of social influence, social 
diffusion and social identity
Dickson-Gomez 
200389,90
H HIV Prevention
Normative influence Anand 200780 M Diet/physical activity
Network diffusion model and Dynamic 
Social Impact Theory
Dickson-Gomez 
200691,92
M HIV infection prevention
Social–Ecological Model Resnicow 2004118 H Diet/physical activity
Earp 200216,63,93,94 H Screening uptake
Emmons 200526,97 M Smoking cessation
Social support Gary 200398–100 L Chronic care
Middle range theory of community 
empowerment
Lujan 2007112 L Chronic care
Communication/learning 
principles
Active learning discovery approach Keyserling 2002108,109 M Diet/physical activity
Adult learning principles Keyserling 2002109,110 M Diet/physical activity
Gary 200398–100 L Chronic care
Theories of persuasion Anand 200780 M Diet/physical activity
Minority Health Communication Model Paskett 2006116,117 M Screening uptake
Theories of decision-making Andersen 200042,81,82 M Screening uptake
a Intervention success: H, high; M, medium; L, low.
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self-efficacy models. Although Ireys 2001103 do not reference supportive theory, they based the 
intervention on previous studies that stated the importance of social networks for well-being.
Elder 200695,96 is the only study that reported relying on behaviour change theories only. The 
evidence suggests202,205 that this may not lead to the most successful outcomes, and most other 
studies used behaviour change in conjunction with other models. Perhaps interestingly, the 
three studies that reported using self-efficacy theory83,101,102,110 focused on chronic care. Kennedy 
2007104–107 and Resnicow et al.118    measured self-efficacy as an outcome, but did not report using 
this model. Most of the studies included in this review based their intervention on theoretical 
bases that capitalise on social networks and influences.
Interventions involving theoretical underpinning seemed to have no bearing on intervention 
success status.
Intervention approach
See Box 14.
None of the studies included in this review reported on community development or engagement 
activities (although some describe efforts to engage participants, this was seen as a mean to 
participation in the study rather than an outcome to be assessed). The approaches adopted 
were more complex and often multicomponent, rendering the second continuum insufficient 
to describe the interventions included. The following distinctions were used to describe 
intervention approaches (Table 14): (1) delivery of a standardised message; (2) nurture 
population groups into behaviour change in line with those messages; (3) create a social context 
within which change is more likely to happen; and (4) remove barriers to access services or 
change behaviour.
Dickson-Gomez 200389,90 described a unique approach, in that the lifestyle advice activity 
was deemed to impact on the LAs themselves (impact on the community not measured), as 
the activity sought to capitalise on African-American drug user’s strong sense of community 
identity, and to increase the participants’ sense of self-identity as community members who could 
improve the health and well-being of family and friends. The LAs in Dickson-Gomez 200389,90 
were often perceived as visible signs of failure by the youth encountered on the street, particularly 
if the advice was given in a moralising tone.
Dickson-Gomez 200691,92 describe on the surface a very straightforward distribution of 
prevention materials and slogans, but because they achieved very good penetration of an 
otherwise hard-to-reach population group, it would be insufficient to describe the intervention 
as information-giving. Because many LAs were living on the streets, they were available to drug 
users in a way that no other outreach worker could be. Some of the LAs who had a home, and 
were making it available to drug-using members of their close network, were in a privileged 
position to nurture these drug users to use harm reduction strategies. They described drug users 
knocking on their door in the middle of the night to ask for prevention material as they became 
known for their prevention work.
Community development and 
engagement
Main activities Evidence-based lifestyle advice, 
goal-setting
Nurturing and supporting Approach Information-giving and signposting
BOX 14 Intervention approach
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Interventions that used a strategy of nurturing to facilitate behaviour change tended to be less 
successful than others; this is true too of interventions that used multipronged approaches 
(interventions using three of the strategies listed).
Intervention delivery mode
See Box 15.
These two continuums were combined in one bidimensional figure (Figure 5), with the intention 
of mapping out the breadth of intervention delivery modes and, potentially, identifying gaps.
TABLE 14 Intervention approach
Studies Intervention focus ISa Message delivery
Nurturing for 
behaviour 
change
Creation of 
supportive social 
conditions Barrier removal
Earp 200216,63,93,94 Screening uptake H  
Bird 199884–87 H 
Andersen 200042,81,82 M  
Paskett 2006116,117 M  
Gary 200398–100 Chronic care L   
Young 2005121–123 M  
Barlow 200083 M 
Griffiths 2005101,102 L 
Kennedy 2007104–107 L  
Lorig 1999110 M   
Lorig 2003111 H 
Lujan 2007112 L  
Woodruff 2002120 Smoking cessation M 
West 199830 H 
May 2006113 M 
Emmons 200526,97 M  
Anand 200780 Diet/physical activity M   
Elder 200695,96 M 
Keyserling 2002108,109 M 
Resnicow 2004118 H 
Staten 2004119 H  
Dennis 200288 Breastfeeding M 
Morrow 1999114,115 M 
Ireys 2001103 Mental health M 
Dickson-Gomez 200389,90 HIV infection 
prevention
H  
Dickson-Gomez 200691,92 M   
a Intervention success: H, high; M, medium; L, low.
Informal Level of formality Formal
Group or community work Mode of delivery One-to-one intervention
BOX 15 Intervention delivery mode
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Figure 5 situates included studies according to whether they targeted individuals, groups or 
the general population, and according to the degree of formality of the intervention. Degree of 
formality was assessed by taking into account the degree of intervention standardisation of both 
the number and content of contacts with study participants.
Most interventions are situated in the upper half of the chart, indicating greater intervention 
formality, and towards the left-hand side, indicating a preference for individually targeted 
interventions. Interventions targeted at people with chronic conditions most often targeted 
groups, as per the Lorig 1999110 model. Anand 200780 is the only intervention targeting families 
and allowing LHAs to tailor frequency and content of contact. Dickson-Gomez 2003,89,90 and 
200691,92 are the only interventions describing opportunistic meetings with drug users, at times 
and places most suited to them. The review does not include any informal intervention targeted 
at wider population groups. Interventions that were either highly formalised and targeting the 
general population or informal but targeting the individual tended to be more successful.
Role/training
Practitioner type
See Box 16.
FIGURE 5 Intervention formality. BF, breastfeeding; CC, chronic conditions; HIV, HIV intervention; MH, mental health; 
D&PA, diet and physical activity; SC, smoking cessation; SU, screening uptake. Intervention success: H, high; M, 
medium; L, low.
One-to-one highly scripted contacts:
Young 2005121–123 (CC, M)
Woodruff 2002120 (SC, M)
Paskett 2006116,117 (SU, M)
Keyserling 2002108–109
(D&PA, M)
Contact frequency specified
but content semi-structured:
Elder 200695,96 (D&PA, M)
Morrow 1999114–115 (BF, M)
High intervention formality
Low intervention formality
Anand 200780 (D&PA, M)
Groups:
Lorig 1999110 (CC, M)
Lorig 2003111 (CC, H)
Barlow 200083 (CC, M)
Griffiths 2005101–102 (CC, L)
Kennedy 2007104–107 (CC, L)
Groups and one-to-one
follow-up:
Staten 2004119 (D&PA, H)
Lujan 2007112 (CC, L)
General population highly scripted:
Bird 199884–87 (SU, H)
Andersen 200042,81,82 (SU, M)
General populationIndividual
Emmons 200526,97 (SC, M)
Gary 200398–100 (CC, L)
Ireys 2001103 (MH,  M)
Contact on demand:
Dennis 200288 (BF, M)
West 199830 (SC, H)
May 2006113 (SC, M)
Opportunistic contacts:
Dickson-Gomez 200389,90 (HIV, H)
Dickson-Gomez 200691,92 (HIV, H)
General population and one-to-
one follow-up semistructured:
Resnicow 2004118 (D&PA, H)
Earp 200216,63,93,94 (SU, H)
Peer or lay led Practitioner type Professionally driven
BOX 16 Role/training
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None of the studies included described a professionally driven intervention. Equally, none 
distinguished between peer and lay roles. Table 15 describes three kinds of peer roles: peer 
with common personal experience; peer with a shared community; peer with both a common 
experience and community; and not a peer.
It is of note that studies that tended to use peers with a common cultural/socioeconomic 
background were more often conducting general health promotion activities (Table 15). The 
detail of peership is unclear in Gary 200398–100 as although the LA is described as ‘local’; the 
details of this locality (geographical or cultural) or their gender (75% of the participants were 
female) or life experience with regards to diabetes are not given.
In Dickson-Gomez 200389,90 LAs were older, previous or current drug-using African-Americans, 
targeting younger people often involved in selling drugs. The study highlights how intervention 
by men could lead to a struggle for respect, whereas there was more chance of a successful 
outreach encounter when the LA was more mature woman who could be perceived as a mother 
figure.
TABLE 15 Practitioner type
Practitioner type Studies Intervention focus Details of ‘peership’ ISa
Peer with common 
personal experience
Dennis 200288 Breastfeeding Multiparous volunteers with at least a 6 months’ 
positive experience of breastfeeding
M
Kennedy 2007104–107 Chronic care People with chronic conditions L
Lorig 200314 H
Lorig 1999110 M
Barlow 200083 M
Ireys 2001103 Mental health Mothers with children with the same chronic 
conditions
M
Emmons 200526,97 Smoking cessation Smoking survivors of childhood cancer M
May 2006113 Smoking buddies M
West 199830 Smoking buddies H
Peer with a shared 
community
Morrow 1999114,115 Breastfeeding Resident of San Pedro Mártir, Mexico M
Lujan 2007112 Chronic care Mexican-Americans L
Anand 200780 Diet/physical activity Aboriginal origin M
Elder 200695,96 Spanish-Latinas M
Resnicow 2004118 African-American churchgoers H
Staten 2004119 Hispanic women H
Dickson-Gomez 
200389,90
HIV infection prevention African-American people living in Baltimore, MD H
Andersen 200042,81,82 Screening uptake Women between 50 and 80 years old from 40 
communities in Washington state
M
Bird 199884–87 Vietnamese-speaking women H
Earp 200216,63,93,94 African-American women in five counties of NC H
Paskett 2006116,117 Native American and African-American women M
Woodruff 2002120 Smoking cessation Latino paraprofessional community members M
Peer with both a 
common experience 
and community
Dickson-Gomez 
200691,92
HIV infection prevention Drug using experiences in the intervention area M
Griffiths 2005101,102 Chronic care Bangladeshi people with chronic diseases L
Keyserling 2002108,109 Diet/ physical activity African-American women with type 2 diabetes M
Not a peer Gary 200398–100 Chronic care A local high school graduate L
Young 2005121–123 Call centre operatives M
a Intervention success: H, high; M, medium; L, low.
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In Earp 200216,63,93,94 women who were interviewed about their experiences of interactions with 
LAs indicated that ‘the LAs own mammography behaviour did not influence whether they 
listened to the LAs’ advice or decided to get mammograms’, perhaps questioning the need for 
health-related LAs to have common personal experience. In Earp 2002,16,63,93,94 however, those 
who had received counselling from LAs did assign credibility to the LAs for having had personal 
or professional experience of breast cancer.
Although in Resnicow 2004118 efforts were made to recruit LAs with a college degree or graduate-
level education, and a background in a helping profession, they were classified as peers with a 
shared community as, in common with the study participants, they were African-American 
churchgoers. Where possible, advisors in Ireys 2001103 were also in close geographical proximity 
to the participants.
Interventions using peers with a shared community tended to be the most successful.
Level of training
See Box 17.
LAs’ qualification status prior to the study was not always described, and most LAs were paid a 
fee for their participation in the study, but this could not be described as a salary. However, some 
level of training was most often described and is categorised in Table 16:
 ■ No training
 ■ Moderate technical (health-related) training If training was < 10 hours overall, or if the 
training was purely related to intervention delivery or communication skills (as opposed to 
more in-depth knowledge about health or disease)
 ■ Intensive training If it was 10 hours or more, and focused on technical health/disease related 
issues
 ■ Not described
 ■ Professionally trained If the health advisor had had previous professional training (as a nurse 
for example) or if they had a minimum of 1 year’s practice experience in a field directly 
relevant to the intervention.
The level of LA training was only partly related to their experience, as both people who were not 
peers116,117,121–123 and people who both had a personal experience and a cultural/socioeconomic 
background in common with study participants91,92,108,109,114,115 received intensive training before 
the start of the intervention. This is true too of their professional background, as, although the 
LAs were provided with a moderate technical training, they had previously been professionally 
trained in Resnicow 2004.118 Of note is Paskett 2006116,117 in which some LAs were professionally 
qualified (as a nurse and social worker), but nevertheless received intensive training in order to 
enable them to increase awareness of the importance of mammogram screening and increase the 
uptake of it.
Unqualified, low/no skill Skill level Qualified, highly skilled
Unpaid volunteers Nature of role Paid employees
BOX 17  Level of training
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May 2006,113 Staten 2004119 and West 199830 are the only studies in which LAs received no 
training, as they were ‘buddies’ in a smoking cessation intervention, and attempting to stop 
smoking themselves in May 2006113 and West 1998,30 and women previously trained as CHWs 
in Staten 2004.119 The training in Elder 200695,96 is different from most of the other studies, as the 
sessions were based on informal discussions between those training to become promotores.
Interventions that used moderate or no technical training tended to be the most successful.
TABLE 16 Level of practitioner training
Intensity of 
training Studies Intervention focus ISa Training focus
Intensive 
technical training
Morrow 1999114,115 Breastfeeding M Breastfeeding technique and promotion
Lujan 2007112 Chronic care L Diabetes self-management
Young 2005121–123 M Diabetes and motivational interviewing
Griffiths 2005101,102 L Expert Patients Programme standard training procedure
Lorig 1999110 M Focus of the training is not described
Lorig 2003111 H Training in the use of the protocol and practice teaching sessions
Kennedy 2007104–
107
L Includes a large amount of observed delivery of sessions, after 
which feedback is given
Barlow 200083 M Very little detail givenb
Keyserling 
2002108,109
Diet/physical activity M Diet and physical activity in diabetes management, general 
diabetes care, diabetes resources, listening skills, skills in stress 
management, goal-setting and problem-solving
Dickson-Gomez 
200389,90
HIV infection prevention H Sexual and drug risk reduction
Dickson-Gomez 
200691,92
M Harm reduction and health advocacy
Ireys 2001103 Mental health M Enhancing skills in listening, reflecting and ‘story swapping’
Paskett 2006116,117 Screening uptake M Breast cancer development and screening
Woodruff 2002120 Smoking cessation M Didactic methods, motivational interviewing
Moderate 
technical training
Dennis 200288 Breastfeeding M Breastfeeding, communication skills
Anand 200780 Diet/physical activity M Assessment and setting of dietary and physical activity goals
Resnicow 2004118 H Motivational interviewing techniques
Earp 200216,63,93,94 Screening uptake H Brest cancer screening
No training Staten 2004119 Diet/physical activity H No training
May 2006113 Smoking cessation M No training
West 199830 H No training
Training not 
described
Gary 200398–100 Chronic care L Not described
Elder 200695,96 Diet/physical activity M Insufficient details given
Andersen 
200042,81,82
Screening uptake M Not described
Bird 199884–87 Screening uptake H Not described
Emmons 200526,97 Smoking cessation M Not described
a Intervention success: H, high; M, medium; L, low.
b Although Barlow et al.83 provided very little detail about the training format, but they mention that training was provided by Arthritis Care and 
they work on the model developed by Lorig and Holman,127 so the assumption was made on training intensity.
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Intensity of intervention
See Box 18.
A review of the interventions described quickly revealed that frequency was only one dimension 
of intervention intensity. What is meant here by intervention intensity is the amount of 
intervention exposure received by participants (Table 17). It has been calculated taking into 
account the population level targeted (general population, small groups of people, family, 
One-off contact Frequency Iterative, ongoing intervention
BOX 18 
TABLE 17 Intervention intensity
Intensity of 
intervention Studies Intervention focus Details ISa
High intensity Barlow 200083 Chronic care Six 2-hour sessions held weekly M
Griffiths 1998101,102 Six weekly 3-hour sessions L
Kennedy 2002104–107 Six 2.5-hour group sessions held weekly L
Lorig 1999110 Seven 2.5-hour group sessions held weekly M
Lorig 2003111 Six 2.5-hour group sessions held weekly H
Lujan 2007112 Eight weekly group sessions; telephone conversation and 
postcards biweekly for 16 weeks
L
Medium intensity bMorrow 1999114,115 Breastfeeding Three or six sessions M
cAnand 200780 Diet/physical activity Regular home visits M
bElder 200695,96 Fourteen home visits/telephone calls and 12 newsletters M
bStaten 2004119 Provider counselling, monthly newsletter, two health 
education sessions, two weekly telephone calls
H
Dickson-Gomez 
200389,90
HIV infection prevention Intervention was the training of LAs H
Ireys 2001103 Mental health Seven visits of 60–90 minutes, telephone calls, three 
special events over a 15-month period
M
Woodruff 2002120 Smoking cessation Four home visits, 1–2 hours long, three telephone calls 
15–30 minutes long, over 78 days
M
Low intensity Dennis 200288 Breastfeeding Five or more telephone calls over 3 months M
Gary 200398–100 Chronic care Sixty-two per cent of participants received at least three 
visits over the 2 years
L
Young 2005121–123 Four to 12 20-minute telephone calls over 12 months M
Keyserling 2002108,109 Diet/physical activity On average, 9.7 calls per participant M
dResnicow 2004118 Not all participants got intervention exposure H
Andersen 200042,81,82 Screening uptake One telephone call/3 years and/or CA M
dBird 199884–87 Not all participants got intervention exposure H
dEarp 200216,63,93,94 Not all participants got intervention exposure H
Paskett 2006116,117 Regular home visits and follow-up telephone calls M
bEmmons 200526,97 Smoking cessation Up to six telephone calls over a period of 7 months M
bMay 2006113 In the first week, 2.7 telephone calls. This dropped to 1.2, 
1.1 and 0.7 in the following weeks
M
bWest 199830 On average, 3.5 times over the 4-weeks study H
a Intervention success: H, high; M, medium; L, low.
b Studies for which contact duration was not stated and was estimated at 20 minutes/telephone call and 30 minutes/home visit.
c Study in which neither the number nor the duration of contacts was reported; it was classified as ‘medium intensity’.
d Studies in which the general population was targeted, and in which not all participants were exposed to the intervention – they were therefore 
classified as ‘low intensity’.
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individual); the nature of the contacts with the LA (group sessions, telephone calls, face to 
face); supporting intervention components (leaflets, newsletters, provision of NRT, referral 
to other professionals, etc.); and the average number of sessions, average duration of sessions 
and the overall duration of the intervention. An intensity score was developed from this (see 
Appendix 11). Scores < 15 are considered as a low intervention intensity; 16–69, medium 
intervention intensity; and > 70, high intervention intensity.
Six studies reported on a high level of intervention intensity; all of them targeted people with 
chronic conditions. They used a variety of LA training intensity and all LAs were peers.
Seven studies reported on medium-level intervention intensity, even if for four of these the rating 
had to be based on estimates. They used a variety of training intensity, but they all involved LAs 
with a shared community, except Ireys 2001103 who used LAs with a shared experience, who were 
also geographically close to participants where possible.
Twelve studies reported on low-level intervention intensity. Of note is that all of the screening 
uptake studies belong to that category. Dennis 200288 found a lack of association between 
frequency of LA contact and infant feeding practices. It was not possible to assess intervention 
intensity in Dickson-Gomez 2006.91,92
Interventions of a high intensity tended to be the least successful, and those of a moderate 
intensity tended to be the most successful.
Outcomes
See Box 19.
None of the studies included measured enhanced capacity or social capital. However, few 
measured individual behaviour change, and most assessed some measure of health status, 
sometimes as an indicator of behaviour change. Tables 18–20 report on the outcomes measured 
in the included studies, grouped in measures of health status, behaviour change and change in 
beliefs and attitudes.
Health status (body function)
Chronic care interventions measured the majority of health status outcomes. No such outcomes 
were measured for interventions targeting breastfeeding, smoking cessation, HIV infection 
prevention or screening.
Health behaviours (activity)
Because most interventions included had a single intervention focus, their outcome measurement 
related to the behaviour change required to tackle that focus.
Enhanced capacity and social 
capital within communities
Key outcomes Health behaviour change within 
individual clients
BOX 19 Outcomes
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TABLE 18 Measurement of health status
Measure Studies Intervention focus
General health Barlow 200083 Chronic care
Kennedy 2007104–107
Lorig 1999110
QoL (measured by EQ-5D) Griffiths 2005101,102 Chronic care
Kennedy 2007104–107
Psychological well-being (included anxiety and 
depression, positive and negative affect)
Barlow 200083 Chronic care
Griffiths 2005101,102
Kennedy 2007104–107
Lorig 1999110
Keyserling 2002108,109 Diet/physical activity
Ireys 2001103 Mental health
Physiological measures (HbA1c, cholesterol, 
blood pressure)
Gary 200398–100 Chronic care
Lujan 2007112
Young 2005121–123
Keyserling 2002108,109 Diet/physical activity
Staten 2004119
Pain Barlow 200083 Chronic care
aGriffiths 2005101,102
Kennedy 2007104–107
Lorig 1999110
Lorig 2003111
Fatigue Barlow 200083 Chronic care
Griffiths 2005101,102
Kennedy 2007104–107
Lorig 2003111
Lorig 1999110
Weight/BMI/waist circumference, skinfold 
thickness, body fat percentage
Gary 200398–100 Chronic care
Diet/physical activityAnand 200780
Keyserling 2002108,109
Staten 2004119
a Also measured shortness of breath.
Health-care beliefs and knowledge (personal factors)
In Anand 200780 change in knowledge about diet was assessed in children but not in adults. 
Paskett 2006116,117 also measured change in reported barriers to mammography uptake. There 
were no measures of self-reported competency, confidence or complaints.
Self-efficacy was measured only in studies tackling chronic care as part of an Expert Patients 
Programme.101,102,104–107 Dickson-Gomez 200389,90 measured self-efficacy in conducting outreach 
but found no statistical difference between the intervention and control groups. Interestingly, 
Keyserling 2002108,109 was the only study targeting people with chronic conditions, adopting a 
health promotion approach and assessing the knowledge gained as a result of it. No other study 
using a health-promoting approach measured the knowledge gained as a result of it.
In Dickson-Gomez 200691,92 LAs reported increased knowledge about HIV infection risk 
prevention, and many reported engaging in safer practices, reducing their drug consumption or 
stopping usage altogether.
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TABLE 19 Measurement of health behaviours
Measure Studies Intervention focus
Physical activity (duration of exercise, energy 
expenditure)
Gary 200398–100 Chronic care
Kennedy 2007104–107
Lorig 1999110
Lorig 2003111
Anand 200780 Diet/physical activity
Keyserling 2002108,109
Staten 2004119
Self-care Griffiths 2005101,102 Chronic care
Gary 200398–100 Chronic care
Consumption of tobacco Emmons 200526,97 Smoking cessation
May 2006113
West 199830
Woodruff 2002120
Diet (energy intake, intake of fats, fruits and 
vegetables)
Gary 200398–100 Chronic care 
Kennedy 2007104–107
Anand 200780 Diet/physical activity
Elder 200695,96
Keyserling 2002108,109
Resnicow 2004118
Staten 2004119
Breastfeeding Dennis 200288 Breastfeeding
Morrow 1999114,115
Safe sex/drug use Dickson-Gomez 200389,90 HIV infection prevention
Uptake of/up-to-date screening Andersen 200042,81,82 Screening uptake
Bird 199884–87
Earp 200216,63,93,94
Paskett 2006116,117
TABLE 20 Measurement of health-care beliefs and knowledge
Measure Studies Intervention focus
Self-efficacy Barlow 200083 Chronic care
Griffiths 2005101,102
Kennedy 2007104–107
Resnicow 2004118 Diet/physical activity
Knowledge Lujan 2007112 Chronic care
Keyserling 2002108,109 Diet/physical activity
Bird 199884–87 Screening uptake
Paskett 2006116,117
Change in attitudes and beliefs Lujan 2007112 Chronic care
Resnicow 2004118 Diet/physical activity
Paskett 2006116,117 Screening uptake
Communication with health-care providers Griffiths 2005101,102 Chronic care
Kennedy 2007104–107
Lorig 2003111
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Intervention acceptability
Dennis 200288 studied participants’ degree of satisfaction with their peer support experience. 
Only three mothers (of the 130 participants) were dissatisfied with the support offered by the 
LA, but all of the participants felt that every new breastfeeding mother should be offered peer 
support. Dennis 200288 also found that the frequency of LA contact was significantly related to 
the mother’s perceptions of peer support (data not provided). In Dickson-Gomez 200389,90 the 
intervention proved highly acceptable to the LAs, who felt that they had become more valued 
part of their community through it. The context of their intervention on the street impacted 
greatly on the acceptability of their approach to the young people they were targeting. This is very 
similar in Dickson-Gomez 200691,92 where LAs reported gaining support and respect from their 
community members for their prevention work. In Gary 200398–100 intervention participation 
was much higher in the LA group versus nurse case manager, suggesting greater intervention 
acceptability.
In Earp 200216,63,93,94 most of the respondents who had received counselling by the LAs indicated 
that they felt comfortable talking to the LA about breast cancer screening – they felt close to the 
LAs; the LAs were a credible source of information and were seen as friendly, understanding, 
open-minded, ‘plain talking’ and able to motivate. However, there may be a need to treat these 
results with caution, as the LAs themselves suggested the names of interviewees and were often 
related to them.
Resnicow 2004118 measured the acceptability of the intervention, finding that 77% of participants 
reported being very satisfied with the cookbook and educational materials, and 72% of those 
receiving at least one call reported being very satisfied with their volunteer advisors.
Young 2005121-123 measured satisfaction with treatment and intervention acceptability and found a 
50% support rate for this intervention format.
West 199830 mention that the intervention was well accepted. However, while the authors advised 
buddies to contact each other at least once a day for the first week, the average frequency of 
contact was only 2.7, which may suggest moderate intervention acceptability.
Keyserling 2002108,109 measured programme acceptability. For the health advisor component, 
85% of 59 respondents felt the number of telephone calls by the LA was appropriate, 86% felt the 
role of the advisors in the programme was important, and 83% strongly agreed that talking to 
someone else with diabetes was very helpful.
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Section 3: analySiS of coSt-effectiveneSS
Introduction
The impact of behaviour and lifestyle changes on HRQoL and health-care costs is highly 
dependent on the potential disease risks averted and the impact of behavioural changes on those 
risks. The assessment of the cost-effectiveness of LA programmes has been considered separately, 
therefore, for each behaviour change or disease risk averted. Within the eight areas identified in 
the review, the papers typically report common outcome measures, allowing comparisons where 
appropriate. Estimates of the effectiveness of the LA programmes are informed from the studies 
reviewed. Few studies reported costs; hence these have been estimated where necessary. Likewise, 
few studies measured changes in quality-adjusted life-years (QALYs). The long-term gains in 
HRQoL arising from changes in behaviour are estimated from appropriate literature sources. 
The synthesis of the resulting cost and outcome data provides estimates of the cost-effectiveness 
of LAs in each of the eight areas identified. The resulting evaluations indicate in which disease/
behaviour areas application of LAs may be cost-effective, and where they are not, although the 
estimates are subject to considerable uncertainty. Only one of the included studies specifically 
compared a lay- and professional-led intervention, and, consequently, the economic analysis has 
not specifically compared the cost-effectiveness of lay- versus professionally-led interventions. 
A comparison with professional-led services has been undertaken whereby data are available 
(smoking cessation). In all other cases the LA intervention is compared with no intervention.
Implementing health economic evaluations
Despite the documented difficulties there is increasing literature on the economic evaluation of 
public health initiatives.206,207 The majority of evaluations are cost–consequence analyses or cost-
effectiveness analyses, although a minority do report outcomes in QALYs or disability-adjusted 
life-years (DALYs).208 A number of authors have developed or applied models to estimate the 
long-term health gains from public health interventions.209–215
It may not always be necessary to construct a model to estimate health gains; published results 
from studies examining clinical interventions can sometimes be applied to public health 
interventions seeking to promote service use or lifestyle changes leading to similar physiological 
outcomes. Mason et al.123 have illustrated a method of estimating the cost-effectiveness of 
promoting behavioural changes from data on the impact of the intervention on behaviour, and an 
estimate of the underlying cost-effectiveness of the behaviour change.123 The approach is similar 
to a previous evaluation of a church-based mammography promotion intervention undertaken 
by Stockdale et al.216 Both approaches stem from the observation that the cost-effectiveness 
of a health promotion programme is a ratio of the change in total costs to the change in total 
benefits, with the total costs being the sum of the costs of the health promotion intervention 
and the costs incurred from the underlying behaviour change promoted. This formulation is 
easily manipulated to isolate the cost-effectiveness of the underlying behaviour change added to 
a ‘loading factor’ representing the impact of the health promotion. A simplified version of the 
derivation from Mason et al.123 is reproduced below:
Policy cost-effectiveness ∆CEp = ∆Cp/∆Bp 
 = (∆ci + ∆Ct)/∆Bp 
 = (∆pi ×∆ci/∆bt) + ∆CEt [Equation 1]
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where:
■■ ∆CEp is the cost-effectiveness of the programme
■■ ∆CEt is the cost-effectiveness of the underlying behaviour change
■■ ∆Cp is the change in overall costs from the programme
■■ ∆Bp is the change in overall health benefits from the programme
■■ ∆ci is cost of the health promotion programme
■■ ∆Ct is the change in costs from the underlying behaviour change
■■ ∆pi is the proportional effect of the health promotion programme on the underlying health 
behaviour relative to the change required to achieve a gain of ∆bt
■■ ∆bt is the health benefit from the change in the underlying health behaviour.
This formulation highlights the fact that health promotion programmes can never be more cost-
effective than the cost-effectiveness of the underlying behaviour change. Promotion programmes 
are unlikely to be cost-effective if the health care promoted is marginally cost-effective. Despite its 
simplicity there are drawbacks to this approach. Lifestyle changes such as smoking cessation and 
increasing physical activity are unlikely to increase health-care resource utilisation; in fact they 
are likely to reduce it. The resulting negative cost-effectiveness ratios ∆CEt are rarely reported. 
Data from medical trials require careful scrutiny, as calculated cost-effectiveness ratios may 
include health-care resource utilisation not relevant to a public health intervention. Care is also 
required in the consideration of relapse rates.
Cost-effectiveness estimates in this chapter
While the approach of Mason et al.123 has value, it is not readily applicable to behaviour changes 
that reduce health-care costs. We applied data on the costs and health gains of behaviour changes 
and the costs of LA interventions, rather than utilising reported cost-effectiveness ratios in 
Equation 1. We took estimates of effect sizes and costs of LA interventions from the studies 
reviewed. Estimates of health benefits are subject to inevitable uncertainty, but this approach is 
a standard method of estimating the benefits of medical interventions.217 However, considerable 
additional uncertainty is introduced through the estimation of relapse rates. Where data are 
unavailable, and relapse rates are likely to influence cost-effectiveness conclusions, we present 
sensitivity analysis over a range of values.
We took a conservative approach in each evaluation: where interventions proved not to be 
cost-effective we based calculations on generous assumptions; where they appeared to offer good 
value for money we applied conservative assumptions. Despite this, there was a wide variation in 
incremental cost-effectiveness ratios (ICERs) across different intervention areas, allowing some 
relatively robust inferences to be made. An explanation of the derivation and use of ICERs is 
provided in Appendix 13.
Cost estimates
We used costs reported in the studies reviewed where these were available. Costs in US dollars 
(US$) or euros (€) were converted to UK pounds sterling (GBP) at an appropriate rate,218 and 
inflated to 2008 prices using hospital and community health services (HCHS) indices.219 In 
the absence of cost data we had to estimate programme costs. Estimates of staff time and role 
were based on intervention details in the reviewed studies. An appropriate unit cost, including 
all overheads, was then applied from Unit costs of health and social care.219 Where assumptions 
have been made about the future reapplication of interventions to maintain adherence, costs are 
discounted at 3.5% per annum.
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Chronic care
Expert Patients Programmes
Introduction
Three of the five studies reviewed are UK based, and Kennedy 2007104–107 evaluates the Expert 
Patients Programme, which has been implemented across the UK. Griffiths 2005101,102 and 
Kennedy 2007104–107 provide costs and all three UK studies provide outcomes measured 
with EQ-5D. In addition, a sister publication to Kennedy 2007104–107 provides a robust cost-
effectiveness analysis.
Assessing evidence of effectiveness
All of the studies provide evidence of significant improvements in patient self-efficacy and self-
care behaviour. In addition, there is evidence of an impact of the intervention on participants’ 
perceptions of their conditions. Griffiths 2005101,102 and Barlow 200083 demonstrate improvements 
in anxiety and depression using HADS, although these changes were not statistically significant 
in Griffiths 2005,101,102 Kennedy 2007104–107 and  Lorig 2003111 find significant improvements in 
psychological well-being and health distress attributable to the intervention. The evidence of an 
impact on physical health is mixed. All three UK studies applied the EQ-5D, although in Barlow 
200083 this was limited to a subset of the participants. Only Kennedy 2007104–107 observed a 
difference that was statistically significant, after allowing for baseline characteristics, in favour of 
the intervention. Only Lorig 2003111 finds a significant reduction in pain.
Evidence is limited on whether health improvements are maintained following the intervention. 
Barlow 200083 and Lorig 2003111 applied outcome measurements after the control group received 
the intervention, and Lorig 2003111 demonstrates that improvements in the intervention group are 
maintained. Barlow 200083 presents plots of several outcome measures for the intervention group 
at 4 and 12 months, and for the control group at 4 months. Results at 12 months suggest a slight 
deterioration in the improvements observed 8 months after the intervention. The controls in this 
study showed improvements in the outcomes measured at 4 months, albeit not as great as in the 
intervention arm, and may have continued to improve at 12 months without the intervention. 
Hence it is possible that the additional benefits from the intervention are short term. The 
intervention may have accelerated the acquisition of long-term disease management skills that 
would have been acquired through experience over time.
Reviews of professionally-led Expert Patients Programmes concur with these findings. In 
their analysis of self-management patient education programmes, Warsi et al.220 found modest 
improvements in clinical outcomes, although there was evidence of publication bias. Chodosh et 
al.221 report similar findings and suggest that the modest benefits observed derive from increased 
medication compliance.
Hence findings that the Expert Patients Programme improves self-efficacy and symptom 
management appear uncontroversial. The evidence for an improvement in HRQoL is weak. The 
findings by Kennedy 2007104–107 were not replicated in Griffiths 2005101,102 or Barlow 2000,83 and 
are not supported by the literature. It is possible that Expert Patients Programmes provide a very 
small improvement in HRQoL.
Evidence from the studies of a reduction in health-care utilisation is inconsistent. Kennedy 
2007104–107 examined a comprehensive range of health-care utilisation and reports reductions in 
both primary and secondary care. Analysed by category, none of the differences are statistically 
significant, but the reduction in inpatient days in the intervention arm is sufficient to offset 
the cost of the programme. Griffiths 2005101,102 and Barlow 200083 examined only primary care 
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contact, and found no evidence of a reduction in health-care utilisation attributable to the 
intervention. Lorig 1999110 found a reduction in hospital stay but no reduction in primary care. 
Lorig 2003111 found a reduction in physician and emergency room visits attributable to the 
intervention, but no change in hospital stay. These results may reflect the diverse morbidities of 
participants in these studies, with considerable heterogeneity in resource use.
Evidence from the literature on costs of profession-led Expert Patients Programmes is mixed. 
A number of studies, including evidence from the CDSM programme222 and evaluations of 
self-care programmes in CVD,223 and asthma,224 have suggested that patient self-management 
programmes are cost saving. However, in their review of the cost-effectiveness of interventions to 
support self-care, Richardson et al.225 conclude that most are methodologically flawed or limited 
in scope. They cite evidence from the UK in which only one out of six studies found evidence of 
cost-effectiveness.
Estimating the cost-effectiveness
Richardson et al.107 undertake a cost-effectiveness analysis of the trial results reported by 
Kennedy 2007.104–10 The authors used bootstrapped samples of the trial data226 to produce a cost-
effectiveness acceptability curve227 and conclude that there is a 94% probability the intervention is 
cost-effective at a threshold of £20,000 per QALY. While this analysis appears to be robust, some 
caution needs to be exercised in interpreting the findings. The majority of cost savings observed 
in the intervention arm derive from a reduction in length of hospital stay. We might expect 
a reduction in primary care contacts rather than hospitalisations following improvements in 
self-efficacy and symptom awareness. The possibility remains that the cost differences observed 
by Kennedy 2007104–107 were driven by a few resource-intensive patients who may not be truly 
representative of their populations.228 This possibility is supported by examination of the baseline 
characteristics of participants in Lorig 2003111 Despite random assignment of 443 participants, 
those in the intervention arm report more than twice the number of hospital days in the previous 
4 months compared with the controls. Nevertheless, it is quite possible that improved disease 
management results in reduced health-care utilisation that entirely offsets the small costs of these 
programmes.
Discussion
Expert Patients Programmes offer the possibility of combining patient empowerment with 
long-term savings for the NHS. Per-patient costs are fairly small; Kennedy 2007104–10 uses 
estimates from the Department of Health of £250 per patient. While direct evidence of cost 
savings is mixed there is evidence that patient self-management courses can lead to measurable 
improvements in clinical indicators of disease control for diabetes229 and CVD.223 The potential 
for cost savings from improved disease control in these two areas is likely to be considerable.230,231 
In areas such as arthritis management the scope for savings may be small. While it is tempting to 
conclude that, overall, these programmes lead to small reductions in resource use that offset their 
cost, there is insufficient evidence to conclude that the costs of the Expert Patients Programme 
are offset by savings across all major chronic disease areas.
It is unclear whether improvements in self-efficacy and symptom management translate 
into gains in HRQoL. However, the impact of chronic diseases on HRQoL is likely to be 
considerable,232 and Expert Patients Programmes may provide support, reassurance and coping 
strategies that are valued by participants, particularly those without extended networks of 
support in the community. For these patients the value of the programme may well outweigh 
the cost before any considerations of long-term cost savings. Further research on Expert Patients 
Programmes might consider ways to capture the value participants place on their experience of 
these programmes.
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Diabetes
Introduction
All three interventions use lay-led counselling to improve lifestyle and disease management 
in poor, urban populations with type 2 diabetes. The impact of each intervention is measured 
by assessing the level of the glycated haemoglobin marker HbA1c, a well-recognised marker 
of diabetes control.233,234 Although the population in Young 2005121-123 is a little older than that 
of the American studies, baseline HbA1c levels are similar in each study (7.9%–8.6%). For the 
purposes of the economic analysis we assume that the target populations are the same. The three 
interventions report different methods of delivering lay-led lifestyle and disease management 
advice to disadvantaged patients with diabetes. The telephone-led intervention described by 
Young 2005121–123 appears to be less resource intensive than the face-to-face interventions. An 
economic analysis of the intervention in Young 2005121–123 has been published123 and provides data 
on costs. The economic analysis presented here will consider all three interventions as alternative 
programmes to promote diabetes disease management in marginalised urban populations.
Assessing evidence of effectiveness
Effect sizes based on differences between intervention and control arms will be applied for 
the modelling of interventions based on Gary 200398–100 and Young 2005121–123 As noted earlier, 
regression to the mean may have exaggerated the upwards trend observed in the control arm 
in Lujan 2007112 Regression to the mean would act to exaggerate the treatment effect in the 
intervention arm, but this might be offset by an expected rise of 0.1% in HbA1c level over 
6 months.235 Hence, the effect size for the intervention was taken as the absolute fall observed in 
the treatment arm over the 6-month period.
Estimating the health gain from changes in effectiveness
Two large trials in the UK235 and USA236 have examined the long-term impact of control of HbA1c 
level. The United Kingdom Prospective Diabetes Study (UKPDS) ran from 1977 to 1991 and 
examined the benefits of intensive blood glucose control in patients with type 2 diabetes. It also 
contained a nested trial examining the impact of lower blood pressure. Intensive drug treatment 
initiated a rapid fall in HbA1c level of 0.9%. This difference between intervention and control was 
maintained over the 10-year observation period, although HbA1c level steadily increased in both 
arms with time. The trial reported a 25% risk reduction in microvascular complications and a 
16% (non-significant) reduction in coronary heart disease (CHD) events in the intervention arm.
A number of models of diabetes have been published,237–244 many utilising the UKPDS data. The 
Centers for Disease Control and Prevention (CDC) model241 examined the cost-effectiveness of 
intensive drug treatment in a typical cohort of newly diagnosed type 2 diabetes patients. In the 
base-case analysis, a reduction in HbA1c level from 7.9% to 7.0% yielded a lifetime QALY gain 
of 0.192 (discounted at 3%). The base case ignored any impact of lowered HbA1c level on CHD. 
Including CHD events increased the QALY gain to 0.333. Based on typical US practice, intensive 
drug treatment to reduce HbA1c level increased overall costs by US$7927 (‘1997’ US$). However, 
under UK management style, costs were US$1309 lower in the intervention arm. The UKPDS 
Outcomes Model242 examined the same data and predicted a lifetime gain of 0.27 QALYs for a 
0.9% reduction in HbA1c level. Bagust et al.237,238 sought to examine the impact of improved HbA1c 
level control for health providers and their cost estimate (£2026 increase) explicitly includes the 
indirect medical costs arising from prolonged longevity.
Two groups have modelled the impact of lowering HbA1c levels. The CORE240 model (Table 21) 
uses data from the National Health and Nutrition Examination Survey (NHANES)245 and the 
INITIATE246 study. The ‘typical’ patient in the model is 59 years old and has had diabetes for 
12 years; hence the model simulates the effects of an intervention to reduce HbA1c levels in the 
existing diabetes population rather than from diagnosis. Costs and outcomes for three scenarios 
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are reported: lowering HbA1c level from 9.5% to 8.0%, from 8.0% to 7.0% and from 7.0% to 
6.5%. A similar modelling exercise using the DiabForecaster model239 (Table 22) provides health 
outcomes and costs from a UK perspective for 1% reductions in HbA1c level over the range 
6%–11%. The results are tabulated below.
Hence, estimates of the health gain of a reduction in HbA1c level from 8% to 7% from the CDC, 
UKPDS, CORE and DiabForecaster models fall in the range of 0.3–0.4 QALYs. The health gain 
from the CORE model (0.38 QALYs), which is slightly lower than that from DiabForecaster, will 
be assumed for a 1% reduction in HbA1c level. The DiabForecaster model estimates of cost, which 
exclude specific drug treatment costs and indirect medical care costs, will be applied. The study 
suggests a £600 saving for a fall from 8% to 7% in HbA1c level. The cost year is unclear in the 
report but appears to be 2004, hence this value was inflated to pounds sterling in 2008 (£686).
Costing the interventions
Mason et al.123 provides detailed costs of the telephone counselling intervention. First-year costs 
are £93,700, including one-off commissioning costs of £9000 (‘2003’ GBP). Long-term running 
costs inflated to pounds sterling in 2008 are £101,800, giving a cost per participant of £258. The 
intervention supported the 394 patients randomised to the centre but could have supported 600. 
If we assume the centre operates at 90% capacity (540 patients) then the cost per patient would be 
£189.
Cost data from Gary 200398–100 and Lujan 2007112 are limited. The intervention in Gary 
200398–100 appears to have employed a full-time nurse and a CHW for the 2-year duration of the 
intervention, with the CHW spending half of his/her time with the participants in the CHW arm. 
A yearly cost of £31,043 was assumed for the CHW based on the cost of a social work assistant,219 
giving a per-participant cost of £757. Lujan 2007112 reports that two promotores provided the 
TABLE 21 The CORE model predictions for HbA1c level change
HbA1c change (%) Change in life expectancy
a Change in QALYsb Change in costs (US$)c
9.5–8.0 1.11 0.58 –5209
8.0–7.0 0.72 0.38 –3099
7.0–6.5 0.33 0.18 –1637
a Undiscounted.
b Discounted at 3%.
c Discounted at 3%, 2005 US$.
TABLE 22 The DiabForecaster predictions for HbA1c level change
HbA1c change (%) Change in QALYs
a Change in costs (£)b
11–10 0.6 –2900
10–9 0.6 –1600
9–8 0.4 –1200
8–7 0.4 –600
7–6 0.2 –400
a Discounted at 1.5%.
b Discounted at 6%.
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3-month intervention to four groups. It seems unlikely that these ran concurrently, hence it 
assumed that the promotores were employed for 1 year. In addition, transport was provided 
for the participants. Applying the same cost estimated for the CHW to the promotores gives 
estimated staff costs of £62,086 for the year. It was assumed that 50% of the participants utilised 
the transport with costs of £20 per trip, giving total transport costs of £12,000. Hence the overall 
cost was estimated at £74,086 (£988 per participant).
Consideration of relapse rates
The three studies report HbA1c levels over different time periods. The long-term effectiveness of 
the interventions in sustaining reduced HbA1c levels is unclear. The economic analysis in Mason 
et al.123 applied best- and worst-case scenarios and a ‘best guess’. The best-case scenario assumes 
that the intervention effects last for the life of the participants. The worst-case scenario assumes 
that they last for only the duration of the intervention. The ‘best-guess’ scenario assumed that 
maintaining reduced levels of HbA1c required 50% of the intervention costs in each subsequent 
year. The model based estimates assume that the changes in physiology are maintained for the 
patient’s life.
In principle, each of the interventions could be repeated yearly (or biannually for Gary 200398–100). 
In practice that might be overkill. We assumed that repeating the intervention at 3, 6 and 10 years 
ensures that 50% of participants maintain the behaviour change. This is in line with the estimates 
that 50% of those who quit smoking subsequently avoid relapse. The benefit of the interventions 
for the other 50% of participants was assumed to be zero. The base-case analysis applied the 
trial costs reported in Mason et al.123 to the telemedicine intervention (first-year costs and 394 
participants). Sensitivity analysis explored the impact of changing these assumptions by varying 
the proportion of those who relapse between 25% and 75%. Further sensitivity analysis explored 
the impact of applying long-term costs by ignoring set-up costs and assuming 90% capacity for 
the telemedicine intervention, and halving the per-participant costs calculated for Gary 200398–100 
and Lujan 2007.112
Estimating the cost-effectiveness
Cost-effectiveness estimates for each intervention are presented in Table 23. Costs are calculated 
assuming that the intervention is repeated at year 3, 6 and 10 (discounted at 3.5%). The 
assumption that 50% of participants relapse was implemented by halving the estimated benefit 
(0.38 QALYs) and costs avoided (£686) for the reported changes in HbA1c level. The benefits and 
costs of lowering HbA1c level were assumed to vary linearly with the magnitude of the change.
In the base-case analysis the telephone-based counselling intervention, Young 2005121–123 is cost-
effective if decision-makers apply a threshold of £30,000 per QALY. The CHW intervention in 
Gary 200398–100 is more expensive per participant than the telephone counselling intervention, 
and less effective in reducing HbA1c level. It is dominated, and consequently not effective. The 
ICER for the promotora intervention112 suggests that it is highly unlikely to be cost-effective 
at a threshold of £30,000. These conclusions are robust to the sensitivity analysis applied here. 
Assuming that only 25% of participants subsequently relapse and return to previous HbA1c levels, 
or halving the estimated costs for the promotora intervention, fails to bring the ICER for Gary 
200398–100 below £30,000. If 75% of participants relapse (i.e. only 25% of participants benefit from 
the programme) the ICER for the telephone intervention is just below £30,000.
Costs saved by the intervention have little impact on the overall costs; hence, conclusions on cost-
effectiveness rest on the estimates of the health gain from the interventions. The benefit estimate 
we used is likely to be conservative as it is estimated purely on the change in HbA1c levels. In 
reality, lifestyle improvements by the participants may have resulted in falls in blood pressure and 
cholesterol levels, too. Nevertheless, it is prudent to consider how the results change when the 
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estimate of the health gain from reducing HbA1c level is varied. The base-case analysis assumes 
that only 50% of participants benefit. This is equivalent to assuming that 100% of the participants 
gain half of the estimated health gain (0.19 QALYs). The sensitivity analysis varies the number of 
patients who relapse (and gain no health improvement) between 25% and 75%. Assuming that 
75% of participants relapse reduces the benefit gained from the intervention by 50% compared 
with the base case. Assuming that 25% of participants relapse increases the benefit gained from 
the intervention by 50%. Hence the sensitivity analysis where the relapse rate is varied between 
25% and 75% is equivalent to varying the benefit of HbA1c level control by ± 50% (0.19–0.57 
QALYs).
Economic analysis in Mason et al.123
Mason et al.123 provided an evaluation of the intervention in Young 2005121–123 using the 
framework elaborated in the introduction (Equation 1). Estimates of the underlying cost-
effectiveness of reducing HbA1c (∆CEt, US$7927/0.1915 QALYs = US$41,400) and the health 
gain (∆bt, 0.1915 QALYs) were taken from the CDC model.241 Mason et al.123 converted the 
ICER to UK pounds sterling (£26,900 per QALY) to estimate ∆CEt. The programme costs ∆ci 
were calculated under the assumption that 50% of the costs were required on an ongoing basis 
per participant to maintain adherence and discounted at 5%. The resulting ‘loading factor’ for 
the programme of £16,500 per QALY was added to ∆CEt (£26,900) to generate an ICER for the 
telemedicine programme of £43,400 per QALY. The authors conclude that the programme is 
unlikely to be cost-effective.
As noted earlier, the estimate of ∆CEt from the CDC model is based on US costs and the authors 
note that under a UK cost scenario the cost of intensive drug management is less than the costs 
of complications averted. This would give a negative value for ∆CEt in a UK setting, but a value 
of zero might be a reasonable, conservative assumption. If we apply a value of zero for ∆CEt then 
TABLE 23 Cost-effectiveness calculations for the Chronic Care diabetes interventions
Intervention Cost (£)
Mean 
percentage fall 
in HbA1c level
QALYs 
gained
Costs 
averted (£)
Overall 
cost (£)
Incremental 
cost (£)
Incremental 
benefit ICER
Base case
Young 2005121–123 905 0.31 0.0589 106 799 799 0.0589 13,565
Lujan 2007112 3467 0.45 0.0855 154 3313 2514 0.0266 94,511
Gary 200398–100 2656 0.30 0.057 103 2553 Dominated
Sensitivity analysis assuming 75% patients relapse to old lifestyle
Young 2005121–123 905 0.31 0.0295 53 852 852 0.0295 28,881
Lujan 2007112 3467 0.45 0.0428 77 3390 2538 0.0133 190,827
Gary 200398–100 2656 0.30 0.0285 52 2604 Dominated
Sensitivity analysis assuming 25% patients relapse to old lifestyle
Young 2005121–123 905 0.31 0.0884 159 746 746 0.0884 8439
Lujan 2007112 3467 0.45 0.1283 231 3236 2490 0.0399 62,406
Gary 200398–100 2656 0.30 0.0855 155 2501 Dominated
Sensitivity analysis assuming lower running costs
Young 2005121–123 663 0.31 0.0589 106 557 557 0.0589 9457
Lujan 2007112 1734 0.45 0.0855 154 1580 1023 0.0266 38,459
Gary 200398–100 1328 0.30 0.057 103 1225 Dominated
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the cost-effectiveness of the telemedicine intervention is simply the loading factor £16,500 (as 
estimated in Mason et al.122). This would indicate that the intervention in Young 2005121–123 is 
cost-effective in a UK setting, although this rests on a series of assumptions about the long-term 
cost and effectiveness of the programme required to calculate the loading factor. An ICER of 
£16,500 is close to our calculation.
Discussion
This analysis suggests that the telephone intervention described by Young 2005121–123 is cost-
effective at a threshold of £30,000 per QALY. That conclusion rests on a number of assumptions, 
chiefly that the intervention needs to be repeated four times over a typical participant’s lifetime, 
and that doing this ensures that 50% of participants maintain improved control of their HbA1c 
levels. Conclusions are sensitive to the assumptions on relapse rates. It would appear feasible to 
reapply the telephone counselling intervention in subsequent years to maintain and reinforce 
behavioural change. In practice, a low-intensity telephone contact might be maintained with 
each participant after the initial intervention. The same assumptions have been applied to 
Gary 200398–100 and Lujan 2007112 and these interventions are not cost-effective at a threshold of 
£30,000 per QALY. The trial data suggest that the promotora intervention in Lujan et al.112 is more 
effective, but far more expensive. The reduction in HbA1c levels does not justify the additional 
resources.
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Smoking cessation
Introduction
The evidence from May 2006113 suggests that the ‘buddy system’ of pairing smokers to provide 
mutual support is not effective; hence it was not evaluated. The target group in Emmons 
200526,97 (cancer survivors) may represent an untypical group who might be particularly 
receptive to motivational literature and counselling on the risks of smoking. In addition, 
there are some doubts over the veracity of self-reported cessation rates in that trial. Woodruff 
2002120 describes an intervention adapted to a specific, marginalised group delivered by LAs 
within that community, and, as such, it is probably representative of individual, LA-delivered 
ethnically targeted smoking cessation services. Consequently, the economic analysis considers 
the intervention in Woodruff 2002.120 Effectiveness was based on the ITT analysis in Woodruff 
2002120 rather than the primary results, which ignored those lost to follow-up. Unfortunately, 
the impact of NRT is not discernible, but it is reasonable to assume that a smoking cessation 
intervention delivered by LAs to marginalised groups would utilise NRT where appropriate. Only 
Emmons 200526,97 provides cost data; hence costs are estimated.
Estimating the health gain from changes in effectiveness
There is considerable literature on the health benefits of quitting smoking and the demonstrable 
health gains are large.247 A number of groups have modelled the epidemiological data to estimate 
the life-years gained through quitting.248–251 Conservative estimates of around 1.5–2 years may be 
low in the light of recent evidence.252 Fewer studies have estimated the QALYs gained by quitting. 
Publications by Fiscella and Franks253 (1.98 QALYs) and Cromwell et al.254 (1.97 QALYs, 1.46 life-
years saved) concur. The estimate of 1.97 QALYs is likely to be conservative in the light of recent 
evidence, but it will be used for the current analysis.
Rates of relapse from quitting have also been investigated. Relapse rates over the first year suggest 
that 65–75% of abstainers at 1 month will have relapsed after 1 year.51,52 Recent evidence on long-
term relapse rates suggests that rates of 30–40% are too low and that 50% of those abstaining for 
1 year may eventually relapse.53 We assumed that 75% of 1-month abstainers and 50% of 3-month 
abstainers would have relapsed at 1 year. Further, we assumed that 50% of 1-year abstainers 
would subsequently relapse, and that all those who relapse gain no overall health benefits. This 
means that 25% of the 3-month quitters reported by Woodruff 2002120 are estimated to quit 
permanently, gaining 1.97 QALYs each, or a gain of 0.49 QALYs per 3-month quitter.
Estimating overall costs
Emmons et al.26,97 gives the total cost of the intervention; Woodruff 2002120 does not but states 
that promotores were paid a modest stipend. The intervention consisted of four home visits of 
1–2 hours’ duration and three telephone calls (15–30 minutes), giving a total time of around 
7 hours for all seven sessions. Mean participation was 3.5 sessions. We applied a rate of £31 
per hour (alcohol health worker)219 to an estimate of 3.5 hours’ contact time to give a cost of 
£109 per participant. We also assumed that recruiters were paid £20 per participant recruited. 
Finally, we assumed that the intervention required co-ordination by a full-time employee for 
3 months. The cost of a social work team leader (£53,651 per year, including all overheads)35 was 
applied (£13,413 over 3 months). The total costs are £33,537 for the 156 participants or £215 per 
participant. This is in line with costs per participant of US$300 reported in Emmons et al.26,97
There is considerable debate over the long-term cost savings from quitting smoking.255,256 Direct 
health-care costs saved have been calculated by a number of authors and are considerable.249,257–259 
The impact on indirect health-care costs is less well established but it seems likely that these will 
rise. Some studies260,261 have suggested that these costs outweigh the direct cost savings but this 
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has been contested.262–264 Indirect costs are often ignored in economic evaluations but, strictly 
speaking, they should be included. It seems likely that quitting smoking has a positive overall 
impact on health-care costs but we have taken a conservative assumption that the impact is 
neutral, with no long-term cost savings.
Estimating the cost-effectiveness
To fully evaluate the cost-effectiveness of this intervention we need to compare it with the 
reasonable alternatives that might be provided. Around one-third of smokers attempt to quite 
each year, mostly without help,265 with 1% succeeding,250 suggesting that around 3% of motivated 
quitters succeed unaided. Estimates of the effectiveness of brief advice vary, with American 
estimates being higher than those in the UK.249,250,254,266,267 We apply an annual quit rate of 4% 
as assumed in the 2002 HTA assessment of the effectiveness of NRT and bupropion268 and a 
cost of £47 based on data from Stapleton et al. (£33 in ‘1998’ GBP).250 Pharmacy services also 
provide smoking cessation services; we apply the data collected by Boyd and Briggs269 in a recent 
evaluation. We assume annual effectiveness rate of 10% for smokers’ clinics in line with published 
evidence.249,270,271 Estimated costs of these clinics vary. Godfrey et al.271 estimated an average cost 
per user of £161, Boyd and Briggs269 report the costs of a smokers’ clinic in Glasgow at £350 per 
user, and data on smokers’ clinics in Health Action Zones272 suggest that the average cost per user 
is £450 (all figures inflated to ‘2008’ GBP). We apply the figure reported by Boyd and Briggs.269 
Cost-effectiveness calculations are presented in Table 24.
These results should be interpreted with considerable caution. The data suggest that smokers’ 
clinics are more effective than an IC from LAs. Costs are similar. The data support a view that 
smokers’ clinics (as the most effective intervention) are cost-effective and the intervention of 
choice. However, this intensive group-based therapy may not be the service of choice for many 
smokers. Tailoring services to smokers’ choices would seem to be very important, given the 
central importance of motivating services users. The LA intervention might be considered as an 
alternative to expanding pharmacy services or as a supplemental service. Costs are higher than 
the pharmacy service but the trial data suggest that a tailored LA-delivered intervention is more 
effective, providing additional health gains for a reasonable cost.
In practice it probably makes sense to offer all of these services. Boyd and Briggs269 argued that 
the pharmacy service and the smokers’ clinic they assessed served different groups and should 
not be compared as alternatives. It is likely that many smokers will try more than one service 
before they quit. As such, they might be seen as complementary, yielding quitters from the 
proportion of users for whom their services are particularly effective.
TABLE 24 Cost-effectiveness calculations for smoking cessation services
Cost (£)
Annual quit 
rate (motivated 
smokers) (%) QALY gain
Incremental gain 
(QALYs)
Incremental 
cost (£) ICER (£)
Willpower 0 3 0.0295 – – –
Brief advice 47 4 0.0394 0.0099 47 ED
Pharmacy 
services
55 5 0.0493 0.0099 8 2800
LHA counselling 215 8.7 0.0857 0.0364 160 4400
Smokers’ clinics 350 10 0.0985 0.0128 135 10,500
ED, extendedly dominated.
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Discussion
Some care needs to be taken in estimating the effectiveness of a LA smoking cessation service 
from the results of one trial. Effectiveness in practice may be considerably less than the trial 
results would suggest. Nevertheless, this intervention appears to be cost-effective. Costs are 
relatively small and the health benefits that accrue to the small number of successful quitters are 
significant. There are insufficient data to determine whether LAs would be more effective than the 
currently available alternatives within the context of a marginalised group. However, it is quite 
likely that some of the people reached by LAs would not seek help from conventional services, 
even if they are effective for those who do. In this respect smoking cessation services from LAs 
may deliver additional health gains to marginalised communities in a cost-effective manner.
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Breastfeeding
Introduction
Of the two studies in the review, the Canadian setting for Dennis 200288 is more similar to the UK 
than Mexico, where the Morrow 1999114,115 studies was set. The Canadian intervention consisted 
of conventional care plus telephone support from a woman experienced with breastfeeding. The 
results of the Canadian study are used as the basis for an exploration of the cost-effectiveness of a 
breastfeeding support programme in the UK.
Assessing evidence of effectiveness
Dennis 200288 found that the peer support programme was effective in increasing the number of 
mothers who breastfeed. Risk ratios were calculated at 4, 8 and 12 weeks. Data on the number of 
babies breastfed at 6 weeks in the UK (2005) are available in the Infant Feeding Survey.273 Using 
the reported figures in a least-squares regression, an estimate of the risk ratio at 6 weeks was 
calculated to be 1.12 (95% CI 1.01 to 2.00). Applying this to the 2005 UK data suggests that the 
peer support programme could raise the percentage of women breastfeeding at 6 weeks from 48% 
to 54% (95% CI 48% to 96%). We assumed that the 12% increase in the numbers of women who 
breastfeed their children at 6 weeks translates into an overall increase in women breastfeeding of 
12%, in order to model the effect of this in terms of outcomes associated with breastfeeding.
Estimating the health gain from changes in effectiveness
Quinn et al.274 examined the association between breastfeeding and cognitive development. 
Between 1984 and 1985 they followed 3880 children from birth to 5 years and found a strong 
positive relationship between breastfeeding and cognitive development. When compared with a 
child who was not breastfed, females who were breastfed at 6 months had a mean difference of 
8.2 (5.8 for males) in the Peabody Picture Vocabulary Test Revised (PPVTR). On average, and 
assuming a causal link, infants whose mother took part in a peer-supported programme would 
have an increased PPVTR score of 0.99 if they were female and 0.70 if they were male.
Research has also linked obesity to breastfeeding: Gillman et al.275 found that children who were 
breastfed for longer periods were less likely to be overweight during adolescence. They found 
a risk ratio of 1.28 (95% CI 1.10 to 1.52), of being overweight associated with not being mostly 
breastfed, among children aged 9–14 years.
Childhood type 1 diabetes has also been linked with breastfeeding. Sadauskaite-Kuehne et al.276 
found that breastfeeding for longer than 5 months was associated with an risk ratio of 0.54 (95% 
CI 0.36 to 0.81), breastfed children being half as likely to have type 1 diabetes.
Estimating the cost-effectiveness
We assumed that full-time LAs could support roughly 1000 mothers per year at a cost of £31,043 
(social work assistant219). Hence, in a notional population of 1000 mothers, the variable costs of 
the programme would be roughly £30,000. And this would increase the number of infants being 
breastfed, at 6 weeks, from 480 to 540. Each pound spent on breastfeeding support, delivered by 
an Early Years practitioner, would increase the rate of breastfeeding, in one notional mother, at 
6 weeks by 0.4%.
The results of the analysis are summarised in Table 25. Each pound spent on the breastfeeding 
support programme would increase cognitive ability by 0.0232 for males and 0.0328 for females. 
In the notional population the £30,000 expenditure would result in increases of 420 in the total 
PPVTR scores across the population of 500 males and 500 females. Each pound spent would 
also result in a 0.0112% reduction in the risk of being obese for one adolescent, or the notional 
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£30,000 expenditure would yield a 3.3% reduction among the population of 1000. Combining 
the estimates of the link between diabetes and insulin-dependent diabetes with the efficacy 
of the support programme gives a cost-effectiveness ratio of 0.00216 for reducing the risk of 
type 1 diabetes, each pound spent ‘buying’ a reduction in risk of 0.00216% in one child. The 
hypothetical £30,000 spent would almost halve the risk of diabetes in 60 of the 1000 children.
Discussion
The results of the Canadian study277 were not replicated in a study in a deprived area of the UK; 
McInnes et al.277 found that increases in breastfeeding at birth were not maintained at 6 weeks, 
despite peer support. The control arm in the Canadian study reported a rate of breastfeeding that 
is greater than the 2005 UK average. There is evidence to suggest that increases in breastfeeding, 
over time, are best maintained in areas with high initial rates of breastfeeding,278 unlike most of 
the UK areas where peer support programmes have been introduced. Potential differences in the 
socioeconomic backgrounds of the study participants and the general UK population also raise 
concerns. Research279,280 has shown that breastfeeding rates vary with socioeconomic and racial 
status. These factors are highly likely to be associated with any health outcomes associated with 
breastfeeding. The cost-effectiveness estimates presented here rely on epidemiological studies of 
the association between breastfeeding and outcomes in later life. In such studies it is very difficult 
to control for confounding sociodemographic characteristics (and others that may confound the 
estimates), and quite possible that these confounders are exaggerating the reported benefits of 
breastfeeding.
The current analysis did not consider potential savings resulting from breastfeeding. These 
could result either from a reduction in medical costs associated with ill health or from a reduced 
number of working days lost by working parents caring for their children. In his study of the 
economic benefits of breastfeeding, Weimar estimated cost savings of a minimum of US$500M 
(‘1998’ US$) in medical and other indirect costs (such as time off work) if breastfeeding rates at 
6 months were raised from 29% to 50%.281
Insufficient data exist to perform any meaningful sensitivity analysis because of the small number 
of studies and their differing choice of observation times. However, the Dennis 200288 estimates 
should be viewed as the upper bound of potential effectiveness. Nevertheless, the comparative 
baselines in Dennis 200288 and the UK in 2005 do suggest there is scope to increase the numbers 
of women breastfeeding their infant.
TABLE 25 Summary of the estimated effects of a breastfeeding programme
Outcome Estimate
Cognitive ability at 5 years Increase in PPVTR of 0.0232 (0.0328) in one male (female) for every £1 spent
Obesity between 9 and 14 years Each pound spent ‘buying’ a reduction in risk of 0.0112% in one child
Childhood type 1 diabetes Each pound spent resulting in 0.00216% reduction in the risk of type 1 diabetes
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Mental health – families of children with chronic diseases
Introduction
The single study in this area included no cost data or utility measures. No attempt has been made 
to estimate the benefit of the intervention in terms of HRQoL.
Assessing evidence of effectiveness
The small study reports a statistically significant improvement in anxiety levels in the 
intervention arm compared with the control arm. The intervention was assessed against a ‘usual 
care’ control, the telephone number of an experienced but untrained mother of a child with 
a long-term health problem. Only two mothers in the control arm contacted their support, 
suggesting the possibility of selective demoralisation of the control arm.
Estimating the cost-effectiveness
With over 10 hours of contact time plus telephone support from the trained and paid peer 
advisors, in addition to support from a clinical specialist, costs of the intervention are likely to 
be significant. Whether these costs are justified depends on the value placed on the outcome – a 
mean improvement of 2.1 points on the PSI282 (range 0–100). It is possible that a less intensive 
and a cheaper intervention might also have lowered anxiety levels. Anxiety levels rose in the 
control arm but the offered support was not utilised, which may suggest that it was not the best 
comparator.
Discussion
Without any measure of benefit it is difficult to gauge whether the reduction in anxiety for 
participants justifies the required resources to support this programme. The use of utility 
measures in the field of mental health is limited, driven by concerns that they do not capture the 
benefits that interventions in this area provide.283 An alternative approach might be to measure 
the value families place on interventions such as this through contingent valuation methods.284
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Screening uptake
Introduction
Three of the reviewed studies target a broadly similar population of poor, rural women, although 
the interventions are of different intensity. Paskett 2006116,117 describes a resource-intensive 
intervention. The intervention arms in Andersen 200282 are all relatively inexpensive. Earp 
200216,63,93,94 does not provide costs, but this study probably lies somewhere in between. The 
setting and approach used in Bird 199884–87 are different; the population targeted is recent 
immigrants, many of whom have little English. It seems likely that the barriers to mammography 
in this community are different, and might require a very different approach to overcome. 
Consequently, the analysis will consider two ‘types’ of intervention: a cheap, low-intensity 
intervention focusing primarily on community events and mass mailshots as described in 
Andersen 200282 (CA arm), and a more resource-intensive intervention using CA to support IC 
as described by Earp 200216,63,93,94 and Paskett 2006.116,117
Estimating the health gain from changes in effectiveness
Health benefits from mammography depend on the user’s age, and risk profile and whether 
screening is maintained. Breast cancer rates increase sharply with age285 but the disease is often 
less aggressive in older women, and the benefits of treatment are smaller.286 Consequently, 
modelling studies indicate that the largest health gains occur for women aged 60–69 years,287 
and the benefits of screening women between the ages of 40 and 50 years are contested.288–290 A 
number of studies have modelled the cost-effectiveness of mammography, with early studies 
typically reporting life-years saved.291–303 Data from these studies are shown in Table 26. The 
Forrest report,296 which examined the feasibility of a national screening service in the UK, used a 
very simple estimate of life-years saved and considered only the costs of screening and additional 
biopsies. Recent studies have used more sophisticated models to provide estimates of the 
lifetime benefits of mammography in the range 0.0324–0.0386 QALYs for biennial or triennial 
screening.295,298,299 We used the estimate of 0.0386 QALYs from Rojnik et al.,298 which most closely 
matches UK screening policy (triennial from 50 to 70 years of age).
A marginal cost from triennial screening of €191 and an ICER of €4953 (cost year not reported, 
assumed to be 2004 euros) is reported in Rojnik et al.298 Publications from the UK296,297,304 report 
ICERs of similar magnitude (around £3500), but costs per individual are not discernible; hence 
the cost data from Rojnik et al.298 were used. The marginal cost was converted to 2008 pounds 
sterling (£148). Costs and ICERs from the US studies are notably higher, which may reflect 
higher health-care costs in the USA.
The calculations in Rojnik et al.298 assume screening from age 50 to 70 years. Women over 
50 years commencing screening for the first time will incur smaller additional costs and smaller 
benefits. As the additional costs from new users of mammography are tiny compared with 
the costs of promotion programmes, applying these estimates will overestimate the benefits of 
mammography promotion.
Estimating the cost-effectiveness
The follow-up period in each of the studies is fairly short and it is far from certain that new users 
will remain mammography users in 5 or 10 years. Clearly, the effectiveness of these interventions 
hinges on whether the changed behaviour is maintained. We have assumed that the intervention 
needs to be repeated at years 3, 6 and 10 to ensure that relapse is restricted to 50% of participants. 
Sensitivity analysis examines the impact of assuming 50% relapse without reapplication of the 
programme and 0% relapse without reapplication of the programme. The data are presented in 
Table 27. In the base case, the ICER for the low-intensity intervention is over £250,000, and the 
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higher intensity intervention ICER is much higher. Even at the extreme assumption of 0% relapse 
without reapplication of the programme, the interventions are not cost-effective at a threshold of 
£30,000 per QALY.
Andersen 200282 undertake a cost-effectiveness analysis of promotion of mammography using 
the cost and effect estimates from the CA arm of the trial. The trial data are modelled to calculate 
a cost per life-year saved of US$56,000 (‘1995’ US$) or £56,000 (‘2008’ GBP). The calculation 
appears to assume that all new users maintain mammography use for life. Details of the 
modelling are very brief. It is unclear what discount rate was used, or even if the promotion of 
mammography was considered as an alternative programme to the provision of mammography 
without promotion. Nevertheless, the figure supports the conclusion that the programme would 
not be considered cost-effective in the UK.
Discussion
We applied costs and outcomes for women commencing a 20-year triennial screening 
programme at 50 years, which is likely to overestimate the benefits of promoting mammography 
to women over 50 years of age. Nevertheless, under the most generous assumptions regarding 
relapse, neither programme is cost-effective at a threshold of £30,000. Under reasonable 
assumptions these programmes offer very poor value for money.
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Diet and physical exercise
Introduction
Each of the reviewed studies utilises LAs to deliver IC and advice with the goal of increasing 
physical exercise and/or improving diets. Keyserling 2002108,109 provides an intervention to 
diabetic women; all four other studies target healthy adults. Only Elder 200695,96 provides costs.
Assessing evidence of effectiveness
The evidence of improvements in diet, based on self-reported intake, is weak given the strong 
evidence of under-reporting of consumption. There is evidence of some improvement in fat 
intake and fruit and vegetable consumption, but no evidence of weight loss. Physiological 
evidence reported in Staten 2004119 is mixed, but Keyserling 2002108,109 reports no improvements 
in HbA1c levels in either of the intervention arms, despite extensive health advice and counselling 
tailored towards a diabetic population with significantly raised HbA1c levels. The evidence of 
unreliability of self-reported dietary intake also casts doubts on the self-reported evidence of 
increased physical activity. Again, it is notable that none of the studies observed any weight loss 
in the intervention arms compared with baseline or controls at follow-up.
Elder 200695,96 reports significant improvements from the promotora intervention at 3 months, 
which dissipated at 6- and 12-month follow-up. They conclude that repetition of the intervention 
may be necessary to maintain change. It is also possible that intensive counselling in the 
intervention group increased the tendency to under-report food consumption, a tendency 
that wore off after the intervention had ended. Overall, the physiological data collected do not 
seem to support the self-reported data showing improvements in diet, and there is evidence 
that changes are not sustained. The results of these studies give little confidence that long-term 
lifestyle changes can be achieved through IC from LAs; hence these interventions are unlikely to 
be cost-effective.
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HIV infection prevention
Introduction
The reviewed studies describe the use of trained LAs to deliver HIV infection prevention 
messages – primarily advocating condom use and the sterilising of drug injection equipment – to 
illegal drug users. The LAs were predominantly drug users who were recruited and trained to 
provide outreach work – counselling, education and materials distribution – to drug-using 
peers. Both studies are primarily qualitative. However, quantitative data on the impact of each 
intervention on risky behaviours among LAs have been published and are analysed here.
Assessing evidence of effectiveness
The small increase in hygienic injection practices among LAs reported in Dickson-Gomez 
200691,92 following the intervention suggests that it was not effective in changing injection risk 
behaviours, given the possibility that LAs felt additional pressure to under-report at review. The 
increase in reported condom use and reductions in the number of sexual partners are more 
impressive, and suggest that the programme may have been effective in reducing risky sexual 
behaviours. The use of a control group who received an appropriate comparison intervention 
lends more weight to the results reported in Dickson-Gomez 2003.89,90 The intervention appears 
to have been effective at reducing both risky sexual and injection behaviours. However, the use 
of an ordinal scale to define the magnitude of risky behaviours makes it difficult to estimate 
the absolute reduction following the intervention, as does the decision to ignore any reported 
increases in risky behaviour. The study design in Dickson-Gomez 200389,90 is more robust and 
this study will be used to inform estimates of behaviour change following outreach interventions 
amongst drug users.
Estimating the reduction in risky behaviour
Evaluation of the health gains from reduction in risky behaviours requires quantification of 
changes in behaviour. The number of LAs reporting increases in condom use during casual sex 
is small (18% intervention vs 5% control) and limited to the small proportion (31, 14%) of LAs 
reporting casual sex. Of these respondents, 26 were in the intervention arm and they reported 
a mean of 2.4 casual sex partners. Applying a conservative assumption that the reduction in 
the frequency of unprotected sexual encounters is 25% would result in an absolute reduction of 
2.4 × 0.25 × (0.18 – 0.05) × 26 = 2.03 unprotected sexual contacts in the intervention arm compared 
with the control. Applying a more generous assumption of a 50% reduction in unprotected sex 
would double this, but, either way, the effect is small.
A small proportion of LAs (22, 19% of injectors) report sharing needles at baseline. Of this 
group, roughly one-half reported sharing more than once a month, and one-half once a month or 
less. Applying an estimate of the frequency of needle sharing of three times a month to the first 
group, and once a month to the second, gives an estimate of 12 incidents of needle-sharing per 
LA who shares over 6 months. At review, 69% report reductions in unhygienic needle practices 
compared with 30% in the control group. The number of needle sharers in the intervention arm 
is not reported but participants were randomised in the ratio 2 : 1 between the intervention and 
control arms, giving an estimate of 10 LAs reducing unsafe practices in total in the intervention 
arm, and an estimated increase of six LAs reducing unsafe practices over and above that achieved 
by the control programme. Again, we do not know by how much those reporting reducing 
unhygienic needle practices actually reduced incidents. Applying a conservative assumption of a 
25% reduction in incidents of needle sharing for those who report reductions gives an estimate 
of nine incidents of needle sharing over the 6-month period per LA reporting reductions. 
This gives an estimate of the reduction in the overall number of incidents of needle sharing 
of (12 – 9) × (10 – 6) = 12 incidents avoided. Given that the likelihood of infection from shared 
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needles is higher than from unprotected vaginal sex (although not unprotected anal sex),305 and 
the change in number of incidents is far higher, only the impact of reduced needle sharing will be 
considered further.
Estimating the number of HIV cases avoided
Translating risk reduction behaviours into health gains requires an estimate of the number of 
infections avoided. Estimates of infections avoided are usually based on a Bernoulli process 
model of transmission, where probability of infection is a function of the number of unsafe acts, 
the risk of transmission from an unsafe act and the general prevalence of disease.306 Application 
of trial data on risk behaviour is combined with literature estimates of the risk of transmission 
and survey data on the prevalence of disease, to estimate the number of infections averted 
through the reported reduction in risk behaviour. A conservative assumption that the observed 
reduction in risk behaviour occurs only for the duration of the intervention is generally applied, 
but the analysis assumes that those protected from infection do not subsequently become 
infected.
A simplified Bernoulli model is presented in Equation 2. The equation estimates the probability 
of infection from sharing injection equipment, assuming that shared injection equipment has 
previously been used by one other user. Using this equation we can calculate the risk of infection 
and the number of infections in the absence and the presence of the programme. The difference 
represents the estimate of the number of infections averted by the programme.
US setting
Probability of infection p = 1 – {(1 – π) + π[1 – (αd × αi)]}n [Equation 2]
where:
■■ π = HIV prevalence = 0.289,90
■■ αd = risk of infection of needle used by seropositive user = 0.9307
■■ αi = risk of infection from infected needle = 0.0067308
 ■ n = number of incidences of needle sharing.
Without the programme, n = 12 and p = 0.0144, but with the programme n = 9 and p = 0.0108. 
Hence the programme reduces the probability of infection by 0.0144 – 0.0108 = 0.0036. For 
the 10 users who report a reduction in risk behaviour, the number of HIV cases averted is 
0.036. Application of the control programme would have averted 0.0036 × 4 = 0.0144 cases. The 
additional gain from the programme is an additional 0.0216 cases averted.
UK setting
The prevalence of HIV in the UK is much lower than in the USA (around 0.13%309). A 
prevalence of around 4.0% is observed among injecting drug users in London, but outside 
London HIV prevalence among injection drug users in England is low (0.6% in 2007).310 These 
values have a dramatic effect on the number of HIV cases averted by the programme (Table 28) 
and, consequently, its cost-effectiveness. Applying Equation 2 with the same parameter and 
programme estimates, but applying a background HIV rate (π) of 0.04 (London) and 0.006 
(outside London), allows calculation of the potential HIV cases averted in a UK setting 
(Table 28).
Estimating health gains
Early work estimated that an infection averted generated a health gain of around 11 QALYs 
(discounted at 3%).311 However, it is likely that the health gain from HIV infection prevention 
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has fallen with the advent of improved antiretroviral treatments (ARTs). More recent modelling 
estimates suggest that the health loss from HIV infection is 5.37 QALYs.312 US estimates of the 
lifetime costs of HIV infection range from US$180,000 to US$303,000.311,313,314 A recent review 
highlighted a paucity of evidence on HIV costs in the UK.315 We used an estimate of £84,500 
(‘1993’ GBP), £143,000 (‘2008’ GBP), which examined costs over the period 1992–7. Evidence 
from a review of global costs suggests that treatment costs for patients with AIDS remained 
constant throughout the 1990s, but costs for HIV infection increased with the introduction of 
highly active ARTs.316 Consequently, this figure is likely to be an underestimate.
Programme costs
Dickson-Gomez 200389,90 report that participants were compensated US$20 for completing 
the baseline interview and US$15 for each of the 10 2-hour training sessions they attended. 
Two-thirds of the 250 participants were randomised to the intervention (approximately 168). 
The training sessions were conducted in small groups. If we assume that the mean group size 
was 7, then this would require training 24 groups. With the associated administration this is 
likely to require a full-time employee for 1 year. The total cost of an alcohol health worker per 
year of £47,317 was applied.219 Assuming that mean attendance is five sessions, the participant 
remuneration costs are US$[20 + (15 × 5)] × 168 = US$15,960. Assuming that costs were in year 
‘2001’ US$, this is equivalent to £11,800 (‘2008’ GBP). Hence implementing the programme 
would cost £59,200.
Estimating the cost-effectiveness of the programme (London)
Applying an estimate of £143,000 saved and 5.37 QALYs gained from each HIV case averted 
generates the following results for the programme, which costs £59,200 and averts 0.00722 
infections.
Compared with the control:
 ■ costs saved = £143,000 × 0.00433 = £619
 ■ QALYs gained = 5.37 × 0.00433 = 0.0233 QALYs.
Compared with no intervention:
 ■ costs saved = £143,000 × 0.00722 = £1032
 ■ QALYs gained = 5.37 × 0.00722 = 0.0388 QALYs
 ■ marginal cost = £59,200 – £1032 = £58,168
 ■ ICER = £58,168/0.0388 = £1,500,000.
Based on these estimates the programme is not cost-effective. However, the estimates of costs 
saved and QALYs gained are based only on the reduction in risky behaviour among LAs during 
the 6-month period of observation. While these very conservative assumptions are typically 
applied in the HIV infection prevention literature they are likely to underestimate the gains 
TABLE 28 HIV cases averted by risk reduction behaviours in drug-using LHAs
London: π = 0.04 Rest of England: π = 0.006
Infection risk without programme 0.002891 0.000434
Infection risk with programme 0.002169 0.000326
Risk reduction 0.000722 0.000109
Cases averted by intervention 0.00722 0.00109
Cases averted by control programme 0.00289 0.000436
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from such programmes. Clearly, LAs are likely to maintain reductions in risky behaviour for at 
least some time after the intervention, and at least some will undertake outreach work that leads 
to risk reductions in their community as well. We can accommodate the impact of extended 
behavioural changes and outreach in a crude fashion by multiplying the estimated number of 
cases averted with a scaling factor. Assuming that LAs maintain their behaviour change for 
3 years would give a scaling factor of 6. (The estimation of HIV cases from the Bernoulli model 
does not scale linearly with time, but the difference is negligible. The calculated HIV cases 
averted over 3 years is 0.00428 – multiplying the 6-month estimate by 6 gives 0.00433.) Assuming 
that LAs achieve similar reductions in risk behaviour by two peers for 18 months would also 
require a further increase in the scaling factor by 6, giving a scale factor of 12. The impact of 
varying the scale factor is shown in Table 29.
A scaling factor of at least 27 is required to achieve an ICER below £30,000 per QALY. This 
amounts to a LA reducing risk behaviour for 13.5 years or two peers reducing risk behaviour for 
7 years. This programme is unlikely be cost-effective in London at a threshold of £30,000, even 
if the most generous assumptions on the long-term effects of behaviour change and outreach are 
made. In the rest of England, where HIV prevalence is far lower, the programme would avert only 
a fraction of the HIV cases averted in London and it is clearly not cost-effective. This programme 
would not be justified in a UK setting based on HIV cases averted because the background 
prevalence, even in London, is too low.
Discussion
Pinkerton et al.317 have reviewed studies reporting on the cost-effectiveness of HIV prevention 
programmes. Each study concluded that the costs averted from HIV infections avoided were 
greater than the cost of the programmes. However, calculations were based on US-based 
HIV prevalence rates. Cohen et al.305 examined the relative cost-effectiveness of different HIV 
infection prevention programmes and concluded that individually focused interventions to 
change behaviour were generally cost-effective only in populations with a high prevalence of HIV. 
For communities with a prevalence of HIV of 0.1%, only mass media campaigns were cost saving.
There is some evidence to suggest that programmes targeting risky behaviours in injecting 
drug users are cost-effective in their US setting, where the prevalence of HIV is high. The mean 
prevalence rates for HIV among injecting drug users in the USA was estimated at 16% in 2007.318 
Cohen et al.’s analysis305 suggests that programmes that are highly cost-effective at this prevalence 
are unlikely to remain cost-effective at prevalences below 1%, as observed in injecting drug users 
in most parts of the UK.
Extremely generous assumptions of the effectiveness of the programme are required for it to be 
cost-effective in London for prevention of HIV. However, unhygienic needle practices are also 
likely to spread hepatitis C with long-term cost implications.319 Prevalences of hepatitis C of 60% 
among intravenous drug users in London and 35% outside London were reported in 2008.310 
Without firm data on the likelihood of transmission of hepatitis C through shared needles, and 
TABLE 29 Impact of extrapolation of changes in risky behaviour in drug users and their peers
Scaling factor Cases averted Costs saved (£) Marginal cost (£) QALYs gained ICER (£)
3 0.02166 3097 56,103 0.116 484,000
6 0.04332 6194 53,006 0.233 227,000
12 0.08664 12,390 46,810 0.465 101,000
20 0.1444 20,649 38,551 0.775 50,000
27 0.1949 27,876 31,324 1.047 29,900
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on the long-term costs and consequences of hepatitis C infection, it is impossible to estimate 
the costs saved and health gains from hepatitis C infections averted through a programme such 
as this. The conclusions on the cost-effectiveness of the programmes in the USA, where HIV 
prevalence among injecting drug users is 16%, may apply equally well to a UK setting when the 
impact on hepatitis C infections (35% prevalence among injection drug users) is considered.
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Chapter 4  
Discussion
This research aimed to identify, describe, classify and analyse the range of models developed to date for delivering HRLA or training, for effectiveness, mechanism of effect, cost-
effectiveness, equity and acceptability in improving the health and well-being of individuals and 
communities, with particular reference to the reduction of inequalities in the UK. One noticeable 
limitation of the review was the fact that only six of the included studies had taken place in the 
UK. While much can be learned from intervention components’ details in other contexts, the 
extent of the transferability of the findings remains to be established. The initial phases of the 
project served to analyse the breadth of the research question, and to clarify the scope of this 
review. This is a key and complex step of the process,69 which highlighted the importance of 
contextual issues and, later, guided the methodology adopted.
Including quantitative and qualitative research designs, the review identified 26 papers 
appropriate for inclusion in a systematic review. The wide variety of LA models, delivered 
in a wide variety of settings, and targeting a variety of populations, prevented the reviewers 
from engaging in establishing firm causal relationships between intervention mode and study 
outcomes. By convention, meta-analysis is designed to utilise results from several related studies 
by identifying a common measure of effect size that is modelled via meta-regression. With regard 
to the current review, however, neither the outcomes under investigation nor the methods used 
are constant. While most of the studies reviewed adopted a quantitative methodology, primary 
outcome measures were of either the parametric or frequency variety, thereby rendering direct 
comparisons impossible. The following section considers the issues surrounding the robustness 
of the review.
Analysis of the robustness of the review (sensitivity analysis)
The criteria for study inclusion in the review are provided in Chapter 2 (see Box 4). This section 
of the report provides further information on the quality assessment of the included studies. The 
purpose is to provide some critical commentary on the strength of evidence on which the review 
is based. The process has been guided by the principles of quality assessment69,320 and the work of 
Jackson and Waters.64
To quote from the CRD guidelines,69 ‘… the aim of assessing study quality is to establish how 
near the “truth” its findings are likely to be and whether the findings are of relevance in the 
particular setting or patient group of interest’ (p. 33). This is an issue worthy of comment, as the 
quality criteria required to achieve inclusion in this review limited data to a particular type of 
evidence. The consequence is that only a partial representation of the current practice of HRLA 
interventions may be reported in the review. This issue is further highlighted by drawing on 
anecdotal, early small-scale and formative evaluation evidence of the PAG with respect to one 
type of HRLA intervention: health trainers. Current practice activity is described as:
1. broader in focus (i.e. not limited to one health improvement issue)
2. possibly be more likely to reach disengaged populations (as, by nature, in research there is a 
process of consent to participate, which may alienate people)
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3. possibly be more likely to link with other services (such as smoking cessation services, for 
example)
4. working on longer timescales, thus informally assessing knowledge acquisition and 
behaviour change
5. having a greater focus on barrier removal, which was addressed only in five of the studies 
included here
6. having more likely to engage in community development activities, which none of the studies 
included here did.
Appropriateness of study design
Some aspects of the study designs may have introduced bias. For example, some studies recruited 
participants from prior studies26,97 or from existing health-care services.119
Some trials were unblinded and combined this with self-report data, for example Earp 
200216,63,93,94 and Paskett 2006116,117 This may be difficult to avoid for some of the interventions 
studied, but there were few efforts to acknowledge or mitigate the problem. Longer follow-up 
would help to determine the duration of effect. This might also allow for the LA role/HRLA 
intervention to develop and mould itself to community-specific needs.
Often comparisons were with control groups receiving ‘standard care’, but studies did not always 
report clearly what that entailed. Another issue relates to ‘background noises’ of health education 
campaigns, which was not acknowledged in any of the studies included here.
It was sometimes difficult to distinguish the effect of diverse intervention components. For 
example, Anand 200780 provided a very brief description of the intervention components, 
which makes it very difficult to assert what element (information giving, nurturing, removing of 
barriers, etc.) was the most important to intervention success. This has to be balanced with the 
fact that complex local needs may be best met with complex interventions, and that a detangling 
of discrete intervention components may come as a second phase to intervention trial for 
effectiveness. This is therefore not necessarily an issue of inappropriateness of study design, but 
a comment about where evidence research on this subject area tends to be placed on the MRC 
continuum of evidence development.67
Choice of outcome measures
Few of the studies included explicitly measured outcomes taking into account socioeconomic 
profile, making it impossible to comment on equity of outcomes. Another issue for consideration 
is that many studies focused on rather homogeneous disadvantaged populations, so differential 
outcomes would be difficult or impossible to measure. Most interventions included aimed 
at changing behaviour. Assumptions thus appeared to be made about the linearity of the 
following chain of action: information provision – knowledge acquisition – behaviour change – 
physiological outcomes. There was very limited description detail of the information provision 
element (see above about ‘background noise’): four studies assessed knowledge acquisition as 
a result of the intervention,84–87,108,109,112,116,117 but none related this to subsequent likelihood of 
behaviour change. Those studies that assessed behaviour change did not relate this to changes in 
physiological outcomes. This may be because clear links have yet to be established in the health 
improvement literature, but reports did not acknowledge this issue or bring any methodological 
solution to it.
The benefits of lifestyle interventions are typically accrued decades into the future for younger 
people, hence capturing long-term outcomes (such as a reduction in mortality from smoking 
cessation) simply is not feasible. As such, the surrogate short-term outcomes reported are 
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appropriate. However, there are concerns that lifestyle changes may not be maintained, and in 
this respect the very short duration of many studies (few were over 1 year – Gary 200398–100 are an 
example of this) raises concerns. There is also a lack of clarity as to whether maintenance requires 
continued input from LA – behavioural theory would suggest that a single input is unlikely to 
maintain behaviour change if the environment that the person is in does not also substantially 
change, for example drug users remaining in a drug-using community (unhelpful), smokers no 
longer being able to smoke in public venues (helpful).
Further concerns arise where self-reported data alone (i.e. not backed up by objective 
measures) are analysed from unblinded trials. There is evidence of inaccuracy in those data 
(particularly when one of the answers may be more socially acceptable), and a potential for bias 
in interventions where the trial (but not the control) arm have established a relationship with 
a LA (in which case the latter should not be involved in data collection). However, it has to be 
acknowledged that some outcomes that are very important can only be gained from self-report 
(e.g. QoL, attitude change, satisfaction). This issue might be mitigated by longer follow-up, and 
it is notable that one publication95,96 found evidence of mitigation of the intervention effects after 
only 12 months. This might indicate either relapse from lifestyle changes or decreased motivation 
to report favourable outcomes (reduction in bias).
Statistical issues
The wide variety of LA models delivered in a wide variety of settings and targeting a variety of 
population groups and covering a range of health improvement aims prevented the reviewers 
from engaging in establishing firm causal relationships between intervention mode and study 
outcomes. Indeed, apart from the fact that the studies have all been designed to test the effect 
of intervention by LAs, neither the outcomes under investigation nor the methods used are 
constant. The disparate nature of the studies meant that no standardised method of estimating 
effect size was viable; hence the reporting of various effect sizes depending on, and restricted to, 
the topic under investigation. For example, the standardised mean difference is applied when 
reviewing studies assessing the same outcome but measured differently, for example via different 
instruments. In such circumstances results are standardised to a uniform scale prior to analysis. 
The resulting statistic communicates the size of the intervention effect in each study relative to 
the study’s observed variability. However such an approach is clearly not applicable when dealing 
with different outcomes from dissimilar studies, albeit with a common, or perhaps similar, 
intervention philosophy.
Quality of reporting
Jackson and Waters64 comment that ‘reviews have been criticised for their focus on individual 
health education interventions rather than complex environmental or structural interventions 
and the poor coverage of issues relating to the social determinants of health’ (p. 368). In this 
review, the evidence assessed did focus mostly on individual behaviour change interventions, and 
attempts were made to counter that by using a realist approach to reporting. This approach is also 
thought to have extracted the most meaning out of the data available.
Quality of intervention
Assessing the quality of interventions may be problematic ‘where there is no preliminary research 
suggesting that an intervention should be administered in a particular way… it is important 
to establish to what extent these are standardised, as this will affect how the results should be 
interpreted’69 (p. 41). There is a methodological dilemma here, as high-quality research would 
require replicable interventions, and our synthesis shows that there was a tendency towards 
standardisation, but the nature of LA intervention may be more intuitive and resistant to the 
production of ‘one-size-fits-all’ model of delivery.
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With respect to complex interventions typical of public health community-based programmes, 
‘the quality can be conceptualised as having two main aspects: (i) whether the intervention has 
been appropriately defined, (ii) whether it has been delivered as planned’69 (p. 42). As discussed 
above, the studies included in this review often lacked a detailed description of their intervention 
mechanisms, as planned and as delivered. Dickson-Gomez 200691,92 in adopting an ethnographic 
approach, is an exception to this. With this exception in mind, it is of note that this issue is linked 
to that of the quality of reporting, as detailed descriptive accounts of intervention components, 
while they would have been considered in a realist synthesis, could not be included in this review.
Interdependency issues
Some studies reported on interventions that would be difficult to implement or be too costly in 
real-life settings (Dickson-Gomez 200691,92 provides an example, in that the LAs would require 
salary to work in the longer term, and in that the background rates of HIV infection in the UK 
would mean that this intervention would not be cost-effective in this setting). Interventions 
are inevitably interdependent on their context, an issue that the realist approach used here has 
started to tease out, but this is rarely acknowledged in the published literature.
Generalisability
There is a particular issue around generalisability of the interventions described, in that (as 
described in Chapter 3, Section 2, Interventions context, mechanism and outcomes) there is 
no such thing as a ‘typical’ practice setting for LAs. The specificity of setting and intervention 
components may well prevent the success of some LA interventions to be generalisable. The 
strategy adopted in this review, which highlighted specificity, may offer service providers and 
funders with a ‘menu’ of intervention characteristics that is flexible enough to allow for local 
specificity and IK.
While not always granted statistical significance, small effect sizes may be important in public 
health setting. Indeed, Sorensen et al.321 assert that ‘when risk is widely distributed in the 
population, small changes in behaviour observed across an entire population are likely to yield 
greater improvements on the population-attributable risk than larger changes among a smaller 
number of high-risk individuals’ (p. 380).
It is also worth bearing in mind that the achievement of a small, or even insignificant, effect size 
in a population, which would not otherwise be accessed by health improvement interventions, is 
not to be neglected. So while the generalisability of trial results could be statistically questionable, 
it may be that the consideration of issues of generalisability of interventions’ contexts and 
components could play a key role in addressing health inequalities, for example.
Evaluation approaches and research designs
All research was conducted by professionals/academics, with no peer involvement in the research 
process; so, for example, when observed by ethnographers89–92 the peers ‘led the ethnographers 
around’, showed them ‘relatively’ safe environments, and people, and probably showed only 
behaviours regarded as ‘positive’ by the researchers. There may be issues of concern regarding 
the ‘not stated’/‘not seen’ behaviours. For example, Ungar et al.37 showed peers wanting to be 
‘invisible’ to fulfil their roles more effectively.
Evidence application and utilisation: processes and challenges
Given the caveats spelled out in the previous section, some caution has to be exercised in terms 
of the practice and service messages that can be drawn out in this discussion. The limitations 
that the review design placed on the type of data that could be included consequently means 
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that there is an information base about HRLA provision outwith this review (see, for example, 
a newly developed database at www://piph.leedsmet.ac.uk/main/litreview.htm). Indeed, the 
quality assessment process that studies had to be submitted to prior to inclusion meant that the 
review favoured single-focus interventions, with defined and often standardised protocols, with 
a predominant focus on individual behaviour change rather than community development. 
This may have eliminated report of practices focusing on engagement or social capital or more 
overtly tackling health inequalities. Thus the series of continuums proposed in the initial phases 
of this review (Appendix 3), which was based on consultation with practice experts, needed 
development for a thorough description of the included studies. Equally, few included studies 
could be positioned on all of the continuums. This highlights the gap that still exists between 
HRLA practice and research. Mapping this review evidence against a model recently developed20 
allowed the location of this evidence base in the wider HRLA knowledge arena. While that model 
maps out practice foci, the model developed here (see Chapter 3, Figure 4) provides a detailing 
of models of practice within the individual/behaviour change quadrant of Visram et al.’s20 model. 
This focus on intervention mechanisms, or intervention theories,79 is a key feature of realist 
synthesis.
So that this discussion may achieve maximum utility to policy-makers and service providers, 
Figure 6 serves as an anchor for the following paragraphs, where each aspect is covered in turn. 
The ambition for this approach is that it will allow readers to locate the evidence synthesis and 
the issues arising from that in their particular cultural and organisational context.
Contextual issues
Evidence
Overall, previous reviews suggest that LAs may be of use in improving access to health care, 
and may reduce health disparities. However, the evidence is variable and can give only limited 
support to LAs having a positive impact on health knowledge, health behaviours and health 
outcomes. All of the previous reviews identified the need for future research that was of high 
methodological quality and high reporting quality. This should clearly identify and describe the 
character and role of the LA, and the character of the population to whom they delivered the 
intervention. More research is needed to understand the health effects of HRLA in combination 
with other interventions. The research should use valid, reliable and sensitive outcomes of 
importance to the participants and increase community involvement. There is a need for 
longitudinal research to evaluate the duration of effect of the interventions and more research 
into the social and health costs of providing such services.
FIGURE 6 Lifestyle advisor intervention.
1. Contextual issues:
evidence; policy priorities;
models of health care;
understanding need;
population focus; and 
location of delivery
3. Outcomes:
continuum of outcomes; acceptability;
equitability; cost, cost-effectiveness;
employment opportunities; and 
enhancement of social capital
2. Mechanisms:
LHA intervention
Context
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Policy priorities
Although most included studies stated that their target population was underprivileged and 
lacked access to services, none referred to tackling health inequalities as a study aim. Some, 
however, such as the screening interventions, tackled inequalities in that they made the screening 
more available to otherwise mostly disengaged populations. However, this was not an explicit 
aim of the study. Maybe more obviously, the HIV infection prevention studies (Dickson-Gomez 
200691,92 in particular) sought to engage drug users in the delivery of health care. As such, they 
fulfilled a dual purpose of (1) engaging these hard-to-reach groups and (2) making safe practice 
advice and materials more available to them, thus reducing barriers to health. The ethnographic 
design of the study also meant that the message delivered was not solely from on high, but also 
took local practices and microcultural dimensions into consideration. Dickson-Gomez 200691,92 
put a particular emphasis on highlighting the benefits of HRLA work on the LAs themselves and 
described how, for many of them, undertaking the LA role was the first step to employment and a 
possible end to homelessness and addiction.
Models of health care
In the introduction to this review the LA role was located within a general movement in the 
public health field away from a paternalistic to a partnership approach. The development of LA 
roles, most of which are rooted in some way in the target community, is an example of this policy 
shift. However, in practice this was only minimally presented in this review, with the premise of 
correcting inappropriate behaviours being at the root of many interventions. Included studies 
thus illustrate a partnership approach that was operationalised through a change in workforce 
rather than a change in message focus. This, however, had an obvious impact on social capital in 
the case of Dickson-Gomez 200691,92 for example.
Understanding need
Few of the studies included in this review make reference to accessing or capitalising on IK as 
a key component of the intervention. As described above, LAs in the included studies acted as 
translational agents, who sometimes removed barriers to the prescribed behaviour or helped 
to create a social environment facilitative or supportive to behaviour change. LAs clearly used 
their IK in Dickson-Gomez 200691,92 to access hard-to-reach individuals, and did report, to an 
extent, on other, unforeseen, local needs and issues. In this case, the use of LAs who were peers 
with a common experience and who had lived in the community for some time was crucial to 
intervention success.
However, the ways in which this capitalisation on IK through LA is realised remained unclear 
in most studies. Questions remain as to what knowledge was lacking to require LA intervention 
in the first place, how it was sought and how the message was delivered. This issue relates to 
an operationalisation of an understanding of local needs, for which techniques such as social 
marketing could offer potential.
Population focus
The original population continuum (see Appendix 3) did not allow for detailed description 
of the complexity of intervention target groups. The studies included showed that multiple 
characteristics can be used simultaneously to describe intervention target groups (Table 10). 
However, the rationale for selecting a particular combination of characteristics was not made 
explicit. In particular, although some studies described the local population as hard to reach, the 
‘hard-to-reachness’ of study participants was not always asserted. The quality assessment process 
that all studies were submitted to allocated lower strength to studies when a low proportion of 
the population agreed to take part. This suggests that some studies that did target disengaged 
populations had to be excluded from this review.
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Intervention location
Intervention location was a key element of intervention delivery mode and approach, in that, 
for example, people with chronic conditions were often part of interventions that took place in 
health-care settings. While both types of interventions were classified as community based, there 
is a key distinction to be made between screening interventions, which had elements of mass 
education campaigns, and HIV infection prevention interventions, in which location was crucial 
to engagement, message delivery and acceptability.
Mechanisms
Intervention aim
No studies described the aim of the intervention in terms of placing themselves on a health 
maintenance–health promotion–primary, secondary or tertiary disease prevention continuum. 
Of note is the fact that no intervention tackled health maintenance in any population. That is 
to say, most studies were narrowly focused on one issue or behaviour pattern, and measured 
outcomes directly related to this. While this is understandable from the methodological point of 
view of study design, it comes at odds with the potential of local or IK as operationalised by the 
use of LAs. Indeed, the problematisation of hard-to-reach communities, whether it is in terms of 
lack of access to services, high prevalence of risky behaviours or diseases, is unlikely to be linked 
to single causal elements that can be addressed by a single intervention foci.
Intervention delivery mode
This was particularly relevant to the included studies, in that by necessity of producing and 
recording evidence (often by means of activity logs), few studies reported on ad hoc informal, but 
yet informative, conversations. Dickson-Gomez 200691,92 was an exception to this, but used an 
ethnographic study design to observe interactions between drug users and trained LAs.
Figure 5 highlights a gap in evidence of informal interventions targeted at groups of the general 
population. The relationship of LA with other service provision was not well articulated. This is 
an important deficit with respect to being a bridge between communities and service providers.
The CDSM and associated programmes deserve particular attention. They have been assessed in 
this review as potentially cost-effective and have been widely replicated throughout the world. In 
contrast with the acknowledgement in the Choosing health7 document that one size fits all might 
not be appropriate; Lorig 1999110 have developed a highly formulaic intervention, adaptable to a 
large number of disease groups. There are a few notable differences between this and other HRLA 
interventions. While groups are defined by behavioural characteristics in the case of interventions 
targeting healthy eating or screening, for example, they are defined by physiological or physical 
characteristics in the case of CDSM programmes. The aims of the interventions also differ, in that 
people with chronic conditions are helped to live with their condition; whereas in other areas, 
participants are not learning to live with lack of exercise or physical activity, but try to change – 
thus a change in engagement with risk is a key differential factor.
This diversity is in keeping with the understanding described in UK policy that ‘different 
neighbourhoods will need different types of health trainers’.7 However, what is not clear from 
the data is why a particular model was selected and also which model achieves the best results 
in which environment, and that different models of provision will be required to achieve best 
outcomes. In other words, the links between contexts, mechanisms and outcomes are not 
explicitly established.
Intervention approach
Most studies included in this review focused on providing information by an alternative message 
giver (as was predominantly the case in the diet and physical activities study group, with the 
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exception of Anand 200780 and Elder 200695,96); seven studies used this approach only. The 
assumption is that the message is thus translated in a more acceptable and effective manner. Less 
than half of the studies described the creation of supportive social environment to help behaviour 
change. It thus appears that most interventions included here were in support of standard advice 
(chronic care, the buddy schemes in smoking cessation or breastfeeding, for example). In a few 
cases, as in the HIV infection prevention studies or in mental health, they were presented as 
an alternative and more effective approach to standard care. The screening studies focused on 
reaching out to populations to bring them to standard screening practices, so fulfilled more the 
role of a bridge between disengaged populations and standard models of care.
Evidence suggests that few studies use one approach only, but, equally, few studies are explicit 
about approach components, and their effect in isolation and/or in combination. This suggests 
that intervention approach may be even less explicit in practice, and left to develop from the IK 
held by the LAs. The categories of information delivery, nurturing for behaviour change, creation 
of supportive social conditions and barrier removal were created inductively from the included 
studies, but may thus be insufficient to describe the complexity of interventions in practice. 
However, crucially, these categories need further unpicking, as some studies appeared to create 
favourable social conditions, for example, how this was achieved remains unclear. While it is in 
keeping with the philosophy of HRLA to capitalise in an informal manner on the knowledge held 
by LA, this is also preventing an articulation of what approach works in what context.
Training
The relationship of the amount and area of LA training to intervention effectiveness remains 
unclear. Equally, the effect of training on the lay and/or peer status of LAs remains unexplored. 
Earp 200216,63,93,94 presents the impact of training on intervention acceptability and credibility, 
as participants nominated the fact that LA had taken a course as one of the reasons why they 
would feel comfortable talking to them. Some studies followed a pseudoprofessional approach 
with respect to recruitment, training and remuneration, and the LAs were rarely selected by the 
community they were intended to serve.
In practice, the LA role is represented by a range of titles that obscure its key characteristics. For 
example, distinction between peerness and layness was not made in any of the studies included in 
this review. This is also true in the UK, where HRLA is often delivered by ‘health trainers’, a title 
that, in itself, does not assume any degree of peerness or layness. This lack of clarity may have 
major implications on the mechanisms of action and intervention outcomes.
Outcomes
Although papers included in the review often discuss the content of the intervention, what they 
do that leads to positive change is very rarely described. So, although it is possible to say that 
LAs are effective in improving health and well-being, the outcome–causality chain is not clear. 
Disappointingly, the situation reported by the WHO 20 years ago with respect to CHWs, i.e. 
a lack of understanding of how to realise the potential of the role12 continues to plague the LA 
role. The dominant mechanisms of action appears to balance on the assumption that a change in 
knowledge leads to change in beliefs, which leads to change in health behaviours, which leads to 
improvements in health, QoL, activity, participation, etc. Three key issues emerge for comment. 
First, the time scale of many of the reported studies is too short to allow demonstration 
of movement along a knowledge to improved health trajectory. The general assumption is 
that the movement is linear and not dependent on continued or evolving and cumulative 
interventions. Second, there is a clear need to identify and measure intermediate outcomes 
to demonstrate progress on such an outcomes continuum. Third, because of the contextual 
sterility of intervention descriptions, it remains unclear to what extent the LA intervention was a 
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contributor to other programmatic interventions, as is often the case with respect to public health 
practice. Thus the partnership or cumulative impact or potential is therefore not clear.
Acceptability
Levels of acceptability appear to be high. However, this is often reported as a generic statement 
with respect to a HRLA service, rather than providing clarity on what aspect of the LA influenced 
acceptability. Earp 200216,63,93,94 presented an exception to this, as participants explained how 
important it was to them that the LA was someone local who they knew well and trusted. 
Other important elements were that the LA had professional or personal experience of breast 
cancer and had undertaken training. So the key element in here is that participants wanted the 
health improvement message translated. In Dickson-Gomez 200691,92 the delivery setting was a 
particularly important acceptability factor, as outreach workers were able to deliver messages in 
settings not usually targeted, such as disused buildings and other drug injection sites.
Equitability
There are clear gaps in HRLA provision, covering both target groups, such as men, older people 
or homeless people, for example. There was indeed a clear dominance of interventions targeted at 
women, but the rationale for this was unclear (i.e. women might be clear change agents in some 
communities, but this was not made explicit). Interventions were always focused and no evidence 
could be found of holistic interventions (i.e. tackling health promotion, maintenance, primary, 
secondary or tertiary prevention).
Cost-effectiveness
The economic analysis suggests that lay-delivered smoking cessation interventions are highly 
cost-effective. Neither promotion of screening nor exercise/healthy eating is cost-effective. 
Programmes directed towards improved disease management have the potential to be cost-
effective. The conclusions on physical activity and healthy eating flow from a lack of evidence 
of effectiveness in these areas. Where there is evidence of effectiveness, LAs are not always 
cost-effective. The key driver is the size of the potential health gain from the behaviour promoted. 
This is large for smoking cessation, and justifies a relatively intensive intervention. The gain 
from mammography is simply insufficient to justify even a low-intensity promotion programme. 
The benefits from improved management of diabetes are potentially large, and may justify a 
low-intensity call centre-based intervention to encourage healthier lifestyles. While the benefits 
of averting HIV infection are large, the background rate is too low to justify intensive peer-
promoted risk reduction programmes for injecting drug users in the UK.
A considerable amount of uncertainty pervades much of this analysis. Estimates of the health 
gains are likely to be robust in mammography and diabetes management, as they are based on 
extensive trial data modelled by experienced groups. Less attention has been paid to modelling 
the health gains from smoking cessation, but extensive epidemiological data suggest that the 
estimate used here is conservative. Consequently, the conclusions on smoking cessation in this 
study are likely to be robust, and they are similar to many published studies of cessation services. 
The analysis of mammography used generous estimates of the benefits of the programme and 
the results are likely to be robust, although other authors have come to different conclusions. 
The greatest uncertainty exists over the benefits of breastfeeding. Few would doubt that benefits 
exist, but the evidence of improvements in cognitive ability and reductions in obesity and type 
1 diabetes is controversial given the inevitable environmental confounders. Without an estimate 
of the health gains from breastfeeding it is very difficult to judge whether promotion is cost-
effective. It should be noted that the small number of studies reviewed in each area raises the 
possibility of publication bias, leading to an overestimate of the effectiveness of LA programmes.
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The greatest uncertainty arises with respect to maintenance of behaviour changes. Data from 
the smoking literature are encouraging, in as much as they suggests that a proportion of quitters 
remain abstinent. Few data exist on whether changes in diet or physical activity are maintained 
but the evidence from the weight loss literature is not encouraging.322 It is quite possible 
that long-term abstinence from smoking is easier to maintain than dietary improvements 
and physical activity routines given the financial incentives to abstain. Data on long-term 
maintenance are essential if judgements on the viability of diet and physical activity promotion 
programmes are to be made.
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Chapter 5  
Conclusions
We identified 269 studies that evaluated HRLA. We excluded a further 243 studies owing to a range of methodological factors that made them unsuitable for inclusion in a systematic 
review. The CRD guidelines69 acknowledge the limitations of traditional criteria for producing 
systematic reviews in public health and advocate the use of far more iterative processes. This 
review has attempted to reconcile the rigour necessary to conduct a systematic review with the 
necessity to provide in-depth description of the interventions included by working iteratively 
across intervention foci, context–mechanism–outcome, and economic approaches to analysis.
There is a vast descriptive and process literature on the subject of LAs. Overall, the evidence is 
not sufficient to support or refute the use of LAs to promote health and improve QoL. Although 
there is likely to be considerable uncertainty about statements of interventions’ cost-effectiveness 
because of the sparse evidence base for effectiveness, some conclusions can be drawn. The 
following summarises the health economic analysis conclusions on each intervention focus type, 
with some descriptive/analytical comments informed by the realist approach.
 ■ Lifestyle advisor interventions in chronic care are cost-effective. The effectiveness of the 
CDSM approach is linked to their largely engaged target group. Their aim varies from 
that of some of the other HRLA in that they help people live with a condition, rather 
than necessarily aiming at behaviour change. For people with chronic conditions, there 
is a pre-existing problematisation, which happened at the time of diagnosis, whereas this 
problematisation is introduced by some of the other HRLA interventions, which inevitably 
impacts on intervention acceptability and impact.
 ■ Lifestyle advisor interventions for smoking cessation are cost-effective, because of the 
important health gains that derive from cessation. The economic analysis excluded two 
studies because their effectiveness did not reach statistical significance.30,113 The buddy 
schemes explored in these studies present, however, a number of advantages: they are not 
costly to run and they adopt the kind of unstructured and informal intervention rarely 
described in the literature. Thus, as a practice model, they may offer potential.
 ■ From the evidence that could be accessed, the cost-effectiveness of LA interventions for 
breastfeeding is inconclusive. In these interventions, peers were selected for their common 
past experience in breastfeeding, and the target group was defined by their stage of life, 
rather than being classified ‘at risk’ or carrying an existing diagnosis. Thus, for these 
interventions the aim may be not so much behaviour change as behaviour enhancement, 
with a dual goal of promoting mother and baby health. These interventions focused on an 
optimal breastfeeding duration of 3–6 months and do not, therefore, present the same issues 
of longitudinality of effect as the other intervention types.
 ■ Included studies did not allow the production of conclusive cost-effectiveness estimates 
for LA interventions for mental health. As for the chronic care intervention model, the 
problematisation (being a mother of a child with a chronic condition) pre-dated the 
intervention. This intervention thus uses other HRLA intervention modes (pairing people 
with similar experiences, as in breastfeeding or smoking cessation) to a group that presents 
similar characteristics to the CDSM programme.
 ■ Lifestyle advisor interventions for screening uptake are not cost-effective. These interventions 
did reach, however, a large number of people, presented on the whole high degrees of 
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acceptability and targeted population groups that tended to be disengaged from mainstream 
service provision.
 ■ Lifestyle advisor interventions for diet and physical activity are not cost-effective. Of note 
here is one of the studies,79 where the intervention target was the whole family, rather 
than solely the individual. In the context of this review, this is a unique approach that has 
potential – in particular, it focused on nurturing and barrier removal. While the approach 
seems to offer an alternative potential, intervention component description was too limited, 
unfortunately, to draw further lessons.
 ■ Lifestyle advisor interventions for HIV infection prevention were cost-effective, but not 
in a UK context. They did, however, succeed in reaching hard-to-reach communities and 
building on social capital, two aims of the health trainer scheme in the UK.7 As far as 
research methodologies are concerned, the Dickson-Gomez et al.89 and Latkin et al.90 study 
offers a unique approach, combining ethnography as a means to understand local needs and 
cultures as well as quantitative description of intervention effect.
Recommendations for practice
Generally, there is a need to develop theoretically sound interventions that map to different 
population health needs. These need to be evaluated with increasing rigour, using the early stages 
of the MRC framework67 as guiding principles, so as to enable a better mapping of concepts, 
application and evaluation. The following points detail some specific recommendations:
 ■ Interventions that are low cost – in terms of monetary cost, training costs and low impact on 
the participants’ normal lives – and have some effect are recommended.
 ■ Further recognition of the IK base of the LA may be required. There needs to be a process 
of surfacing this for the LA, which would also maximise the potential for understanding 
inequalities to be enhanced.
 ■ The model driving approach to, and level of, training may also be worthy of some 
consideration. A balance may be required between what the service providers consider is 
required, with some input from the LA and their self-identified needs for training to fulfil the 
role.
 ■ The nature of the message should be tailored to the community and the LA delivering it, 
so that it is acceptable and safe for the LA to deliver. This may be particularly important in 
harder-to-reach populations. The process of tailoring and the effectiveness of inclusion of 
different aspects of community allegiance and IK requires further exploration.
 ■ There is a need for clearer definitions of target groups, with their characteristics and 
particular needs.
 ■ Intervention approaches need to be made more explicit in terms of single versus multiple 
foci, a positioning on a health maintenance–tertiary disease prevention continuum and a 
clear intervention aim (from raising awareness to behaviour change to improved health).
 ■ Peership and layness need to be considered and defined for the particular setting.
 ■ Short-, medium- and long-term intervention outcomes need to be clearly identified and 
measured.
Recommendations for a future programme of research
The following recommendations are focused particularly on the UK, but may be of international 
relevance. They are in order of priority, and designed to form a programme of research on HRLA, 
around the identification of needs, the broadening of population focus and intervention aims, the 
measurement of outcomes and the reviewing of evidence. Given the lack of evidence generated in 
the UK, the following recommendations bear particular relevance to the UK context.
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Identifying need:
 ■ Concept mapping might help identify what people believe helps them adhere to healthy 
lifestyle advice and triangulate this to the views of public health professionals and 
community leaders.
Target groups:
 ■ Interventions in missing groups (men, transient populations, homeless people, etc.), broader 
interventions in groups with specific issues, for example physical health in mental health 
population groups, and prevention in general health promotion (such as stop smoking plus 
diet exercise and screening) need further development.
 ■ Research on alternative target groups, which may be of broader focus than health related, 
such as, for example, faith groups, youth groups, community centres, gangs, playschemes, 
etc. Within each group, existing leaders could be identified and collaborative relationships 
nurtured to identify, assess and address local needs. Such schemes are likely to lead to 
community development activities but would require longitudinal funding schemes.
Intervention aim:
 ■ Research is needed on the building of social capital or community development through LA 
schemes. This would entail a focus on social, rather than individual, determinants of health 
inequalities.
 ■ A development of research led by, or conducted in collaboration with, community guides 
would help to develop ways for health-care providers to maximise the potential of pre-
existing ‘unofficial’ health improvement activities.
Outcome identification and measurement:
This review endorses the need for a strategic movement along the MRC continuum of evidence, 
so that research evolves from scoping practice to evaluating outcomes.
 ■ Health-related lifestyle advice schemes would benefit from a development of current 
methodological advancements323 to help identify and assess short-, medium- and long-term 
intervention outcomes. In the long term, this would encourage the publication of promising 
outcomes and thus strengthen the HRLA evidence base.
 ■ There is a need to identify what enables long-term effects, i.e. regular low-cost ‘top-up’ 
interventions or multidimensional interventions with changes in approach over time.
Systematic reviewing in public health:
 ■ A greater engagement with realistic review or synthesis principles would allow exposure 
of contexts and mechanism components that influence a range of outcomes in HRLA 
interventions. Indeed this review, in using realist principles in the synthesis of the data, has 
refined programme theories (theoretical underpinning, intervention aim, approach, intensity 
and delivery mode and role/training) so that they may now be reviewed individually.
 ■ This review supports previously published commentaries64,69 on the necessity for the 
development of quality assessment tools that could allow increased methodological 
flexibility.
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Appendix 1  
Review of reviews
Rationale for inclusion of reviews
We wanted to determine if any previous reviews had made conclusions regarding health-related 
LAs that would inform our review and/or reinforce our conclusions (see Tables 30 and 31, for the 
characteristics of included reviews). Searches were made by two reviewers for existing relevant 
systematic reviews using Cochrane, Campbell, CRD/Database of Abstracts of Reviews of Effects 
(DARE) and EPPI-Centre databases. As we were conducting a systematic review (in order to 
reduce bias and increase the robustness of our conclusions), the reviews included for evaluation 
had to also be systematic in nature. That is, they had to have searched more than one database, 
preferably with a stated search strategy. They had to state some form of inclusion and exclusion 
criteria. They had to give a list of the included studies and preferably their characteristics. 
Preferably, they would have assessed the methodological quality of the studies included and used 
this information in the assessment of the reliability of the results they presented. In this way we 
could identify the studies used in these reviews, and how the study’s results informed the review’s 
conclusions. We could also identify where there was overlap with our review, where studies 
differed and for what reasons.
Preferably, they had to define the character of their health-related LAs delivering the 
interventions. Reviews that included interventions delivered by health-related LAs and others 
had to present the results for the LAs separately. We excluded reviews that exclusively evaluated 
trained health-care professionals or that addressed the treatment of illnesses and their symptoms 
specifically.
Excluded studies
Twenty reviews were identified but excluded (see Table 32, for excluded reviews). One review324 
that was identified involved investigation the effectiveness of any kind of psychological treatment 
for anxiety and depressive disorders performed by paraprofessionals. The authors wanted to 
examine whether the results applied to clinically significant disorders. As this is the direct 
treatment of a mental disorder – rather than the promotion of a healthy lifestyle in people 
with mental diseases – this study was excluded. Foster et al.325 reviewed studies that primarily 
addressed self-management of chronic disease. As this was also deemed to be disease focused 
rather than the promotion of healthy lifestyles this review was excluded. Two other reviews did 
search more than one electronic database, but Logsdon and Davis326 included only studies with 
statistically significant results that could have introduced bias into the review and Persily327 did 
not specify the search terms or databases used, and did not clearly define the selection criteria, 
which, again, could have introduced bias into the review. On the basis of these methodological 
flaws these two reviews were excluded from consideration. One review328 assessed 10 techniques 
used to identify opinion leaders to promote behaviour change. It proposed these 10 techniques as 
ways to identify health-related LAs, and suggested that the method of identification has impact 
on the character of training required and the likelihood of long-lasting effects on the community 
after the initial intervention has finished. Unfortunately, the authors did not cite the 191 studies 
they claimed to identify, so we could not evaluate the association between the evidence and their 
conclusions. Therefore, this review was excluded.
The remaining 15 reviews covered a wide variety of areas, some of which are not covered by 
the systematic reviews included below, but none of them made any claims to be systematic, and 
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in fact some of the excluded reviews were explicitly opinion pieces that presented a particular 
argument with no attempt at impartiality. Therefore we did not feel we could include their 
conclusions because of the significant risk of bias.
Lifestyle advisors engaged in general health improvement or health 
promotion
Six reviews examined the impact of health-related LAs for general health improvement or 
promotion. One of these329 examined telephone support as the mode of delivery of advice from 
peers with similar or relevant health experience. One review13 examined the effectiveness of lay 
health workers in primary or community health care. One330 examined the effectiveness of CHWs 
in the USA. Three reviews331–333 examined interventions in ethnic minority communities, all in 
the USA. Andrews et al.331 examined CHWs with US ethnic minority women. Rhodes et al.333 
examined LHAs in adult Hispanic/Latino communities in the USA. Fisher et al.332 evaluated 
strategies or interventions using cultural leverage to determine if they are effective at decreasing 
health disparities for communities of colour.
Two reviews included RCTs alone;13,329 the remaining four reviews did not limit the 
methodologies used by their included studies. Three of the six reviews assessed the 
methodological quality of the papers they reviewed13,329,332 and used this information to evaluate 
the reliability of the studies’ results. None of these three reviews used the quality standard of the 
identified studies as an inclusion criterion.
The poor quality of the RCTs’ methods meant that we excluded the majority (six of seven) of 
the studies included in the review of Dale et al.329 in our review (see Table 33 for review studies 
included or excluded from this review). Dale et al.’s329 review of telephone support concluded 
that, although their review of seven RCTs provided some evidence that peer support telephone 
calls can be effective for certain health-related concerns, few of the studies were of high quality 
and so results should be interpreted cautiously. There were many methodological limitations, 
thus limiting the generalisability of findings.
Only 4 of the 43 studies in the review by Lewin et al.13 were included in ours.14,88,103,114 The review 
stated that lay health workers show promising benefits in promoting immunisation uptake when 
compared with usual care. They also showed benefit in condition-specific management, for 
example acute respiratory infections and malaria. For other health issues, evidence is insufficient 
to justify recommendations for policy or practice.
Only one of the studies included in Swider330 met the criteria for inclusion in our review.84 
Swider330 indicated preliminary support for CHWs in increasing access to care, particularly in 
underserved populations. They identified a smaller number of studies documenting outcomes 
in the areas of increased health knowledge, improved health status outcomes and behavioural 
changes, with inconclusive results. In their opinion, although LAs show some promise as an 
intervention, the role can be doomed by overly high expectations, lack of a clear focus and lack of 
documentation.
Four of the 24 studies included in Andrews et al.331 were also included in our review.63,84,94,108 The 
integrative analysis331 concluded that, despite varying roles and functions, the evidence indicates 
that CHWs are effective in increasing access to health services, increasing knowledge and 
promoting behaviour change among ethnic minority women. Other advantages of using CHWs 
are to provide social support and culturally competent, cost-effective care.
Rhodes et al.’s review333 included 37 studies of a variety of methodologies of which only two were 
included in our review.87,120 Rhodes et al.333 concluded that given the long history of using LAs 
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as an approach to health promotion and disease prevention, and the current emphasis of LA 
approaches as a potential solution to health disparities in general, and among Hispanics/Latinos 
in particular, few rigorous studies have been published that document the effectiveness of LAs on 
a variety of public health concerns.
Two of the 23 studies included in Fisher et al.’s review332 were included in our review.84,98 
Fisher et al.332 concluded that the delivery of processes of care or intermediate health outcomes 
was significantly improved in 23 interventions. Interventions using cultural leverage showed 
tremendous promise in reducing health disparities, but that more research is needed to 
understand their health effects in combination with other interventions.
Overall very few of the studies included in these six reviews covering aspects of health-related 
LAs engaged in general health improvement or health promotion were included in our 
review. The reviews above often included non-evaluative studies; none excluded studies on 
methodological quality criteria, and some evaluated areas outside our review’s remit. Overall, 
the six reviews give cautious support for health-related LAs in improving access to health care, 
particularly in underserved communities. However, they all note the small quantity and generally 
poor quality of research in the area, and the limitations this imposes on the interpretation of the 
available data.
Lifestyle advisor engaged in improving diet
One review334 was identified which assessed the impact of peer education/counselling on 
nutrition and health outcomes among Latino communities in the USA. The review included 22 
studies, did not limit the methodologies used and did assess the methodological quality of the 
studies. Methodological quality was not used as an inclusion or exclusion criterion. The results 
of the quality assessment were not presented and it was not obvious how the quality assessment 
has influenced the authors’ assessment of the reliability of the studies’ results. Three of the 22 
studies were included in our review.95,112,119 Pérez-Escamilla et al.334 concluded that peer nutrition 
education has a positive influence on diabetes self-management and breastfeeding outcomes, as 
well as on general nutrition knowledge and dietary intake behaviours, among Latinos.
Lifestyle advisor engaged in improving maternal and infant health
Five reviews were identified that used LAs to improve maternal and infant health. One review335 
examined traditional birth attendants, one336 examined interventions for women at risk of 
preterm or low-birthweight babies (including lay advisors), one337 examined interventions 
for pregnant or post partum women with drug or alcohol problems (including lay advisors), 
and two338,339 examined interventions to support breastfeeding (including lay advisors). Three 
reviews assessed random or quasirandomised trials,336–338 one335 assessed experimental or quasi-
experimental designs. All five reviews assessed the methodological quality of the papers they 
reviewed and used this information to evaluate the reliability of the studies’ results. None of the 
five reviews used methodological quality as an inclusion or exclusion criterion.
One review335 was a combined narrative review and meta-analytic review conducted to 
summarise published and unpublished studies, completed between 1970 and 2002, on the 
relationship between LA training and increased use of professional antenatal care (ANC). 
None of the 15 studies was included in our review. This was because many of them evaluated 
the impact of education on the LAs, rather than LAs’ impact on health outcomes for mothers, 
which would match the focus of our review. Sibley et al.335 concluded that the overall quality of 
the studies included in this review was variable, making it impossible to attribute causality to the 
observed outcomes in relation to LA training. Despite this, the results suggest that training may 
increase ANC attendance rates by about 38%. This magnitude of improvement could contribute 
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to a reduction in maternal and perinatal mortality in areas where women have access to quality 
ANC and emergency obstetric care.
One review336 examined interventions for women at risk of preterm or low-birthweight babies, 
but identified only two studies339,340 that assessed lay advisors. They state that the results of these 
two studies were consistent with the other interventions assessed. The study by McLaughlin et 
al.340 was excluded from our review as they provided support with a multidisciplinary team that 
included laywomen, so the impact of the lay advisors alone was impossible to extract. Spencer et 
al.339 was not included in our review, as the study focused only on infant health. Hodnett et al.336 
concluded that while programmes that offer additional support during pregnancy are unlikely to 
prevent the pregnancy from resulting in a low-birthweight or preterm baby, they may be helpful 
in reducing the likelihood of caesarean birth.
One review337 examined interventions for pregnant or post partum women with drug or alcohol 
problems, and identified two studies341,342 that used lay advisors. Grant et al.341 reported only 
outcomes for child health (and so was excluded from our review). Schuler et al.342 reported no 
significant difference for continued illicit drug use, continued alcohol use or failure to enrol in a 
drug treatment programme. Overall, the review concluded that there was insufficient evidence to 
recommend the routine use of home visits for women with a drug or alcohol problem.
One review338 examined interventions to support breastfeeding and identified nine studies 
with lay advisors. They concluded that there was significant heterogeneity present in these 
studies. Two of these studies were included in our review.88,114 These nine studies demonstrated 
a significant reduction in breastfeeding cessation at the time of the last study assessment. In the 
studies of lay support that reported exclusive breastfeeding there was a marked reduction in the 
cessation of exclusive breastfeeding before the last study assessment.
One review339 evaluated the effectiveness of interventions which aimed to encourage women to 
breastfeed. They concluded that health education and peer-support interventions can result in 
some improvement in the number of women beginning to breastfeed. These 11 trials suggest that 
larger increases are likely to result from needs-based informal repeated education sessions than 
more generic, formal antenatal sessions.
Overall, these five reviews examining aspects of HRLA engaged in improving maternal and infant 
health showed that traditional birth attendants could increase access to professional ANC, and 
lay advisors may reduce the rates of cessation of breastfeeding. However, there is little evidence of 
effect on women with drug or alcohol problems, or women at risk of low-birth-weight babies.
LAs to support smoking cessation
Two reviews160,343 examined the impact of peer support to aid smoking cessation rates. The two 
reviews examined RCTs and both assessed their methodological quality. The quality assessment 
was not used for inclusion or exclusion of studies. The effectiveness of the interventions was 
discussed in relation to the quality of the studies.
Only one study from each review was included in our final review.30,113 There was substantial 
overlap of studies between the two reviews, with them having six studies in common. 
Unsurprisingly, their conclusions were similar. Park et al.161 failed to detect an increase in quit 
rates after partner support interventions. Limited data from several of the trials suggest that these 
interventions did not increase partner support either. No conclusions can be made about the 
impact of partner support on smoking cessation. May and West160 concluded that the research 
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methodology in many cases was poor. The evidence would suggest that in the context of a 
smokers’ clinic the use of buddies may be of some benefit. There is a lack of evidence regarding 
the efficacy of the use of buddies in community interventions. May and West’s160 greater 
optimism for buddy support may have been influenced by their involvement in the conduct of 
those studies.
LAs using specific models of intervention
One review205 aimed to systematically assess the effectiveness of interventions using a stages-
of-change-based approach in bringing about positive changes in health-related behaviour. They 
reviewed 37 RCTs, and assessed their methodological quality. The quality assessment was not 
used for inclusion or exclusion of studies. The effectiveness of the interventions was discussed in 
relation to the quality of the studies.
The stages-of-change approach is proposed to be one of the models of interventions used 
by health-related LAs. In fact, only 5 of the 37 studies evaluated in the review examined 
interventions delivered by health-related LAs (e.g. telephone counsellors, peer educators), and the 
results for these studies were not examined separately. The remaining studies were delivered by 
health-care professionals or via modes such as computers or mailed information sheets. Riemsma 
et al.205 concluded that given the limited evidence for the effectiveness of interventions tailored 
to the stages-of-change approach, practitioners and policy-makers need to recognise that this 
approach has a status that appears to be unwarranted when it is evaluated in a systematic way. 
In the light of so few studies evaluating the stages-of-change approach in the context of health-
related LAs, Riemsma et al.205 could not conclude any effect.
Reviews’ research recommendations
All of the reviews identified the need for future research that was of high methodological quality 
and high reporting quality. The research should clearly identify and describe the character and 
role of the health-related LA, and the character of the population to whom they delivered. The 
intervention’s mechanism of action, theoretical framework, and the character of the intervention 
delivered should be clearly defined and described. More research is needed to understand the 
health effects of health-related LAs in combination with other interventions. The research 
should use valid, reliable and sensitive outcomes of importance to the participants and increase 
community involvement. There is a need for longitudinal research to evaluate the duration of 
effect of the interventions and for more research into the social and health costs of providing 
such services.
Discussion
Overall, the reviews suggest that health-related LAs may be of use in improving access to health 
care, and may reduce health disparities – in part by acting as cultural leverage. The evidence is 
variable and can give only limited support to health-related LAs having a positive impact on 
health knowledge, health behaviours and health outcomes. It is likely that factors that are often 
poorly described in the original studies, such as the context (e.g. the character of the advisors 
and advisees and their communities), mechanism (e.g. proposed mechanism of action, detailed 
descriptions of the actual delivery of the interventions) and outcomes (e.g. justify the outcomes 
in terms of relevance to the participants, their community, their reliability, sensitivity, validity, 
and the minimum size of relevant change, and the costs in terms of time, impact on lifestyle, and 
monetary costs), are of importance in the development of successful interventions. Without the 
information on context, mechanism and outcomes, an understanding of which interventions 
mediated by health-related LAs are likely to succeed or fail will remain elusive.
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TABLE 30 Tables of included reviews
Dale 2008329
Study Dale J, Caramlau IO, Lindenmeyer A, Williams SM. Peer support telephone calls for improving health. Cochrane 
Database Syst Rev 2008; Issue 4, Art. No. CD006903.329
Aim To assess the effects of peer support telephone calls in terms of physical (e.g. blood pressure), psychological (e.g. 
depressive symptoms), and behavioural health outcomes (e.g. uptake of mammography) and other outcomes
Search strategy The Cochrane Library databases [Cochrane Central Register of Controlled Trials (CENTRAL), DARE, CDSR (issue 4 
2007); MEDLINE (Ovid) (January 1966 to December 2007); EMBASE (Ovid) (January 1985 to December 2007); 
CINAHL (Athens) (January 1966 to December 2007)], trials registers and reference lists of articles, with no language 
restrictions
Selection criteria RCTs of peer support interventions delivered by telephone call
Character of peer The peer is someone selected to provide support because they have similar or relevant health experience
Assessment of risk of bias We assessed and reported on the risk of bias of included studies in accordance with the guidelines of the Cochrane 
Consumers and Communication Review Group and the Cochrane Handbook, which recommended the explicit reporting 
of the following individual quality elements for RCTs: sequence generation (including the method used); allocation 
concealment (including the method used); blinding (participants, providers, outcome assessors, data analysts); 
completeness of outcome data; and selective reporting. We incorporated the results of the assessment into the review 
through systematic narrative description and commentary about each of the these domains, leading to an overall 
assessment of the risk of bias of included studies and a judgement about the internal validity of the review’s results
Data collection and 
analysis
Two review authors independently extracted data. We present results narratively and in tabular format. Meta-analysis 
was not possible due to heterogeneity between studies
Results We included seven studies involving 2492 participants. Peer support telephone calls were associated with an increase 
in mammography screening, with 49% of women in the intervention group and 34% of women in the control group 
receiving a mammogram since the start of the intervention (p ≤ 0.001). In another study, peer support telephone calls 
were found to maintain mammography screening uptake for baseline adherent women (p = 0.029)
Peer support telephone calls for postmyocardial infarction patients were associated at 6 months with a change in diet 
in the intervention and usual care groups of 54% and 44%, respectively (p = 0.03). In another study of post myocardial 
infarction patients there were no significant differences between groups for self-efficacy, health status and mental 
health outcomes
Peer support telephone calls were associated with greater continuation of breastfeeding in mothers at 3 months post 
partum (p = 0.01)
Peer support telephone calls were associated with reduced depressive symptoms in mothers with postnatal depression 
(EPDS > 12). The peer support intervention significantly decreased depressive symptomatology at the 4-week 
assessment (OR 6.23, 95% CI 1.15 to 33.77, p = 0.02)) and 8-week assessment (OR 6.23, 95% CI 1.40 to 27.84, 
p = 0.01)
One study investigated the use of peer support for patients with poorly controlled diabetes. There were no significant 
differences between groups for self-efficacy, HbA
1C
, cholesterol level and BMI
Conclusions While this review provides some evidence that peer support telephone calls can be effective for certain health-
related concerns, few of the studies were of high quality and so results should be interpreted cautiously. There were 
many methodological limitations, thus limiting the generalisability of findings. Overall, there is a need for further well 
designed randomised controlled studies to clarify the cost-effectiveness and clinical effectiveness of peer support 
telephone calls for improvement in health and health-related behaviour
EPDS, Edinburgh Postnatal Depression Scale.
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Lewin 200513
Study Lewin S, Dick J, Pond P, Zwarenstein M, Aja GN, vanWyk BE, et al. Lay health workers in primary and community 
health care. Cochrane Database Syst Rev 2005; Issue 1, Art. No. CD004015.13
Aim To assess the effects of LHW interventions in primary and community health care on health-care behaviours, patients’ 
health and well-being, and patients’ satisfaction with care
Search strategy We searched the Cochrane Effective Practice and Organisation of Care and Consumers and Communication 
specialised registers (to August 2001); CENTRAL (to August 2001); MEDLINE (1966 to August 2001); EMBASE (1966 
to August 2001); Science Citations (to August 2001); CINAHL (1966 to June 2001); HealthSTAR (1975–2000); AMED 
(1966 to August 2001); the Leeds Health Education Effectiveness Database, and the reference lists of articles
Selection criteria RCTs of any intervention delivered by LHWs (paid or voluntary) in primary or community health care which are intended 
to promote health, manage illness or provide support to patients. An LHW was defined as any health worker carrying 
out functions related to health-care delivery, trained in some way in the context of the intervention, and having no 
formal RCTs of any intervention delivered by LHWs (paid or voluntary) in primary or community health care and 
intended to promote health, manage illness or provide support to patients. An LHW was defined as any health worker 
carrying out functions related to health-care delivery, trained in some way in the context of the intervention, and having 
no formal professional or paraprofessional certificated or degreed tertiary education. There were no restrictions on 
the types of consumers, professional or paraprofessional, certificated or degreed tertiary education. There were no 
restrictions on the types of consumers
Character of peer Any LHW (paid or voluntary) including community health workers, village health workers, cancer supporters, birth 
attendants, etc.
For the purposes of this review, a ‘LHW’ was defined as any health worker:
•	 carrying out functions related to health-care delivery
•	 trained in some way in the context of the intervention
•	 having no formal professional or paraprofessional certificated or degreed tertiary education
Assessment of risk of bias Two reviewers independently assessed the quality of all eligible trials using the methodological quality criteria for RCTs 
listed in the Cochrane EPOC Review Group module. Studies were assessed as high quality if they reported allocation 
concealment, higher than 80% patient follow-up and intention-to-treat analysis. Studies were assessed as low quality 
if they did not meet these criteria or if they did not report the information necessary for assessment
Data collection and 
analysis
Two reviewers independently extracted data on to a standard form and assessed study quality. Studies that compared 
broadly similar types of interventions were grouped together. Where feasible, the results of included studies were 
combined and an estimate of effect obtained
Results Forty-three studies met the inclusion criteria, involving more than 210,110 consumers. These showed considerable 
diversity in the targeted health issue and the aims, content and outcomes of interventions. Most were conducted in 
high-income countries (n = 35), but nearly half of these focused on low-income and minority populations (n = 15). 
Study diversity limited meta-analysis to outcomes for five subgroups (n = 15 studies) {LHW interventions to promote the 
uptake of breast cancer screening, immunisation and breastfeeding promotion [(before 2 weeks and between 2 weeks 
and 6 months post partum) and to improve diagnosis and treatment for selected infectious diseases]}. Promising 
benefits in comparison with usual care were shown for LHW interventions to promote immunisation uptake in children 
and adults (RR = 1.30, 95% CI 1.14 to 1.48, p = 0.0001) and LHW interventions to improve outcomes for selected 
infectious diseases (RR = 0.74, 95% CI 0.58 to 0.93, p = 0.01). LHWs also appear promising for breastfeeding 
promotion. They appear to have a small effect in promoting breast cancer screening uptake when compared with usual 
care. For the remaining subgroups (n = 29 studies), the outcomes were too diverse to allow statistical pooling. We can 
therefore draw no general conclusions on the effectiveness of these subgroups of interventions
Conclusions LHWs show promising benefits in promoting immunisation uptake and improving outcomes for acute respiratory 
infections and malaria, when compared with usual care. For other health issues, evidence is insufficient to justify 
recommendations for policy and practice. There is also insufficient evidence to assess which LHW training or 
intervention strategies are likely to be most effective. Further research is needed in these areas
AMED, Allied and Complementary Medicine Database; CENTRAL, the Cochrane Register of Controlled Trials; EPOC, Effective Practice and 
Organisation of Care Group; LHW, lay health worker; RR, rate ratio.
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Swider 2002330
Study Swider SM. Outcome effectiveness of community health workers: an integrative literature review. Public Health Nurs 
2002;19:11–20.330
Aim Are CHWs effective in community health promotion and disease prevention efforts?
Search strategy MEDLINE 1981–99; HealthSTAR 1975–99; CINAHL 1982–99; EBM Review Best Evidence 1991–9 (September/
October); PsycINFO 1984–99; NCBI PubMed 1980–99
Selection criteria (1) CHWs. (2) Location: only studies conducted in the USA were included in this review. (3) Types of studies: only 
studies that were listed in a database and that focused on outcomes or effectiveness of CHW work were included. All 
studies purporting to measure outcomes were included, because the literature on types of outcomes defined them 
broadly. (4) Health promotion and disease prevention: CHWs are described as functioning across a wide range of 
populations, diseases and conditions. Thus, any study with a health focus for the activities of the CHWs was included 
in this review. (5) Time period: from 1980 to present
Character of peer Definition of CHW: For the studies reviewed here, the terms CHW, community health advocate, promotora de salud, 
community health promoter, lay health worker and community outreach worker were used interchangeably. Often in 
these articles the definitions are not given explicitly, and thus, the definition used by each researcher was allowed to 
stand, and each study was coded by the functions of the worker
Assessment of risk of bias None described
Data collection and 
analysis
The studies identified from these databases were entered into a search chart by relevant characteristics. An initial 
reading of the studies, in conjunction with the research question, culminated in the development of a codebook to 
document all relevant variables. This codebook was used to review three studies; it was then revised based on these 
three reviews and used to review the remaining studies (Broome 1993343). Analysis: The author coded all data as 
described previously here, with results displayed in tabular form and examined for frequencies, common themes, 
weaknesses, gaps, and the need for future studies
Results Overall, CHWs were found to result in some positive outcomes in 79% (n = 15) of the reviewed studies. Eleven of 
the 15 studies (73%) documented at least partial effectiveness of the CHWs in changing access to health-care 
services in the target population. There is limited evidence from two studies of the CHW effectiveness with knowledge 
improvement outcomes. However, several other studies documented behaviour change and health-outcome changes 
from CHW health education interventions. Three of the four studies documented a positive change in health status 
indicators. Five of the six studies documented positive results in behaviour change on the part of the target population. 
Two studies measured the costs of care but found they did not differ between the groups
Conclusions This article reviews the data-based literature on CHW effectiveness, which indicates preliminary support for CHWs in 
increasing access to care, particularly in underserved populations. There are a smaller number of studies documenting 
outcomes in the areas of increased health knowledge, improved health status outcomes, and behavioural changes, 
with inconclusive results. Although CHWs show some promise as an intervention, the role can be doomed by overly 
high expectations, lack of a clear focus and lack of documentation. Further research is required with an emphasis on 
stronger study design, documentation of CHW activities, and carefully defined target populations
EBM, evidence-based medicine; NCBI, National Center for Biotechnology Information.
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Andrews 2004331
Study Andrews JO, Feiton G, Wewers ME, Heath J. Use of community health workers in research with ethnic minority women. 
J Nurs Scholarsh 2004;36:358–65.331
Aim To explore roles and effectiveness of CHWs in research with ethnic minority women in the USA
Search strategy MEDLINE (1966–2002) and CINAHL (1982–2002) databases were used to locate published research studies on the 
use of CHWs with ethnic minority women in the USA. Key words for searches were CHWs, community health aides, 
health promoters and community workers
Selection criteria Selection criteria were that the studies be data based, with ethnic minority women as the targeted population, use 
CHWs and be conducted in the USA. Reasons for exclusion were programme description only and lack of data-based 
results; international focus; or ethnic minority women not included in at least 75% of the sample
Character of peer All of the CHWs in these studies were women and were matched according to the ethnicity of the target population
Assessment of risk of bias Methodological limitations were coded but not reported
Data collection and 
analysis
A codebook to document all relevant variables was designed for review of these studies, in consideration with the 
research questions. The variables used in this analysis included the role of CHWs, targeted health outcomes (i.e. 
access, behaviour, knowledge), design, sample size, theoretical framework, preparation and training of CHWs, 
perceived benefits of CHWs, and methodological limitations
Results The CHW role varied according to the purpose, design and intervention protocols of each study. The roles were coded 
to one of the following four areas: educator, ‘outreacher’, case manager and data collector. CHWs’ training, payment, 
recruitment and supervision also varied in the included studies. Outcomes related to access to health services were 
evaluated in 16 studies; all 16 found improvements in access, specifically for ethnic minority women, to prenatal 
care, mammography screening, Pap testing, sick child visits, pre- and postnatal care, STD testing, smoking cessation 
programme, and maternal–child health visits. Five of the seven studies showed positive outcomes in knowledge of 
participants. Positive outcomes in behaviour change were reported in five of the six studies. CHWs promoted social 
support, cultural competence and other intangible resources among community members. These outcomes were 
not quantitatively measured in these studies, but they were described in process evaluation and qualitative data. 
Conceptually, the use of CHWs in research is often considered cost-effective. Two of the studies in this review showed 
improved outcomes and reduced costs related to the use of CHWs. In comparison with other health-care providers, 
CHWs are relatively inexpensive to train, hire and supervise
Conclusions An integrative analysis of 24 studies showed that despite varying roles and functions, evidence indicates that CHWs 
are effective in increasing access to health services, increasing knowledge, and promoting behaviour change among 
ethnic minority women. Other advantages of using CHWs are to provide social support and culturally competent, 
cost-effective care. Recommendations for future directions of research with CHWs and ethnic minority women include 
improved conceptualisation of the CHW role, theoretical frameworks for research designs, enhanced methods for 
evaluating effectiveness and increased community involvement
164 Appendix 1
Fischer 2007332
Study Fisher TL, Burnet DL, Huang ES, Chin MH, Cagney KA. Cultural leverage: interventions using culture to narrow racial 
disparities in health care. Med Care Res Rev 2007;64:S243–82.332
Aim This particular review examined a broad range of interventions that used cultural aspects of race to: (1) modify the 
health behaviours of individuals within communities; (2) increase access from communities to the existing health-care 
system; and (3) amend or transform the health-care system to better serve patients of colour and their communities
Search strategy The reviewers searched MEDLINE, CENTRAL, and a cross-referenced engine, Web of Knowledge. In addition, we 
searched the grey literature using The New York Academy of Medicine Grey Literature Report. To augment this search 
strategy, we reviewed the reference lists of key reviews, websites, reference articles, systematic reviews and books
Selection criteria We reviewed all non-white racial and ethnic categories, including African-American, Hispanic, American Indian/
Alaska Native, and Asian/Pacific Islander. We included interventions that encompassed cultural constructs related 
to race, such as language, religion, diet, sexuality, family structure, neighbourhood, class and gender. We excluded 
articles published before 1985. We also excluded articles that did not describe interventions arising from health-
care organisations or connecting communities or patients of colour to health-care organisations, those that did not 
include evaluations of interventions, those that did not focus on populations of at least 50% people of colour, and 
those describing interventions that took place outside the USA. Beyond these exclusion criteria, we chose to include 
a wide range of study designs. There are very few RCTs comparing interventions with and without cultural leverage, 
and to limit this review to those studies would have left out many innovative studies in the field. Similarly, there are 
very few intervention studies designed to examine an outcome such as the level of health disparities between white 
patients and coloured people. As such, we chose to also include studies that focused on the health of racial and ethnic 
minorities
Character of peer Not specified
Assessment of risk of bias Articles included in the final analysis were reviewed for quality using multiple criteria, because of the difficulty in 
comparing and contrasting heterogeneous study approaches. To capture the value of studies that ranged from 
descriptive to controlled trials, we started with a descriptive discussion of their strengths and weaknesses. We then 
applied Downs and Black’s344 criteria for assessing methodological quality, using the first 26 items in the scoring 
system, which had a possible total score of 27
Data collection and 
analysis
The first author identified relevant abstracts through review of citations obtained from this search strategy. Each 
abstract was assigned to a team member for independent review to confirm relevance to the research question. We 
developed a standardised form to facilitate the review of abstracts and articles to determine relevance to the study 
question, document study characteristics, extract data, and assess the quality of evidence. Full articles were obtained 
for those abstracts appearing eligible and in cases in which determinations could not be made from the abstracts 
alone. Three team members (TLF, DLB and KAC) reviewed articles independently and then compared findings; each 
article was reviewed by at least two reviewers, and differences were adjudicated by team consensus
Results Thirty-eight interventions of three types were identified: interventions that modified the health behaviours of individual 
patients of colour, that increased the access of communities of colour to the existing health-care system, and that 
modified the health-care system to better serve patients of colour and their communities. Individual-level interventions 
typically tapped community members’ expertise to shape programmes. Access interventions largely involved screening 
programmes, incorporating patient navigators and lay educators. Health-care interventions focused on the roles of 
nurses, counsellors, and CHWs to deliver culturally tailored health information. These interventions increased patients’ 
knowledge for self-care, decreased barriers to access, and improved providers’ cultural competence
Conclusions The delivery of processes of care or intermediate health outcomes was significantly improved in 23 interventions. 
Interventions using cultural leverage show tremendous promise in reducing health disparities, but more research is 
needed to understand their health effects in combination with other interventions
CENTRAL, the Cochrane Central Register of Controlled Trials.
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Rhodes 2007333
Study Rhodes SD, Foley KL, Zometa CS, Bloom FR. Lay health advisor interventions among hispanics/latinos: a qualitative 
systematic review. Am J Prevent Med 2007;33:418–27.333
Aim The primary goal of this systematic review was to explore how LHA approaches have been used and evaluated within 
Hispanic/Latino communities in the USA
Search strategy Ten literature databases were used: AgeLine, CINAHL, EBSCO Academic Search Elite and Premier, Education 
Resources Information Center (ERIC), Health Source Consumer and Nursing and Nursing/Academic Editions, pre-
CINAHL, PsycINFO and PubMed. Each database was searched from its inception through to July 2006
Terms for the search included keywords as defined by the Medical Subject Headings (MeSH). Keywords used in a 
Boolean search included: Hispanic or Latino and village health worker, natural helper, promoter, promotora, partera, 
volunteer health worker, allied health personnel, LHA, lay health, community outreach worker, community health service 
volunteer, public health aide, peer health promoter, community health representative, community health advocate, or 
health advisor. In addition, citations from the bibliographies of identified papers were analysed and relevant citations 
were selected for review
Selection criteria This review consisted of human studies (which included adult Hispanics or Latinos of either gender), conducted in the 
USA, that were published in English-language peer-reviewed journals, and contained enough abstractable information. 
Often, editorials, letters, book chapters, and commentaries have been excluded in systematic reviews;15 however, when 
appropriate, such articles were included to supplement data about studies that had been identified. These inclusion 
and exclusion criteria were selected to ensure that findings could best inform future LHA intervention research among 
Hispanic/Latino communities within the USA. Because some studies included non-Hispanics and non-Latinos, these 
studies were included if at least half of the LHAs were Hispanic/Latino. Furthermore, because studies may have had 
multiple articles published, this analysis explored LHA approaches by study
Character of peer All studies indicated that the LHAs matched the target population in their communities in terms of countries of origin 
and current geographic location
Assessment of risk of bias Not described
Data collection and 
analysis
Data abstraction was completed independently by three data abstractors using a standardised abstraction form that 
collected intervention characteristics and study results
Results A total of 172 studies were identified and 37 met the selection criteria. Of these, 28 included female LHAs exclusively 
and five included a small number of male as well as female LHAs. Training for LHAs ranged from 6 to 160 hours. 
Primary roles of LHAs included: supporting participant recruitment and data collection, serving as health advisors and 
referral sources, distributing materials, being role models, and advocating on behalf of community members. Fourteen 
studies found evidence of effectiveness
Conclusions Given the long history of using LHAs as an approach to health promotion and disease prevention, and the current 
emphasis of LHA approaches as a potential solution to health disparities in general, and among Hispanics/Latinos in 
particular, few rigorous studies have been published that document the effectiveness of LHAs on a variety of public 
health concerns. A stronger empirical evidence base is clearly needed
166 Appendix 1
Pérez-Escamilla 2008334
Study Pérez-Escamilla R, Hromi-Fiedler A, Vega-López S, Bermúdez-Millán A, Segura-Pérez S. Impact of peer nutrition 
education on dietary behaviors and health outcomes among latinos: a systematic literature review. J Nutri Educ Behav 
2008;40:208–25.334
Aim This systematic review assesses the impact of peer education/counseling on nutrition and health outcomes among 
Latinos and identifies future research needs
Search strategy A systematic literature search was conducted by: (1) searching internet databases (PubMed); (2) conducting backward 
searches from reference lists of articles of interest; (3) manually reviewing the archives of the Center for Eliminating 
Health Disparities among Latinos; (4) searching the J Nutri Educ Behav; and (5) directly contacting researchers in 
the field. The PubMed search was conducted using the following keywords and combinations: Latino(s), Hispanic(s), 
CHW(s), peer(s), educator(s), peer education, promotora(s), promoter(s), diabetes, nutrition, la cocina saludable, salud 
para su corazón, su corazón su vida, your health your life, partner(s) in health, compañeros en salud, EFNEP, FSNE and 
breastfeeding
Selection criteria Nutrition education is defined as ‘any set of learning experiences designed to facilitate the voluntary adoption of eating 
and other nutrition-related behaviours conducive to health and well being’. Thirteen nutrition education impact studies 
were included if they met the following criteria: (1) experimental or quasiexperimental design; (2) include Latino-
specific results or a predominantly Latino study population (> 60%); (3) use of reliable and valid scales; (4) nutrition 
education intervention(s) clearly described; (5) published since 1994; and (6) conducted in the USA
Character of peer Community members who work almost exclusively in community settings and serve as connectors between health-
care consumers and providers to promote health among groups that have traditionally lacked access to adequate care
Assessment of risk of bias The only bias assessed was those associated with the use of reliable and valid scales: a Cronbach α of at least 0.85 
was established a priori as a criterion for assessing internal validity of scales. Reliability was assessed based on 
intracorrelation coefficients of repeated scale applications using preset criteria of an r-value of at least 0.35 and a 
p-value < 0.05
Data collection and 
analysis
All abstracts of articles generated from the database searches were reviewed by community nutrition academic 
and agency experts (i.e. the authors of this paper) to identify those that met the selection criteria. Each article was 
assessed for the internal and external validity of the study as well as for the behavioural theory base (or lack thereof) of 
the intervention. Internal and external validity were assessed following the guidelines recommended by Jekel et al.345 
The collective interpretation of study findings was the product of a consensus process involving all authors
Results Peer nutrition education has a positive influence on diabetes self-management and breastfeeding outcomes, as well as 
on general nutrition knowledge and dietary intake behaviours among Latinos
Conclusions There is a need for longitudinal randomised trials testing the impact of peer nutrition education interventions grounded 
on goal-setting and culturally appropriate behavioural change theories. Inclusion of reliable scales and the construct 
of acculturation are needed to further advance knowledge in this promising field. Operational research is also needed 
to identify the optimal peer educator characteristics, the type of training that they should receive, the client loads and 
dosage (i.e. frequency and amount of contact needed between peer educator and client), and the best educational 
approaches and delivery settings
EFNEP, Expanded Food and Nutrition Program; FSNE, Food Stamp Nutrition Education Program.
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Sibley 2004335
Study Sibley LM, Sipe TA, Koblinsky M. Does traditional birth attendant training increase use of antenatal care? A review of 
the evidence. J Midwifery Womens Health 2004;49:298–305.335
Aim A combined narrative review and meta-analytic review was conducted to summarise published and unpublished 
studies completed between 1970 and 2002 on the relationship between TBA training and increased use of 
professional ANC
Search strategy A search for potentially eligible studies was conducted for the period 1970 to 1999. Sources included 17 electronic 
bibliographic databases available through Emory University POPLine database, including the TBA Annotated 
Bibliography derived from POPLine and compiled Family Health International; WHO bibliographic database; USAID 
electronic network; contracting and donor agencies; the invisible college; cross-referencing (i.e. ancestry); and hand 
searching table of contents from selected published journals having the greatest yield. Secondary source documents 
were considered if the primary source document was unavailable. Several secondary source documents containing 
English translations of primary documents were accepted. The search was conducted in stages. First, a set of key 
words was developed for alternative expressions of the concept ‘traditional birth attendant’. Second, an extensive set 
of key words was developed for alternative expressions of the concepts ‘training’, ‘evaluation’, ‘comparison’, ‘effect, 
impact, outcome’, ‘performance’, ‘knowledge, practice, or attitude’, ‘maternal mortality’, and ‘perinatal and neonatal 
mortality’. Copies of potentially eligible documents were obtained, and their bibliographies were searched
In January 2003, we conducted an update search of the literature for the period July 1999 through December 2002. 
However, the one study identified from this search as being suitable for inclusion in the review was a more recent 
report of a study already included in the meta-analysis, so it was not included in the present study
Selection criteria (1) Treatment was TBA training; (2) treatment group data were derived from trained TBAs or mothers and neonates, 
whose care was provided by trained TBAs or who were living in areas where more than 50% of births were attended 
by trained TBAs; (3) comparison group data were available; (4) dependent measures were related to knowledge, 
attitude, behaviour, or maternal and perineonatal health outcomes; (5) documents were in English and completed or 
published between January 1970 and June 1999; (6) research design was either experimental or quasiexperimental; 
and (7) data were sufficient to calculate an effect size
Character of peer TBA
Assessment of risk of bias Loevinsohn describes features of study quality that are considered ‘desirable’.346 The overall quality of the studies 
included in this review was variable, making it impossible to attribute causality to the observed outcomes in relation 
to TBA training. Rather, we describe the magnitude and direction of the association between TBA training and the 
observed outcomes
Data collection and 
analysis
Narrative review: specific ANC-related outcomes, measured as percentages, were independently sorted into three 
categories: (1) TBA knowledge, (2) TBA behaviour, and (3) maternal behaviour. We describe the narrative review results 
as follows: a positive result indicates that all percentages reported for specific outcomes in a category were higher 
for the trained TBA group than for the untrained TBA group, an equivocal result indicates that the percentages were 
similar for the trained and untrained TBA groups, a mixed result indicates that percentages reported were higher in 
the trained TBA group for some outcomes but the same or lower for other outcomes, and a negative result indicates 
that all percentages reported for specific outcomes in a category were lower for the trained TBA group than for the 
untrained TBA group
Meta-analytic review: the per cent difference associated with each outcome was converted to the effect size index. 
The effect size index represents the standardised difference between the treatment or trained TBA group and 
comparison or untrained TBA group on the particular outcome of interest. The variance-weighted mean effect size for 
each subgroup of outcomes was then calculated, and homogeneity tests were performed on the distributions of the 
weighted mean effect sizes. With few exceptions, homogeneity of variance was rejected, and the weighted mean effect 
size and 95% CI were calculated by using formulas based on a random effects model. The strategy used to combine 
effect sizes and sample sizes within and across studies resulted in independent data sets for analysis. Sensitivity 
analyses, conducted to detect the presence of publication bias, revealed no evidence of bias. Stratified analyses of the 
outcomes, by study design and sampling procedure, were also performed to examine the influence of these potential 
moderating variables on the weighted mean effect sizes. To assist interpretation, we converted the weighted mean 
effect sizes into per cent increase over baseline. Per cent increase over baseline represents the trained TBA and 
untrained TBA group success rate difference divided by the untrained TBA group success rate, using the grand median 
of the groups’ distributions as the point of reference. The narrative review and meta-analytic review results were 
compared
Results Fifteen studies (n = 15) from eight countries and two world regions were analysed. There are, to varying degrees, 
positive associations between TBA training and TBA knowledge of the value and timing of ANC services, TBA behaviour 
in offering advice or assistance to obtain ANC, and compliance and use of ANC services by women cared for by TBAs 
or living in areas served by TBAs. There is a serious lack of information about TBA training programme characteristics
Conclusions Although the findings cannot be causally attributed to TBA training, the results suggest that training may increase 
ANC attendance rates by about 38%. This magnitude of improvement could contribute to a reduction in maternal and 
perinatal mortality in areas where women have access to quality antenatal and emergency obstetric care. There is 
an urgent need to improve capacity for evaluation and research of the effect of TBA training programmes and other 
factors that influence women’s use of ANC services
ANC, antenatal care; TBA, trained birth attendant.
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Hodnett 2003336
Study Hodnett ED, Fredericks S. Support during pregnancy for women at increased risk of low birth weight babies. Cochrane 
Database Syst Rev 2003; Issue 3, Art. No. CD000198.336
Aim The objective of this review was to assess the effects of programmes offering additional social support for pregnant 
women who are believed to be at risk for giving birth to preterm or low-birthweight babies
Search strategy We searched the Cochrane Pregnancy and Childbirth Group’s Trials Register (March 2009)
Selection criteria Randomised trials of additional support during at-risk pregnancy by either a professional (social worker, midwife or 
nurse) or specially trained layperson, compared with routine care. Additional support was defined as some form of 
emotional support (e.g. counseling, reassurance, sympathetic listening) and information or advice or both, either 
in home visits or during clinic appointments, and could include tangible assistance (e.g. transportation to clinic 
appointments, assistance with the care of other children at home)
Character of peer Laywomen
Assessment of risk of bias Both review authors independently assessed risk of bias for each study using the criteria outlined in the Cochrane 
Handbook for Systematic Reviews of Interventions.347 Any disagreements were resolved by discussion or by involving a 
third assessor
Data collection and 
analysis
We independently assessed trial quality and extracted data. Double data entry was performed. We contacted study 
authors to request additional information
Results Eighteen trials, involving 12,658 women, were included. The trials were generally of good to excellent quality, although 
three used an allocation method likely to introduce bias. Programmes offering additional social support for at-risk 
pregnant women were not associated with improvements in any perinatal outcomes, but there was a reduction in the 
likelihood of caesarean birth and an increased likelihood of elective termination of pregnancy. Some improvements in 
immediate maternal psychosocial outcomes were found in individual trials
Because there was only one trial in which the support was provided by laywomen,348 and in another trial the support 
was provided by a multidisciplinary team that included laywomen,349 the planned subgroup analysis was not 
performed. However, the results of these two trials were remarkably consistent with those of the other trials
Conclusions Pregnant women need the support of caring family members, friends and health professionals. While programmes that 
offer additional support during pregnancy are unlikely to prevent the pregnancy from resulting in a low-birthweight or 
preterm baby, they may be helpful in reducing the likelihood of caesarean birth
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Doggett 2005337
Study Doggett C, Burrett SL, Osborn DA. Home visits during pregnancy and after birth for women with an alcohol or drug 
problem. Cochrane Database Syst Rev 2005; Issue 4, Art. No. CD004456.337
Aim To determine the effects of home visits during pregnancy and/or after birth for pregnant women with a drug or alcohol 
problem
Search strategy We searched the Cochrane Pregnancy and Childbirth Trials Register (30 April 2004), CENTRAL (The Cochrane Library, 
Issue 2, 2004), MEDLINE (1966 to April 2004), EMBASE (1980 to week 16, 2004), CINAHL (1982 to April 2004), 
PsycINFO (1974 to April 2004), citations from previous reviews and trials, and contacted expert informants
Selection criteria Studies using random or quasirandom allocation of pregnant or post partum women with a drug or alcohol problem to 
home visits. Trials enrolling high-risk women of whom more than 50% were reported to use drugs or alcohol were also 
eligible
Character of peer Trained laypeople (not the sole focus of the review)
Assessment of risk of bias We assessed the methodological quality of included trials according to the criteria in the Cochrane Reviewers’ 
Handbook,350 with a grade allocated to each trial on the basis of allocation concealment: A (adequate), B (unclear), and 
C (clearly inadequate). Details regarding randomisation method, completeness of follow-up, and blinding of outcome 
measurement were documented for all trials. Cluster randomised and quasirandomised designs, such as alternate 
allocation and use of record numbers, were included if found. Differences of opinion regarding trials for inclusion were 
resolved by consensus
Data collection and 
analysis
Assessments of trials were performed independently by all review authors. Statistical analyses were performed using 
fixed and random effects models where appropriate
Results Six studies (709 women) compared home visits after birth with no home visits. None provided a significant antenatal 
component of home visits. The visitors included community health nurses, paediatric nurses, trained counsellors, 
paraprofessional advocates, midwives and lay African-American women. Most studies had methodological limitations, 
particularly large losses to follow-up. There were no significant differences in continued illicit drug use (two studies, 
248 women: RR 0.95, 95% CI 0.75 to 1.20), continued alcohol use (RR 1.08, 95% CI 0.83 to 1.41), failure to enrol 
in a drug treatment programme (two studies, 211 women: RR 0.45, 95% CI 0.10 to 1.94). There was no significant 
difference in the Bayley MDI (three studies, 199 infants: WMD 2.89, 95% CI –1.17 to 6.95) or PDI (WMD 3.14, 95% 
CI –0.03 to 6.32). Other outcomes reported by one study only included breastfeeding at 6 months (RR 1.00, 95% CI 
0.81 to 1.23), incomplete 6-month infant vaccination schedule (RR 1.07, 95% CI 0.58 to 1.96), non-accidental injury 
and non-voluntary foster care (RR 0.16, 95% CI 0.02 to 1.23), failure to use post partum contraception (RR 0.41, 95% 
CI 0.20 to 0.82), child behavioural problems (RR 0.46, 95% CI 0.21 to 1.01) and involvement with child protective 
services (RR 0.38, 95% CI 0.20 to 0.74)
Two studies reported home visits by trained layworkers.351,352 Schuler 2000352 reported no significant difference for 
continued illicit drug use (RR 1.20, 95% CI 0.79 to 1.85), continued alcohol use (RR 1.01, 95% CI 0.75 to 1.35) or 
failure to enrol in a drug treatment programme (RR 0.84, 95% CI 0.63 to 1.12). Grant 1996351 reported, at 3 years, 
no significant difference in incidence of cognitive delay using the Bayley MDI (RR 1.36, 95% CI 0.41 to 4.45) and an 
increase in incidence of psychomotor delay using the Bayley PDI of borderline statistical significance (RR 3.26, 95% CI 
1.00 to 10.59; RR 0.27, 95% CI 0.03 to 0.51). Meta-analysis of two studies351,352 found no significant differences in 
cognitive development (Bayley MDI: FE WMD 3.92, 95% CI –0.56 to 8.41) or psychomotor development (Bayley PDI: 
FE WMD 3.22, 95% CI –0.01 to 6.44). Schuler 2000352 reported a significant reduction in child protection services (RR 
0.38, 95% CI 0.20 to 0.74)
Conclusions There is insufficient evidence to recommend the routine use of home visits for women with a drug or alcohol problem. 
Further large, high-quality trials are needed, and women’s views on home visiting need to be assessed
CENTRAL, the Cochrane Central Database of Controlled Trials; FE, fixed effect; MDI, Mental Development Index; PDI, Psychomotor Development 
Index; RR, rate ratio; WMD, weighted mean difference.
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Britton 2007338
Study Britton C, McCormick FM, Renfrew MJ, Wade A, King SE. Support for breastfeeding mothers. Cochrane Database Syst 
Rev 2007; Issue 1, Art. No. CD001141.338
Aim To assess the effectiveness of support for breastfeeding mothers
Search strategy We searched the Cochrane Pregnancy and Childbirth Group’s Trials Register (January 2006), MEDLINE (1966 to 
November 2005), EMBASE (1974 to November 2005) and MIDIRS (1991 to September 2005)
Selection criteria Types of studies – All RCTs or quasi-RCTs, with or without blinding, and with a minimum of 75% follow-up
Types of participants – Participants were pregnant women intending to breastfeed, post partum women intending to 
breastfeed and women breastfeeding their babies
Types of interventions – Contact with an individual or individuals (either professional or volunteer) offering support 
which is supplementary to standard care (in the form of, for example, appropriate guidance and encouragement), with 
the purpose of facilitating continued breastfeeding. Studies were included if the intervention occurred in the postnatal 
period alone or also included an antenatal component. Interventions taking place in the antenatal period alone were 
excluded from this review, as were interventions described as solely educational in nature
Character of peer Nine studies used laypeople for support
Assessment of risk of bias We assessed the method of allocation concealment used in each study using criteria outlined in the Cochrane 
Handbook for Systematic Reviews of Interventions.353 We categorised studies according to whether the method of 
allocation concealment reported was judged to have been adequate (A), unclear (B) or inadequate (C) or if allocation 
was not concealed (D). We also checked study reports for clear descriptions of inclusion and exclusion criteria; 
randomisation methods; withdrawals and dropouts; statistical analysis used; blinding of outcome assessment; and 
intention-to-treat analysis. Included trials had a minimum of 75% initial follow-up. When included, trials reported data 
at more than one time point and follow-up rates fell, we included only data from time points at which follow-up rates 
were at least 75% in the analysis
Data collection and 
analysis
Two authors independently assessed trial quality and extracted data
Results We have included 34 trials (29,385 mother–infant pairs) from 14 countries. All forms of extra support analysed 
together showed an increase in duration of ‘any breastfeeding’ (includes partial and exclusive breastfeeding) (RR for 
stopping any breastfeeding before 6 months 0.91, 95% CI 0.86 to 0.96). All forms of extra support together had a 
larger effect on duration of exclusive breastfeeding than on any breastfeeding (RR 0.81, 95% CI 0.74 to 0.89). Lay and 
professional support together extended duration of any breastfeeding significantly (RR before 4–6 weeks 0.65, 95% 
0.51 to 0.82; RR before 2 months 0.74, 95% CI 0.66 to 0.83). Exclusive breastfeeding was significantly prolonged 
with use of WHO/UNICEF training (RR 0.69, 95% CI 0.52 to 0.91). Maternal satisfaction was poorly reported
Nine studies included used laypeople for support. Trials that used laypeople to deliver the intervention demonstrated 
a significant reduction in breastfeeding cessation at the time of the last study assessment (RR 0.86, 95% CI 0.76 to 
0.98).88,114,354–360 Significant heterogeneity was present among these studies (I2 = 75.6%). Further subgroup analysis 
did not reveal a statistically significant effect at any time point up to 4 months. However, in the studies of lay support 
that reported exclusive breastfeeding, there was a marked reduction in the cessation of exclusive breastfeeding before 
the last study assessment (RR 0.72, 95% CI 0.57 to 0.90).114,355,356,358–360 There was heterogeneity among these 
studies (I2 = 96.3%). Further subgroup analysis indicated that this effect was significant within the first 3 months (RR 
before 4–6 six weeks 0.66, 95% 0.46 to 0.96; RR before 2 months 0.44, 95% CI 0.26 to 0.73; RR before 3 months 
0.42, 95% CI 0.31 to 0.57)
Conclusions Additional professional support was effective in prolonging any breastfeeding, but its effects on exclusive breastfeeding 
were less clear. WHO/UNICEF training courses appeared to be effective for professional training. Additional lay 
support was effective in prolonging exclusive breastfeeding, while its effects on duration of any breastfeeding were 
uncertain. Effective support offered by professionals and laypeople together was specific to breastfeeding, and was 
offered to women who had decided to breastfeed. Further trials are required to assess the effectiveness (including 
cost-effectiveness) of both lay and professional support in different settings, particularly those with low rates of 
breastfeeding initiation, and for women who wish to breastfeed for longer than 3 months. Trials should consider timing 
and delivery of support interventions and relative effectiveness of intervention components, and should report women’s 
views. Research into appropriate training for supporters (whether lay or professional) of breastfeeding mothers is also 
needed
MIDIRS, Midwives Information and Resource Service; RR, rate ratio; UNICEF, United Nations Children’s Fund.
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Dyson 2005361
Study Dyson L, McCormick FM, Renfrew MJ. Interventions for promoting the initiation of breastfeeding. Cochrane Database 
Syst Rev 2005; Issue 2, Art. No. CD001688.361
Aim To evaluate the effectiveness of interventions which aim to encourage women to breastfeed in terms of changes in the 
number of women who start to breastfeed
Search strategy We searched the Cochrane Pregnancy and Childbirth Group’s Trials Register (July 2007), handsearched the Journal 
of Human Lactation, Health Promotion International and Health Education Quarterly from inception to 15 August 2007, 
and scanned reference lists of all articles obtained
Selection criteria RCTs, with or without blinding, of any breastfeeding promotion intervention in any population group except women and 
infants with a specific health problem
Character of peer Not specified
Assessment of risk of bias We assessed the validity of each included study according to the criteria outlined in the Cochrane Handbook.362 We 
assessed selection bias on the basis of concealment of allocation: adequate or unclear or inadequate. We rated 
performance bias, attrition bias and detection bias as: adequate or unclear or partially adequate or inadequate
Data collection and 
analysis
One review author independently extracted data and assessed trial quality, checked by a second author. We contacted 
investigators to obtain missing information
Results Eleven trials were included. Statistical analyses were conducted on data from eight trials (1553 women). Five studies 
(582 women) on low incomes in the USA, whose participants had typically low breastfeeding rates, showed that 
breastfeeding education had a significant effect on increasing initiation rates compared with standard care (RR 1.57, 
95% CI 1.15 to 2.15, p = 0.005). Subgroup analyses showed that one-to-one, needs-based, informal repeat education 
sessions and generic, formal antenatal education sessions are effective in terms of an increase in breastfeeding rates 
among women on low incomes, regardless of ethnicity and feeding intention. Needs-based, informal peer support in 
the antenatal and postnatal periods was also shown to be effective in one study conducted among Latina women who 
were considering breastfeeding in the USA (RR 4.02, 95% CI 2.63 to 6.14, p < 0.00001)
A single study evaluating the effect of prenatal, perinatal and postnatal peer support services among a total of 165 
participants354 was shown to be effective at increasing initiation rates among predominantly Latina women who 
were considering breastfeeding in the USA (RR 4.02, 95% CI 2.63 to 6.14, p < 0.00001). Authors describe many 
of the study population as feeling socially uncomfortable with breastfeeding in the USA. The personalised, problem-
solving approach of the intervention had been developed for 10 years in collaboration with the study hospital. Peer 
counsellors were community women who have completed high school, breastfed for 6 months and received 30 hours 
of internationally recognised classroom training in breastfeeding management. Counsellors served as observers for 
3–6 months with experienced peer counsellors, received a payment (US$12) and the potential for health benefits if 
working at least 20 hours per week. Counselling services included at least one prenatal home visit, daily postpartum 
visits during hospitalisation and at least three home visits following return from hospital. Routine care was patient 
led, comprising breastfeeding information in response to participants’ questions and written materials available at 
the prenatal clinic. Perinatal care included hands-on assistance and education from maternity ward nurses. Written 
breastfeeding materials and access to a lactation consultant for breastfeeding problems were also available if 
requested, as was a ‘warm line’, where nurses answered postpartum breastfeeding questions. A significant increase 
in duration rates of breastfeeding was not demonstrated at 1 or 3 months post partum. Failure to adhere to protocol, 
particularly the delivery of half of postnatal home visits in the first month, was a study limitation due to staffing 
problems
Conclusions This review showed that health education and peer support interventions can result in some improvements in the 
number of women beginning to breastfeed. Findings from these studies suggest that larger increases are likely to 
result from needs-based, informal repeat education sessions than more generic, formal antenatal sessions. These 
findings are based only on studies conducted in the USA, among women on low incomes with varied ethnicity and 
feeding intention, and this raises some questions regarding generalisability to other settings
RR, rate ratio.
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May 2000160
Study May S, West R. Do social support interventions (‘buddy systems’) aid smoking cessation? A review. Tob Control 
2000;9;415–22.160
Aim To provide an overview of the role of social support in smoking cessation and to critically review evidence regarding 
the use of ‘buddy systems’ (where smokers are specifically provided with someone to support them) to aid smoking 
cessation
Search strategy Studies were located by searching MEDLINE and PsycLIT using the keywords ‘smoking’, ‘smoking cessation’, ‘social 
support’ and ‘buddy’. Additional studies were identified through reference lists. Only studies reported in English and 
published since 1980 were included
Selection criteria Studies were selected on four criteria: publication in a peer-reviewed journal; RCT using smokers who wanted to stop; 
the use of a social support intervention, including a ‘buddy’; and dependent variable of smoking abstinence. Most 
research in this area does not use a randomised design so only a small proportion of the originally identified studies 
were included
Character of peer Buddy support
Assessment of risk of bias Not described
Data collection and 
analysis
Not described
Results In view of the diverse nature of the studies, a meta-analysis was not attempted. Ten studies were identified: nine 
were clinic-based smoking trials, eight used a group format, and nine used buddies from among smokers’ existing 
relationships. Support training varied from role play and rehearsal to a simple instruction to call each other regularly. 
Intervention and follow-up periods varied between studies. Two studies showed a significant benefit of the intervention 
in the short term
Conclusions Research methodology in many cases was poor. The evidence would suggest that in the context of a smokers‘ clinic 
the use of buddies may be of some benefit. There is a lack of evidence regarding the efficacy of the use of buddies in 
community interventions. This is an important area for future research
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Park 2004161
Study Park EW, Schultz JK, Tudiver FG, Campbell T, Becker LA. Enhancing partner support to improve smoking cessation. 
Cochrane Database Syst Rev 2004; Issue 3, Art. No. CD002928.161
Aim The purpose of this review was to determine if an intervention to enhance partner support helps smoking cessation 
when added as an adjunct to a smoking cessation programme
Search strategy The search was performed in: Cochrane Tobacco Addiction Group specialised register (October 2007), Cochrane 
Controlled Trials Register (October 2007), (1966 to October 2007), MEDLINE (1966 to October 2007), EMBASE (1974 
to October 2007), PsycINFO (1861 to Oct 2007). The search terms used were ‘smoking’ (prevention, control, therapy), 
‘smoking cessation’ and ‘support’ (family, marriage, spouse, partner, sexual partner, buddy, friend, cohabitees and 
coworker)
Selection criteria RCTs of smoking cessation interventions that compared an intervention which included a partner support component 
with an otherwise identical intervention and reported follow-up of 6 months or longer
Character of peer Partners were defined as spouses, friends, coworkers, ‘buddies’ or other significant others who supported the smokers 
as a part of the cessation programme to which they were assigned
Assessment of risk of bias Not described
Data collection and 
analysis
Two authors independently identified the included studies and extracted data using a structured form. A third author 
was consulted to aid in the resolution of discrepancies. Abstinence, biochemically validated if possible, was the primary 
outcome measure and was extracted at two post-treatment intervals: 6–9 months and > 12 months. The scores of 
PIQ were also analysed to assess partner support. A fixed-effect model was used to pool RRs from each study and 
estimate a summary effect
Results A total of 49 articles were identified for this review. Only 10 articles (11 studies, > 2000 participants) met the inclusion 
criteria. The definition of partner varied between studies. All studies gave self-reported smoking cessation rates, but 
there was limited biochemical validation of abstinence. The RR for self-reported abstinence at 6–9 months was 1.01 
(95% CI, 0.86 to 1.18); at 12 months the RR post treatment was 1.04 (95% CI, 0.87 to 1.24). Of the six studies 
that measured partner support at follow-up, only two studies reported significant increase in partner support in the 
intervention groups
Conclusions In this review of RCTs of interventions designed to enhance partner support for smokers in cessation programmes, 
we failed to detect an increase in quit rates. Limited data from several of the trials suggest that these interventions 
did not increase partner support either. No conclusions can be made about the impact of partner support on smoking 
cessation. More systematic intervention to affect partnership significantly should be delivered if partner support were 
part of an existing cessation programme
PIQ, partner interaction questionnaire; RR, rate ratio.
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Riemsma 2002205
Study Riemsma RP, Pattenden J, Bridle C, Sowden AJ, Mather J, Watt IS, et al. A systematic review of the effectiveness of 
interventions based on a stages-of-change approach to promote individual behaviour change. Health Technol Assess 
2002;6(24).205
Aim To systematically assess the effectiveness of interventions using a stage-based approach in bringing about positive 
changes in health-related behaviour
Search strategy A wide range of electronic databases were searched from inception to May 2000: AMED; ASSIA; BIOSIS; British 
Education Index; British Library Catalogue; British Nursing Index; CAB-Health; CINAHL; Cochrane Library CD-ROM; 
Conference Papers Index; DARE; DH-Data; Dissertation Abstracts; EconLIT; EMBASE; EPPI-Centre Register of Reviews 
of Effectiveness; ERIC; HEBS; HealthPromis/Health Education Authority; Unicorn Database; HEED; HELMIS; HTA 
database; Index to Scientific and Technical Proceedings; International Bibliography of the Social Sciences; King’s Fund 
Database; MANTIS; MEDLINE; Mental Health Abstracts; NHS EED; NRR; PsycLIT; SCI; SIGLE; SSCI; and Sociological 
Abstracts. In addition, searches of the internet were carried out using a range of search engines
The bibliographies of retrieved references were scanned for further relevant publications. The authors of abstracts 
appearing in conferences proceedings identified by the literature search were contacted for further information about 
their research
Selection criteria RCTs evaluating interventions which aimed to influence individual health behaviour, used within a stages-of-change 
approach, were eligible for inclusion. Only studies that reported health-related behaviour change, such as smoking 
cessation, reduced alcohol consumption or dietary intake and stage movement, were included. The target population 
included individuals whose behaviour could be modified, primarily in order to prevent the onset, or progression, of 
disease. There was no limitation of study by country of origin, language or date
Character of peer Not relevant
Assessment of risk of bias Each included trial was assessed against a comprehensive checklist for methodological quality and quality of the 
implementation of the intervention. Quality assessment was performed by one reviewer and checked by a second, with 
disagreements resolved by discussion
Data collection and 
analysis
Assessment of titles and abstracts was performed independently by two reviewers. If either reviewer considered a 
reference to be relevant, the full paper was retrieved. Full papers were assessed against the review selection criteria 
by two independent reviewers, and disagreements were resolved through discussion. Data were extracted by one 
reviewer into structured summary tables and checked by a second reviewer. Health behaviour change was the 
primary outcome of interest. Secondary outcomes included assessment of stage movement, health-related outcomes, 
intermediate outcomes, any adverse effects resulting from the intervention, as well as cost-effectiveness data. 
Information about the implementation of each intervention and how the relevant professionals were trained was also 
recorded where given. Any disagreements about data extraction were resolved by discussion
Results Thirty-seven RCTs were included in the review. Three studies evaluated interventions aimed at prevention (two for 
alcohol consumption and one for cigarette smoking). In 13 trials the interventions were aimed at smoking cessation, 
seven studies evaluated interventions aimed at the promotion of physical activity, and five studies evaluated 
interventions aimed at dietary change. Six trials evaluated interventions aimed at multiple lifestyle changes. Two 
studies evaluated interventions aimed at the promotion of screening mammography, and one study evaluated an 
intervention aimed at the promotion of treatment adherence. Four of these studies also included an economic 
evaluation
The methodological quality of the trials was mixed, and ranged from 2 to 11 out of 13 quality items present. The main 
problems were lack of detail on the methods used to produce true randomisation (methods of randomisation and 
concealment of allocation); lack of blinding of participants (where appropriate), outcome assessors and care providers, 
and failure to use intention-to-treat analysis. The main issue with the quality of the implementation was lack of 
information on the validity of the instrument used to assess an individual’s stage of change
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In 1 of the 13 trials aimed at smoking cessation the results could not be compared to a non-stage-based intervention 
because only stage-based interventions were included. In 4 of the remaining 12 smoking cessation trials, significant 
differences favouring the intervention group for scores on quit rates were found; in three of these the comparator 
was a usual-care control group and in one a non-stage-based intervention. One study showed mixed outcomes. 
In the remaining seven smoking cessation trials no significant differences between groups in behavioural change 
outcomes were found. One of the seven trials aimed at the promotion of physical activity did not report any data on 
behaviour change. Three trials found no significant differences between groups in behavioural change outcomes. Two 
trials showed mixed effects, and one trial mainly showed significant effects in favour of the stage-based intervention. 
Two of the five trials aimed at dietary change reported significant effects in favour of the stage-based intervention; 
in one trial this was in comparison to a non-stage-based intervention and in the other to a usual-care control group. 
Two trials showed mixed effects, and in one trial no significant differences between groups in behavioural change 
outcomes were found. Three of the six studies aimed at multiple lifestyle changes showed no differences between 
groups for any outcomes included. Two studies showed mixed effects, and one study showed positive effects for all 
outcomes included: smoking cessation, fat intake and physical activity. One of the two trials aimed at the promotion 
of screening mammography found no significant differences between groups for nearly all outcomes. The other trial 
showed a significant difference in favour of the stage-based intervention. The trial aimed at the promotion of treatment 
adherence showed significant results in favour of the stage-based intervention. Two out of three trials aimed at 
prevention showed no significant differences between groups for any measure of behaviour change. The other trial 
showed mixed outcomes. Studies with low-income participants tended not to report effects favouring the stage-based 
intervention. Other study characteristics, such as number of respondents, age and gender of respondents, year of 
publication, setting and verification of outcome measures, seemed to have little relationship with the effectiveness of 
the stage-based intervention
Conclusions Overall, there appears to be little evidence to suggest that stage-based interventions are more effective than non-
stage-based interventions. Similarly, there is little evidence that stage-based interventions are more effective than no 
intervention or usual care. Out of 37 trials, 17 showed no significant differences between groups, eight trials showed 
mixed effects, and 10 trials showed effects in favour of the stage-based intervention(s). One trial presented no data 
on behavioural outcomes, and another included stage-based interventions only. Twenty trials compared a stage-based 
intervention with a non-stage-based intervention, 10 trials reported no significant differences between groups, five 
reported mixed effects and five reported significant effects in favour of the stage-based intervention. There does not 
seem to be any relationship between the methodological quality of the study, the targeted behaviour or quality of the 
implementation (both in terms of exposure and in terms of full use of the model) and effectiveness of the stage-based 
intervention
The methodological quality of studies was mixed, and few studies mentioned validation of the stages of change 
instrument. In addition, there was little consistency in the types of interventions used once participants were classified 
into stages, and little knowledge about the types of interventions needed once people were classified. It was unclear in 
a number of trials whether the intervention was properly stage based. Given the limited evidence for the effectiveness 
of interventions tailored to the stages-of-change approach practitioners and policy-makers need to recognise that this 
approach has a status that appears to be unwarranted when it is evaluated in a systematic way.
There is a need for well-designed and appropriately implemented RCTs that are characterised by tailored interventions 
derived from accurate stage measurement, and which involve frequent reassessment of readiness to change in order 
to permit evolving, stage-specific interventions
AMED, Allied and Complementary Database; ASSIA, Applied Social Sciences Index and Abstracts; DARE, Database of Abstracts and Reviews 
of Effects; ERIC, Educational Resources Information Center; HEBS, Health Education Board for Scotland; HEED, Health Economic Evaluations 
Database; HELMIS, Health Management Information Service; MANTIS, Manual, Alternative and Natural Therapy Index System; NHS EED, NHS 
Economic Evaluation Database; NRR, National Research Register; SCI, Science Citation Index; SIGLE, System for Information on Grey Literature in 
Europe; SSCI, Social Sciences Citation Index.
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TABLE 31 Characteristics of included reviews
Study
Date of last 
search of 
databases
No. of studies 
included Study method
Type of health 
advisor Type of participant
Type/mode of 
intervention Area of health
Dale 
2008329
December 
2007
Seven RCTs RCTs Peer with 
similar or 
relevant health 
experience
People living with 
acute or long-term 
illness, carers of 
people with acute 
or long-term illness, 
parents, people 
with psychological 
symptoms, and 
people requiring 
screening or who 
had any other health 
and well-being-
related concerns
Telephone 
support
Any health 
concern
Lewin 
200513
June–August 
2001
43 studies RCTs Lay health 
workers (paid 
or voluntary) 
in primary or 
community 
health care 
Any Any To promote 
health, manage 
illness or 
provide support 
to patients
Swider 
2002330
1999 19 studies Focused on 
outcomes or 
effectiveness 
of CHW work
CHWs in USA Any in USA Any Health 
promotion 
and disease 
prevention
Andrews 
2004331
2002 24 studies Any studies 
on the use of 
CHWs in social 
sciences 
research
CHW Ethnic minority 
women in USA
Any Any; cervical 
cancer, 
maternal 
health, breast 
cancer, 
diabetes 
management, 
STD 
prevention, 
HIV infection 
risk reduction, 
weight loss, 
and physical 
activity
Rhodes 
2007333
July 2006 37 studies Any LHAs Adult Hispanic/
Latinos living in the 
USA
Any interventions 
to promote health 
and prevent 
disease
Any
Fischer 
2007332
1985 to 
June 2006
38 studies Any Evaluation of 
strategies or 
interventions 
using cultural 
leverage to 
see if they 
are effective 
at decreasing 
health 
disparities for 
communities of 
colour
Populations of at 
least 50% people of 
colour in the USA
Any Any; also 
process 
outcomes
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Study
Date of last 
search of 
databases
No. of studies 
included Study method
Type of health 
advisor Type of participant
Type/mode of 
intervention Area of health
Pérez-
Escamilla 
2008334
1994 to not 
stated
22 studies Any CHWs Latino-specific 
results or a 
predominantly Latino 
study population 
(> 60%)
Nutrition 
education 
intervention
Diet
Sibley 
2004335
January 
1970 to 
June 1999
15 studies Experimental 
or quasi-
experimental 
designs
Traditional birth 
attendant
Pregnant women Any Maternal 
health and 
baby health
Hodnett 
2003336
March 2009 18 studies 
(two with lay 
advisors)
Randomised 
trials
Specially trained 
layperson
Pregnant women 
who are believed to 
be at risk for giving 
birth to preterm 
or low-birthweight 
babies
Additional 
support was 
defined as some 
form of emotional 
support (e.g. 
counselling, 
reassurance, 
sympathetic 
listening) and 
information 
or advice or 
both, either in 
home visits or 
during clinic 
appointments, 
and could 
include tangible 
assistance (e.g. 
transportation 
to clinic 
appointments, 
assistance with 
the care of other 
children at home)
Maternal 
health and 
baby health
Doggett 
2005337
April 2004 Six studies 
(two with lay 
advisors)
Studies using 
random or 
quasi-random 
allocation
Trained lay 
advisors
Pregnant or post 
partum women with 
a drug or alcohol 
problem
Any Any, reduction 
of drug and 
alcohol use
Britton 
2007338
September/
November 
2005 or 
January 
2006
34 studies 
(nine with lay 
advisors)
RCTs or quasi-
RCTs
LHAs Any pregnant 
women intending 
to breastfeed, 
post partum 
women intending 
to breastfeed 
and women 
breastfeeding their 
babies
Any Breastfeeding 
support
Dyson 
2005362
July to 
August 2007 
(search 
updated no 
change in 
review)
11 studies 
(one with peer 
support)
RCTs Peers Any breastfeeding 
promotion 
intervention in any 
population group 
except women 
and infants with 
a specific health 
problem
Any 
breastfeeding 
promotion 
intervention
Breastfeeding 
support
continued
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Study
Date of last 
search of 
databases
No. of studies 
included Study method
Type of health 
advisor Type of participant
Type/mode of 
intervention Area of health
May 
2006113
1980 to date 
not stated
10 studies RCTs Smoking 
buddies
Smokers Interventions 
aimed at 
supporting 
smoking 
cessation
Smoking 
cessation 
support
Park 
2004343
October 
2007
10 studies RCTs Smoking 
buddies
Smokers Interventions 
aimed at 
supporting 
smoking 
cessation
Smoking 
cessation 
support
Riemsma 
2002205
May 2000 37 studies RCTs Not relevant Any Any interventions 
based on a 
stages-of-
change approach 
to promote 
individual 
behaviour change
Any
TABLE 31 Characteristics of included reviews (continued)
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TABLE 32 Table of excluded reviews
Study Reason for exclusion Area reviewed
Boer 2005324 Did not search multiple databases Training of paraprofessionals as behaviour 
modifiers
Battersby 2004363 Did not search multiple databases Breastfeeding peer support cost-effectiveness
Devilly 200523 Did not search multiple databases Prison-based peer education
Durlak 1979364 Did not search multiple databases Forty-two studies comparing the effectiveness 
of professional and paraprofessional
Helpers – mental health therapy
Fogelholm 2002365 Did not search multiple databases Community interventions for prevention of CVD
Forster 2007366 Primarily addressing self management of chronic disease – not lifestyle 
advice
Self-management of chronic conditions
Hill 1995367 Did not search multiple databases Nurses and health workers CVD
Hattie 1984368 Search strategy not described Professional and paraprofessional counsellors 
– meta-analysis
Logsdon 2004326 Review only included studies with statistically significant results Paraprofessional support for pregnant and 
parenting women
Nash 1978369 Did not search multiple databases Paraprofessionals and community mental 
health
Parkin 2000370 Did not search multiple databases History of peer education techniques and 
outlines some of the definitional diversity in 
attempts at characterising peer education 
projects
Persily 2003327 The search for and identification of studies was not systematic
The reviewers used a variety of search terms (not specified), an exhaustive 
search of the literature was conducted using several large electronic 
databases (not specified). Twenty-five citations that directly related to lay 
home visiting in pregnancy were found. Additional citations were located by 
reviewing the reference lists of relevant lists of relevant articles. Particular 
attention was paid to those manuscripts referred to by more than one 
author. Studies carried out within the last 15 years were desired; however, 
those considered to be foundational or classic work were also included 
(criteria for foundational or classic were not specified)
Pregnancy, breastfeeding
Ross 2002371 Did not search multiple databases Community HIV/STD prevention programmes
Rossman 2007372 Search strategy not described Breastfeeding peer counsellors in the USA
Scott 1999373 Did not search multiple databases Continuous support from doula in childbirth
Torres 2002–3374 Did not search multiple databases Nineteen articles on sex education in Latino 
populations
Valente 2007328 Although 191 studies were identified they were not cited so the 
association between the studies and the review’s conclusions could not be 
corroborated
Ten techniques used to identify opinion leaders 
to promote behaviour change
Walt 198832 Did not search multiple databases Are national CHWs programmes in crisis
Wilson 2008375 Did not search multiple databases Expert Patients Programme
Wilson 2006376 Did not search multiple databases Expert Patients Programme
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Appendix 2  
Original protocol
Project title
An evidence synthesis of qualitative and quantitative research on the component intervention 
techniques, effectiveness, cost-effectiveness, equity and acceptability of different versions of the 
health-related LA role in improving health and well-being in the UK.
Background – policy context and existing literature
Policy context
Behaviour is recognised as a key determinant of health; for example, in the USA, more than a 
third of all deaths are estimated to be due to modifiable behaviours such as smoking, physical 
inactivity, unhealthy eating and excessive alcohol use.1,2 These major health risks tend to be 
more prevalent among lower socioeconomic groups and, consequently, large sociodemographic 
differences exist in both experiences and expectations of health.3,4 The Public Health White 
Paper Choosing health: making healthy choices easier sought to address this issue by taking 
action to encourage and enable individuals to make healthier choices, with a particular focus on 
those living in disadvantaged communities.5 It recognises the central importance of changing 
behaviour to improve population health and also builds on the vision of a ‘fully engaged scenario’, 
in which people take control of their own health and the wider determinants of ill health are 
addressed.6 Many Western health-care systems are currently undergoing a shift from paternalistic 
to partnership models of care, with policy-makers, clinicians and consumers all seeking ways to 
promote increased involvement of patients and the wider public.7 These shifts in policy require an 
expanded portfolio of public health interventions, including an expanded workforce continuum, 
in order to effective address the health needs of both the general population and the most 
vulnerable groups in society.
The introduction of new roles or the expansion of existing roles to deliver health-related lifestyle 
advice (HRLA) or training represents one response to these developments. Peer support in 
particular represents a strategy that has been widely used to promote behaviour change and self-
care across diverse conditions and population groups, and is becoming increasingly important 
in health-care environments that are challenged by limited financial and human resources. 
Peer- or lay-led interventions have the potential to address key issues such as the need to care 
cost-effectively for expanding populations with chronic illness, increase engagement with ‘hard-
to-reach’ groups, enhance equity of service provision and ensure compliance with interventions.8,9 
Preliminary work conducted in relation to the implementation of health trainers in the NHS 
(see below) identified a range of models varying by degree of targeting and mode of delivery.10,11 
However, it is not currently known what the effects of these various models are on health 
outcomes. Given the increasing interest in this area, the funding that is now being committed to 
it by the Department of Health (DoH) and the opportunity it offers to address health inequalities, 
it is timely to bring together the available data on the impacts of HRLA or training to determine 
how effective the various approaches are. Using systematic methods, we will therefore seek to 
(1) describe and classify the range of HRLA models; (2) identify key dimensions that appear 
to characterise these models; and (3) investigate associations between these dimensions and 
measures of effectiveness, cost-effectiveness, equity and acceptability. Table 1 provides a summary 
of the dimensions identified through our preliminary work on this subject.
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Existing literature
Much of the formal literature describing peer-based models comes from North America, where 
health promotion and disease prevention programmes that rely on lay health advisors (LHAs) 
have proliferated since the 1970s.12 Research has shown that people are more likely to hear and 
personalise messages, and thus to change their attitudes and behaviours, if they believe the 
messenger is similar to them.13 In addition, peer-based interventions can often be implemented 
economically, allow for direct involvement of clients and can result in long-term benefits for the 
peer educators themselves.14 A recent Cochrane Review, involving studies mainly from North 
America and the UK, found promising benefits in the use of LHWs to promote immunisation, 
breastfeeding and breast cancer screening uptake and to improve outcomes for selected infectious 
diseases, in comparison with usual care, i.e. care delivered by qualified health professionals.15 
However, there was insufficient evidence to assess which lay health worker strategies were likely 
to be most effective. An earlier meta-analysis from the USA found a consistent, but modest, 
positive effect of peer-based health education programmes, but could not answer the question 
of whether these effect sizes justified the investment of the extra time and resources needed to 
recruit, train and support peer educators.16 Additional reviews have found that lay or CHWs are 
most effective in the area of increasing access to care, particularly in underserved populations, 
but that further work is needed to determine whether or not this strategy can be cost-effective.17,18
In the UK, NHS health trainers were introduced in the Choosing health White Paper, offering 
a range of approaches to helping people change their behaviour in relation to their health.5 A 
review of the existing literature to support the implementation of health trainers found little 
evidence of the effectiveness of similar roles (e.g. community parents, Healthlink workers, 
community health educators), particularly from the UK.10 Research and evaluation studies 
plus descriptive accounts of programmes were identified via systematic searches of electronic 
databases [e.g. ASSIA, Bath Information and Data Service (BIDS), MEDLINE, Science Direct] 
and the internet. As most of the evidence did not exist in the formal literature, it was also 
necessary to use a ‘snowball approach’ to build up a network of contacts with access to this 
information, identified through professional networks, internet searches and conference 
proceedings. The main reason cited for the lack of published literature in this area is that many 
projects are relatively small in scale and do not have the resources or expertise for rigorous, 
scientific evaluation. Quantitative evaluations have, therefore, rarely been randomised or 
controlled and generally take a before-and-after approach to study design. The review also 
revealed that many evaluations are qualitative or contain a qualitative element in addition to a 
quantitative element. These frequently obtain information on the experience of the intervention 
from the perspectives of clients, the advisors or trainers, and from others in the health care or 
community team involved in referral to or from the service. Furthermore, although the majority 
of programmes identified tended to conduct at least some process evaluation, few have sought to 
rigorously evaluate the impact of the intervention in terms of improvements in health behaviours 
and health and well-being.
There are, therefore, large gaps in terms of the published evidence in this area from the UK and 
a predominance of formal literature from North America, where interventions delivered by lay 
or peer advisors tend to focus on specific health issues, such as cancer screening, cardiovascular 
health or sex education. The full range of existing HRLA formats is difficult to clearly capture 
and categorise, but previous attempts to model the health trainer intervention will be expanded 
upon further in the research proposed here.10,11 The search strategies we propose to use recognise 
that, although randomised controlled trials (RCTs) are widely accepted as the ‘gold standard’ of 
research evidence, a range of different study designs are considered appropriate for the evaluation 
of health promotion interventions.19 Although RCTs are questions of safety and effectiveness 
(does it work?), qualitative studies and surveys are best for questions of appropriateness, 
satisfaction and salience (does it matter?), and questions concerning acceptability and process 
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may be addressed by qualitative studies or quantitative studies using mediation analyses (how 
does it work?). 20 Hence, the research we propose here will attempt to incorporate studies that 
have utilised various qualitative and quantitative methodologies. By reviewing the current 
diverse range of evidence, a set of criteria will be developed detailing the conditions and 
contexts in which different versions of the HRLA or trainer format are more or less effective 
and cost-effective than others. The importance of looking at the existing models broadly across 
different dimensions, including different health topic areas and communities, is to understand 
under which conditions, in which settings and in what ways different types of support are more 
effective, efficient, equitable and acceptable.
Research aim and objectives
This research aims to identify, describe, classify and analyse the range of models, developed to 
date for delivering HRLA or training, for effectiveness, mechanism of effect, cost-effectiveness, 
equity and acceptability in improving the health and well-being of individuals and communities, 
with particular reference to the reduction of inequalities in the UK. This aim will be achieved by 
meeting the following objectives:
Phase I Intervention modelling and problem definition:
1. Define and model the range of HRLA interventions currently in use, via secondary analysis 
of national survey data and telephone interviews with key stakeholders.
2. Elicit stakeholders’ [the Project Advisory Group (PAG) and a recruited sample] perceptions 
of key issues surrounding the role of HRLAs to be taken into account when shaping, 
planning and executing the systematic review.
Phase II Evidence synthesis:
3. Identify, critically appraise and, if appropriate, meta-analyse effectiveness and model cost-
effectiveness data from studies addressing interventions for delivering HRLA or training in 
the UK or similar settings. Integral to this will be a theoretical analysis of the component 
intervention techniques identified in the studies. The review will be limited to ‘developed’ 
countries in which there is similarity of the main behaviours associated with ill health and 
similar types of health inequalities, i.e. Western Europe, North America, Australia and New 
Zealand. There will be no limitation by study population but the review will seek a particular 
focus on interventions targeting those living in areas of multiple social and economic 
deprivation.
4. Seek data from published evaluations on differential outcomes of interventions by factors 
such as age, gender, ethnicity and socioeconomic position.
Phase III Development of proposals for definitive research and dissemination of findings:
5. Present a summary of the existing evidence base and present practice, in order to identify the 
most appropriate future research questions and research designs that will provide the NHS 
with best evidence for the effectiveness and cost-effectiveness of HRLAs or trainers in the 
future.
Research methods
The difficulty of conducting systematic reviews of public health interventions directly reflects 
the complexity of the interventions reviewed and the subsequent determination of effectiveness. 
Some of the key challenges in this field include: the focus on populations rather than individuals, 
multicomponent interventions, the use of qualitative as well as quantitative approaches, an 
emphasis on processes of implementation, and the complexity and long-term nature of the 
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interventions and outcomes. 20 The concept of HRLAs is multifaceted and as such represents 
a complex public health intervention. Hence, any assessment of the effectiveness and cost-
effectiveness of the models identified needs to take into consideration the nature of this type of 
intervention and will require multiple methods of enquiry. This has implications for the research 
proposed here, which will be divided into the following three elements:
1. problem definition and intervention modelling, leading to classification of the various 
intervention dimensions
2. evidence synthesis, including a systematic review, economic modelling and meta-analysis of 
the results
3. development of a proposal for definitive research studies to provide evidence for the 
effectiveness, cost-effectiveness, and mechanisms of change equity and acceptability of the 
HRLA role.
These three phases are framed by a staged approach to intervention development, evaluation and 
implementation, as exemplified by Nutbeam’s20,23 outcome model for health promotion and the 
Medical Research Council (MRC) framework for the evaluation of complex interventions. The 
process will very much be an iterative one, incorporating a number of overlapping phases and 
activities, and leading to specific outcomes and deliverables.
Phase I: problem definition and intervention modelling
The PAG will be consulted on their views and perceptions of key issues surrounding the role of 
HRLAs to be taken into account when planning and executing the research. An initial scoping 
exercise will be undertaken in order to identify, describe and categorise the various intervention 
dimensions that currently exist, and to set the parameters for the systematic review (Phase 
II). This phase will build directly on a national survey of health trainer activity, funded by the 
Department of Health and currently being undertaken by Professor Michie and colleagues at the 
Centre for Outcomes Research and Effectiveness, University College London (UCL). The survey 
will be completed and reported in September 2007. A secondary analysis of the survey data will 
be undertaken and, along with the outcomes of the Advisory Group consultation, will be used to 
produce a primary classification of the intervention dimensions with respect to the following:
 ■ referral system (who initiates)
 ■ timing or stage of intervention, in relation to access to target groups and stage of life (when?)
 ■ aims, including whether primary or secondary prevention or positive health promotion 
(why?)
 ■ theoretical basis (how does it work?)
 ■ level of delivery (population, group, individual, national, regional, local, etc.) and target 
audience (for whom?)
 ■ actors (who delivers it?)
 ■ setting of delivery (where?)
 ■ method of intervention, i.e. component techniques (what?)
 ■ intensity, i.e. frequency, duration, amount of specific components (how much?)
 ■ mode of delivery, for example one-to-one, face-to-face versus telephone contact (how 
delivered?)
 ■ cost (what price?).
Our primary classification of intervention dimensions will aim to identify the smallest number 
of discrete intervention types that are distinctive, can be identified from searches in the 
subsequent systematic review and could be expected to be differentiated in terms of outcomes. 
Our experience is that the number will not exceed 30. We will then undertake semistructured 
telephone interviews with local project leads/coordinators (largely those with some involvement 
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in local health trainer projects) in order to refine the classification. We will analyse the interviews 
in batches of 10 and cease interviewing when the analysis is saturated and no new categories are 
identified (we estimate that this will be 30–40 interviews). We will identify categories that are 
well populated by instances of interventions, develop specific questions regarding differences 
expected and interview several from each category. Our expectation is that the number will not 
exceed 30. We will develop an interview schedule, informed by Phase I of the MRC framework 
for evaluation of complex interventions, and the Advisory Group will be consulted on this via 
email.19 Interviews will be audio-recorded, with participants’ consent, and later transcribed 
verbatim. Analysis of transcripts will be undertaken using the framework analysis method to 
verify the classification and modify it according to the findings.24 The resulting classification 
will be mailed out to all health trainer leads and hub leads for them to provide instances where 
interventions do not fit on to the classification. The final classification will be will be emailed to 
the PAG for comment via email and teleconference.
At conclusion of Phase I, search terms will have been defined and we will have developed the 
analytical framework for Phase II. The framework will both inform and be informed by each of the 
subsequent phases.
Phase II: evidence synthesis
We will conduct a systematic review to determine the effectiveness, mechanisms of change 
(to understand why changes happen and therefore enable more effective intervention), cost-
effectiveness, equity and acceptability of different versions of the HRLA in improving health 
behaviours and health and well-being. The methods detailed below for identifying and selecting 
relevant material, assessing its quality and synthesising the results have been developed from the 
guidelines issued by the NHS Centre for Reviews and Dissemination (CRD).25 For the integration 
of qualitative research with quantitative studies in systematic reviews, we will draw on the 
framework set out by Thomas et al. (2004).26
Planned inclusion/exclusion criteria
Explicit inclusion and exclusion criteria will be set following completion of Phase I. Studies 
will be considered relevant and included in the review if they report an evaluation of HRLA or 
training delivered to patients or the public in the UK or a sufficiently similar setting, in terms 
of the outcomes listed below. As the impacts of HRLA in all adult groups are of interest, no 
exclusions will be made on the basis of the population studied. Furthermore, as much of the 
available evidence has not been formally published in peer-reviewed journals, no exclusions will 
be made on the basis of lack of peer review in the first instance. In order to provide an assessment 
of the best available evidence on lifestyle advice, we will not restrict inclusion in the review on 
the basis of study design, date or language (subject to translation into English). However, study 
quality will be rigorously appraised (see below).
We will adopt a broad and inclusive approach to interventions that involve paid or voluntary 
work with an individual or group of peers acting in an advisory role, offering training, support 
or counselling (in person, over the telephone or online) focused on delivering HRLA or training 
in terms of health improvement. We will include advice delivered by post or electronically only 
if this involves an iterative process of interaction between the individual and the advisor (i.e. 
excluding simple web-based information sources or online peer support groups).
This review will exclude interventions delivered without the explicit aim of health improvement. 
For example, community-based secondary prevention for chronic disease will be included, but 
lifestyle advice or training delivered as part of treatment or care for acute illness will be excluded. 
Other exclusion criteria will include: interventions focusing solely on the delivery of training or 
advice to children or adolescents as intervention methods and factors determining effectiveness 
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are likely to be very different from those in adults; and studies or reports detailing descriptive 
accounts of programmes, without any evaluation. Although this descriptive information will not 
be included in the review per se, it may be included in the intervention modelling phase (Phase I) 
as part of the process of problem definition.
Proposed outcome measures
The outcomes to be assessed in the review will be refined after Phase I is complete. For now, we 
propose that studies reporting at least one of the following outcomes will be included:
 ■ health status [including self-rated health, health-related quality of life (HRQoL) or individual 
quality of life (QoL), psychological well-being, pain, fatigue, disability]; physiological 
measures (such as blood pressure, lung function or glycaemic control)
 ■ health behaviour (including physical activity, consumption of tobacco, alcohol and food, 
symptom management)
 ■ health-care use (including doctor visits, hospital admissions, length of stay)
 ■ costs of delivering a programme or intervention; cost-effectiveness [life-years and quality-
adjusted life-years (QALYs) gained per unit cost].
Secondary outcomes or mediators are likely to include: self-efficacy (confidence) to improve 
health; knowledge acquisition; changes in attitudes or beliefs; social role or activities; self-
reported competence; uptake; communication with a health-care professional; effects on relatives 
or carers; and adverse outcomes, such as complaints or other adverse effects of interventions. We 
will also record the differential effects of the interventions in terms of primary and secondary 
outcomes and mediators by measures of socioeconomic position, ethnicity, age and gender, 
where these are available and reported.
Search strategies
Searches will be made by two reviewers for existing relevant systematic reviews using Cochrane, 
Campbell, CRD/DARE and EPPI-Centre databases, in addition to searches for primary studies. 
Our initial scoping review suggests that the formal literature base (i.e. from peer-reviewed 
journals) on HRLAs is relatively small. However, there does appear to be a substantial amount 
of ‘grey’ literature on this subject and therefore we will access as much of this as possible using a 
variety of search strategies, including:
1.  Searches of electronic databases Searches will be made of relevant electronic databases using 
various combinations of search terms (Boxes 1 and 2). These initial search strategies have 
been developed from the scoping review but will be refined and expanded based on the 
results of Phase I.
2.  Searches of the internet Searches will be made of the internet using the Google search engine 
(www.google.com) using the search strategies listed in Box 2. The first 100 results returned by 
each search strategy will be scanned for relevance and those judged to be potentially relevant 
followed up. If this strategy identifies HRLA or training programmes but no information 
on evaluation is available on the internet, attempts will be made to contact programme 
organisers directly by telephone or email in order to access the results of any evaluation that 
has been performed.
3.  Suggestions from experts and those working in the field Requests for help with accessing 
relevant literature will be posted on the NHS Health Trainers’ Network discussion forum 
(www.networks.nhs.uk/forums/showthread.php?p=11#post11) and sent to relevant 
mailbases (listed in Box 3). ‘Experts’ – identified as such either by responses to postings, 
frequent publication in the area or through personal contacts of the research team – will 
also be contacted directly and asked for help with identifying relevant literature or providing 
further contacts.
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4.  Searches of specific websites A number of specific websites of organisations that sponsor and/
or conduct relevant research will be searched to identify publications of interest (listed in 
Box 4). Searches will also be made of various trial and research registers for completed and 
ongoing research of relevance.
5.  Reference lists of relevant studies The reference lists of all studies assessed to be relevant will 
be hand searched to identify additional studies that may be of relevance. Reference lists of 
previous reviews will also be searched to ensure thoroughness.
6.  Searches of the Science Citation Index (SCI) and Social Sciences Citation Index (SSCI) Citation 
searches of the SCI and SSCI will be made in order to identify all citations of studies 
identified as relevant, and therefore identify any further possible relevant studies.
7.  Hand searches of relevant journals The contents pages of journals considered to be highly 
relevant (i.e. found to contain a significant number of relevant articles using the above 
methods) will be scanned to identify additional relevant publications.
Additional information from authors
Our solution to the anticipated problem of only brief description of intervention and evaluation 
protocols being presented in published evaluation will be to contact all authors of included 
studies to gather the full details required for the purpose this review. Excellent response rates, for 
example 80%, to such requests has been achieved in other reviews we have conducted.
Selection of studies
Titles of studies identified using the above search strategies will be scanned by two reviewers to 
make an initial assessment of relevance. In cases where there is any doubt concerning relevance 
at this stage, abstracts will be retrieved in order to make a further judgement. If doubt concerning 
relevance remains at this stage or no abstract is available, full reports will be retrieved for review. 
Abstracts and relevant articles will be reviewed independently by two reviewers based on the 
inclusion criteria and specified outcomes of interest. Studies excluded after reviewing abstracts or 
full reports will be detailed in a ‘table of excluded studies’.
As we will make substantial efforts to access the grey literature, it is likely that there will be cases 
where we retrieve both an internal report and peer-reviewed paper on the same study. In these 
cases, both documents will be scrutinised. If there are any discrepancies in results, those reported 
in peer-reviewed journals will be favoured. However, results described in internal reports but not 
peer-reviewed journals will also be abstracted and included in the review.
Data abstraction
We will abstract data on all outcomes reported with the aid of a data abstraction form developed 
by Professor White and colleagues,27 which has been modified to fit this review (Table 2). As 
we are interested in all possible health behaviour and health and well-being impacts of lifestyle 
advice, no explicit outcomes are stated in the data collection sheets and data on all and any 
measurements instruments used will be abstracted.
Data abstraction from each study retrieved will be performed independently by two reviewers, 
with information entered either directly on to a Microsoft access database or recorded on 
paper data abstraction sheets and then entered into the Microsoft access database. In any cases 
where reviewers are found to disagree in the data abstracted, a third reviewer will be asked 
to independently review the study and a majority decision taken. If substantive disagreement 
remains then the whole review team will meet and agree the data that will be included in the 
review.
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Assessment of study quality (quantitative)
We will use the Quality assessment tool for quantitative studies developed by the Effective Public 
Health Practice Project, Canada.28 The tool assesses the following quality criteria: selection 
bias, study design, confounders, blinding, data collection methods, withdrawals and dropouts, 
intervention integrity, and statistical analyses. It is suitable to be used in systematic reviews of 
effectiveness, and can be used for RCTs, quasi-experimental studies and uncontrolled studies.29 
Content and construct validity have also been established. As few studies in this area are likely to 
be RCTs, we may not be able to use a formal scoring framework to determine the quality of each 
study. In such cases, we will collect information on various aspects of methodology – as shown 
in the data abstraction sheet – and report this in a descriptive analysis. In addition, we will report 
our results in categories based on the strength of the study designs used to obtain data (e.g. RCTs, 
non-RCTs, uncontrolled before and after studies, etc.) in order to make clear the methodological 
strength of the evidence available.
Statistical procedures
Where baseline data are available from quantitative studies, pre- and post-interventions, means 
will be reported for both intervention and control groups, and the absolute change from baseline 
will be calculated, together with 95% CIs. When baseline data are not available, results will be 
expressed as the relative percentage change. For dichotomous outcomes, we will present the RR 
of the outcome compared with the control group. We will also calculate the risk difference, which 
is the absolute difference in the proportions of each treatment group. The number needed to treat 
will also be calculated.
As the scoping review identified few occasions where the effect of lifestyle advice on health 
behaviour and health or well-being outcomes was investigated using quantitative methods, it 
is unlikely that we will collect much data that will be susceptible to combination and formal 
meta-analysis. Nevertheless, we will perform meta-analyses where possible, using a random 
effects model where there is statistical heterogeneity and a fixed effects model where there is no 
significant statistical heterogeneity. We will use funnel plots to examine publication bias, and 
use sensitivity studies to examine the effects of heterogeneity and study quality on the results. 
Sensitivity analyses will address: effectiveness of specific programmes, study quality, differential 
dropout and intention-to-treat. If a sufficient number of studies is identified, we will perform 
subgroup analyses for the following: gender, age groups, intervention type, socioeconomic status, 
ethnicity, and the various dimensions described in Table 1.
Treatment of qualitative data
Quality appraisal is a much-discussed issue in relation to the role of qualitative research in 
systematic reviews.33 We will utilise the Critical Appraisal Skills Programme (CASP) checklist 
for qualitative research, which is a tool for reviewers recommended by the Cochrane Qualitative 
Research Methods Group.34 The checklist comprises 10 questions designed to help the reviewer 
to appraise the report of qualitative research by thinking systematically about the key issues of 
rigour, credibility and relevance. As with the quantitative evaluative work, few qualitative studies 
or components of studies, identified in the scoping review for this proposal appeared to meet 
some of the standards for high-quality qualitative research that have been proposed.35,36 Whilst 
we will include all qualitative research identified as relevant in a narrative analysis, we may not 
be able to apply any formal framework for determining quality. In these cases, information on 
various aspects of methodology will be recorded and reported descriptively.
Expected output of the review
We will prepare tables of included and excluded studies. Within each of these sets of tables, 
interventions will be further grouped according to type of study, type of intervention, HRLA 
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and participant characteristics. Interventions will be classified as: effective, potentially effective, 
ineffective or uncertain in improving behaviours related to health and well-being.
Economic modelling
We will attempt to combine data on the economic impacts of HRLA or training in order 
to determine the cost-effectiveness of the various advisor formats. The economic models 
constructed will be based on care pathways and on a detailed analysis of previously conducted 
economic evaluations retrieved in the systematic review. Given the challenges in evaluating 
such complex interventions, in particular the likely lack of RCTs, lack of direct evidence of the 
effect on long-term outcomes such as QoL and uncertainty in appropriate measures of benefit, 
the initial phase of structuring the model will therefore draw on Phase I data relating to relevant 
measures of benefit.
When assessing efficiency, by whatever economic evaluation method, data are required on the 
costs and outcomes of different interventions and procedures. By deriving and linking estimates 
of relative costs and effectiveness for the alternative advisor formats under consideration, it 
should be possible to determine whether one format is:
 ■ less costly and at least as effective as its comparator, in which case it would be judged, 
unequivocally, to be a better use of health-care resources; or
 ■ more costly, and more effective, than its comparator, in which case a judgement would have 
to be made about whether the extra cost is worth the gains in health achieved.
The basic approach we will use to classify interventions in this way comprises three main stages:
Structuring of the model The decision models constructed will have the following main features:
 ■ They will be used to estimate final outcomes, for example probability (for a given time 
horizon) of developing a given disease condition, given participation in a HRLA/training 
intervention, by estimating the intermediate relationships of probability of intermediate 
outcome given intervention and probability of final given intermediate.
 ■ The choice of outcomes will be determined by consultation with key stakeholders.
 ■ Expected cost will be the sum of the costs associated with each outcome, weighted by their 
probabilities, and including the cost of the intervention itself. If QALYs were deemed an 
appropriate measure, and health–state utility data are available for each of the relevant states, 
then QALYs will be similarly estimated.
 ■ Subgroup analysis will be used if relevant and in order to provide evidence of any 
inequalities, for example by socioeconomic status (where the data can be extracted in the 
review).
 ■ We will seek to include the full range of intervention dimensions as considered in the 
systematic review of effectiveness.
 ■ A time horizon will be chosen in consultation with the key stakeholders.
Populating the model The models will be populated by the following data:
 ■ Estimates of effects (probabilities) derived from the systematic review of effectiveness.
 ■ Utility values (if deemed appropriate and available). Here, we will use literature-based values 
for corresponding outcomes. Some adjustment will have to be made to estimate the utility 
given multiple outcomes, for example stroke plus diabetes, if no literature estimates were 
available.
 ■ Estimated unit costs and resource quantities derived from the systematic review, and 
nationally or locally available data, modified by an appropriate discount rate.
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For the above three bullets, consideration will be given to using all sources regardless of quality, 
weighting the estimates according to quality using the shape of the second-order probability 
distribution (on the parameter estimates). We will use the most cost-effective method of locating 
estimates, such as from routinely collected data, industry or expert opinion. If only expert 
opinion is available we will use appropriate methods (e.g. consensus development), but which 
permit the estimation of uncertainty.
Estimating uncertainty Inevitably, there will be considerable uncertainty in estimates of cost and 
effectiveness, and our strategy for dealing with this will be to:
 ■ estimate appropriate probability distributions [surrounding the parameter (e.g. probability, 
cost and any utility) estimates] based on plausibility and the sampling distribution, using 
sample statistics
 ■ estimate the expected cost and benefit, given the prior distributions
 ■ summarise by subgroup in terms of:
 – incremental net benefit for plausible levels of a threshold (incremental cost per QALY) to 
inform the recommending of interventions (i.e. which are cost-effective).
 – cost-effectiveness acceptability curve (CEAC) for illustrative purposes.
 ■ conduct non-probabilistic sensitivity analysis (e.g. one-way) as considered appropriate, such 
as to take into variation in unit costs.
All the new modelling processes in this research will follow guidelines on economic evaluation, 
such as those by Drummond et al. (1997),30 guidelines on technology appraisal, such as by the 
National Institute of Clinical Excellence (2004); and guidelines on decision modelling, such as by 
Phillips et al. (2004).30–32
Phase III: development of proposals for definitive research and 
dissemination of findings
The findings of the previous two phases will be used to identify the main evaluation question(s) 
to be considered by the HTA for future research in examining the effectiveness, cost-effectiveness, 
equity and acceptability of the health-related LA role. Assessing the applicability of the findings 
and the feasibility of replicating the interventions included in the review to other settings will 
form a key part of the process of summarising evidence. The Cochrane Review guidelines contain 
a detailed framework that will be used by the reviewers in determining applicability. 38 This 
framework is based on the RE-AIM model for conceptualising the public health impact of an 
intervention. 39
Dissemination
Papers will be produced for publication in journals indexed in major databases such as 
MEDLINE, as well as for presentation at relevant local, national and international conferences. 
Summary articles will be produced for publication in both professional and academic journals, 
such as the Health Service Journal, Nursing Times and Quality in Health Care. Specialist health 
publications and relevant consumer magazines will also be targeted. A summary of the research 
will be published electronically and be made available to download freely through Northumbria 
University’s web pages, and we will also ask for it to be assessed for inclusion in DARE, an 
electronic database of published reviews. Key contacts identified through the research and the 
PAG will be asked to distribute the review to all interested parties. Dissemination will also take 
place via workshops targeted at the DoH, Strategic Health Authorities, Primary Care Trusts and 
health trainer leads. We will offer to run workshops for other organisations, such as professional 
and public bodies, if funded by these organisations.
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Research governance
The review of published and publicly available literature will not require ethical approval. 
However, any stakeholder events and telephone interviews conducted as part of Phase I will 
require submission of all project documentation to the relevant NHS Research Ethics Committee 
and Trust Research & Governance Department. Northumbria University, as the employing 
organisation of the Principal Investigator, will act as sponsor for the research.
Expertise
We have convened a collaborative, multidisciplinary team of highly skilled individuals who will 
make a significant contribution to the research by offering their expertise in public health, social 
sciences, health psychology, epidemiology, health economics, medicine and nursing. Particular 
skills in the team include experience of conducting quantitative and qualitative systematic 
reviews and economic modelling. The systematic review will be undertaken by two researchers 
at Northumbria University. They will draw on the expertise of Dr Katherine Deane, a Research 
Fellow at Northumbria University, who has undertaken numerous Cochrane reviews, and who 
will provide guidance with respect to quantitative systematic reviewing and with any meta-
analyses required. Economic modelling expertise will be provided by the Health Economics team 
within the Institute of Health and Society at Newcastle University.
Dr Susan Carr, Reader in Public Health in the Health Improvement Research Programme 
(HIRP), at Northumbria University, is the Principal Investigator. Experience of concurrent 
management of multiple projects will provide a template for leadership, management and probity 
of the overlapping phases of this project. She will draw on HIRP research foci of enhancement of 
understanding of population need, service innovation and evaluation and output and outcome 
evaluation to contribute to this project. Professor Cam Donaldson, Director of the Institute of 
Health and Society at Newcastle University, has expertise in measuring and valuing the benefits 
of health care and the economic evaluation of health-care interventions. Professor Susan Michie 
of the Centre for Outcomes Research and Effectiveness (CORE) at UCL will take responsibility 
for an analysis of the possible mechanisms of change underlying any effects found. This will 
include appropriate coding of the interventions and linking this with theoretical principles of 
behaviour change. Professor Martin White, Director of the Public Health Research Programme 
at Newcastle University, will offer his expertise in conducting systematic reviews and the 
development and evaluation of complex public health interventions. He will contribute to all 
phases of the research, in particular providing advice on analysis of differential intervention 
effects within the systematic review and on development of future research questions, 
intervention strategies and evaluation designs.
An Advisory Group (n =8) representing a range of key stakeholders and expertise has been 
recruited from different geographical locations, service, user and academic backgrounds and 
disciplines. The group will provide guidance to the review team to ensure appropriate inclusion 
and exclusion criteria; discuss and define the range of intervention dimensions following the 
survey analysis; contribute to decisions about the scope of the review; assisting the reviewers in 
prioritising outcomes and interpreting the findings of the review; and disseminating the review 
to relevant groups, ensuring that it is readable and understandable from a range of perspectives. 
This group will meet a minimum of four times over the duration of the project, at approximately 
the following times:
 ■ October 2007 commence project, finalise roles and timetable, undertake initial consultation
 ■ April 2008 completion of Phase I, preparation for Phase II and production of interim report
 ■ October 2008 review of economic modelling and data abstraction, interim report 
preparation
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 ■ February 2009 research question formulation, preparation of final report and framework 
paper for publication.
Justification of support required
In accordance with standard practice to ensure rigour, two reviewers will be used to avoid bias. 
This means that the equivalent of one part-time Research Associate (RA) and one part-time 
Senior Research Assistant (SRA) at Northumbria University will be required for 18 months, with 
input from Dr Deane for the equivalent of 10 days, and one part-time RA/economic modeller 
at Newcastle University for 18 months. Overall supervision and leadership will be provided by 
Dr Carr at Northumbria University, with Professors Donaldson, Michie and White providing 
expertise and specific leadership at appropriate points during the project. Progress review 
meetings will be conducted with Dr Carr and the research team on a monthly basis, and the 
core team will convene every 3 months, with regular email and telephone communication as 
and when required. The PAG will attend four steering group meetings over the course of the 
18 months, with reimbursement of travel and subsistence costs.
Flow diagram
Project timetable
We estimate that the project will take approximately 18 months to complete, starting in 
November 2007 and completing in May 2009. The relevant milestones will be as follows:
Ethical approval sought
and obtained
Interviews with key
stakeholders
Protocol development, including
searches to locate the association
between intermediate and final outcomes
Six-monthly interim report of activity
Searching and assessing relevance of studies
Six-monthly interim report of activity
Systematic review/synthesis of economic, quantitative and qualitative data collated
Formulation of further research question
Final report production and development of further work
Dissemination of findings
Data abstraction
Cleaning and analysis
Quantitative
meta-analysis
Qualitative
data synthesis
Economic
model structure
Parameterisation and analysis
Advisory group meeting
Modelling phase
Advisory group meeting: finalise roles, timetable
and initial consultation including establishment of
pathways and setting measures of benefit
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Progress reports will be submitted at 6-monthly intervals during the project, detailing progress 
towards or against the above milestones. A final report will be produced and submitted to Health 
Technology Assessment (HTA) by May 2009, along with at least one paper for publication in a 
relevant peer-reviewed journal.
Should we become aware of any further studies performed after the review has been completed, 
we will append these to the review as necessary. If a number of studies that challenge the 
conclusions of the review become available, and the original conclusions become untenable, we 
will repeat the review if we have the resources available to do so.
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TABLE 1 The multi-dimensional nature of the HRLA formata
Dimension
Bottom up, emergent Origins Top down, mandated
Informal Level of formality Formal
Generic, focus on overall health and well-being Topic focus Targeted, focus on specific health topics or 
behaviours
Whole population within a specified locality Population focus Particular target groups or local communities
Community outreach Referral Biomedical referral model
One-off contact Frequency Iterative, ongoing intervention
Peer or lay led Practitioner type Professionally driven
Unqualified, low/no skill Skill level Qualified, highly skilled
Unpaid volunteers Nature of role Paid employees
Part-time/sessional workers Hours Full-time advisors/trainers
Group or community work Mode of delivery One-to-one intervention
Community development and engagement Main activities Evidence-based lifestyle advice, goal setting
Community setting Context Health-care setting
Nurturing and supporting Approach Information giving and signposting
Enhanced capacity and social capital within 
communities
Key outcomes Health behaviour change within individual clients
a Interventions and programmes for the delivery of HRLA can be loosely classified along the dimensions detailed above. However, none of these 
is mutually exclusive and there is inevitably a high degree of overlap and blurring of the boundaries between the categories. For example, 
initiatives described as taking a one-to-one approach may occasionally involve some group work, and those that focus on a particular issue 
often deal with wider health concerns by signposting clients to other services.
ASSIA
Article 1st
British Humanities Index
CINAHL
EMBASE
FRANCIS
NHS Economic Evaluation Database (NHS EED)
IBSS
MDX Health
MEDLINE
PAIS
PsycINFO 
Science Citation Index (SCI)
SIRS Researcher
Social Sciences Citation Index (SSCI)
Social Services Abstracts
Sociological Abstracts
Web of Knowledge
WorldCat
Zetoc 
BOX 1 Electronic databases that will be searched
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(Health trainer OR lifestyle advi$/ train$ OR lay health worker/adviser OR peer educ$/counsel$/support$ OR 
health activator/activist OR health aide OR health advocate OR link worker OR community champion OR 
community health educator OR outreach worker) AND (evaluation OR effectiveness OR cost-effectiveness OR 
equity OR acceptability OR behaviour change OR health promotion/improvement OR disease prevention)
AND/OR searches for specific health-related behaviours: (smoking OR physical activity OR diet OR overweight/
obesity OR alcohol OR breastfeeding OR sexual health)
BOX 2 Strategy for searching electronic databases
HEALTH-EQUITY-NETWORK@JISCMAIL.AC.UK
COMMUNITY-HEALTH@JISCMAIL.AC.UK
GP-UK@JISCMAIL.AC.UK
GPRD-RESEARCH@JISCMAIL.AC.UK
HEALTH-FOR-ALL@JISCMAIL.AC.UK
HEALTH-PROMOTION@JISCMAIL.AC.UK
HEALTH-SERVICES-RESEARCH@JISCMAIL.AC.UK
PUBLIC-HEALTH@JISCMAIL.AC.UK
PUBLIC-HEALTH-IN-TRUSTS@JISCMAIL.AC.UK
SOCIALWORK-HEALTHINEQUALITIES@JISCMAIL.AC.UK
EVIDENCE-BASED-HEALTH@JISCMAIL.AC.UK
HEALTH-SECTOR-DEVELOPMENT@JISCMAIL.AC.UK
HEALTHFUTURESUK@JISCMAIL.AC.UK
APIG@JISCMAIL.AC.UK
LEEDSPEERSUPERVISION@JISCMAIL.AC.UK
primarycarenursingresearchnetwork@yahoogroups.com
evidencenetwork.com
click4HP@yorku.ca
address_healthcare_disparities@list.ahrq.gov
health-disparities@lis.ahrq.gov
public-health@latrobe.edu.au
SDOH@yorku.ca
BOX 3 Mailbases and ListServs that requests for information will be posted on
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TABLE 2 Data abstraction sheet
Authors
Title
Year
Journal and reference
Institution (if report)
Reviewer Review date
Entered on EndNote EndNote ref.
Entered on Access Access ref.
Screening
Does this study describe an intervention involving some form of HRLA or trainer?
If not, this study should not be included in the review – may need to discuss with team
Description of intervention
What was the referral system?
When was the intervention delivered – timing or stage?
What were the aims of the intervention?
Who was eligible for the intervention?
Who delivered the intervention?
Where was the intervention delivered?
What was the content of the intervention (specific technique/s)?23
Theoretical basis of the intervention?
What was the intensity of the intervention?
How as the intervention delivered?
What was the cost of the intervention?
Evaluation
Type of evaluation performed Quantitative
Qualitative
Economic
The National Audit Office: www.nao.org.uk
The Home Office: www.homeoffice.gov.uk
The Joseph Rowntree Foundation: www.jrf.org.uk
The Office of the Deputy Prime Minister: www.odpm.gov.uk
ISRCTN Register: www.controlled-trials.com/isrctn
The Department of Health: www.dh.gov.uk
The American Institutes for Research: www.air.org
The Office of Policy: www.ssa.gov/policy
The Medical Research Council: www.mrc.ac.uk
The Urban Institute: www.urban.org
Wellcome Trust: www.wellcome.ac.uk
National Institute of Health: www.nice.org.uk/
The Society of Behavioural Medicine: www.sbm.org/
BOX 4 Websites to be hand searched for relevant publications
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Quantitative evaluation
Type of quantitative evaluation Uncontrolled before and after
Controlled/comparison group
Uncontrolled before-and-after studies
Size, e.g. number seen by advisor(s)
Timescale that those included in evaluation seen
Health outcomes Measurement instrument 1
Data collection method
Baseline mean & SD Baseline N
FU mean & SD Follow-up N
Stats performed? Result of stats
Measurement instrument 2
Data collection method
Baseline mean & SD Baseline N
FU mean & SD Follow-up N
Stats performed? Result of stats
Other outcomes Measurement instrument 1
Data collection method
Baseline mean & SD Baseline N
FU mean & SD Follow-up N
Stats performed? Result of stats
Measurement instrument 2
Data collection method
Baseline mean & SD Baseline N
FU mean & SD Follow-up N
Stats performed? Result of stats
Controlled studies/studies with comparison groups
Size No. in intervention/effect group at baseline
No. in intervention/effect group at follow-up
No. in control/comparison group at baseline
No. in control/comparison group at follow-up
Timescale/follow-up
Random assignment to control/intervention group?
Researchers blind to control/intervention group status?
Health outcomes Measurement instrument 1
effect grp score at baseline
comp grp score at baseline
effect grp score at FU
comp grp score at FU
stats performed?
results of stats
Measurement instrument 2
effect grp score at baseline
comp grp score at baseline
effect grp score at FU
comp grp score at FU
stats performed?
results of stats
continued
TABLE 2 Data abstraction sheet (continued)
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Other outcomes Measurement instrument 1
control grp score at baseline
int grp score at baseline
control grp score at FU
int grp score at FU
stats performed?
results of stats
Measurement instrument 2
control group score at baseline
int group score at baseline
control group score at FU
int group score at FU
stats performed?
result of stats
Qualitative evaluation
Sample Size
Composition
How chosen
Data collection method
Analytical method
Main themes identified
Economic evaluation
Size 
Timescale that those included in evaluation seen
Economic outcomes Measurement instrument 1
Measurement instrument 2
TABLE 2 Data abstraction sheet (continued)
© Queen’s Printer and Controller of HMSO 2011. All rights reserved.
205 Health Technology Assessment 2011; Vol. 15: No. 9DOI: 10.3310/hta15090
Appendix 3  
Multidimensional nature of the HRLA 
format
TABLE 34 The multidimensional nature of the HRLA format
Dimension
Bottom up, emergent Origins Top down, mandated
Informal Level of formality Formal
Generic, focus on overall health and well-being Topic focus Targeted, focus on specific health topics or 
behaviours
Whole population within a specified locality Population focus Particular target groups or local communities
Community outreach Referral Biomedical referral model
One-off contact Frequency Iterative, ongoing intervention
Peer or lay led Practitioner type Professionally driven
Unqualified, low/no skill Skill level Qualified, highly skilled
Unpaid volunteers Nature of role Paid employees
Part-time/sessional workers Hours Full-time advisors/trainers
Group or community work Mode of delivery One-to-one intervention
Community development and engagement Main activities Evidence-based lifestyle advice, goal setting
Community setting Context Health-care setting
Nurturing and supporting Approach Information giving and signposting
Enhanced capacity and social capital within 
communities
Key outcomes Health behaviour change within individual clients
Interventions and programmes for the delivery of HRLA can be loosely classified along the 
dimensions detailed above. However, none of these are mutually exclusive and there is inevitably 
a high degree of overlap and blurring of the boundaries between the categories. For example, 
initiatives described as taking a one-to-one approach may occasionally involve some group work, 
and those that focus on a particular issue often deal with wider health concerns by signposting 
clients to other services.
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Appendix 4  
Project Advisory Group
Rachel Baker, Lecturer, Newcastle University
Sharon Bartram, Health Trainer Manager, Hartlepool Primay Care Trust
Dr Susan Carr, Reader in Public Health & Primary Care, Northumbria University
Professor Cam Donaldson, Director of the Institute of Health and Society, Newcastle University
Dr Katherine Deane, Senior Lecturer, Newcastle University (2008–9), University of East Anglia 
(2009)
Professor Chris Drinkwater, Emeritus Chair of Primary Care Development, Northumbria 
University
Gwen Ellison, Health Trainer Lead, North East Hub, Newcastle Primary Care Trust
Natalie Forster, Research Assistant, Northumbria University
Lesley Geddes, Principal Lecturer, Northumbria University
Philip Hodgson, Research Assistant/Administrator, Northumbria University
Diane Jones, Research Associate, Northumbria University (August–November 2009)
Farzana Latif, Public Health Practitioner, East Berkshire Primary Care Trust
Dr Monique Lhussier, Senior Lecturer, Northumbria University
Dr Marianne Morris, Principal Lecturer, University of West England
Professor Susan Michie, Professor of Health Psychology, University College London
Mark Pennington, Research Associate, Newcastle University
Jane South, Reader in Health Promotion, CoDirector of the Centre for Health Promotion 
Research, Leeds Metropolitan University
Professor Martin White, Professor of Public Health, Director of the Centre for Translational 
Research in Public Health, Newcastle University
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Appendix 5  
Interview schedule
Stakeholders’ perceptions of key issues surrounding the role of health-
related LAs
1. Role definitions/descriptions
i. What services/interventions do you provide that are delivered by a health-related LA?
ii. Do you have one or multiple models/versions of the health-related LA role? What is 
their role title?
iii. What is the skill level of those delivering the intervention?
iv. Number of hours worked, for example full-time/part-time/sessional, etc.
v. What are the origins/history of the service/intervention, i.e. was it previously undertaken 
by another post holder, is it delegated from another post holder ?
2. Referral process
i. Is a referral required for the service to be offered/delivered?
ii. What type of referral, e.g. community outreach/biomedical referral?
3. Aims and objectives of the intervention delivered by the health-related LA
i. What is the intervention intending to achieve, i.e. is it about primary or secondary 
prevention or positive health promotion?
ii. Does it have a specific disease or health topic focus?
iii. Does it focus on one particular health improvement issue (e.g. smoking cessation), more 
than one issue (e.g. smoking cessation, obesity and exercise) or general health and well-
being (i.e. a generic focus)?
iv. What are the key outcomes for the intervention?
v. How do you define and measure success of the health-related LA role?
4. Eligibility for service
i. Who are the target audience for the intervention?
ii. What is the level of delivery, i.e. individual, group, community, local/regional/national 
population, etc.?
iii. Is there any specific targeting of particular populations?
5. Setting
i. Where is the intervention delivered?
ii. What is the context in which the intervention is delivered?
6. Mode of delivery
i. What are the main activities undertaken?
ii. What is the approach of the intervention? Nurturing and supporting or signposting and 
giving information
iii. How is the intervention delivered, e.g. face-to-face contact with individuals/groups 
versus telephone contact?
iv. What is the method of the intervention, i.e. what are its component techniques?
7. Intensity
i. What is the intensity of the intervention, i.e. frequency, duration, amount of specific 
components?
ii. Theoretical basis
iii. How does the intervention work?
iv. Were any theories used to develop the intervention, e.g. stages of change?
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8. Price
i. Has any cost analysis of the intervention been carried out?
ii. How much does the intervention cost? Overall cost/cost per contact?
9. Grey literature
i. Any supporting documentation that could be used within the review?
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Appendix 6  
Search strategies for electronic 
databases
Database: Applied Social Sciences Index and Abstracts
Name of host: CSA Illumina
Years covered: 1960–present
Search strategy
List one:
1. kw= (health train*)
2. kw= (lifestyle within 1 (advi* or train* or coach*))
3. kw= (lay health within 1 (worker or advis?r or support*))
4. kw= (lay within 1 (practitioner or leader or midwi*))
5. kw= (peer within 1 (leader or educ* or counsel* or support* or mentor* or network* or 
assist*))
6. kw= (health within 1 (activ* or aide or advoc* or coach or promot?r))
7. kw= ((patient or peer) within 1 navig*)
8. kw= ((community or health) within 1 champion)
9. kw= (community health within 1 (educ* or work* or advis* or activ* or representative))
10. kw= (community wellness advocate)
11. kw= (community within 1 (parent or mother))
12. kw= (outreach within 1 (worker or specialist))
13. kw= (expert patient) or kw= (natural help*)
14. kw= ((neighborhood or neighbourhood) within 1 (help* or leader or assistant))
15. kw= (family health advis*)
16. kw= (breastfeeding supporter)
17. kw= (lactation consultant)
18. kw= ((village or indigenous) within 1 health worker)
19. kw= (promotor*)
20. kw= (paraprofessional)
21. kw= (workplace health advi*)
22. kw= ((professional* or nurs* or physician* or clinician*) within 2 (delegat* or substitut*))
23. kw= (staff* within 1 model*)
24. kw= (nurs* within 2 (led or managed or directed or run))
25. kw= ((lay or voluntary or volunteer* or untrained or unlicensed or nonprofessional* or non 
professional* or paraprofessional* or paramedical) within 1 (worker* or staff))
26. kw= (community within 3 (volunteer* or aid* or support))
27. kw= ((birth or childbirth or child birth or labor or labour) within 1 (attendant* or 
assistant*))
28. kw= (doula* or douladural* or monitrice* or linkworker* or link worker* or barefoot 
doctor*)
29. kw= (home within 1 (aid or aides or health or nursing or support or intervention* or 
treatment* or visit*))
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List two:
30. kw= (public health)
31. kw= ((behaviour or behavior or lifestyle or lifestyle) within 1 change)
32. kw= (health within 1 (promotion or education or improvement))
33. kw= ((disease or illness) within 1 prevention)
34. kw= (smoking)
35. kw= (tobacco use)
36. kw= (exercise)
37. kw= (diet)
38. kw= (nutrition)
39. kw= (overweight)
40. kw= (obesity)
41. kw= (alcohol)
42. kw= (substance misuse)
43. kw= (breastfeeding)
44. kw= (sexual health)
45. kw= (condom use)
46.  kw= (HIV)
47. kw= (AIDS)
48. kw= (mental health)
49. kw= (wellbeing)
List three
50. kw= (evaluation)
51. kw= (randomi?ed controlled trial)
52. kw= (RCT)
53. kw= (controlled clinical trial)
54. kw= ((questionnaire or survey or interview or focus group) within 5 method)
55. kw= (program evaluation)
56. kw= (multicenter study)
57. kw= (experiment*)
58. kw= (time within 1 series)
59. kw= (interrupted time series)
60. kw=(pre test or pretest or (post test or posttest))
61. kw= (impact)
62. kw= (intervention*)
63. kw= (chang*)
64. kw= (compar*)
65. kw= (random allocation)
66. kw= (double blind method)
67. kw= (single blind method)
68. kw= (clinical trial)
69. kw= (clin* within 5 trial*)
70. kw= ((singl* or doubl* or trebl* or tripl*) within 5 (blind* or mask*))
71. kw= (placebo*)
72. kw= (random*)
73. kw= (comparative study)
74. kw= (follow up studies)
75. kw= (prospective studies)
76. kw= (control* or prospective* or volunteer*)
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77. kw= ((effect* or impact or evaluat* or introduc* or compar* or implement*) within 3 
treatment within 1 (program* or strateg* or test* or questionnaire* or process* or procedure* 
or method*))
78. kw= ((effect* or impact or evaluat* or introduc* or compar* or implement*) within 1 care 
within 1 (program* or strateg* or test* or questionnaire* or process* or procedure* or 
method*))
79. kw= ((effect* or impact or evaluat* or introduc* or compar* or implement*) within 3 
screening within 1 (program* or strateg* or test* or questionnaire* or process* or procedure* 
or method*))
80. kw= ((effect* or impact or evaluat* or introduc* or compar* or implement*) within 3 
intervention* within 1 (program* or strateg* or test* or questionnaire* or process* or 
procedure* or method*))
81. kw= ((effect* or impact or evaluat* or introduc* or compar* or implement*) within 3 
prevention* within 1 (program* or strateg* or test* or questionnaire* or process* or 
procedure* or method*))
82. kw= ((effect* or impact or evaluat* or introduc* or compar* or implement*) within 3 
(protocol* or guideline* or strateg* or audit* or method*))
83. kw= ((critical* within 3 apprais*) or evaluat*)
List four
84. kw= (econom*) or kw= (cost*) or kw= (pric*) or kw= (pharmacoecon*)
85. kw= (cost within 1 (effectiveness or utili* or benefit or minimi* or energy or oxygen or 
metabolic)) or kw= (expenditure not energy)
86. kw= (value within 2 money) or kw= (budget*) or kw= (preference) or kw= (QALY) or kw= 
(quality within 1 adjusted)
87. kw= (utility*)
88. kw= (financ* within 1 (management or support or organized)) or kw= (econom* or cost or 
costs or costly or costing or price or prices or pricing or pharmacoeconomic*)
89. kw= (expenditure* not energy)
90. kw= (value within 1 money) or kw= (budget*)
91. List five
92. kw= (editorial)
93. kw= (letter)
94. kw= (comment)
95. kw= (animal)
Database: Articles 1st
Name of host: OCLC FirstSEARCH
Years covered: earliest to latest
Search strategy
((kw: Health w train*) or (kw: Lifestyle w advi*) or (kw: Lifestyle w train*) or (kw: Lifestyle w 
coach*) or (kw: Lay w health w worker) or (kw: Lay w health w advis#r) or (kw: Lay w health w 
support) or (kw: Lay w practitioner) or (kw: Lay w leader) or (kw: Lay w midwi*) or (kw: Peer 
w leader) or (kw: Peer w edu*) or (kw: Peer w counsel*) or (kw: Peer w support*) or (kw: Peer 
w mentor*) or (kw: Peer w network*) or (kw: Peer w assist*) or (kw: Health w activ*) or (kw: 
Health w aide) or (kw: Health w advoc*) or (kw: Health w coach) or (kw: Health w promot#r) or 
(kw: Patient w navig*) or (kw: Peer w navig*) or (kw: Community w champion) or (kw: Health 
w champion) or (kw: Community w health w educ*) or (kw: Community w health w work*) or 
(kw: Community w health w advis*) or (kw: Community w health w activ*) or (kw: Community 
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w health w representative) or (kw: Community w wellness w advocate) or (kw: Community 
w parent) or (kw: Community w mother) or (kw: Outreach w worker) or (kw: Outreach w 
specialist) or (kw: Expert w patient) or (kw: Natural w help*) or (kw: Neighborhood w help*) 
or (kw: Neighborhood w leader) or (kw: Neighborhood w assistant) or (kw: Neighbourhood w 
help*) or (kw: Neighbourhood w leader) or (kw: Neighbourhood w assistant) or (kw: Family 
w health w advis*) or (kw: Breastfeeding w supporter) or (kw: Lactation w consultant) or (kw: 
Village w health w worker) or (kw: Indigenous w health w worker) or (kw: Promotor*) or (kw: 
Paraprofessional) or (kw: Workplace w health w advi*))
AND
((kw: Public w health) Or (kw: Behaviour w change) Or (kw: Behavior w change) Or (kw: 
Lifestyle w change) Or (kw: Life w style w change) Or (kw: Health w promotion) Or (kw: Health 
w education) Or (kw: Health w improvement) Or (kw: Disease w prevention) Or (kw: Illness 
w prevention) Or (kw: Smoking) Or (kw: Tobacco w use) Or (kw: Physical w activity) Or (kw: 
Exercise) Or (kw: Diet) Or (kw: Nutrition) Or (kw: Overweight) Or (kw: Obesity) Or (kw: 
Alcohol) Or (kw: Substance w misuse) Or (kw: Breastfeeding) Or (kw: Sexual w health) Or (kw: 
Condom w Use) Or (kw: HIV) Or (kw: AIDS) Or (kw: Mental w health) Or (kw: Wellbeing))
AND
((kw: Evaluation) Or (kw: Randomi#ed w controlled w trial) Or (kw: RCT) Or (kw: Controlled 
w clinical w trail) Or (kw: controlled w before w after w 3 w study) Or (kw: cohort w 3 kw: study) 
Or (kw: case-control w 3 kw: study) Or (kw: longitudinal w 3 kw: study) Or (kw: observational w 
3 kw: study) Or (kw: case w 3 kw: study) Or (kw: qualitative w 3 kw: study) Or (kw: quantitative 
w 3 kw: study) Or (kw: questionnaire w 25 kw: method) Or (kw: survey w 25 kw: method) Or 
(kw: interview w 25 kw: method) Or (kw: focus w group w 25 kw: method) OR (kw: econom*) 
Or (kw: cost*) Or (kw: pric*) Or (kw: pharmacoecon*) Or (kw: cost w effectiveness) Or (kw: cost 
w utili*) Or (kw: cost w benefit) Or (kw: cost w minimi*) Or (kw: cost w energy) Or (kw: cost 
w oxygen) Or (kw: cost w metabolic) Or (kw: expenditure NOT kw: energy) Or (kw: value w 2 
kw: money) Or (kw: budget*) Or (kw: preference) Or (kw: QALY) Or (kw: quality w adjusted) 
Or (kw: utility*) Or (kw: financ* w management) Or (kw: financ* w support) Or (kw: financ* w 
organized))
NOT
((kw: editorial) or (kw: letter) or (kw: comment) or (kw: animal))
Database: British Humanities INDEX
Name of host: CSA
Years covered: earliest to latest
Search strategy
List one:
1. kw= (health train*)
2. kw= (lifestyle within 1 (advi* or train* or coach*))
3. kw= (lay health within 1 (worker or advis?r or support*))
4. kw= (lay within 1 (practitioner or leader or midwi*))
5. kw= (peer within 1 (leader or educ* or counsel* or support* or mentor* or network* or 
assist*))
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6. kw= (health within 1 (activ* or aide or advoc* or coach or promot?r))
7. kw= ((patient or peer) within 1 navig*)
8. kw= ((community or health) within 1 champion)
9. kw= (community health within 1 (educ* or work* or advis* or activ* or representative))
10. kw= (community wellness advocate)
11. kw= (community within 1 (parent or mother))
12. kw= (outreach within 1 (worker or specialist))
13. kw= (expert patient) or kw= (natural help*)
14. kw= ((neighborhood or neighbourhood) within 1 (help* or leader or assistant))
15. kw= (family health advis*)
16. kw= (breastfeeding supporter)
17. kw= (lactation consultant)
18. kw= ((village or indigenous) within 1 health worker)
19. kw= (promotor*)
20. kw= (paraprofessional)
21. kw= (workplace health advi*)
22. kw= ((professional* or nurs* or physician* or clinician*) within 2 (delegat* or substitut*))
23. kw= (staff* within 1 model*)
24. kw= (nurs* within 2 (led or managed or directed or run))
25. kw= ((lay or voluntary or volunteer* or untrained or unlicensed or nonprofessional* or non 
professional* or paraprofessional* or paramedical) within 1 (worker* or staff))
26. kw= (community within 3 (volunteer* or aid* or support))
27. kw= ((birth or childbirth or child birth or labor or labour) within 1 (attendant* or 
assistant*))
28. kw= (doula* or douladural* or monitrice* or linkworker* or link worker* or barefoot 
doctor*)
29. kw= (home within 1 (aid or aides or health or nursing or support or intervention* or 
treatment* or visit*))
List two: 
30. kw= (public health)
31. kw= ((behaviour or behavior or lifestyle or life style) within 1 change)
32. kw= (health within 1 (promotion or education or improvement))
33. kw= ((disease or illness) within 1 prevention)
34. kw= (smoking)
35. kw= (tobacco use)
36. kw= (exercise)
37. kw= (diet)
38. kw= (nutrition)
39. kw= (overweight)
40. kw= (obesity)
41. kw= (alcohol)
42. kw= (substance misuse)
43. kw= (breastfeeding)
44. kw= (sexual health)
45. kw= (condom use)
46.  kw= (HIV)
47. kw= (AIDS)
48. kw= (mental health)
49. kw= (wellbeing)
216 Appendix 6
List three: 
50. kw= (evaluation)
51. kw= (randomi?ed controlled trial)
52. kw= (RCT)
53. kw= (controlled clinical trial)
54. kw= ((questionnaire or survey or interview or focus group) within 5 method)
55. kw= (program evaluation)
56. kw= (multicenter study)
57. kw= (experiment*)
58. kw= (time within 1 series)
59. kw= (interrupted time series)
60. kw=(pre test or pretest or (post test or posttest))
61. kw= (impact)
62. kw= (intervention*)
63. kw= (chang*)
64. kw= (compar*)
65. kw= (random allocation)
66. kw= (double blind method)
67. kw= (single blind method)
68. kw= (clinical trial)
69. kw= (clin* within 5 trial*)
70. kw= ((singl* or doubl* or trebl* or tripl*) within 5 (blind* or mask*))
71. kw= (placebo*)
72. kw= (random*)
73. kw= (comparative study)
74. kw= (follow up studies)
75. kw= (prospective studies)
76. kw= (control* or prospective* or volunteer*)
77. kw= ((effect* or impact or evaluat* or introduc* or compar* or implement*) within 3 
treatment within 1 (program* or strateg* or test* or questionnaire* or process* or procedure* 
or method*))
78. kw= ((effect* or impact or evaluat* or introduc* or compar* or implement*) within 1 care 
within 1 (program* or strateg* or test* or questionnaire* or process* or procedure* or 
method*))
79. kw= ((effect* or impact or evaluat* or introduc* or compar* or implement*) within 3 
screening within 1 (program* or strateg* or test* or questionnaire* or process* or procedure* 
or method*))
80. kw= ((effect* or impact or evaluat* or introduc* or compar* or implement*) within 3 
intervention* within 1 (program* or strateg* or test* or questionnaire* or process* or 
procedure* or method*))
81. kw= ((effect* or impact or evaluat* or introduc* or compar* or implement*) within 3 
prevention* within 1 (program* or strateg* or test* or questionnaire* or process* or 
procedure* or method*))
82. kw= ((effect* or impact or evaluat* or introduc* or compar* or implement*) within 3 
(protocol* or guideline* or strateg* or audit* or method*))
83. kw= ((critical* within 3 apprais*) or evaluat*)
List four: 
84. kw= (econom*) or kw= (cost*) or kw= (pric*) or kw= (pharmacoecon*)
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85. kw= (cost within 1 (effectiveness or utili* or benefit or minimi* or energy or oxygen or 
metabolic)) or kw= (expenditure not energy)
86. kw= (value within 2 money) or kw= (budget*) or kw= (preference) or kw= (QALY) or kw= 
(quality within 1 adjusted)
87. kw= (utility*)
88. kw= (financ* within 1 (management or support or organized)) or kw= (econom* or cost or 
costs or costly or costing or price or prices or pricing or pharmacoeconomic*)
89. kw= (expenditure* not energy)
90. kw= (value within 1 money) or kw= (budget*)
91. List five
92. kw= (editorial)
93. kw= (letter)
94. kw= (comment)
95. kw= (animal)
Database: CINAHL
Name of host: Ovid
Years covered: 1982 to week 1 September, 2008
Search strategy
1. health train*.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
2. (lifestyle adj (advi* or train* or coach*)).mp. [mp=title, original title, abstract, name of 
substance word, subject heading word]
3. (lay health adj (worker or advis?r or support*)).mp. [mp=title, original title, abstract, name of 
substance word, subject heading word]
4. (lay adj (practitioner or leader or midwi*)).mp. [mp=title, original title, abstract, name of 
substance word, subject heading word]
5. (peer adj (leader or educ* or counsel* or support* or mentor* or network* or assist*)).mp. 
[mp=title, original title, abstract, name of substance word, subject heading word]
6. (health adj (activ* or aide or advoc* or coach or promot?r)).mp. [mp=title, original title, 
abstract, name of substance word, subject heading word]
7. ((patient or peer) adj navig*).mp. [mp=title, original title, abstract, name of substance word, 
subject heading word]
8. ((community or health) adj champion).mp. [mp=title, original title, abstract, name of 
substance word, subject heading word]
9. (community health adj (educ* or work* or advis* or activ* or representative)).mp. [mp=title, 
original title, abstract, name of substance word, subject heading word]
10. community wellness advocate.mp. [mp=title, original title, abstract, name of substance word, 
subject heading word]
11. (community adj (parent or mother)).mp. [mp=title, original title, abstract, name of substance 
word, subject heading word]
12. (outreach adj (worker or specialist)).mp. [mp=title, original title, abstract, name of substance 
word, subject heading word]
13. expert patient.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
14. natural help*.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
15. ((neighborhood or neighbourhood) adj (help* or leader or assistant)).mp. [mp=title, original 
title, abstract, name of substance word, subject heading word]
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16. family health advis*.mp. [mp=title, original title, abstract, name of substance word, subject 
heading word]
17. breastfeeding supporter.mp. [mp=title, original title, abstract, name of substance word, 
subject heading word]
18. lactation consultant.mp. [mp=title, original title, abstract, name of substance word, subject 
heading word]
19. ((village or indigenous) adj health worker).mp. [mp=title, original title, abstract, name of 
substance word, subject heading word]
20. promotor*.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
21. paraprofessional.mp. [mp=title, original title, abstract, name of substance word, subject 
heading word]
22. workplace health advi*.mp. [mp=title, original title, abstract, name of substance word, 
subject heading word]
23. “delegation of authority”/
24. exp *voluntary workers/
25. ((professional* or nurs* or physician* or clinician*) adj2 (delegat* or substitut*)).tw
26. (staff* adj model*).tw
27. (nurs* adj2 (led or managed or directed or run)).tw
28. ((lay or voluntary or volunteer* or untrained or unlicensed or nonprofessional* or non 
professional* or paraprofessional* or paramedical) adj (worker* or staff)).tw
29. (community adj3 (volunteer* or aid* or support)).tw
30. ((birth or childbirth or child birth or labor or labour) adj (attendant* or assistant*)).tw
31. (doula* or douladural* or monitrice* or linkworker* or link worker* or barefoot doctor*).tw
32. (home adj (aid or aides or health or nursing or support or intervention* or treatment* or 
visit*)).tw
33. health personnel, health educators.sh
34. or/1–33
35. public health.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
36. ((behaviour or behavior or lifestyle or life style) adj change).mp. [mp=title, original title, 
abstract, name of substance word, subject heading word]
37. (health adj (promotion or education or improvement)).mp. [mp=title, original title, abstract, 
name of substance word, subject heading word]
38. ((disease or illness) adj prevention).mp. [mp=title, original title, abstract, name of substance 
word, subject heading word]
39. smoking.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
40. “tobacco use”.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
41. physical activity.mp. [mp=title, original title, abstract, name of substance word, subject 
heading word]
42. exercise.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
43. diet.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
44. nutrition.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
45. overweight.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
46. obesity.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
47. alcohol.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
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48. substance misuse.mp. [mp=title, original title, abstract, name of substance word, subject 
heading word]
49. breastfeeding.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
50. sexual health.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
51. “condom use”.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
52. HIV.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
53. AIDS.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
54. mental health.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
55. wellbeing.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
56. exp *community health services/
57. exp *public health/
58. “Tobacco Use Cessation”/
59. smoking/
60. patient compliance/
61. risk reduction behavior/
62. food habits/
63. or/35–62
64. evaluation.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
65. randomi?ed controlled trial.mp. [mp=title, original title, abstract, name of substance word, 
subject heading word]
66. RCT.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
67. controlled clinical trial.mp. [mp=title, original title, abstract, name of substance word, subject 
heading word]
68. (((controlled before and after) or cohort or case-control or longitudinal or observational or 
case or qualitative or quantitative) adj3 stud*).mp. [mp=title, original title, abstract, name of 
substance word, subject heading word]
69. ((questionnaire or survey or interview or focus group) adj25 method).mp. [mp=title, original 
title, abstract, name of substance word, subject heading word]
70. *program evaluation/
71. program evaluation.tw
72. exp *research/
73. multicenter studies/
74. experimental studies/
75. experiment*.tw
76. (time adj series).tw
77. time series/
78. (pre test or pretest or (post test or posttest)).tw
79. impact.tw
80. intervention*.tw
81. chang*.tw
82. compar*.tw
83. (controlled before and after stud*).mp
84. random assignment.sh
85. double – blind studies.sh
86. single -blind studies.sh
87. clinical trials.pt
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88. exp Clinical Trial/
89. (clin* adj25 trial*).ti,ab
90. ((singl* or doubl* or trebl* or tripl*) adj25 (blind* or mask*)).ti,ab
91. placebo*.ti,ab
92. random*.ti,ab
93. comparative studies.sh
94. exp evaluation research/
95. follow up studies.sh
96. prospective studies.sh
97. (control* or prospective* or volunteer*).ti,ab
98. ((effect* or impact or evaluat* or introduc* or compar* or implement*) adj3 treatment adj 
(program* or strateg* or test* or questionnaire* or process* or procedure* or method*)).tw
99. ((effect* or impact or evaluat* or introduc* or compar* or implement*) adj3 care adj 
(program* or strateg* or test* or questionnaire* or process* or procedure* or method*)).tw
100. ((effect* or impact or evaluat* or introduc* or compar* or implement*) adj3 screening adj 
(program* or strateg* or test* or questionnaire* or process* or procedure* or method*)).tw
101. ((effect* or impact or evaluat* or introduc* or compar* or implement*) adj3 intervention* 
adj (program* or strateg* or test* or questionnaire* or process* or procedure* or method*)).
tw
102. ((effect* or impact or evaluat* or introduc* or compar* or implement*) adj3 prevention* adj 
(program* or strateg* or test* or questionnaire* or process* or procedure* or method*)).tw
103. ((effect* or impact or evaluat* or introduc* or compar* or implement*) adj3 (protocol* or 
guideline* or strateg* or audit* or method*)).tw
104. ((critical* adj3 apprais*) or evaluat*).tw
105. *utilization review/
106. or/64–105
107. econom*.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
108. cost*.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
109. pric*.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
110. pharmacoecon*.mp. [mp=title, original title, abstract, name of substance word, subject 
heading word]
111. (cost adj (effectiveness or utili* or benefit or minimi* or energy or oxygen or metabolic)).mp. 
[mp=title, original title, abstract, name of substance word, subject heading word]
112. (expenditure not energy).mp. [mp=title, original title, abstract, name of substance word, 
subject heading word]
113. value NEAR2 money.mp. [mp=title, original title, abstract, name of substance word, subject 
heading word]
114. budget*.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
115. preference.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
116. QALY.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
117. (quality adj adjusted).mp. [mp=title, original title, abstract, name of substance word, subject 
heading word]
118. utility*.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
119. (financ* adj (management or support or organized)).mp. [mp=title, original title, abstract, 
name of substance word, subject heading word]
120. economics/
121. exp *costs/ and cost analysis/
122. economic value of life.sh
123. economics, dental/
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124. exp *health care costs/
125. economic aspects of illness/
126. nursing costs/
127. economics, pharmaceutical/
128. (econom* or cost or costs or costly or costing or price or prices or pricing or 
pharmacoeconomic*).tw
129. (expenditure* not energy).tw
130. (value adj1 money).tw
131. budget*.tw
132. or/107–131
133. editorial.pt
134. letter.pt
135. comment.pt
136. animals/
137. human/
138. or/133–135
139. 136 not 137
140. 138 or 139
141. 34 and 63
142. 106 or 132
143. 141 and 142
144. 143 not 140
Database: EMBASE
Name of host: Ovid
Years covered: 1980–2008 week 36
Search strategy
1. health train*.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
2. (lifestyle adj (advi* or train* or coach*)).mp. [mp=title, original title, abstract, name of 
substance word, subject heading word]
3. (lay health adj (worker or advis?r or support*)).mp. [mp=title, original title, abstract, name of 
substance word, subject heading word]
4. (lay adj (practitioner or leader or midwi*)).mp. [mp=title, original title, abstract, name of 
substance word, subject heading word]
5. (peer adj (leader or educ* or counsel* or support* or mentor* or network* or assist*)).mp. 
[mp=title, original title, abstract, name of substance word, subject heading word]
6. (health adj (activ* or aide or advoc* or coach or promot?r)).mp. [mp=title, original title, 
abstract, name of substance word, subject heading word]
7. ((patient or peer) adj navig*).mp. [mp=title, original title, abstract, name of substance word, 
subject heading word]
8. ((community or health) adj champion).mp. [mp=title, original title, abstract, name of 
substance word, subject heading word]
9. (community health adj (educ* or work* or advis* or activ* or representative)).mp. [mp=title, 
original title, abstract, name of substance word, subject heading word]
10. community wellness advocate.mp. [mp=title, original title, abstract, name of substance word, 
subject heading word]
11. (community adj (parent or mother)).mp. [mp=title, original title, abstract, name of substance 
word, subject heading word]
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12. (outreach adj (worker or specialist)).mp. [mp=title, original title, abstract, name of substance 
word, subject heading word]
13. expert patient.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
14. natural help*.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
15. ((neighborhood or neighbourhood) adj (help* or leader or assistant)).mp. [mp=title, original 
title, abstract, name of substance word, subject heading word]
16. family health advis*.mp. [mp=title, original title, abstract, name of substance word, subject 
heading word]
17. breastfeeding supporter.mp. [mp=title, original title, abstract, name of substance word, 
subject heading word]
18. lactation consultant.mp. [mp=title, original title, abstract, name of substance word, subject 
heading word]
19. ((village or indigenous) adj health worker).mp. [mp=title, original title, abstract, name of 
substance word, subject heading word]
20. promotor*.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
21. paraprofessional.mp. [mp=title, original title, abstract, name of substance word, subject 
heading word]
22. workplace health advi*.mp. [mp=title, original title, abstract, name of substance word, 
subject heading word]
23. professional delegation/
24. voluntary worker/
25. ((professional* or nurs* or physician* or clinician*) adj2 (delegat* or substitut*)).tw
26. (staff* adj model*).tw
27. (nurs* adj2 (led or managed or directed or run)).tw
28. ((lay or voluntary or volunteer* or untrained or unlicensed or nonprofessional* or non 
professional* or paraprofessional* or paramedical) adj (worker* or staff)).tw
29. (community adj3 (volunteer* or aid* or support)).tw
30. ((birth or childbirth or child birth or labor or labour) adj (attendant* or assistant*)).tw
31. (doula* or douladural* or monitrice* or linkworker* or link worker* or barefoot doctor*).tw
32. (home adj (aid or aides or health or nursing or support or intervention* or treatment* or 
visit*)).tw
33. health care personnel,health education, healthy care delivery, health promotion, health 
program, health center, rural area.sh
34. or/1–33
35. public health.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
36. ((behaviour or behavior or lifestyle or life style) adj change).mp. [mp=title, original title, 
abstract, name of substance word, subject heading word]
37. (health adj (promotion or education or improvement)).mp. [mp=title, original title, abstract, 
name of substance word, subject heading word]
38. ((disease or illness) adj prevention).mp. [mp=title, original title, abstract, name of substance 
word, subject heading word]
39. smoking.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
40. “tobacco use”.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
41. physical activity.mp. [mp=title, original title, abstract, name of substance word, subject 
heading word]
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42. exercise.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
43. diet.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
44. nutrition.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
45. overweight.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
46. obesity.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
47. alcohol.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
48. substance misuse.mp. [mp=title, original title, abstract, name of substance word, subject 
heading word]
49. breastfeeding.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
50. sexual health.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
51. “condom use”.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
52. HIV.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
53. AIDS.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
54. mental health.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
55. wellbeing.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
56. exp *community health services/
57. exp *public health/
58. “Tobacco Use Cessation”/
59. smoking/
60. patient compliance/
61. risk reduction behavior/
62. food habits/
63. or/35–62
64. evaluation.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
65. randomi?ed controlled trial.mp. [mp=title, original title, abstract, name of substance word, 
subject heading word]
66. RCT.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
67. controlled clinical trial.mp. [mp=title, original title, abstract, name of substance word, subject 
heading word]
68. (((controlled before and after) or cohort or case-control or longitudinal or observational or 
case or qualitative or quantitative) adj3 stud*).mp. [mp=title, original title, abstract, name of 
substance word, subject heading word]
69. ((questionnaire or survey or interview or focus group) adj25 method).mp. [mp=title, original 
title, abstract, name of substance word, subject heading word]
70. Health Care Quality/
71. program evaluation.tw
72. multicenter study.pt
73. intervention study/
74. experiment*.tw
75. (time adj series).tw
76. time series analysis.mp
77. (pre test or pretest or (post test or posttest)).tw
78. impact.tw
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79. intervention*.tw
80. chang*.tw
81. compar*.tw
82. (controlled before and after stud*).mp
83. randomization.sh
84. double blind procedure/
85. single blind procedure/
86. clinical trial.pt
87. exp Clinical Trial/
88. (clin* adj25 trial*).ti,ab
89. ((singl* or doubl* or trebl* or tripl*) adj25 (blind* or mask*)).ti,ab
90. placebo*.ti,ab
91. random*.ti,ab
92. comparative study.sh
93. exp evaluation/
94. follow up.sh
95. prospective study.sh
96. (control* or prospective* or volunteer*).ti,ab
97. ((effect* or impact or evaluat* or introduc* or compar* or implement*) adj3 treatment adj 
(program* or strateg* or test* or questionnaire* or process* or procedure* or method*)).tw
98. ((effect* or impact or evaluat* or introduc* or compar* or implement*) adj3 care adj 
(program* or strateg* or test* or questionnaire* or process* or procedure* or method*)).tw
99. ((effect* or impact or evaluat* or introduc* or compar* or implement*) adj3 screening adj 
(program* or strateg* or test* or questionnaire* or process* or procedure* or method*)).tw
100. ((effect* or impact or evaluat* or introduc* or compar* or implement*) adj3 intervention* 
adj (program* or strateg* or test* or questionnaire* or process* or procedure* or method*)).
tw
101. ((effect* or impact or evaluat* or introduc* or compar* or implement*) adj3 prevention* adj 
(program* or strateg* or test* or questionnaire* or process* or procedure* or method*)).tw
102. ((effect* or impact or evaluat* or introduc* or compar* or implement*) adj3 (protocol* or 
guideline* or strateg* or audit* or method*)).tw
103. ((critical* adj3 apprais*) or evaluat*).tw
104. *utilization review/
105. econom*.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
106. cost*.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
107. pric*.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
108. pharmacoecon*.mp. [mp=title, original title, abstract, name of substance word, subject 
heading word]
109. (cost adj (effectiveness or utili* or benefit or minimi* or energy or oxygen or metabolic)).mp. 
[mp=title, original title, abstract, name of substance word, subject heading word]
110. (expenditure not energy).mp. [mp=title, original title, abstract, name of substance word, 
subject heading word]
111. value NEAR2 money.mp. [mp=title, original title, abstract, name of substance word, subject 
heading word]
112. budget*.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
113. preference.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
114. QALY.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
115. (quality adj adjusted).mp. [mp=title, original title, abstract, name of substance word, subject 
heading word]
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116. utility*.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
117. (financ* adj (management or support or organized)).mp. [mp=title, original title, abstract, 
name of substance word, subject heading word]
118. economics,health economics,environmental economics/
119. exp *cost, cost benefit analysis/
120. socioeconomics.sh
121. pharmacoeconomics/
122. (econom* or cost or costs or costly or costing or price or prices or pricing or 
pharmacoeconomic*).tw
123. (expenditure* not energy).tw
124. (value adj1 money).tw
125. budget*.tw
126. or/64–125
127. Editorial/
128. Letter/
129. comment.pt
130. animal/
131. human/
132. or/127–129
133. 130 not 131
134. 132 or 133
135. 34 and 63
136. 135 and 126
137. 136 not 134
Database: FRANCIS
Name of host: OCLC FirstSEARCH
Years covered: earliest to latest
Search strategy
((kw: Health w train*) or (kw: Lifestyle w advi*) or (kw: Lifestyle w train*) or (kw: Lifestyle w 
coach*) or (kw: Lay w health w worker) or (kw: Lay w health w advis#r) or (kw: Lay w health w 
support) or (kw: Lay w practitioner) or (kw: Lay w leader) or (kw: Lay w midwi*) or (kw: Peer 
w leader) or (kw: Peer w edu*) or (kw: Peer w counsel*) or (kw: Peer w support*) or (kw: Peer 
w mentor*) or (kw: Peer w network*) or (kw: Peer w assist*) or (kw: Health w activ*) or (kw: 
Health w aide) or (kw: Health w advoc*) or (kw: Health w coach) or (kw: Health w promot#r) or 
(kw: Patient w navig*) or (kw: Peer w navig*) or (kw: Community w champion) or (kw: Health 
w champion) or (kw: Community w health w educ*) or (kw: Community w health w work*) or 
(kw: Community w health w advis*) or (kw: Community w health w activ*) or (kw: Community 
w health w representative) or (kw: Community w wellness w advocate) or (kw: Community 
w parent) or (kw: Community w mother) or (kw: Outreach w worker) or (kw: Outreach w 
specialist) or (kw: Expert w patient) or (kw: Natural w help*) or (kw: Neighborhood w help*) 
or (kw: Neighborhood w leader) or (kw: Neighborhood w assistant) or (kw: Neighbourhood w 
help*) or (kw: Neighbourhood w leader) or (kw: Neighbourhood w assistant) or (kw: Family 
w health w advis*) or (kw: Breastfeeding w supporter) or (kw: Lactation w consultant) or (kw: 
Village w health w worker) or (kw: Indigenous w health w worker) or (kw: Promotor*) or (kw: 
Paraprofessional) or (kw: Workplace w health w advi*))
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AND
((kw: Public w health) Or (kw: Behaviour w change) Or (kw: Behavior w change) Or (kw: 
Lifestyle w change) Or (kw: Life w style w change) Or (kw: Health w promotion) Or (kw: Health 
w education) Or (kw: Health w improvement) Or (kw: Disease w prevention) Or (kw: Illness 
w prevention) Or (kw: Smoking) Or (kw: Tobacco w use) Or (kw: Physical w activity) Or (kw: 
Exercise) Or (kw: Diet) Or (kw: Nutrition) Or (kw: Overweight) Or (kw: Obesity) Or (kw: 
Alcohol) Or (kw: Substance w misuse) Or (kw: Breastfeeding) Or (kw: Sexual w health) Or (kw: 
Condom w Use) Or (kw: HIV) Or (kw: AIDS) Or (kw: Mental w health) Or (kw: Wellbeing))
AND
((kw: Evaluation) Or (kw: Randomi#ed w controlled w trial) Or (kw: RCT) Or (kw: Controlled 
w clinical w trail) Or (kw: controlled w before w after w 3 w stud*) Or (kw: cohort w 3 kw: stud*) 
Or (kw: case-control w 3 kw: stud*) Or (kw: longitudinal w 3 kw: stud*) Or (kw: observational w 
3 kw: stud*) Or (kw: case w 3 kw: stud*) Or (kw: qualitative w 3 kw: stud*) Or (kw: quantitative 
w 3 kw: stud*) Or (kw: questionnaire w 25 kw: method) Or (kw: survey w 25 kw: method) Or 
(kw: interview w 25 kw: method) Or (kw: focus w group w 25 kw: method) OR (kw: econom*) 
Or (kw: cost*) Or (kw: pric*) Or (kw: pharmacoecon*) Or (kw: cost w effectiveness) Or (kw: cost 
w utili*) Or (kw: cost w benefit) Or (kw: cost w minimi*) Or (kw: cost w energy) Or (kw: cost 
w oxygen) Or (kw: cost w metabolic) Or (kw: expenditure NOT kw: energy) Or (kw: value w 2 
kw: money) Or (kw: budget*) Or (kw: preference) Or (kw: QALY) Or (kw: quality w adjusted) 
Or (kw: utility*) Or (kw: financ* w management) Or (kw: financ* w support) Or (kw: financ* w 
organized))
NOT
((kw: editorial) or (kw: letter) or (kw: comment) or (kw: animal))
Database: NHS Economic Evaluation Database
Name of host: OCLC First SEARCH
Years covered: earliest to latest
Search strategy
“health train*”
“lifestyle advi*”
“lifestyle train*”
“lifestyle coach*”
“lay health worker”
“lay health advis?r”
“lay health support*”
“lay practitioner”
“lay leader”
© Queen’s Printer and Controller of HMSO 2011. All rights reserved.
227 Health Technology Assessment 2011; Vol. 15: No. 9DOI: 10.3310/hta15090
“lay midwi*”
peer AND ( leader OR educ* OR counsel* OR support* OR mentor* OR network* OR assist*)
“health activ*”
“health aide”
“health advoc*”
“health coach”
“health promot?r”
“(patient or peer) and navig*”
“community champion”
“health champion”
“community health” AND ( educ* OR work* OR advis* OR activ* OR representative)
“community wellness advocate”
“community mother”
“community parent”
“outreach worker”
“outreach specialist”
“expert patient”
“natural help*”
“(neighborhood or neighbourhood) and (help or leader or assistant)*”
“family health advis*”
“breastfeeding supporter”
“lactation consultant”
“indigenous health worker”
“village health worker”
promotor*
paraprofessional
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“workplace health advi*”
community AND ( volunteer* OR aid* OR support)
( birth OR childbirth OR child OR birth OR labor OR labour) AND ( attendant* OR assistant*)
“health educator*”
“rural health personnel”
“community health workers”
“lay midwifery”
“community role”
“peer counselling”
“public health”
( behaviour OR behavior OR lifestyle OR life OR style) AND change
“health and promotion”
“health and education”
“health and improvement”
“disease prevention”
“illness prevention”
smoking
“tobacco use”
“physical activity”
exercise
diet
nutrition
overweight
obesity
alcohol
“substance misuse”
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breastfeeding
“sexual health”
“condom use”
HIV
AIDS
“mental health”
wellbeing
“community health services”
“tobacco use cessation”
“patient compliance”
“risk reduction behavior”
“food habits”
“preventive health care”
wellness
“life style changes”
evaluation
“randomi?ed controlled trial”
RCT
“controlled clinical trial”
“controlled before and after stud*”
“cohort stud*”
“case-control stud*”
“longitudinal stud*”
“observational stud*”
“case stud*”
“qualitative stud*”
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“quantitative stud*”
( questionnaire OR survey OR interview OR focus OR group) AND method
“program evaluation”
“multicenter study”
“intervention studies”
time AND series
“interrupted time series”
“pre test or pretest or (post test or posttest)”
“random allocation”
“double blind method”
“single blind method”
“clinical trial”
“comparative study”
“comparative study”
“follow up studies”
“prospective studies”
( effect* OR impact OR evaluat* OR introduc* OR compar* OR implement*) AND treatment 
AND ( program* OR strateg* OR test* OR questionnaire* OR process* OR procedure* OR 
method*)
( effect* OR impact OR evaluat* OR introduc* OR compar* OR implement*) AND care AND ( 
program* OR strateg* OR test* OR questionnaire* OR process* OR procedure* OR method*)
( effect* OR impact OR evaluat* OR introduc* OR compar* OR implement*) AND screening 
AND ( program* OR strateg* OR test* OR questionnaire* OR process* OR procedure* OR 
method*)
( effect* OR impact OR evaluat* OR introduc* OR compar* OR implement*) AND intervention* 
AND ( program* OR strateg* OR test* OR questionnaire* OR process* OR procedure* OR 
method*)
( effect* OR impact OR evaluat* OR introduc* OR compar* OR implement*) AND prevention* 
AND ( program* OR strateg* OR test* OR questionnaire* OR process* OR procedure* OR 
method*)
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( effect* OR impact OR evaluat* OR introduc* OR compar* OR implement*) AND ( protocol* 
OR guideline* OR strateg* OR audit* OR method*)
“utilization review”
pharmacoecon*
“cost effectiveness”
“cost utili*”
“cost benefit”
“cost minimi*”
expenditure NOT energy
budget*
preference
QALY
“quality adjusted”
utility*
“financ management*”
“financ support*”
“financ organized*”
#1 or #2 or #5 or #10 or #11 or #14 or #20 or #24 or #26 or #31 or #34 or #35 or #37 or #38 or #39 
or #41 or #43 or #44 or #46 or #47 or #48 or #49 or #50 or #51 or #52 or #53 or #54 or #55 or #56 
or #57 or #58 or #59 or #60 or #61 or #62 or #63 or #64 or #65 or #66 or #67 or #68 or #69 or #70 
or #71 or #72 or #73 or #74 or #75 or #76
#125 or #45
#79 or #80 or #81 or #82 or #83 or #84 or #85 or #86 or #87 or #88 or #89 or #90 or #91 or #92 or 
#93 or #94 or #95 or #96 or #97 or #98 or #99 or #100 or #101 or #102 or #103 or #110 or #111 or 
#112 or #113 or #114 or #115 or #116 or #117 or #118 or #119 or #120 or #121 or #122 or #123
#125 and #127
#126 and #127
#1 or #2 or #4 or #5 or #10 or #11 or #14 or #20 or #24 or #26 or #31 or #34 or #35 or #38 or #39 
or #41 or #43 or #44 or #46 or #47 or #49 or #50 or #51 or #52 or #53 or #54 or #58 or #61 or #62 
or #63 or #64 or #68 or #69 or #70 or #71 or #72 or #73 or #74 or #75 or #76
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#130 and #127
Database: International Bibliography of the Social Sciences
Name of host: EBSCO
Years covered: earliest to latest
Search strategy
S16 (S14 and S10 and S6) not S15
S15 TX editorial or TX letter or TX comment or TX animal
S14 S13 or S12 or S11
S13 TX cost oxygen or TX cost metabolic or TX (expenditure NOT energy) or TX value W 2 money or TX budget* or TX preference or TX 
QALY or TX quality adjusted or TX utility* or TX financ* management or TX financ* support or TX financ* organized
S12 TX survey W25 method or TX interview W25 method or TX focus group W25 method or TX econom* or TX cost* or TX pric* or TX 
pharmacoecon* or TX cost effectiveness or TX cost utili* or TX cost benefit or TX cost minimi* or TX cost energy
S11 TX evaluation or TX randomi?ed controlled trial or TX RCT or TX controlled clinical trial or TX cohort W3 stud* or TX case-control 
W3 stud* or TX longitudinal W3 stud* or TX observational W3 stud* or TX case W3 stud* or TX qualitative W3 stud* or TX 
quantitative W3 stud* or TX questionnaire W25 method
S10 S9 or S8 or S7
S9 TX AIDS or TX mental health or TX wellbeing
S8 TX physical activity or TX exercise or TX diet or TX nutrition or TX overweight or TX obesity or TX alcohol or TX substance misuse or 
TX breastfeeding or TX sexual health or TX condom use or TX HIV
S7 TX public health or TX behaviour change or TX behavior change or TX lifestyle change or TX life style change or TX health 
promotion or TX health education or TX health improvement or TX disease prevention or TX illness prevention or TX smoking or TX 
tobacco use
S6 S5 or S4 or S3 or S2 or S1
S5 TX indigenous health worker or TX promotor* or TX paraprofessional or TX workplace health advi*
S4 TX expert patient or TX natural help* or TX neighborhood help* or TX neighborhood leader or TX neighborhood assistant or TX 
neighbourhood help* or TX neighbourhood leader or TX neighbourhood assistant or TX family health advis* or TX breastfeeding 
supporter or TX lactation consultant or TX village health worker
S3 TX community champion or TX health champion or TX community health educ* or TX community health work* or TX community 
health advis* or TX community health activ* or TX community health representative or TX community wellness advocate or TX 
community parent or TX community mother or TX outreach worker or TX outreach specialist
S2 TX peer counsel* or TX peer support* or TX peer mentor* or TX peer network* or TX peer assist* or TX health activ* or TX health 
aide or TX health advoc* or TX health coach or TX health promot?r or TX patient navig* or TX peer navig*
S1 TX health train* or TX lifestyle advi* or TX lifestyle train* or TX lifestyle coach* or TX lay health worker or TX lay health advis?r or TX 
lay health support* or TX lay practitioner or TX lay leader or TX lay midwi* or TX peer leader or TX peer educ*
Database: MEDLINE
Name of host: Ovid
Years covered: 1950 to week 4 May, 2008
Search strategy
1. health train*.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
2. (lifestyle adj (advi* or train* or coach*)).mp. [mp=title, original title, abstract, name of 
substance word, subject heading word]
3. (lay health adj (worker or advis?r or support*)).mp. [mp=title, original title, abstract, name of 
substance word, subject heading word]
4. (lay adj (practitioner or leader or midwi*)).mp. [mp=title, original title, abstract, name of 
substance word, subject heading word]
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5. (peer adj (leader or educ* or counsel* or support* or mentor* or network* or assist*)).mp. 
[mp=title, original title, abstract, name of substance word, subject heading word]
6. (health adj (activ* or aide or advoc* or coach or promot?r)).mp. [mp=title, original title, 
abstract, name of substance word, subject heading word]
7. ((patient or peer) adj navig*).mp. [mp=title, original title, abstract, name of substance word, 
subject heading word]
8. ((community or health) adj champion).mp. [mp=title, original title, abstract, name of 
substance word, subject heading word]
9. (community health adj (educ* or work* or advis* or activ* or representative)).mp. [mp=title, 
original title, abstract, name of substance word, subject heading word]
10. community wellness advocate.mp. [mp=title, original title, abstract, name of substance word, 
subject heading word]
11. (community adj (parent or mother)).mp. [mp=title, original title, abstract, name of substance 
word, subject heading word]
12. (outreach adj (worker or specialist)).mp. [mp=title, original title, abstract, name of substance 
word, subject heading word]
13. expert patient.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
14. natural help*.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
15. ((neighborhood or neighbourhood) adj (help* or leader or assistant)).mp. [mp=title, original 
title, abstract, name of substance word, subject heading word]
16. family health advis*.mp. [mp=title, original title, abstract, name of substance word, subject 
heading word]
17. breastfeeding supporter.mp. [mp=title, original title, abstract, name of substance word, 
subject heading word]
18. lactation consultant.mp. [mp=title, original title, abstract, name of substance word, subject 
heading word]
19. ((village or indigenous) adj health worker).mp. [mp=title, original title, abstract, name of 
substance word, subject heading word]
20. promotor*.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
21. paraprofessional.mp. [mp=title, original title, abstract, name of substance word, subject 
heading word]
22. workplace health advi*.mp. [mp=title, original title, abstract, name of substance word, 
subject heading word]
23. *delegation, professional/
24. exp *voluntary workers/
25. ((professional* or nurs* or physician* or clinician*) adj2 (delegat* or substitut*)).tw
26. (staff* adj model*).tw
27. (nurs* adj2 (led or managed or directed or run)).tw
28. ((lay or voluntary or volunteer* or untrained or unlicensed or nonprofessional* or non 
professional* or paraprofessional* or paramedical) adj (worker* or staff)).tw
29. (community adj3 (volunteer* or aid* or support)).tw
30. ((birth or childbirth or child birth or labor or labour) adj (attendant* or assistant*)).tw
31. (doula* or douladural* or monitrice* or linkworker* or link worker* or barefoot doctor*).tw
32. (home adj (aid or aides or health or nursing or support or intervention* or treatment* or 
visit*)).tw
33. health personnel, health educators.sh
34. or/1–33
35. public health.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
234 Appendix 6
36. ((behaviour or behavior or lifestyle or life style) adj change).mp. [mp=title, original title, 
abstract, name of substance word, subject heading word]
37. (health adj (promotion or education or improvement)).mp. [mp=title, original title, abstract, 
name of substance word, subject heading word]
38. ((disease or illness) adj prevention).mp. [mp=title, original title, abstract, name of substance 
word, subject heading word]
39. smoking.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
40. “tobacco use”.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
41. physical activity.mp. [mp=title, original title, abstract, name of substance word, subject 
heading word]
42. exercise.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
43. diet.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
44. nutrition.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
45. overweight.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
46. obesity.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
47. alcohol.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
48. substance misuse.mp. [mp=title, original title, abstract, name of substance word, subject 
heading word]
49. breastfeeding.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
50. sexual health.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
51. “condom use”.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
52. HIV.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
53. AIDS.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
54. mental health.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
55. wellbeing.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
56. exp *community health services/
57. exp *public health/
58. “Tobacco Use Cessation”/
59. smoking/
60. patient compliance/
61. risk reduction behavior/
62. food habits/
63. or/35–62
64. evaluation.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
65. randomi?ed controlled trial.mp. [mp=title, original title, abstract, name of substance word, 
subject heading word]
66. RCT.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
67. controlled clinical trial.mp. [mp=title, original title, abstract, name of substance word, subject 
heading word]
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68. (((controlled before and after) or cohort or case-control or longitudinal or observational or 
case or qualitative or quantitative) adj3 stud*).mp. [mp=title, original title, abstract, name of 
substance word, subject heading word]
69. ((questionnaire or survey or interview or focus group) adj25 method).mp. [mp=title, original 
title, abstract, name of substance word, subject heading word]
70. *program evaluation/
71. program evaluation.tw
72. exp *health care evaluation mechanisms/
73. multicenter study.pt
74. intervention studies/
75. experiment*.tw
76. (time adj series).tw
77. interrupted time series.mp
78. (pre test or pretest or (post test or posttest)).tw
79. impact.tw
80. intervention*.tw
81. chang*.tw
82. compar*.tw
83. (controlled before and after stud*).mp
84. random allocation.sh
85. double blind method.sh
86. single blind method.sh
87. clinical trial.pt
88. exp Clinical Trial/
89. (clin* adj25 trial*).ti,ab
90. ((singl* or doubl* or trebl* or tripl*) adj25 (blind* or mask*)).ti,ab
91. placebo*.ti,ab
92. random*.ti,ab
93. comparative study.sh
94. exp evaluation studies/
95. follow up studies.sh
96. prospective studies.sh
97. (control* or prospective* or volunteer*).ti,ab
98. ((effect* or impact or evaluat* or introduc* or compar* or implement*) adj3 treatment adj 
(program* or strateg* or test* or questionnaire* or process* or procedure* or method*)).tw
99. ((effect* or impact or evaluat* or introduc* or compar* or implement*) adj3 care adj 
(program* or strateg* or test* or questionnaire* or process* or procedure* or method*)).tw
100. ((effect* or impact or evaluat* or introduc* or compar* or implement*) adj3 screening adj 
(program* or strateg* or test* or questionnaire* or process* or procedure* or method*)).tw
101. ((effect* or impact or evaluat* or introduc* or compar* or implement*) adj3 intervention* 
adj (program* or strateg* or test* or questionnaire* or process* or procedure* or method*)).
tw
102. ((effect* or impact or evaluat* or introduc* or compar* or implement*) adj3 prevention* adj 
(program* or strateg* or test* or questionnaire* or process* or procedure* or method*)).tw
103. ((effect* or impact or evaluat* or introduc* or compar* or implement*) adj3 (protocol* or 
guideline* or strateg* or audit* or method*)).tw
104. ((critical* adj3 apprais*) or evaluat*).tw
105. *utilization review/
106. or/64–105
107. econom*.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
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108. cost*.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
109. pric*.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
110. pharmacoecon*.mp. [mp=title, original title, abstract, name of substance word, subject 
heading word]
111. (cost adj (effectiveness or utili* or benefit or minimi* or energy or oxygen or metabolic)).mp. 
[mp=title, original title, abstract, name of substance word, subject heading word]
112. (expenditure not energy).mp. [mp=title, original title, abstract, name of substance word, 
subject heading word]
113. value NEAR2 money.mp. [mp=title, original title, abstract, name of substance word, subject 
heading word]
114. budget*.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
115. preference.mp. [mp=title, original title, abstract, name of substance word, subject heading 
word]
116. QALY.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
117. (quality adj adjusted).mp. [mp=title, original title, abstract, name of substance word, subject 
heading word]
118. utility*.mp. [mp=title, original title, abstract, name of substance word, subject heading word]
119. (financ* adj (management or support or organized)).mp. [mp=title, original title, abstract, 
name of substance word, subject heading word]
120. economics/
121. exp *costs/ and cost analysis/
122. economic value of life.sh
123. economics, dental/
124. exp *economics, hospital/
125. economics, medical/
126. economics, nursing/
127. economics, pharmaceutical/
128. (econom* or cost or costs or costly or costing or price or prices or pricing or 
pharmacoeconomic*).tw
129. (expenditure* not energy).tw
130. (value adj1 money).tw
131. budget*.tw
132. or/107–131
133. editorial.pt
134. letter.pt
135. comment.pt
136. animal/
137. human/
138. or/133–135
139. 136 not 137
140. 138 or 139
141. 34 and 63
142. 106 or 132
143. 141 and 142
144. 143 not 140
Database: PsycINFO
Name of host: APA PsychNET
Years covered: earliest to latest
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Search strategy
Subject:(evaluation) OR Subject:(randomi?ed controlled trial) OR Subject:(RCT) OR 
Subject:(controlled clinical trial) OR Subject:((controlled before AND after OR cohort OR 
case-control OR longitudinal OR observational OR case OR qualitative OR quantitative) adj3 
stud*) OR Subject:((questionnaire OR survey OR interview OR focus group) adj25 method) 
OR Subject:(econom*) OR Subject:(cost*) OR Subject:(pric*) OR Subject:(pharmacoecon*) 
OR Subject:(cost adj (effectiveness OR utili* OR benefit OR minimi* OR energy OR oxygen 
OR metabolic)) OR Subject:(expenditure NOT energy) OR Subject:(value NEAR/2 money) OR 
Subject:(budget*) OR Subject:(preference) OR Subject:(QALY) OR Subject:(quality adj adjusted) 
OR Subject:(utility*) OR Subject:(financ* adj (management OR support OR organized)) NOT 
Subject:(editorial) OR Subject:(letter) OR Subject:(comment) OR Subject:(animal) AND 
Subject:(public health) OR Subject:((behaviour OR behavior OR lifestyle OR life style) change) 
OR Subject:(health adj (promotion OR education OR improvement)) OR Subject:((disease OR 
illness) adj prevention) OR Subject:(smoking) OR Subject:(tobacco use) OR Subject:(physical 
activity) OR Subject:(exercise) OR Subject:(diet) OR Subject:(nutrition) OR Subject:(overweight) 
OR Subject:(obesity) OR Subject:(alcohol) OR Subject:(substance misuse) OR 
Subject:(breastfeeding) OR Subject:(sexual health) OR Subject:(condom use) OR Subject:(HIV) 
OR Subject:(AIDS) OR Subject:(mental health) OR Subject:(wellbeing) AND Subject:(health 
train*) OR Subject:(lifestyle adj (advi* OR train* OR coach*)) OR Subject:(lay health adj 
(worker OR advis?r OR support*)) OR Subject:(lay adj (practitioner OR leader OR midwi*)) 
OR Subject:(peer adj (leader OR educ* OR counsel* OR support* OR mentor* OR network* 
OR assist*)) OR Subject:(health adj (activ* OR aide OR advoc* OR coach OR promot?r)) OR 
Subject:((patient OR peer) adj navig) OR Subject:((community OR health) adj champion) OR 
Subject:(community health adj (educ* OR work* OR advis* OR activ* OR representative)) OR 
Subject:(community wellness advocate) OR Subject:(community adj (parent OR mother)) OR 
Subject:(outreach adj (worker OR specialist)) OR Subject:(expert patient) OR Subject:(natural 
help*) OR Subject:((neighborhood OR neighbourhood) adj (help* OR leader OR assistant)) 
OR Subject:(family health advis*) OR Subject:(breastfeeding supporter) OR Subject:(lactation 
consultant) OR Subject:((village OR indigenous) adj health worker) OR Subject:(promotor*) OR 
Subject:(paraprofessional) OR Subject:(workplace health advi*)
Database: SCI (part of web of Science)
Name of host: APA PsychNET
Years covered: earliest to latest
Search strategy
#14 #13 AND #9
#13 #12 OR #11 OR #10
#12 TS=(“preference”) OR TS=(“QALY”) OR TS=(“quality adjusted”) OR TS=(“utility*”) OR TS=(“financ* management”) OR TS=(“financ* 
support”) OR TS=(“financ* organized”) NOT TS=(“editorial”) NOT TS=(“letter”) NOT TS=(“comment”) NOT TS=(“animal”)
#11 TS=(“focus group method”) OR TS=(“econom*”) OR TS=(“cost*”) OR TS=(“pric*”) OR TS=(“pharmacoecon*”) OR TS=(“cost 
effectiveness”) OR TS=(“cost utili*”) OR TS=(“cost benefit”) OR TS=(“cost minimi*”) OR TS=(“cost energy”) OR TS=(“cost oxygen”) OR 
TS=(“cost metabolic”) OR TS=(“expenditure NOT energy”) OR TS=(“value NEAR/2 money”) OR TS=(“budget*”)
#10 TS=(“evaluation”) OR TS=(“randomi?ed controlled trial”) OR TS=(“RCT”) OR TS=(“controlled clinical trial”) OR TS=(“controlled before 
and after stud*”) OR TS=(“cohort stud*”) OR TS=(“case-control stud*”) OR TS=(“longitudinal stud*”) OR TS=(“observational stud*”) OR 
TS=(“case stud*”) OR TS=(“qualitative stud*”) OR TS=(“quantitative stud*”) OR TS=(“questionnaire method”) OR TS=(“survey method”) 
OR TS=(“interview method”)
#9 #8 AND #5
#8 #7 OR #6
#7 TS=(“nutrition”) OR TS=(“overweight”) OR TS=(“obesity”) OR TS=(“alcohol”) OR TS=(“substance misuse”) OR TS=(“breastfeeding”) OR 
TS=(“sexual health”) OR TS=(“condom use”) OR TS=(“HIV”) OR TS=(“AIDS”) OR TS=(“mental health”) OR TS=(“wellbeing”)
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#6 TS=(“public health”) OR TS=(“behaviour change”) OR TS=(“behavior change”) OR TS=(“lifestyle change”) OR TS=(“life style change”) 
OR TS=(“health promotion”) OR TS=(“health education”) OR TS=(“health improvement”) OR TS=(“disease prevention”) OR TS=(“illness 
prevention”) OR TS=(“smoking”) OR TS=(“tobacco use”) OR TS=(“physical activity”) OR TS=(“exercise”) OR TS=(“diet”)
#5 #4 OR #3 OR #2 OR #1
#4 TS=(“family health advis*”) OR TS=(“breastfeeding supporter”) OR TS=(“lactation consultant”) OR TS=(“village health worker”) OR 
TS=(“indigenous health worker”) OR TS=(“promotor*”) OR TS=(“paraprofessional”) OR TS=(“workplace health advi*”)
#3 TS=(“community health representative”) OR TS=(“community wellness advocate”) OR TS=(“community parent”) OR TS=(“community 
mother”) OR TS=(“outreach specialist”) OR TS=(“outreach worker”) OR TS=(“outreach specialist”) OR TS=(“expert patient”) 
OR TS=(“natural help*”) OR TS=(“neighborhood help*”) OR TS=(“neighborhood leader”) OR TS=(“neighborhood assistant”) OR 
TS=(“neighbourhood help*”) OR TS=(“neighbourhood leader”) OR TS=(“neighbourhood assistant”)
#2 TS=(“peer network*”) OR TS=(“peer assist*”) OR TS=(“health activ*”) OR TS=(“health aide”) OR TS=(“health advoc*”) OR TS=(“health 
coach”) OR TS=(“health promot?r”) OR TS=(“patient navig*”) OR TS=(“peer navig*”) OR TS=(“community champion”) OR TS=(“health 
champion”) OR TS=(“community health educ*”) OR TS=(“community health work*”) OR TS=(“community health advis*”) OR 
TS=(“community health activ*”)
#1 TS=(“health train*”) OR TS=(“lifestyle advi*”) OR TS=(“lifestyle train*”) OR TS=(l”ifestyle coach*”) OR TS=(“lay health worker”) OR 
TS=(“lay health advis?r”) OR TS=(“lay health support*”) OR TS=(“lay practitioner”) OR TS=(“lay leader”) OR TS=(“lay midwi*”) OR 
TS=(“peer leader”) OR TS=(“peer educ*”) OR TS=(“peer counsel*”) OR TS=(“peer support*”) OR TS=(“peer mentor*”)
Database: SIRS Researcher
Name of host: OCLC FirstSEARCH
Years covered: earliest to latest
Search strategy
((kw: Health w train*) or (kw: Lifestyle w advi*) or (kw: Lifestyle w train*) or (kw: Lifestyle w 
coach*) or (kw: Lay w health w worker) or (kw: Lay w health w advis#r) or (kw: Lay w health w 
support) or (kw: Lay w practitioner) or (kw: Lay w leader) or (kw: Lay w midwi*) or (kw: Peer 
w leader) or (kw: Peer w edu*) or (kw: Peer w counsel*) or (kw: Peer w support*) or (kw: Peer 
w mentor*) or (kw: Peer w network*) or (kw: Peer w assist*) or (kw: Health w activ*) or (kw: 
Health w aide) or (kw: Health w advoc*) or (kw: Health w coach) or (kw: Health w promot#r) or 
(kw: Patient w navig*) or (kw: Peer w navig*) or (kw: Community w champion) or (kw: Health 
w champion) or (kw: Community w health w educ*) or (kw: Community w health w work*) or 
(kw: Community w health w advis*) or (kw: Community w health w activ*) or (kw: Community 
w health w representative) or (kw: Community w wellness w advocate) or (kw: Community 
w parent) or (kw: Community w mother) or (kw: Outreach w worker) or (kw: Outreach w 
specialist) or (kw: Expert w patient) or (kw: Natural w help*) or (kw: Neighborhood w help*) 
or (kw: Neighborhood w leader) or (kw: Neighborhood w assistant) or (kw: Neighbourhood w 
help*) or (kw: Neighbourhood w leader) or (kw: Neighbourhood w assistant) or (kw: Family 
w health w advis*) or (kw: Breastfeeding w supporter) or (kw: Lactation w consultant) or (kw: 
Village w health w worker) or (kw: Indigenous w health w worker) or (kw: Promotor*) or (kw: 
Paraprofessional) or (kw: Workplace w health w advi*))
AND
((kw: Public w health) Or (kw: Behaviour w change) Or (kw: Behavior w change) Or (kw: 
Lifestyle w change) Or (kw: Life w style w change) Or (kw: Health w promotion) Or (kw: Health 
w education) Or (kw: Health w improvement) Or (kw: Disease w prevention) Or (kw: Illness 
w prevention) Or (kw: Smoking) Or (kw: Tobacco w use) Or (kw: Physical w activity) Or (kw: 
Exercise) Or (kw: Diet) Or (kw: Nutrition) Or (kw: Overweight) Or (kw: Obesity) Or (kw: 
Alcohol) Or (kw: Substance w misuse) Or (kw: Breastfeeding) Or (kw: Sexual w health) Or (kw: 
Condom w Use) Or (kw: HIV) Or (kw: AIDS) Or (kw: Mental w health) Or (kw: Wellbeing))
AND
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((kw: Evaluation) Or (kw: Randomi#ed w controlled w trial) Or (kw: RCT) Or (kw: Controlled 
w clinical w trail) Or (kw: controlled w before w after w 3 w stud*) Or (kw: cohort w 3 kw: stud*) 
Or (kw: case-control w 3 kw: stud*) Or (kw: longitudinal w 3 kw: stud*) Or (kw: observational w 
3 kw: stud*) Or (kw: case w 3 kw: stud*) Or (kw: qualitative w 3 kw: stud*) Or (kw: quantitative 
w 3 kw: stud*) Or (kw: questionnaire w 25 kw: method) Or (kw: survey w 25 kw: method) Or 
(kw: interview w 25 kw: method) Or (kw: focus w group w 25 kw: method) OR (kw: econom*) 
Or (kw: cost*) Or (kw: pric*) Or (kw: pharmacoecon*) Or (kw: cost w effectiveness) Or (kw: cost 
w utili*) Or (kw: cost w benefit) Or (kw: cost w minimi*) Or (kw: cost w energy) Or (kw: cost 
w oxygen) Or (kw: cost w metabolic) Or (kw: expenditure NOT kw: energy) Or (kw: value w 2 
kw: money) Or (kw: budget*) Or (kw: preference) Or (kw: QALY) Or (kw: quality w adjusted) 
Or (kw: utility*) Or (kw: financ* w management) Or (kw: financ* w support) Or (kw: financ* w 
organized))
NOT
((kw: editorial) or (kw: letter) or (kw: comment) or (kw: animal))
Database: Social Sciences Citation Index (part of web of science)
Name of host: OCLC FirstSEARCH
Years covered: earliest to latest
Search strategy
#14 #13 AND #9
#13 #12 OR #11 OR #10
#12 TS=(“preference”) OR TS=(“QALY”) OR TS=(“quality adjusted”) OR TS=(“utility*”) OR TS=(“financ* management”) OR TS=(“financ* 
support”) OR TS=(“financ* organized”) NOT TS=(“editorial”) NOT TS=(“letter”) NOT TS=(“comment”) NOT TS=(“animal”)
#11 TS=(“focus group method”) OR TS=(“econom*”) OR TS=(“cost*”) OR TS=(“pric*”) OR TS=(“pharmacoecon*”) OR TS=(“cost 
effectiveness”) OR TS=(“cost utili*”) OR TS=(“cost benefit”) OR TS=(“cost minimi*”) OR TS=(“cost energy”) OR TS=(“cost oxygen”) OR 
TS=(“cost metabolic”) OR TS=(“expenditure NOT energy”) OR TS=(“value NEAR/2 money”) OR TS=(“budget*”)
#10 TS=(“evaluation”) OR TS=(“randomi?ed controlled trial”) OR TS=(“RCT”) OR TS=(“controlled clinical trial”) OR TS=(“controlled before 
and after stud*”) OR TS=(“cohort stud*”) OR TS=(“case-control stud*”) OR TS=(“longitudinal stud*”) OR TS=(“observational stud*”) OR 
TS=(“case stud*”) OR TS=(“qualitative stud*”) OR TS=(“quantitative stud*”) OR TS=(“questionnaire method”) OR TS=(“survey method”) 
OR TS=(“interview method”)
#9 #8 AND #5
#8 #7 OR #6
#7 TS=(“nutrition”) OR TS=(“overweight”) OR TS=(“obesity”) OR TS=(“alcohol”) OR TS=(“substance misuse”) OR TS=(“breastfeeding”) OR 
TS=(“sexual health”) OR TS=(“condom use”) OR TS=(“HIV”) OR TS=(“AIDS”) OR TS=(“mental health”) OR TS=(“wellbeing”)
#6 TS=(“public health”) OR TS=(“behaviour change”) OR TS=(“behavior change”) OR TS=(“lifestyle change”) OR TS=(“life style change”) 
OR TS=(“health promotion”) OR TS=(“health education”) OR TS=(“health improvement”) OR TS=(“disease prevention”) OR TS=(“illness 
prevention”) OR TS=(“smoking”) OR TS=(“tobacco use”) OR TS=(“physical activity”) OR TS=(“exercise”) OR TS=(“diet”)
#5 #4 OR #3 OR #2 OR #1
#4 TS=(“family health advis*”) OR TS=(“breastfeeding supporter”) OR TS=(“lactation consultant”) OR TS=(“village health worker”) OR 
TS=(“indigenous health worker”) OR TS=(“promotor*”) OR TS=(“paraprofessional”) OR TS=(“workplace health advi*”)
#3 TS=(“community health representative”) OR TS=(“community wellness advocate”) OR TS=(“community parent”) OR TS=(“community 
mother”) OR TS=(“outreach specialist”) OR TS=(“outreach worker”) OR TS=(“outreach specialist”) OR TS=(“expert patient”) 
OR TS=(“natural help*”) OR TS=(“neighborhood help*”) OR TS=(“neighborhood leader”) OR TS=(“neighborhood assistant”) OR 
TS=(“neighbourhood help*”) OR TS=(“neighbourhood leader”) OR TS=(“neighbourhood assistant”)
#2 TS=(“peer network*”) OR TS=(“peer assist*”) OR TS=(“health activ*”) OR TS=(“health aide”) OR TS=(“health advoc*”) OR TS=(“health 
coach”) OR TS=(“health promot?r”) OR TS=(“patient navig*”) OR TS=(“peer navig*”) OR TS=(“community champion”) OR TS=(“health 
champion”) OR TS=(“community health educ*”) OR TS=(“community health work*”) OR TS=(“community health advis*”) OR 
TS=(“community health activ*”)
#1 TS=(“health train*”) OR TS=(“lifestyle advi*”) OR TS=(“lifestyle train*”) OR TS=(l”ifestyle coach*”) OR TS=(“lay health worker”) OR 
TS=(“lay health advis?r”) OR TS=(“lay health support*”) OR TS=(“lay practitioner”) OR TS=(“lay leader”) OR TS=(“lay midwi*”) OR 
TS=(“peer leader”) OR TS=(“peer educ*”) OR TS=(“peer counsel*”) OR TS=(“peer support*”) OR TS=(“peer mentor*”)
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Database: Social Services Abstracts
Name of host: CSA
Years covered: earliest to latest
Search strategy
List one:
1. kw= (health train*)
2. kw= (lifestyle within 1 (advi* or train* or coach*))
3. kw= (lay health within 1 (worker or advis?r or support*))
4. kw= (lay within 1 (practitioner or leader or midwi*))
5. kw= (peer within 1 (leader or educ* or counsel* or support* or mentor* or network* or 
assist*))
6. kw= (health within 1 (activ* or aide or advoc* or coach or promot?r))
7. kw= ((patient or peer) within 1 navig*)
8. kw= ((community or health) within 1 champion)
9. kw= (community health within 1 (educ* or work* or advis* or activ* or representative))
10. kw= (community wellness advocate)
11. kw= (community within 1 (parent or mother))
12. kw= (outreach within 1 (worker or specialist))
13. kw= (expert patient) or kw= (natural help*)
14. kw= ((neighborhood or neighbourhood) within 1 (help* or leader or assistant))
15. kw= (family health advis*)
16. kw= (breastfeeding supporter)
17. kw= (lactation consultant)
18. kw= ((village or indigenous) within 1 health worker)
19. kw= (promotor*)
20. kw= (paraprofessional)
21. kw= (workplace health advi*)
22. kw= ((professional* or nurs* or physician* or clinician*) within 2 (delegat* or substitut*))
23. kw= (staff* within 1 model*)
24. kw= (nurs* within 2 (led or managed or directed or run))
25. kw= ((lay or voluntary or volunteer* or untrained or unlicensed or nonprofessional* or non 
professional* or paraprofessional* or paramedical) within 1 (worker* or staff))
26. kw= (community within 3 (volunteer* or aid* or support))
27. kw= ((birth or childbirth or child birth or labor or labour) within 1 (attendant* or 
assistant*))
28. kw= (doula* or douladural* or monitrice* or linkworker* or link worker* or barefoot 
doctor*)
29. kw= (home within 1 (aid or aides or health or nursing or support or intervention* or 
treatment* or visit*))
List two: 
30. kw= (public health)
31. kw= ((behaviour or behavior or lifestyle or life style) within 1 change)
32. kw= (health within 1 (promotion or education or improvement))
33. kw= ((disease or illness) within 1 prevention)
34. kw= (smoking)
35. kw= (tobacco use)
36. kw= (exercise)
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37. kw= (diet)
38. kw= (nutrition)
39. kw= (overweight)
40. kw= (obesity)
41. kw= (alcohol)
42. kw= (substance misuse)
43. kw= (breastfeeding)
44. kw= (sexual health)
45. kw= (condom use)
46.  kw= (HIV)
47. kw= (AIDS)
48. kw= (mental health)
49. kw= (wellbeing)
List three: 
50. kw= (evaluation)
51. kw= (randomi?ed controlled trial)
52. kw= (RCT)
53. kw= (controlled clinical trial)
54. kw= ((questionnaire or survey or interview or focus group) within 5 method)
55. kw= (program evaluation)
56. kw= (multicenter study)
57. kw= (experiment*)
58. kw= (time within 1 series)
59. kw= (interrupted time series)
60. kw=(pre test or pretest or (post test or posttest))
61. kw= (impact)
62. kw= (intervention*)
63. kw= (chang*)
64. kw= (compar*)
65. kw= (random allocation)
66. kw= (double blind method)
67. kw= (single blind method)
68. kw= (clinical trial)
69. kw= (clin* within 5 trial*)
70. kw= ((singl* or doubl* or trebl* or tripl*) within 5 (blind* or mask*))
71. kw= (placebo*)
72. kw= (random*)
73. kw= (comparative study)
74. kw= (follow up studies)
75. kw= (prospective studies)
76. kw= (control* or prospective* or volunteer*)
77. kw= ((effect* or impact or evaluat* or introduc* or compar* or implement*) within 3 
treatment within 1 (program* or strateg* or test* or questionnaire* or process* or procedure* 
or method*))
78. kw= ((effect* or impact or evaluat* or introduc* or compar* or implement*) within 1 care 
within 1 (program* or strateg* or test* or questionnaire* or process* or procedure* or 
method*))
79. kw= ((effect* or impact or evaluat* or introduc* or compar* or implement*) within 3 
screening within 1 (program* or strateg* or test* or questionnaire* or process* or procedure* 
or method*))
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80. kw= ((effect* or impact or evaluat* or introduc* or compar* or implement*) within 3 
intervention* within 1 (program* or strateg* or test* or questionnaire* or process* or 
procedure* or method*))
81. kw= ((effect* or impact or evaluat* or introduc* or compar* or implement*) within 3 
prevention* within 1 (program* or strateg* or test* or questionnaire* or process* or 
procedure* or method*))
82. kw= ((effect* or impact or evaluat* or introduc* or compar* or implement*) within 3 
(protocol* or guideline* or strateg* or audit* or method*))
83. kw= ((critical* within 3 apprais*) or evaluat*)
List four: 
84. kw= (econom*) or kw= (cost*) or kw= (pric*) or kw= (pharmacoecon*)
85. kw= (cost within 1 (effectiveness or utili* or benefit or minimi* or energy or oxygen or 
metabolic)) or kw= (expenditure not energy)
86. kw= (value within 2 money) or kw= (budget*) or kw= (preference) or kw= (QALY) or kw= 
(quality within 1 adjusted)
87. kw= (utility*)
88. kw= (financ* within 1 (management or support or organized)) or kw= (econom* or cost or 
costs or costly or costing or price or prices or pricing or pharmacoeconomic*)
89. kw= (expenditure* not energy)
90. kw= (value within 1 money) or kw= (budget*)
91. List five
92. kw= (editorial)
93. kw= (letter)
94. kw= (comment)
95. kw= (animal)
Database: Sociological Abstracts
Name of host: CSA
Years covered: all available
Search strategy
List one:
96. kw= (health train*)
97. kw= (lifestyle within 1 (advi* or train* or coach*))
98. kw= (lay health within 1 (worker or advis?r or support*))
99. kw= (lay within 1 (practitioner or leader or midwi*))
100. kw= (peer within 1 (leader or educ* or counsel* or support* or mentor* or network* or 
assist*))
101. kw= (health within 1 (activ* or aide or advoc* or coach or promot?r))
102. kw= ((patient or peer) within 1 navig*)
103. kw= ((community or health) within 1 champion)
104. kw= (community health within 1 (educ* or work* or advis* or activ* or representative))
105. kw= (community wellness advocate)
106. kw= (community within 1 (parent or mother))
107. kw= (outreach within 1 (worker or specialist))
108. kw= (expert patient) or kw= (natural help*)
109. kw= ((neighborhood or neighbourhood) within 1 (help* or leader or assistant))
110. kw= (family health advis*)
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111. kw= (breastfeeding supporter)
112. kw= (lactation consultant)
113. kw= ((village or indigenous) within 1 health worker)
114. kw= (promotor*)
115. kw= (paraprofessional)
116. kw= (workplace health advi*)
117. kw= ((professional* or nurs* or physician* or clinician*) within 2 (delegat* or substitut*))
118. kw= (staff* within 1 model*)
119. kw= (nurs* within 2 (led or managed or directed or run))
120. kw= ((lay or voluntary or volunteer* or untrained or unlicensed or nonprofessional* or non 
professional* or paraprofessional* or paramedical) within 1 (worker* or staff))
121. kw= (community within 3 (volunteer* or aid* or support))
122. kw= ((birth or childbirth or child birth or labor or labour) within 1 (attendant* or 
assistant*))
123. kw= (doula* or douladural* or monitrice* or linkworker* or link worker* or barefoot 
doctor*)
124. kw= (home within 1 (aid or aides or health or nursing or support or intervention* or 
treatment* or visit*))
List two: 
125. kw= (public health)
126. kw= ((behaviour or behavior or lifestyle or life style) within 1 change)
127. kw= (health within 1 (promotion or education or improvement))
128. kw= ((disease or illness) within 1 prevention)
129. kw= (smoking)
130. kw= (tobacco use)
131. kw= (exercise)
132. kw= (diet)
133. kw= (nutrition)
134. kw= (overweight)
135. kw= (obesity)
136. kw= (alcohol)
137. kw= (substance misuse)
138. kw= (breastfeeding)
139. kw= (sexual health)
140. kw= (condom use)
141.  kw= (HIV)
142. kw= (AIDS)
143. kw= (mental health)
144. kw= (wellbeing)
List three: 
145. kw= (evaluation)
146. kw= (randomi?ed controlled trial)
147. kw= (RCT)
148. kw= (controlled clinical trial)
149. kw= ((questionnaire or survey or interview or focus group) within 5 method)
150. kw= (program evaluation)
151. kw= (multicenter study)
152. kw= (experiment*)
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153. kw= (time within 1 series)
154. kw= (interrupted time series)
155. kw=(pre test or pretest or (post test or posttest))
156. kw= (impact)
157. kw= (intervention*)
158. kw= (chang*)
159. kw= (compar*)
160. kw= (random allocation)
161. kw= (double blind method)
162. kw= (single blind method)
163. kw= (clinical trial)
164. kw= (clin* within 5 trial*)
165. kw= ((singl* or doubl* or trebl* or tripl*) within 5 (blind* or mask*))
166. kw= (placebo*)
167. kw= (random*)
168. kw= (comparative study)
169. kw= (follow up studies)
170. kw= (prospective studies)
171. kw= (control* or prospective* or volunteer*)
172. kw= ((effect* or impact or evaluat* or introduc* or compar* or implement*) within 3 
treatment within 1 (program* or strateg* or test* or questionnaire* or process* or procedure* 
or method*))
173. kw= ((effect* or impact or evaluat* or introduc* or compar* or implement*) within 1 care 
within 1 (program* or strateg* or test* or questionnaire* or process* or procedure* or 
method*))
174. kw= ((effect* or impact or evaluat* or introduc* or compar* or implement*) within 3 
screening within 1 (program* or strateg* or test* or questionnaire* or process* or procedure* 
or method*))
175. kw= ((effect* or impact or evaluat* or introduc* or compar* or implement*) within 3 
intervention* within 1 (program* or strateg* or test* or questionnaire* or process* or 
procedure* or method*))
176. kw= ((effect* or impact or evaluat* or introduc* or compar* or implement*) within 3 
prevention* within 1 (program* or strateg* or test* or questionnaire* or process* or 
procedure* or method*))
177. kw= ((effect* or impact or evaluat* or introduc* or compar* or implement*) within 3 
(protocol* or guideline* or strateg* or audit* or method*))
178. kw= ((critical* within 3 apprais*) or evaluat*)
List four: 
179. kw= (econom*) or kw= (cost*) or kw= (pric*) or kw= (pharmacoecon*)
180. kw= (cost within 1 (effectiveness or utili* or benefit or minimi* or energy or oxygen or 
metabolic)) or kw= (expenditure not energy)
181. kw= (value within 2 money) or kw= (budget*) or kw= (preference) or kw= (QALY) or kw= 
(quality within 1 adjusted)
182. kw= (utility*)
183. kw= (financ* within 1 (management or support or organized)) or kw= (econom* or cost or 
costs or costly or costing or price or prices or pricing or pharmacoeconomic*)
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184. kw= (expenditure* not energy)
185. kw= (value within 1 money) or kw= (budget*)
186. List five
187. kw= (editorial)
188. kw= (letter)
189. kw= (comment)
190. kw= (animal)
Database: Web of Knowledge
Name of host: ISI
Years covered: earliest to latest
Search strategy
#14 #13 AND #9
#13 #12 OR #11 OR #10
#12 Topic=(“preference”) OR Topic=(“QALY”) OR Topic=(“quality adjusted”) OR Topic=(“utility*”) OR Topic=(“financ* management”) OR 
Topic=(“financ* support”) OR Topic=(“financ* organized”) NOT Topic=(“editorial”) NOT Topic=(“letter”) NOT Topic=(“comment”) NOT 
Topic=(“animal”)
#11 Topic=(“focus group method”) OR Topic=(“econom*”) OR Topic=(“cost*”) OR Topic=(“pric*”) OR Topic=(“pharmacoecon*”) OR Topic=(“cost 
effectiveness”) OR Topic=(“cost utili*”) OR Topic=(“cost benefit”) OR Topic=(“cost minimi*”) OR Topic=(“cost energy”) OR Topic=(“cost 
oxygen”) OR Topic=(“cost metabolic”) OR Topic=(“expenditure NOT energy”) OR Topic=(“value NEAR/2 money”) OR Topic=(“budget*”)
#10 Topic=(“evaluation”) OR Topic=(“randomi?ed controlled trial”) OR Topic=(“RCT”) OR Topic=(“controlled clinical trial”) OR 
Topic=(“controlled before and after stud*”) OR Topic=(“cohort stud*”) OR Topic=(“case-control stud*”) OR Topic=(“longitudinal 
stud*”) OR Topic=(“observational stud*”) OR Topic=(“case stud*”) OR Topic=(“qualitative stud*”) OR Topic=(“quantitative stud*”) OR 
Topic=(“questionnaire method”) OR Topic=(“survey method”) OR Topic=(“interview method”)
#9 #8 AND #5
#8 #7 OR #6
#7 Topic=(“nutrition”) OR Topic=(“overweight”) OR Topic=(“obesity”) OR Topic=(“alcohol”) OR Topic=(“substance misuse”) OR 
Topic=(“breastfeeding”) OR Topic=(“sexual health”) OR Topic=(“condom use”) OR Topic=(“HIV”) OR Topic=(“AIDS”) OR Topic=(“mental 
health”) OR Topic=(“wellbeing”)
#6 Topic=(“public health”) OR Topic=(“behaviour change”) OR Topic=(“behavior change”) OR Topic=(“lifestyle change”) OR Topic=(“life style 
change”) OR Topic=(“health promotion”) OR Topic=(“health education”) OR Topic=(“health improvement”) OR Topic=(“disease prevention”) 
OR Topic=(“illness prevention”) OR Topic=(“smoking”) OR Topic=(“tobacco use”) OR Topic=(“physical activity”) OR Topic=(“exercise”) OR 
Topic=(“diet”)
#5 #4 OR #3 OR #2 OR #1
#4 Topic=(“family health advis*”) OR Topic=(“breastfeeding supporter”) OR Topic=(“lactation consultant”) OR Topic=(“village health worker”) 
OR Topic=(“indigenous health worker”) OR Topic=(“promotor*”) OR Topic=(“paraprofessional”) OR Topic=(“workplace health advi*”)
#3 Topic=(“community health representative”) OR Topic=(“community wellness advocate”) OR Topic=(“community parent”) OR 
Topic=(“community mother”) OR Topic=(“outreach specialist”) OR Topic=(“outreach worker”) OR Topic=(“outreach specialist”) 
OR Topic=(“expert patient”) OR Topic=(“natural help*”) OR Topic=(“neighborhood help*”) OR Topic=(“neighborhood leader”) OR 
Topic=(“neighborhood assistant”) OR Topic=(“neighbourhood help*”) OR Topic=(“neighbourhood leader”) OR Topic=(“neighbourhood 
assistant”)
#2 Topic=(“peer network*”) OR Topic=(“peer assist*”) OR Topic=(“health activ*”) OR Topic=(“health aide”) OR Topic=(“health advoc*”) OR 
Topic=(“health coach”) OR Topic=(“health promot?r”) OR Topic=(“patient navig*”) OR Topic=(“peer navig*”) OR Topic=(“community 
champion”) OR Topic=(“health champion”) OR Topic=(“community health educ*”) OR Topic=(“community health work*”) OR 
Topic=(“community health advis*”) OR Topic=(“community health activ*”)
#1 Topic=(“health train*”) OR Topic=(“lifestyle advi*”) OR Topic=(“lifestyle train*”) OR Topic=(l”ifestyle coach*”) OR Topic=(“lay health worker”) 
OR Topic=(“lay health advis?r”) OR Topic=(“lay health support*”) OR Topic=(“lay practitioner”) OR Topic=(“lay leader”) OR Topic=(“lay 
midwi*”) OR Topic=(“peer leader”) OR Topic=(“peer educ*”) OR Topic=(“peer counsel*”) OR Topic=(“peer support*”) OR Topic=(“peer 
mentor*”)
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Database: WorldCat
Name of host: OCLC FirstSEARCH
Years covered: earliest to latest
Search strategy
((kw: Health w train*) or (kw: Lifestyle w advi*) or (kw: Lifestyle w train*) or (kw: Lifestyle w 
coach*) or (kw: Lay w health w worker) or (kw: Lay w health w advis#r) or (kw: Lay w health w 
support) or (kw: Lay w practitioner) or (kw: Lay w leader) or (kw: Lay w midwi*) or (kw: Peer 
w leader) or (kw: Peer w edu*) or (kw: Peer w counsel*) or (kw: Peer w support*) or (kw: Peer 
w mentor*) or (kw: Peer w network*) or (kw: Peer w assist*) or (kw: Health w activ*) or (kw: 
Health w aide) or (kw: Health w advoc*) or (kw: Health w coach) or (kw: Health w promot#r) or 
(kw: Patient w navig*) or (kw: Peer w navig*) or (kw: Community w champion) or (kw: Health 
w champion) or (kw: Community w health w educ*) or (kw: Community w health w work*) or 
(kw: Community w health w advis*) or (kw: Community w health w activ*) or (kw: Community 
w health w representative) or (kw: Community w wellness w advocate) or (kw: Community 
w parent) or (kw: Community w mother) or (kw: Outreach w worker) or (kw: Outreach w 
specialist) or (kw: Expert w patient) or (kw: Natural w help*) or (kw: Neighborhood w help*) 
or (kw: Neighborhood w leader) or (kw: Neighborhood w assistant) or (kw: Neighbourhood w 
help*) or (kw: Neighbourhood w leader) or (kw: Neighbourhood w assistant) or (kw: Family 
w health w advis*) or (kw: Breastfeeding w supporter) or (kw: Lactation w consultant) or (kw: 
Village w health w worker) or (kw: Indigenous w health w worker) or (kw: Promotor*) or (kw: 
Paraprofessional) or (kw: Workplace w health w advi*))
AND
((kw: Public w health) Or (kw: Behaviour w change) Or (kw: Behavior w change) Or (kw: 
Lifestyle w change) Or (kw: Life w style w change) Or (kw: Health w promotion) Or (kw: Health 
w education) Or (kw: Health w improvement) Or (kw: Disease w prevention) Or (kw: Illness 
w prevention) Or (kw: Smoking) Or (kw: Tobacco w use) Or (kw: Physical w activity) Or (kw: 
Exercise) Or (kw: Diet) Or (kw: Nutrition) Or (kw: Overweight) Or (kw: Obesity) Or (kw: 
Alcohol) Or (kw: Substance w misuse) Or (kw: Breastfeeding) Or (kw: Sexual w health) Or (kw: 
Condom w Use) Or (kw: HIV) Or (kw: AIDS) Or (kw: Mental w health) Or (kw: Wellbeing))
AND
((kw: Evaluation) Or (kw: Randomi#ed w controlled w trial) Or (kw: RCT) Or (kw: Controlled 
w clinical w trail) Or (kw: controlled w before w after w 3 w stud*) Or (kw: cohort w 3 kw: stud*) 
Or (kw: case-control w 3 kw: stud*) Or (kw: longitudinal w 3 kw: stud*) Or (kw: observational w 
3 kw: stud*) Or (kw: case w 3 kw: stud*) Or (kw: qualitative w 3 kw: stud*) Or (kw: quantitative 
w 3 kw: stud*) Or (kw: questionnaire w 25 kw: method) Or (kw: survey w 25 kw: method) Or 
(kw: interview w 25 kw: method) Or (kw: focus w group w 25 kw: method) OR (kw: econom*) 
Or (kw: cost*) Or (kw: pric*) Or (kw: pharmacoecon*) Or (kw: cost w effectiveness) Or (kw: cost 
w utili*) Or (kw: cost w benefit) Or (kw: cost w minimi*) Or (kw: cost w energy) Or (kw: cost 
w oxygen) Or (kw: cost w metabolic) Or (kw: expenditure NOT kw: energy) Or (kw: value w 2 
kw: money) Or (kw: budget*) Or (kw: preference) Or (kw: QALY) Or (kw: quality w adjusted) 
Or (kw: utility*) Or (kw: financ* w management) Or (kw: financ* w support) Or (kw: financ* w 
organized))
NOT
((kw: editorial) or (kw: letter) or (kw: comment) or (kw: animal))
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Database: Zetoc
Name of host: Mimas
Years covered: earliest to latest
Search strategy
Health train$ OR lifestyle advi$ OR lifestyle train$ OR lay health worker OR lay health advis*r 
OR peer educ$ OR peer counsel$ OR peer support$ OR health activ$ OR health aide OR health 
advoc$ OR link worker OR community champion OR community health educ$ OR outreach 
worker
AND
Evaluation OR effectiveness OR cost-effectiveness OR equity OR acceptability OR behaviour 
change OR health promotion OR health improvement OR disease prevention
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Appendix 7  
Search strategy for Google
List one (role)
1. “health trainer”
2. “lifestyle adviser” OR “lifestyle advisor” OR “lifestyle trainer” OR “lifestyle coach”
3. “lay health worker” OR “lay health adviser” OR “lay health advisor” OR “lay health 
supporter”
4. “lay practitioner” OR “lay leader” OR “lay midwife”
5. health (“peer leader” OR “peer educator” OR “peer counsellor” OR “peer supporter” OR 
“peer mentor” OR “peer networker” OR “peer assistant”)
6. “health activist” OR “health aide” OR “health advocate” OR “health coach” OR “health 
promoter”
7. “patient navigator” OR “peer navigator”
8. “community champion” OR “health champion”
i. a) “community health educator” OR “community health worker” OR “community health 
adviser” OR “community health advisor” OR “community health activist”
ii. b) “community health representative”
9. “community wellness advocate”
10. “community parent” OR “community mother”
11. “outreach worker” OR “outreach specialist”
12. “expert patient”
13. “natural helper”
14. “neighborhood helper” OR “neighborhood leader” OR “neighborhood assistant” OR 
“neighbourhood helper” OR “neighbourhood leader” OR “neighbourhood assistant”
15. “family health adviser” OR “family health advisor”
16. “breastfeeding supporter”
17. “lactation consultant”
18. “village health worker” OR “indigenous health worker”
19. promotoras OR promotores
20. “workplace health adviser” OR “workplace health advisor”
21. “community volunteer” OR “community aide”
22. “birth attendant” OR “childbirth attendant” OR “child birth attendant” OR “labor attendant” 
OR “labour attendant”
23. “birth assistant” OR “childbirth assistant” OR “child birth assistant” OR “labor assistant” OR 
“labour assistant”
24. linkworker OR “link worker”
25. “lay staff ” OR “untrained staff ” OR “unlicensed staff ” OR “nonprofessional staff ” OR “non 
professional staff ” OR “paraprofessional staff ” OR “paramedical staff ”
26. “barefoot doctor”
27. “lay worker” OR “untrained worker” OR “unlicensed worker” OR “nonprofessional worker” 
OR “non professional worker” OR “paraprofessional worker” OR “paramedical worker”
28. doula OR douladural OR monitrice
List two (method or general outcome)
(evaluation OR trial OR RCT OR study OR questionnaire OR survey OR interview OR focus 
group OR observation OR economic OR effectiveness OR cost effectiveness OR equity OR 
acceptability)
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Appendix 8  
Results returned for each Google 
search string
Search string Number of results
“lifestyle adviser” OR “lifestyle advisor” OR “lifestyle trainer” OR “lifestyle coach” 744
“lay practitioner” OR “lay leader” OR “lay midwife” 15,200
“health activist” OR “health aide” OR “health advocate” OR “health coach” OR “health promoter” 191,000
“community champion” OR “health champion” 1210
“community wellness advocate” 19
“outreach worker” OR “outreach specialist” 83,900
health (“natural helper”) 377
“family health adviser” OR “family health advisor” 23
promotoras OR promotores 104,000
Health (“community volunteer” OR “community aide”) 11,200
“lay staff” OR “untrained staff” OR “unlicensed staff” OR “nonprofessional staff” OR “non professional staff” OR 
“paraprofessional staff” OR “paramedical staff”
112,000
“lay worker” OR “untrained worker” OR “unlicensed worker” OR “nonprofessional worker” OR “non professional worker” OR 
“paraprofessional worker” OR “paramedical worker”
728
“breastfeeding supporter” 26
“village health worker” OR “indigenous health worker” 15,300
“birth attendant” OR “childbirth attendant” OR “child birth attendant” OR “labor attendant” OR “labour attendant” 6010
health (linkworker OR “link worker”) 2110
“barefoot doctor” 898
“doula” OR “douladural” OR “monitrice” 55,700
“health trainer” 797
“lay health worker” OR “lay health adviser” OR “lay health advisor” OR “lay health supporter” 10,000
Health (“peer leader” OR “peer educator” OR “peer counsellor” OR “peer supporter” OR “peer mentor” OR “peer networker” 
OR “peer assistant”)
10,800
“patient navigator” OR “peer navigator” 992
“community health educator” OR “community health worker” OR “community health adviser” OR “community health advisor” 
OR “community health activist”
57,700
“community health representative” 544
“community parent” OR “community mother” 18,800
“neighborhood helper” OR “neighborhood leader” OR “neighborhood assistant” OR “neighbourhood helper” OR 
“neighbourhood leader” OR “neighbourhood assistant”
602
“expert patient” 6210
“workplace health adviser” OR “workplace health advisor” 7
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Appendix 9  
Website search results
Website URL (number of results received) Date searched
The National Audit Office www.nao.org.uk (61) 16 October 2008
The Home Office www.homeoffice.gov.uk (54) 16 October 2008
The Joseph Rowntree Foundation www.jrf.org.uk (4312) 16 October 2008
The Office of the Deputy Prime Minister  
(now Communities.gov)
www.odpm.gov.uk (191) 16 October 2008
ISRCTN Register www.controlled-trials.com/isrctn (2) 16 October 2008
The Department of Health www.dh.gov.uk (251) 16 October 2008
The American Institutes for Research www.air.org (2) 17 October 2008
The Office of Policy www.ssa.gov/policy (12) 17 October 2008
The Medical Research Council www.mrc.ac.uk (310) 17 October 2008
The Urban Institute www.urban.org( 4) 17 October 2008
Wellcome Trust www.wellcome.ac.uk (26) 17 October 2008
Total search results = 5225
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Appendix 10  
Table of excluded studies
Study Reference(s) Reason for exclusion Design
Adair (1960) Adair J. The Indian Health Worker in the Cornell-Navaho Project. Hum 
Organ 1960;19:59–63
Poor methodological 
quality
Qualitative
Aiken et al. 
(1984)
Aiken LS, LoSciuto LA, Ausetts MA, Brown BS. Paraprofessional versus 
professional Drug Counselors: The Progress of Clients in Treatment. Int J 
Addict 1984;19:383–401
Poor methodological 
quality
Quantitative
Albrecht and 
Petres (1997)
Albrecht L, Petres KE. Peer intervention in case management practice.  
J Case Manag 1997;6:43–9
Not an evaluative design Descriptive material
Allen (2004) Allen T. Preventing falls in older people: evaluating peer education 
approach. Br J Community Nurs 2004;9:195–200
Poor methodological 
quality
Quantitative
Andrews et al. 
(2004)
Andrews JO, Felton G, Wewers ME, Heath J. Use of community health 
workers in research with ethnic minority women. J Nurs Scholarsh 
2004;36:358–65
Not an evaluative design Review
Artz et al. (1981) Artz L, Cooke CJ, Meyers A, Stalgaitis S. Community change agents and 
health interventions: hypertension screening. Am J Community Psychol 
1981;9:361–70
Not an evaluative design Quantitative 
Baker et al. 
(1997)
Baker EA, Bouldin N, Durham M, Lowell, ME, Gonzalez M, Jodaitis N, et 
al. The Latino Health Advocacy Program: a collaborative lay health advisor 
approach. Health Educ Behav 1997;24:495–509
Poor methodological 
quality
Qualitative
Barnett and 
Parker (1985)
Barnett B, Parker G. Professional and non-professional intervention for 
highly anxious primiparous mothers. Br J Psychiatry 1985;146:287–93
Poor methodological 
quality
Quantitative
Beckham et al. 
(2008)
Beckham S, Bradley S, Washburn A, Taumua T. Diabetes management: 
utilizing community health workers in a Hawaiian/Samoan population.  
J Health Care Poor Underserved 2008;19:416–27
Poor methodological 
quality
Quantitative
Birkel et al. 
(1993)
Brikel RC, Golaszewski T, Koman JJ, Singh BK, Catan V, Souply K. Findings 
from the Horizontes Acquired Immune Deficiency Syndrome education 
project: The impact of indigenous outreach workers as change agents for 
injection drug users. Health Educ Q 1993;20:523–38
Poor methodological 
quality
Quantitative
Boyd et al. 
(2005)
Boyd MR, Moneyham L, Murdaugh C, Phillips KD, Tavakoli A, Jackwon K, 
et al. A peer-based substance abuse intervention for HIV+ rural women: a 
pilot study. Arch Psychiatr Nurs 2005;19;10–17
Poor methodological 
quality
Quantitative
Braun et al. 
(2005)
Braun KL, Fong M, Kaanoi ME, Kamaka ML, Gotay CC. Testing a culturally 
appropriate, theory-based intervention to improve colorectal cancer 
screening among Native Hawaiians. Prev Med 2005;40:619–27
Poor methodological 
quality
Quantitative
Briscoe and 
Pichert (1999)
Briscoe VJ, Pichert JW. Evaluation of a program to promote diabetes 
care via existing agencies in African American communities. ABNF J 
1999;10:111–15
Poor methodological 
quality
Quantitative
Brooker and 
Moore (2007)
Brooker C, Moore S. New futures health trainers: an impact assessment – 
summary of findings. Lincoln: University of Lincoln, Centre for Clinical and 
Academic Workforce Innovation; 2007
Poor methodological 
quality
Quantitative
Buller et al. 
(2000)
Buller D, Buller MK, Larkey L, Sennott-Miller L, Taren D, Aickin M, et al. 
Implementing a 5-a-day peer health educator program for public sector 
labor and trades employees. Health Educ Behav 2000;27:232–40
Poor methodological 
quality
Quantitative
Bullock et al. 
(1995)
Bullock LFC, Wells JE, Duff GB, Hornblow AR. Telephone support for 
pregnant women: Outcome in late pregnancy. N Z Med J 1995;108: 
476–8
Poor methodological 
quality
Quantitative
Burnhill et al. 
(1985)
Burnhill MS, King E, Koteen E. Impact of counselling on repeated 
unplanned pregnancy and contraceptive behavior in low SES abortion 
population. New Brunswick, NJ: Department of Obstetrics and Gynecology 
Rutgers Medical School; 1985
Poor methodological 
quality
Quantitative
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Castro et al. 
(1995)
Castro F, Elder J, Coe K, Tafoya-Barraza H, Moratto S, Campbell N, et 
al. Mobilizing churches for health promotion in Latino communities: 
Companeros en la Salud. J Natl Cancer Inst Monogr 1995;18:127–35
Poor methodological 
quality
Quantitative
Caufield et al. 
(1998)
Caufield LE, Gross SM, Bentley ME, Bronner Y, Kessler L, Jensen J, et 
al. WIC-based interventions to promote breastfeeding among African-
American women in Baltimore: Effects on breastfeeding initiation and 
continuation. J Hum Lact 1998;14:15–22
Poor methodological 
quality
Quantitative
Centres for 
Disease Control 
and prevention 
(CDC) (1996)
CDC. Community-level prevention of human immunodeficiency virus 
infection among high-risk populations: the AIDS Community Demonstration 
Projects. Morb Mortal Wkly Rep 1996;45:1–17
Not an evaluative design Quantitative
CDC AIDS 
Community 
Demonstration 
Projects 
Research Group 
(1999)
CDC. Community-level HIV intervention in 5 cities: final outcome data from 
the CDC AIDS Community Demonstration Projects. Am J Public Health 
1999;89:336–45
Poor methodological 
quality
Quantitative
Cohen et al. 
(1986)
Cohen J, Sauter S, DeVellis R, DeVellis B. Evaluation of arthritis self 
management courses led by laypersons and by professionals. Arthritis 
Rheum 1986;29:388–93
Poor methodological 
quality
Corkery et al. 
(1997)
Corkery E, Palmer C, Foley M, et al. Effect of a bicultural community health 
worker on completion of diabetes education in a Hispanic population. 
Diabetes Care 1997;20:254–7
Poor methodological 
quality
Quantitative
Cottler et al. 
(1998) 
Cottler LB, Compton WM, Ben AA, Cunningham-Williams R, Abram 
F, Fichtenbaum C, et al. Peer-delivered interventions reduce HIV 
risk behaviors among out-of-treatment drug abusers. Public Health 
Rep;113(Suppl. 1):31–41.
Poor methodological 
quality
Quantitative
Cox (1979) Cox C. A pilot study: using the elderly as community health educators. Int J 
Health Educ 1979;22:49–52.
Poor methodological 
quality 
Quantitative
Crose et al. 
(1987)
Crose R, Warren J, Duffy M, Franklin B. Project OASIS: volunteer mental 
health paraprofessionals serving nursing home residents. Gerontologist 
1987;27:359–62
Poor methodological 
quality
Quantitative
Dale (2007) Dale J. Telecare motivational interviewing for diabetes patient education 
and support: a randomised controlled trial based in primary care 
comparing nurse and peer supporter delivery. Trials 2007;8:1–8
Poor methodological 
quality
Quantitative
Davis et al. 
(1994)
Davis DT, Bustamante A, Brown CP, et al. The urban church and cancer 
control: a source of social influence in minority communities. Public Health 
Rep 1994; 109:500–6
Poor methodological 
quality
Quantitative
Davison et al. 
(1999)
Davison DM, Reeder GD, Teverbaugh K. African-American volunteers 
carrying an HIV prevention message: selective communication. AIDS Educ 
Prev 1999;11:436–49
Poor methodological 
quality
Quantitative
Deakin et 
al.(2002)
Deakin TA, Cade JE, Williams DRR, Greenwood D. Expert patient education 
versus routine treatment (X-PERT) Diabetologia 2002;45:A317.
Poor methodological 
quality
Quantitative
Delveaux and 
Blanchette(2001)
Delveaux K, Blanchette K. Results of an evaluation of the Peer Support 
Program at Nova Institution for women (R-87, 2000). Forum Correct Res 
2001;13:28–9
Not an evaluative design Descriptive material
DeNardo et al. 
(1995)
DeNardo BA, Stebulis JA, Tucker LB, Schaller JG. Parents of children with 
rheumatic disease as peer counselors. Arthritis Care Res 1995;8:120–5
Poor methodological 
quality
Quantitative
Dennis et al. 
(2002)
Dennis CL, Hodnett E, Gallop R, Simmer K. Telephone-based peer support 
increased the duration of breast feeding in primiparous mothers. Evid 
Based Med 2002;7:156
Poor methodological 
quality
Quantitative
Dennis (2003) Dennis CL. The effect of peer support on post-partum depression: a pilot 
randomised controlled trial. Can J Psychol 2003;48:115–24
Poor methodological 
quality
Quantitative
deWeerdt et al. 
(1991)
deWeerdt I, Visser A, Kok G, deWeerdt O, van der Veen E. Randomized 
controlled multicentre evaluation of an education programme for insulin-
treated diabetic patients: effects on metabolic control, quality of life, and 
costs of therapy. Diabet Med 1991;8:338–45.
Poor methodological 
quality
Quantitative
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deWeerdt et al. 
(1989)
deWeerdt I, Visser A, Kok G, van der Veen E. Randomized controlled 
evaluation of an education program for insulin treated patients with 
diabetes: effects on psychosocial variables. Patient Educ Couns 
1989;14:191–215
Poor methodological 
quality
Quantitative
Diggle (2008) Diggle S. An evaluation of the Nottingham City Health Trainer Programme. 
Nottingham: NHS; 2008
Poor methodological 
quality
Combined
Dignan et al. 
(1996)
Dignan M, Michielutte R, Blinson K, Wells H, Case L, Sharp P, et al. 
Effectiveness of health education to increase screening for cervical cancer 
among eastern-band Cherokee Indian women in North Carolina. J Natl 
Cancer Inst 1996;88:1670–6
Poor methodological 
quality
Quantitative
Dignan et al. 
(1998)
Dignan M, Michielutte R, Wells HB, Sharp P, Blinson K, Case Ld, et al. 
Health education to increase screening for cervical cancer among Lumbee 
Indian women in North Carolina. Health Educ Res 1998;13:545–56
Poor methodological 
quality
Quantitative
Dracup and 
Frerichs (1986)
Dracup K, Frerichs, P. Evaluation of a community-based health information 
service. Am J Prev Med 1986;2:6–13
Poor methodological 
quality
Quantitative
Duan et al. 
(2000)
Duan N, Fox SA, Derose KP, Carson S. Maintaining mammography 
adherence through telephone counseling in a church-based trial. Am J 
Public Health 2000;90:1468–71
Poor methodological 
quality
Quantitative
Elder (2005) Elder JP, Ayala GX, Campbell NR, Slymen D, Lopez-Madurga ET, Engelberg 
M, Baquero B. Interpersonal and print nutrition communication for a 
Spanish-dominant Latino population: Secretos de la Buena Vida Health 
Psychol 2005;24:49–57
Poor methodological 
quality
Quantitative
Elder et al. 
(1986)
Elder JP, McKenna CA, Lazieh M, Ferreira A, Lasater TM, Carleton RA. The 
use of volunteers in mass screening for high blood pressure. Am J Prev 
Med 1986;2:268–72
Not an evaluative design Descriptive material
Elford et al. 
(2001)
Elford J, Bolding G, Sherr L. Peer education has no significant impact on 
HIV risk behaviours among gay men in London. AIDS 2001;15:535–8
Poor methodological 
quality
Quantitative
Elford et al. 
(2002)
Elford J, Sherr L, Bolding G, Serle F, Maguire M. Peer-led HIV prevention 
among gay men in London: process evaluation. AIDS Care 2002;14:351–
60
Poor methodological 
quality
Quantitative
Ell et al. (2002) Ell K, Padgett D, Vourlekis B, Nissly J, Pineda D, Sarabia O, Walther V, 
Blumenfield S, Lee P. Abnormal mammogram follow-up: a pilot study 
in women with low income. Cancer Pract: Multidisciplin J Cancer Care 
2002;10:130–8
Poor methodological 
quality
Quantitative
Eng (1993) Eng E. The Save our Sisters Project. A social network strategy for reaching 
rural black women Cancer 1993;72:1071–7
Not an evaluative design Qualitative 
(descriptive)
Eng and Smith 
(1995)
Eng E, Smith J. Natural helping functions of lay health advisors in breast 
cancer education Breast Cancer Res Treat 1995;35: 23–9
Not an evaluative design Qualitative 
(descriptive)
Fedder et al. 
(2003)
Fedder DO, Chang RJ, Curry S, Nichols G. The effectiveness of a 
community health worker outreach program on health-care utilization 
of West Baltimore City Medicaid patients with diabetes, with or without 
hypertension. Ethn Dis 2003;13:22–7
Poor methodological 
quality
Quantitative
Fernandez-
Esquer et al. 
(2003)
Fernandez-Esquer ME, Espinoza P, Torres I, Ramirez AG, McAlister AL. A 
Su Salud: a quasi-experimental study among Mexican American women. 
Am J Health Behav 2003;27:536–45
Poor methodological 
quality
Quantitative
Flaskerud et al. 
(1997)
Flaskerud JH, Nyamathi AM, Uman C. Longitudinal effects of an HIV testing 
and counseling programme for low-income Latina women. Ethn Health 
1997;2:89–103
Poor methodological 
quality
Quantitative
Flowers et al. 
(2000)
Flowers P, Frankis J, Hart G. Evidence and the evaluation of a community-
level intervention: research the Gay Men’s Task Force. In Watson J, Platt 
S, editors. Researching health promotion. London: Routledge; 2000. 
pp.102–24
Poor methodological 
quality
Combined 
Flowers et al. 
(2002)
Flowers P, Hart GJ, Williamson LM, Frankis JS, Der GJ. Does bar-based, 
peer-led sexual health promotion have a community-level effect amongst 
gay men in Scotland? Int J STD AIDS 2002;13:102–8
Poor methodological 
quality
Quantitative
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Fogarty (2001) Fogarty LA, Heilig CM, Armstrong K, Cabral R, Galavotti C, Gielen AC, 
Green BM. Long-term effectiveness of a peer-based intervention to 
promote condom and contraceptive use among HIV-positive and at-risk 
women. Public Health Rep 2001;116(Suppl. 1):103–19
Poor methodological 
quality
Quantitative
Foley et al. 
(2005)
Foley K, Duran B, Morris P, Lucero J, Jiang YZ, Baxter B, et al. Using 
motivational interviewing to promote HIV testing at an American Indian 
substance abuse treatment facility. J Psychoactive Drugs 2005;37:321–9
Poor methodological 
quality
Quantitative
Foley and Pollard 
(1998)
Foley RM, Pollard CM. Food Cent$: implementing and evaluating a 
nutrition education project focusing on value for money. Austr N Z J Public 
Health 1998;22:494–501
Poor methodological 
quality
Quantitative
Fourth Hurdle 
Consulting Ltd 
(2007)
Fourth Hurdle Consulting Ltd. Connect 4 Life economic evaluation report; 
2007
Not an evaluative design Quantitative
Fridinger and 
Vincent (1989)
Fridinger FW, Vincent ML. A comparison of peer educator, media and 
screening only approaches in reducing cardiovascular risk among 
corrections personnel. Health Educ 1989;20:30–5
Poor methodological 
quality
Quantitative
Gabram et al. 
(2008)
Gabram SGA, Lund MJB, Gardner J, Hatchett N, Bumpers HL, Okoli J, 
et al. Effects of an outreach and internal navigation program on breast 
cancer diagnosis in an urban cancer center with a large African-American 
population. Cancer 2008;113:602–7
Poor methodological 
quality
Quantitative
Garret (2006) Garret R. Expert Patient Mentoring Project: evaluation report. Sheffield: 
Sheffield Hallam University Mentoring and Coaching Research Unit; 2006
Poor methodological 
quality
Quantitative
Garrido 
Rodriguez et al. 
(1995)
Garrido Rodriguez P, Castillo Herraiz I, Colomer Revuelta C. A support 
intervention for giving up smoking at health centers. A pilot experience 
with trained volunteer therapists. Rev Espa Salud Publica 1995;69: 
419–26
Article written in Spanish
Gielen et al. 
(1997)
Gielen AC, Windsor R, Faden RR, O’Campo P, Repke J, Davis M. Evaluation 
of a smoking cessation intervention for pregnant women in an urban 
prenatal clinic. Health Education Res 1997;12:247–54
Poor methodological 
quality
Quantitative
Gifford et al. 
(1998)
Gifford A, Laurent D, Gonzales V, Chesney M, Lorig K. Pilot randomized trial 
of education to improve self-management skills of men with symptomatic 
HIV/AIDS. J Acquir Immune Defic Syndr Human Retrovirol 1998;18: 
136–44
Poor methodological 
quality
Quantitative
Glasgow et al. 
(1986)
Glasgow RE, Klesges RC, O’Neill HK. Programming social support 
for smoking modification: an extension and replication. Addict Behav 
1986;11:453–7
Poor methodological 
quality
Quantitative
Glasgow et al. 
(1995)
Glasgow RE, Terborg JR, Hollis JF Severson HH, Boles SM. Take Heart: 
results from the initial phase of work-site Wellness Program. Am J Public 
Health 1995;85:209–16
Poor methodological 
quality
Quantitative
Goldfinger et al. 
(2008)
Goldfinger JZ, Arniella G, Wylie-Rosett J, Horowitz CR. Project HEAL: peer 
education leads to weight loss in Harlem. J Health Care Poor Underserved 
2008;19:180–92
Poor methodological 
quality
Quantitative
Graffy et al. 
(2004)
Graffy J, Taylor J, Williams A, Eldridge S. Randomised controlled trial of 
support from volunteer counsellors for mothers considering breast feeding. 
BMJ 2004;328:26–31
Poor methodological 
quality
Quantitative
Graham (1992) Graham AV, Frank SH, Zyzanski SJ, Kitson GC, Reeb KG. A Clinical Trial to 
Reduce the Rate of Low Birth Weight in an Inner- City Black Population. 
Fam Med 1992;24:439–46.
Poor methodological 
quality
Quantitative
Grant et al. 
(1996)
Grant TM, Ernst CC, Streissguth AP. An intervention with high-risk mothers 
who abuse alcohol and drugs: the Seattle Advocacy Model. Am J Public 
Health 1996;86:1816–17
Poor methodological 
quality
Qualitative
Green Green J. One step closer to the real people: An evaluation of 
HealthWORKS’ Linkworker scheme. Newcastle Upon Tyne: Northumbria 
University
Poor methodological 
quality
Qualitative
Grinstead et al. 
(1997)
Grinstead O, Faigeles B, Zack B. The effectiveness of peer HIV education 
for male inmates entering state prison. J Health Educ 1997;28:S31–7
Poor methodological 
quality
Quantitative
© Queen’s Printer and Controller of HMSO 2011. All rights reserved.
259 Health Technology Assessment 2011; Vol. 15: No. 9DOI: 10.3310/hta15090
Study Reference(s) Reason for exclusion Design
Haas et al. 
(2005)
Haas M, Groupp E, Muench J, Kraemer D, Brummel S, Sharma R, et 
al. Chronic disease self-management program for low back pain in the 
elderly. J Manipulative Physiol Ther 2005;28:228–37
Poor methodological 
quality
Quantitative
Hager and 
Krasse (1983)
Hager B, Krasse B. Dental health education by “barefoot doctors”. 
Community Dent Oral Epidemiol 1983;11:333–6
Poor methodological 
quality
Quantitative
Hammond et al. 
(2000)
Hammond SL, Leonard B, Fridinger F. The Centers for Disease Control 
and Prevention Director’s Physical Activity Challenge: an evaluation of a 
worksite health promotion intervention. Am J Health Promot 2000;15: 
17–20
Poor methodological 
quality
Quantitative
Han et al. (2008) Hae-Ra H, Lee H, Kim MT, Kim KB. Tailored lay health worker intervention 
improves breast cancer screening outcomes in non-adherent Korean-
American women. Health Educ Res 2008;24:318–29
Poor methodological 
quality
Quantitative
Hansen et al. 
(2005)
Hansen LK, Feigl P, Modiano MR, et al. An educational program to increase 
cervical and breast cancer screening in Hispanic women: a Southwest 
Oncology Group study. Cancer Nurs 2005;28:47–53
Poor methodological 
quality
Qualitative
Hanson (1998) Hanson J. Parental self-efficacy and asthma self-management skills.  
J Spec Pediatr Nurs 1998;3:146–54
Poor methodological 
quality
Quantitative
Haour-Knipe et 
al. (1999)
Haour-Knipe M, Fleury F, Dubois-Arber F. HIV/AIDS prevention for 
migrants and ethnic minorities: three phases of evaluation. Soc Sci Med 
1999;49:1357–72
Poor methodological 
quality
Qualitative
Harding et al. 
(2004)
Harding R, Bensley J, Corrigan N. Targeting smoking cessation to high 
prevalence communities: outcomes from a pilot intervention for gay men. 
BMC Public Health 2004;4:43–7
Poor methodological 
quality
Quantitative
Harris and 
Larsen (2007)
Harris GE, Larsen D. HIV peer counseling and the development of hope: 
perspectives from peer counselors and peer counseling recipients. AIDS 
Patient Care STDS 2007;21:843–59
Poor methodological 
quality
Qualitative
Hart et al. (2004) Hart GJ, Williamson LM, Flowers P. Good in parts: The Gay Men’s Task 
Force in Glasgow: a response to Kelly. AIDS Care 2004;16:159–65
Not an evaluative design Qualitative
Havas et al. 
(1998)
Havas S, Anliker J, Damron D, Langenburg P, Ballesteros M, Feldman 
R. Final results of the Maryland WIC 5-a-day Promotion Program. Am J 
Public Health 1998;88:1161–7
Poor methodological 
quality
Quantitative
Healthworks 
(2004)
Healthworks. Link Workers Report; 2004 Not an evaluative design Qualitative 
(descriptive)
Heller et al. 
(1991)
Heller K, Thompson MG, Trueba PE, Hogg JR, Vlachos-Weber I. Peer 
support telephone dyads for elderly women: was this the wrong 
intervention? Am J Community Psychol 1991;19:53–74
Not solely health-related 
LAs
Combined
Heller (1995) Heller RF. A randomized controlled trial of community based counselling 
among those discharged from hospital with ischaemic heart disease. Austr 
N Z J Med 1995;25:362–4
Poor methodological 
quality
Quantitative
Henderson et al. 
(1989)
Henderson JB, Glekin BM, McIntosh WB, Dunnigan MG. A Health 
Education campaign to prevent osteomalacia in Asian women in Glasgow: 
1984–86. J Hum Nutr Diet 1989;2:237–51
Poor methodological 
quality
Quantitative
Hill et al. (1999) Hill MN, Bone LR, Hilton SC, Roary MC, Kelen GD, Levine DM. A clinical 
trial to improve high blood pressure care in young urban black men—
Recruitment, follow-up, and outcomes. Am J Hypertens 1999;12:548–
554.
Poor methodological 
quality
Quantitative
Hill et al. (2003) Hill MN, Han HR, Dennison CR, Kim MT, Roary MC, Blumenthal RS, et al. 
Hypertension care and control in underserved urban African American 
men: Behavioral and physiologic outcomes at 36 months. Am J Hypertens 
2003;16:906–13
Poor methodological 
quality
Quantitative
Hoare et al. 
(1994)
Hoare T, Thomas C, Biggs A, Booth M, Bradley S, Friedman E. Can 
the uptake of breast screening by Asian women be increased? A 
randomized controlled trial of a linkworker intervention. J Pub Health Med 
1994;16:179–85
Poor methodological 
quality
Quantitative
Hodnett (1999) Hodnett E. Efficacy of home-based peer counseling to promote exclusive 
breast-feeding: a randomized controlled trial. J Pediatr 1999;135:649–50
Poor methodological 
quality
Quantitative
260 Appendix 10
Study Reference(s) Reason for exclusion Design
Holtrop et al. 
(2002)
Holtrop JS, Hickner J, Dosh S, Noel M, Ettenhofer TL. “Sticking to it – 
diabetes mellitus”: a pilot study of an innovative behavior change program 
for women with type 2 diabetes. Am J Health Educ 2002;33:161–6
Poor methodological 
quality
Quantitative
Holtrop and 
Slonim (2000)
Holtrop JS, Slonim A. Sticking to it: a multifactor cancer risk-reduction 
program for low-income clients. J Health Educ 2000;31:122–7
Poor methodological 
quality
Quantitative
Holtrop et al. 
(2002)
Holtrop JS, Hickner J, Dosh S, Noel M, Ettenhofer TL. “Sticking to it: 
diabetes mellitus”: a pilot study of an innovative behavior change program 
for women with type 2 diabetes. Am J Health Educ 2002;33:161–6
Poor methodological 
quality
Quantitative
Hovell et al. 
(1984)
Hovell MF, Geary DC, Black DR. The effects of lay counseling on 
medication adherence and blood pressure: Adjunctive treatment for 
hypertension. Patient Educ Couns 1984;6:91–4.
Poor methodological 
quality
Qualitative
Ingram et al. 
(2007)
Ingram M, Torres E, Redondo F, Bradford G, Wang C, O’Toole ML. The 
impact of promotoras on social support and glycemic control among 
members of a farm worker community on the US-Mexico border. Diabetes 
Educ 2007;33(Suppl. 6):S172–8
Poor methodological 
quality
Qualitative
Ireys et al. 
(1996)
Ireys HT, Sills EM, Kolodner KB. A Social Support Intervention for Parents 
of Children with Juvenile Rheumatoid Arthritis: Results of a Randomized 
Trial. J Pediatr Psychol 1996;21:633–41
Poor methodological 
quality
Quantitative
Jandorf et al. 
(2005)
Jandorf L, Gutierrez Y, Lopez J, Christie J, Itzkowitz SH. Use of a 
patient navigator to increase colorectal cancer screening in an urban 
neighborhood health clinic. J Urban Health 2005;82:216–24
Poor methodological 
quality
Quantitative
Jenner (1988) Jenner S. The influence of additional information, advice and support on 
the success of breast feeding in working class primiparas. Child Care 
Health Dev 1988;14:319–28
Poor methodological 
quality
Quantitative
Jolemore and 
Steeves (2006)
Jolemore S, Steeves D. A capital approach: Tobacco treatment and 
cessation within Nova Scotia’s Capital Health District. Healthc Q 
2006;9:66–70
Not an evaluative design Qualitative
Kaczorowski et 
al. (2008)
Kaczorowski J, Chambers LW, Karwalajtys T, Dolovich L, Farrell B, 
McDonough B. Cardiovascular Health Awareness Program (CHAP): A 
community cluster-randomised trial among elderly Canadians. Prevent 
Med 2008;46:537–44
Poor methodological 
quality
Quantitative
Kalampakorn 
(2000)
Kalampakorn S. Linking practice and research. Effects of peer education 
on dietary change. AAOHN J 2000;48:551–2
Poor methodological 
quality
Quantitative
Katz et al. (2007) Katz ML, Tatum CM, Degraffinreid CR, Dickinson S, Paskett ED. Do cervical 
cancer screening rates increase in association with an intervention 
designed to increase mammography usage? J Womens Health 
2007;16:24–35
Poor methodological 
quality
Quantitative
Katz et al. (2007) Katz ML, Tatum C, Dickinson SL, Murray DM, Long-Foley K, Cooper MR, et 
al. Improving colorectal cancer screening by using community volunteers: 
results of the Carolinas cancer education and screening (CARES) project. 
Cancer 2007;110:1602–10
Poor methodological 
quality
Quantitative
Kegeles et al. 
(2002)
Kegeles SM, Rebchook GM, Hays RB, Pollack LM. Staving off increases in 
young gay/bisexual men’s risk behavior in the HAART era. XIV International 
Conference on AIDS, Barcelona, 2002
Poor methodological 
quality
Quantitative
Kelly et al. 
(1991)
Kelly JA, St. Lawrence JS, Diaz YE, et al. HIV risk behavior reduction 
following intervention with key opinion leaders of population: an 
experimental analysis. Am J Public Health 1991;81:168–71
Poor methodological 
quality
Quantitative
Kelly et al. 
(1997)
Kelly JA, Murphy DA, Sikkema KJ, et al. Randomised, controlled, 
community-level HIV-prevention intervention for sexual-risk behaviour 
among homosexual men in US cities. Lancet 1997;350:1500–5
Poor methodological 
quality
Quantitative
Keyserling et al. 
(2008)
Keyserling TC, Samuel Hodge CD, Jilcott SB, Johnston LF, Garcia BA, 
Gizlice Z, et al. Randomized trial of a clinic-based, community-supported, 
lifestyle intervention to improve physical activity and diet: The North 
Carolina enhanced WISEWOMAN project. Prevent Med 2008;46:499–510
Poor methodological 
quality
Quantitative
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Kim et al. (2004) Kim S, Koniak-Griffin D, Flaskerud JH, Guarnero PA. The impact of lay 
health advisors on cardiovascular health promotion: using a community 
based participatory approach. J Cardiovasc Nurs 2004;19:192–9
Poor methodological 
quality
Quantitative
Klecan (1999) Klecan D. Development and evaluation of a smoking cessation training for 
border lay advisors. Cancer Res Ther Control; 2004;8:233–44
Poor methodological 
quality
Quantitative
Kleiman et al. 
(1977)
Kleiman MA, Mantell JE, Alexander ES. RX for social death: the cancer 
patient as counsellor. Commun Ment Health J 1977;13:115–24
Poor methodological 
quality
Qualitative
Kocken et al. 
(2001)
Kocken PL, Voorham T, Brandsma J, Swart W. Effects of peer-led AIDS 
education aimed at Turkish and Moroccan male immigrants in The 
Netherlands: A randomised controlled evaluation study. Eur J Pub Health 
2001;11:153–9
Poor methodological 
quality
Quantitative
Kocken and 
Voorham (1998)
Kocken PL, Voorham AJJ. Effects of a peer-led senior health education 
program. Patient Educ Couns 1998;34:15–23
Poor methodological 
quality
Quantitative
Komaroff et al. 
(1974)
Komaroff AL, Black WL, Flatley M, Knopp RH, Reiffen B, Sherman 
H. Protocols for physician assistants: management of diabetes and 
hypertension. N Engl J Med 1974;290:307–12
Poor methodological 
quality
Quantitative 
Konstant et al. 
(1991)
Konstant LC, Hughes KV, Dowdy RP. Using trained volunteer instructors: 
an example of community health education programming. SO: Source J 
Commun Dev Soc 1991;22:99–117
Poor methodological 
quality
Qualitative
Krieger et al. 
(1999)
Krieger J, Collier C, Song L, Martin D. Linking community based blood 
pressure measurement to clinical care: A randomized controlled trial of 
outreach and tracking by community health workers. Am J of Pub Health 
1999;89:856–61
Poor methodological 
quality
Quantitative
Kviz et al. (1994) Kviz FJ, Crittenden KS, Madura KJ, Madura RB. Use and effectiveness of 
buddy support in a self-help smoking cessation program. Am J Health 
Promotion 1994;8:191–201
Poor methodological 
quality
Quantitative
Lacey et al. 
(1991)
Lacey L, Tukes S, Manfredi C, Wamecke R. Use of lay health educators 
for smoking cessation in a hard-to-reach urban community. J Commun 
Health 1991;16:269–82
Poor methodological 
quality
Quantitative
Lam et al. (2003) Lam TK, McPhee SJ, Mock J, Wong C, Doan HT, Nguyen T, et al. 
Encouraging Vietnamese-American women to obtain Pap tests through 
lay health worker outreach and media education. J Gen Intern Med 
2003;18:516–24
Poor methodological 
quality
Quantitative
Lapham et al. 
(1993)
Lapham SC, Hall M, McMurray-Avila M, Beaman H. Residential Care: 
Alburquerque, Evanston/VA, Los Angeles. Alcohol Treat Q 1993; 
10(3–4):139–54
Poor methodological 
quality
Quantitative
Lapham et al. 
(1995)
Lapham SC, Hall M, Skipper BJ. Homelessness and Substance Use Among 
Alcohol Abusers Following Participation in ProjectH&ART. J Addict Dis 
1995;14:41–55
Poor methodological 
quality
Quantitative
Larkey et al. 
(1999)
Larkey LK, Alatorre C, Buller DB, Morrill C, Klein Buller M, Taren D, et al. 
Communication strategies for dietary change in a worksite peer educator 
intervention. Health Educ Res 1999;14:777–90
Poor methodological 
quality
Quantitative
Larkey (2006) Larkey L. Las Mujeres Saludables: reaching Latinas for breast, cervical 
and colorectal cancer prevention and screening. J Commun Health 
2006;31:69–77. 
Poor methodological 
quality
Quantitative
Latka et al. 
(2008)
Latka MH, Hagan H, Kapadia F, Golub ET, Bonner S, Campbell JV, et al. 
A randomized intervention trial to reduce the lending of used injection 
equipment among injection drug users infected with hepatitis C. Am J Pub 
Health 2008;98:853–61
Poor methodological 
quality
Quantitative
Latkin (1998) Latkin CA. Outreach in natural settings: the use of peer leaders for 
HIV prevention among injecting drug users’ networks. Pub Health Rep 
1998;113:S151–9
Poor methodological 
quality
Quantitative
Latkin et al. 
(2003)
Latkin CA, Sherman S, Knowlton A. HIV prevention among drug users: 
outcome of a network-oriented peer outreach intervention. Health Psychol 
2003;22:332–9
Poor methodological 
quality
Quantitative
Lavallee et al. 
(1991)
Lavallee C, James CA, Robinson EJ. Evaluation of a Community Health 
Representative Program among the Cree of Northern Quebec. Can J Pub 
Health 1991;82:181–4
Not an evaluative design Combined
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Lesser et al. 
(2005)
Lesser PA, Maurer M, Stephens S, Yolkut R. Doulas for all. Int J Childbirth 
Educ 2005;20:28–32
Poor methodological 
quality
Quantitative
Levine and Bone 
(1990)
Levine DM, Bone L. The impact of a planned health education approach 
on the control of hypertension in a high risk population. J Hum Hypertens 
1990;4:317–21
Poor methodological 
quality
Quantitative
Liberty et al. 
(1998)
Liberty HJ, Johnson BD, Jainchill N, Ryder J, Messina M, Reynolds S, et 
al. Dynamic recovery: comparative study of therapeutic communities in 
homeless shelters for men. J Subs Abuse Treat 1998;15:401–23
Poor methodological 
quality
Quantitative
Lieberman 
(2002)
Lieberman. Practice notes: strategies in health education. Health Educ 
Behav 2002;29:649–55
Not an evaluative design Combined
Lierman et al. 
(1994)
Lierman LM, Young HM, Powell-Cope G, Georgiadou F, Benoliel JQ. Effects 
of education and support on breast self-examination in older women. Nurs 
Res 1994;43:158–63
Poor methodological 
quality
Quantitative
Lipkus et al. 
(1999)
Lipkus IM, Lyna PR, Rimer BK. Using tailored interventions to enhance 
smoking cessation among African-Americans at a community health 
center. Nicotine Tob Res 1999;1:77–85
Poor methodological 
quality
Quantitative
Malchodi et al. 
(2003)
Malchodi ,CS, Oncken C, Dornelas EA, Caramanica L, Gregonis E, Curry 
SL. The effects of peer counseling on smoking cessation and reduction. 
Obstet Gynecol 2003;101:504–10
Poor methodological 
quality
Quantitative
Malott et al. 
(1984)
Malott JM, Glasgow RE, O’Neill K, et al. Co-worker social support in a 
worksite smoking control program. J Appl Behav Anal 1984;17:485–95
Poor methodological 
quality
Quantitative
Margolis et al. 
(1998)
Margolis K, Lurie N, McGovern P, Tyrell M, Slater J. Increasing breast 
and cervical cancer screening in low-income women. J Gen Int Med 
1998;13:515–21
Poor methodological 
quality
Quantitative
Martin et al. 
(2005)
Martin M, Camargo M, Ramos L, Lauderdale D, Krueger L, Lantos J. The 
evaluation of a Latino community health worker HIV prevention program. 
Hisp J Behav Sci 2005;27:371–84
Poor methodological 
quality
Quantitative
Martijn et al. 
(2004)
Martijn C, de Vries NK, Voorham T, Brandsma J, Meis M, Hospers HJ. The 
effects of AIDS prevention programs by lay health advisors for migrants in 
The Netherlands. Patient Educ Couns 2004;53:157–65
Poor methodological 
quality
Quantitative
Mayo et al. 
(2004)
Mayo RM, Sherrill WW, Crew L, Watt P, Mayo WW. Connecting rural African 
American and Hispanic women to cancer education and screening: the 
Avon Health Connector Project. J Cancer Educ 2004;19:123–6
Poor methodological 
quality
Combined
McCormick et al. 
(1989)
McCormick M, Brooks-Gunn J, Shorter T, Holmes J, Wallace C, Heagarty 
M. Outreach as case finding: its effect on enrolment in prenatal care. Med 
Care 1989;27:103–11
Poor methodological 
quality
Quantitative
McFarlane and 
Fehir (1994)
McFarlane J, Fehir J. De Madres a Madres: A community, primary health 
care program based on empowerment. Health Educ Q 1994;21:381–94
Poor methodological 
quality
Quantitative
McGregor (2008) McGregor A. Health Trainer Programme, Bradford and Airedale primary 
care trust. BMJ Health Intelligence; 2008
Poor methodological 
quality
Qualitative
McIntyre-
Kingsolver et al. 
(1986)
McIntyre-Kingsolver K, Lichtenstein E, Mermelstein RJ. Spouse 
Training in a Multicomponent Smoking-Cessation Program. Behav Ther 
1986;17:67–74
Poor methodological 
quality
Quantitative
McNeil (1995) McNeil JK. Effects of nonprofessional home visit programs for subclinically 
unhappy and unhealthy older adults. J Appl Gerontol 1995;14:333–42
Poor methodological 
quality
Quantitative
Medina et al. 
(2007)
Medina A, Balcazar H, Hollen ML, Nkhoma E, Mas FS. Promotores de 
Salud: educating Hispanic communities on heart-healthy living. Am J 
Health Educ 2007;38:194–202
Poor methodological 
quality
Combined
Merelle et al. 
(2006)
Merelle S, Sorbi M, Passchier J. The preliminary effectiveness of migraine 
lay trainers in a home-based behavioural management training. Patient 
Educ Couns 2006;61:307–11
Poor methodological 
quality
Quantitative
Mermelstein et 
al. (1986)
Mermelstein R, Cohen S, Lichtenstein E, Baer JS, Kamarck T. Social 
Support and Smoking Cessation and maintenance. J Consult Clin Psychol 
1986;54:447–53
Poor methodological 
quality
Quantitative
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Miller et al. 
(1998)
Miller RL, Klotz D, Eckholdt HM. HIV prevention with male prostitutes and 
patrons of hustler bars: replication of an HIV preventive intervention. Am J 
Community Psychol 1998;26:97–131
Poor methodological 
quality
Combined
Mishra et al. 
(1998)
Mishra SI, Chavez LR, Magana JR, Nava P, Valdez RB, Hubbell FA. 
Improving breast cancer control among Latinas: Evaluation of a theory-
based educational program. Health Educ Behav 1998;25:653–70
Poor methodological 
quality
Quantitative
Mock et al. 
(2006)
Mock J, Nguyen T, Nguyen K, Bui-Tong N, McPhee S. Processes and 
capacity-building benefits of lay health worker outreach focused on 
preventing cervical cancer among Vietnamese. Health Prev Pract 
2006;7:S223–32.
Not an evaluative design Descriptive material
Mock et al. 
(2007)
Mock J, McPhee SJ, Nguyen T, Wong C, Doan H, Lai KQ. Effective lay 
health worker outreach and media-based education for promoting cervical 
cancer screening among Vietnamese American women. Am J Public 
Health 2007;97:1693–700
Poor methodological 
quality
Quantitative
Mohr et al. 
(2005)
Mohr DC, Burke H, Beckner V, Merluzzi N. A preliminary report on a skills-
based telephone-administered peer support programme for patients with 
multiple sclerosis. Mul Scler 2005;11:222–6
Poor methodological 
quality
Quantitative
Moore et al. 
(1974)
Moore F, Ballinger P, Beasley J. Influence of postpartum home visits on 
postpartum clinic attendance. Public Health Rep 1974;89:360–4
Not solely a health related 
LA
Quantitative
Morisky et al. 
(2002)
Morisky DE, Lees NB, Sharif BA, Liu KY, Ward HJ. Reducing disparities 
in hypertension control: a community-based hypertension control 
project (CHIP) for an ethnically diverse population. Health Promot Pract 
2002;3:264–75
Not an evaluative design Quantitative
Muirhead et al. 
(2006)
Muirhead PE, Butcher G, Rankin J, Munley A. The effect of a programme 
of organised and supervised peer support on the initiation and duration of 
breastfeeding: a randomised trial. Br J Gen Pract 2006;56:191–7
Poor methodological 
quality
Quantitative
Nair et al. (2002) Nair P, Schuler ME, Kettinger L, Harrington D. Cumulative environmental 
risk in substance abusing women: parenting stress, child abuse potential, 
and development. Pediatr Res 2002;51:186A
Poor methodological 
quality
Quantitative
Navarro et al. 
(1995)
Navarro AM, Senn KL, Kaplan RM, McNicholas L, Campo MC, Roppe B. 
Por La Vida intervention model for cancer prevention in Latinas. J Nat 
Cancer Inst Monogr 1995;18:137–45
Poor methodological 
quality
Quantitative
Navarro et al. 
(1998)
Navarro A, Senn K, McNicholas L, Kaplan R, Roppe B, Campo M. Por La 
Vida model intervention enhances use of cancer screening tests among 
Latinas. Am J Prev Med 1998;15:32–41
Poor methodological 
quality
Quantitative
Navarro et al. 
(2007)
Navarro AM, Raman R, McNicholas LJ, Loza O. Diffusion of cancer 
education information through a Latino community health advisor 
program. Prev Med 2007;45:135–8
Poor methodological 
quality
Quantitative
Nebelkopf et al. 
(2005)
Nebelkopf E, Penagos M. Holistic Native Network: Integrated HIV/AIDS, 
substance abuse, and mental health services for native Americans in San 
Francisco. J Psychoactive Drugs 2005;37:257–64
Poor methodological 
quality
Quantitative
Neittaanmaki et 
al. (1980)
Neittaanmaki L, Koskela K, Puska P, McAlister AL. The role of lay workers 
in community health education: experiences of the North Karelia project. 
Scand J Soc Med 1980;8:1–7
Poor methodological 
quality
Quantitative
Nielsen et al. 
(1972)
Nielsen M, Blenker M, Bloom M, Downs T, Beggs H. Older Persons after 
Hospitalization: A Controlled Study of Home Aide Service. Am J Public 
Health 1972;62:1094–101
Poor methodological 
quality
Quantitative
Newman et al. 
(1996)
Newman DK, Wallace J, Blackwood N, Spencer C. Promoting healthy 
bladder habits for seniors: the development, implementation, and results 
of a health promotion project, DRY EXPECTATIONS, for incontinence 
education in the community. Ostomy Wound Manage 1996;42:18–20
Poor methodological 
quality
Quantitative
Nies et al. (2004) Nies MA, Artinian NT, Schim SM, Vander Wal JS, Sherrick-Escamilla S. 
Effects of lay health advisor interventions on activity, diet, and health risks 
in an urban Mexican American community. J Prim Prev 2004,25:441–55
Poor methodological 
quality
Quantitative
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Norr et al. (2003) Norr KF, Crittenden KS, Lehrer EL, Reyes O, Boyd CB, Nacion KW. Maternal 
and infant outcomes at one year for a nurse-health advocate home visiting 
program serving African Americans and Mexican Americans. Public Health 
Nurs 2003;20:190–203
Not adult health focused Quantitative
Nyamathi et al. 
(2001)
Nyamathi A, Flakerud J, Leake B, Dixon E, Lu A. Evaluating the impact of 
peer, nurse case-managed, and standard HIV risk reduction programs on 
psychosocial and health promoting behavioral outcomes among homeless 
women. Res Nurs Health 2001;24:410–22
Poor methodological 
quality
Quantitative
Olney et al. 
(2007)
Olney CA, Warner DG, Reyna G, Wood FB, Siegel ER. MEDLINE Plus and 
the challenge of low health literacy: findings from the Colonias project. J 
Med Libr Assoc 2007;95:31–9
Poor methodological 
quality
Qualitative
Perez-Stable et 
al. (1996)
Perez-Stable EJ, Otero-Sabogal R, Sabogal F, Napoles-SpringerAM. 
Pathways to early cancer detection for Latinas: En Acción Contra el 
Cáncer. Health Educ Q 1996;23:S41–59
Poor methodological 
quality
Quantitative
Perkins and 
MacFarlane 
(2001)
Perkins ER, MacFarlane J. Family support by lay workers: a health visiting 
initiative. Br J Community Nurs 2001;6:26–32
Poor methodological 
quality
Combined
Persily (2003) Persily CA. Lay home visiting may improve pregnancy outcomes. Holist 
Nurs Pract 2003;17:231–8
Not an evaluative design Review
Plescia et al. 
(2008)
Plescia M, Herrick H, Chavis L. Improving health behaviors in an African 
American community: the Charlotte Racial and Ethnic Approaches to 
Community Health project. Am J Public Health 2008;98:1678–84
Poor methodological 
quality
Quantitative
Powell and 
McCann (1981)
Powell DR, McCann BS. The effects of a multiple treatment program and 
maintenance procedures on smoking cessation. Prev Med 1981;10:94–
104
Poor methodological 
quality
Quantitative
Powell et al. 
(2005)
Powell ME, Carter V, Bonsi E, Johnson G, Williams L, Taylor-Smith L, et al. 
Increasing mammography screening among African American women in 
rural areas. J Health Care  Poor Underserved 2005;16:11–21
Poor methodological 
quality
Quantitative
Quinn and 
McNabb (2001)
Quinn M, McNabb W. Training lay health educators to conduct a church-
based weight-loss program for African American women. Diabetes Educ 
2001;27:231–8
Not an evaluative design Descriptive material
Ratima et al. 
(1999)
Ratima MM, Fox C, Fox B, Te Karu H, Gemmell T, Slater T, et al. Long-term 
benefits for Maori of an asthma self-management program in a Maori 
community which takes a partnership approach. Austr N Z J Public Health 
1999;23:601–5
Poor methodological 
quality
Qualitative
Reath and Carey 
(2008)
Reath J, Carey M. Breast and cervical cancer in indigenous women 
– Overcoming barriers to early detection. Austr Fam Physician 
2008;37:178–82
Not an evaluative design Quantitative
Reijneveld et al. 
(2003)
Reijneveld SA, Westhoff MH, Hopman-Rock M. Promotion of health 
and physical activity improves the mental health of elderly immigrants: 
results of a group randomised controlled trial among Turkish immigrants 
in the Netherlands aged 45 and over. J Epidemiol Community Health 
2003;57:405–11
Poor methodological 
quality
Quantitative
Rene et al. 
(1992)
Rene, J. Weinberg, M. Mazzuca, S.A. Brandt, K.D. Katz, B.P. Reduction of 
joint pain in patients with knee osteoarthritis who have received monthly 
telephone calls from lay personnnel and whose medical treatment 
regimens have remained stable. Arthritis Rheum 1992;35:511–15
Poor methodological 
quality
Quantitative
Reinschmidt et 
al. (2006)
Reinschmidt KM, Hunter JB, Fernandez ML, Lacy-Martinez CR, Guernsey 
de Zapien J, Meister J. Understanding the success of promotoras in 
increasing chronic diseases screening. J Health Care Poor Underserved 
2006;17:256–64
Poor methodological 
quality
Qualitative
Resnicow et al. 
(2002)
Resnicow K, Jackson A, Braithwaite R, DiIorio C, Blisset D, Rahotep S, 
et al. Healthy Body/Healthy Spirit: a church-based nutrition and physical 
activity intervention. Health Educ Res 2002;17:562–73
Poor methodological 
quality
Quantitative
Rhodes et al. 
(2007)
Rhodes SD, Foley KL, Zometa CS, Bloom FR. Lay health advisor 
interventions among Hispanics/Latinos: a qualitative systematic review. 
Am J Prev Med 2007;33:418–27
Not an evaluative design Review
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Richert et al. 
(2007)
Richert ML, Webb AJ, Morse NA, O’Toole ML, Brownson CA. Move More 
Diabetes: using lay health educators to support physical activity in a 
community-based chronic disease self-management program. Diabetes 
Educ 2007;33(Suppl. 6):S179–84
Poor methodological 
quality
Combined
Rodney et al. 
(1998)
Rodney M, Clasen C, Goldman G, Market R, Deane D. Three evaluation 
methods of a community health advocate program. J Community Health 
1998;23:371–81
Poor methodological 
quality
Quantitative
Romer et al. 
(2002)
Romer LT, Richardson ML, Nahom D, Aigbe E, Porter A. Providing family 
support through community guides. Ment Retard 2002;40:191–200
Poor methodological 
quality
Quantitative
Rose (1992) Rose MA. Evaluation of a peer-education program on heart disease 
prevention with older adults. Public Health Nurs 1992;9:242–7
Poor methodological 
quality
Quantitative
Ross et al. 
(2006)
Ross MW, Harzke AJ, Scott DP, McCann K, Kelley M. Outcomes of Project 
Wall Talk: an HIV/AIDS peer education program implemented within the 
Texas State prison system. AIDS Educ Prev 2006;18:504–17
Poor methodological 
quality
Quantitative
Ross and 
Williams (2002)
Ross MW, Williams ML. Effective targeted and community HIV/STD 
prevention programs. J Sex Res 2002; 39:58–62
Not an evaluative design Review
Russell et al. 
(1976)
Russell RK, Wise F. Treatment of speech anxiety by cue-controlled 
relaxation and desensitization with professional and paraprofessional 
counselers. J Couns Psychol 1976;23:583–6
Poor methodological 
quality
Quantitative
Ryan et al. 
(1999)
Ryan T, Smith I, Hancock J, Dovaston G, Smith M. Applying aspects of the 
community reinforcement approach to alcohol and drug services. J Subst 
Use 1999,4:70–5
Poor methodological 
quality
Quantitative
Sadler et al. 
(2000)
Sadler GR, Thomas AG, Yen JY, Dhanjal SK, Ko CM, Tran HQ, et al. Breast 
cancer education program based in Asian grocery stores. J Cancer Educ 
2000;15:173–7
Poor methodological 
quality
Quantitative
Samuel-Hodge et 
al. (2006)
Samuel-Hodge CD, Keyserling TC, France R, Ingram AF, Johnston 
LF, Pullen Davis L, Davis G, Cole AS. A church-based diabetes self-
management education program for African Americans with type 2 
diabetes. Prev Chronic Dis 2006;3:101–6
Poor methodological 
quality
Quantitative
Schafer et al. 
(1998)
Schafer E, Vogel MK, Viegas S, Hausafus C. Volunteer peer counselors 
increase breastfeeding duration among rural low-income women. Birth 
1998;25:101–6
Poor methodological 
quality
Quantitative
Schover et al. 
(2006)
Schover LR, Jenkins R, Sui D, Adams JH, Marion MS, Jackson KE. 
Randomized trial of peer counseling on reproductive health in African 
American breast cancer survivors. J Clin Oncol 2006;24:1620–6
Poor methodological 
quality
Quantitative
Shannon et al. 
(1983)
Shannon BM, Smiciklas Wright H, Davis BW, Lewis C. A peer educator 
approach to nutrition for the elderly. Gerontologist 1982;23:123–126.
Poor methodological 
quality
Quantitative
Shulkin et al. 
(1991)
Shulkin JJ, Mayer JA, Wessel LG, de Moor C, Elder JP, Franzini LR. Effects 
of a peer-led AIDS intervention with university students. J Am Col Health 
1991;40:75–9
Poor methodological 
quality
Quantitative
Simoni et al. 
(2007)
Simoni JM, Pantalone DW, Plummer MD, Huang B. A randomized 
controlled trial of a peer support intervention targeting antiretroviral 
medication adherence and depressive symptomatology in HIV-positive 
men and women. Health Psychol 2007;26:488–95
Poor methodological 
quality
Quantitative
Sixta and 
Ostwald (2008)
Sixta CS, Ostwald S. Border intervention by Promotores for type 2 
diabetes. Texas: University of Texas School of Nursing; 2007
Poor methodological 
quality
Quantitative
Soloman and 
Flynn (2005)
Soloman LJ, Flynn BS. Telephone support for pregnant smokers who want 
to stop smoking. Health Prom Pract 2005;6:105–8
Poor methodological 
quality
Quantitative
Soloman et al. 
(2000)
Soloman LJ, Scharoun GM, Flynn BS, Secker-Walker RH, Sepinwall D. Free 
nicotine patches plus proactive telephone peer support to help low-income 
women stop smoking. Prev Med 2000;31:68–74
Poor methodological 
quality
Quantitative
South et al. 
(2006)
South J, Woodward J, Lowcock D, Woodall J. An Evaluation of the Bradford 
District Health Trainers programme: an early adopters. Leeds: Leeds 
Metropolitan University; 2006
Poor methodological 
quality
Combined
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South et al. 
(2007)
South J, Woodward J, Lowcock D. New beginnings: stakeholder 
perspectives on the role of health trainers. J R Soci Promot Health 
2007;127:224–30
Poor methodological 
quality
Qualitative
Spencer (1988) Spencer B. The family workers project: evaluation of a randomized 
controlled trial of a pregnancy social support service. Proceedings 
of International Symposium on Advances in the Prevention of Low 
Birthweight. Cape Cod, MA; 1988. pp.109–21
Poor methodological 
quality
Quantitative
Spencer and 
Morris (1986)
Spencer B, Morris J. The family worker project: social support in 
pregnancy. Papiernik E, Breart G, Spira editors. Prev Preterm Birth 
1986;138:363–82
Poor methodological 
quality
Quantitative
Squire et al. 
(2006)
Squire S, Hill P. The expert patients programme. Clin Gov Int J 
2006;11:17–21
Not an evaluative design Qualitative
Steen and 
Dallabetta. 
(2003)
Steen R, Dallabetta G. Sexually transmitted infection control with sex 
workers: regular screening and presumptive treatment augment efforts to 
reduce risk and vulnerability. Reprod Health Matters 2003;11:74–90
Focus on implementation 
strategies not on 
effectiveness 
Qualitative
Stewart et al. 
(1998)
Stewart MJ, Doble S, Hart G, Langille L, MacPherson K. Peer visitor 
support for family caregivers of seniors with stroke. Can J Nurs Res 
1998;30:87–117
Poor methodological 
quality
Qualitative
Suarez et al. 
(1993)
Suarez L, Nichols DC, Brady CA. Use of peer role models to increase 
Pap smear and mammogram screening in Mexican-American and black 
women. Am J Prev Med 1993;9:290–6
Poor methodological 
quality
Quantitative
Sung et al. 
(1997)
Sung JF, Blumenthal DS, Coates RJ. Effect of a cancer screening 
intervention conducted by lay health workers among inner-city women. 
Am Jo Prev Med 1997;13:51–6
Poor methodological 
quality
Quantitative
Swerissen et al. 
(2006)
Swerissen H, Belfrage J, Weeks A, Jordan L, Walker C, Furler J, et al. A 
randomised control trial of a self-management program for people with a 
chronic illness from Vietnamese, Chinese, Italian and Greek backgrounds. 
Patient Educ Couns 2006;64:360–8
Poor methodological 
quality
Quantitative
Tameside and 
Glossop PCT 
(2006)
Tameside and Glossop PCT. Connect for life: Health and Wellbeing 
Evaluation Report. Manchester: Vielife; 2006
Poor methodological 
quality
Quantitative
Taylor (1994) Taylor S. NSW prison HIV Peer Education Program: an evaluation. New 
South Wales, NSW Department of Health; 1994
Poor methodological 
quality
Quantitative
Taylor et al. 
(2002)
Taylor VM, Jackson JC, Yasui Y, Kuniyuki A, Acorda E, Marchand A, et 
al. Evaluation of an outreach intervention to promote cervical cancer 
screening among Cambodian American women. Cancer Detect Prev 
2002;26:320–7
Poor methodological 
quality
Quantitative
Tessaro et al. 
(2000)
Tessaro IA, Taylor S, Belton L, Campbell MK, Benedict S, Kelsey K, et 
al. Adapting a natural (lay) helpers model of change for worksite health 
promotion for women. Health Educ Res 2000;15:603–14
Poor methodological 
quality
Combined
Thompson et al. 
(2007)
Thompson JR, Horton C, Flores C. Advancing diabetes self management in 
the Mexican American population: a community health worker model in a 
primary care setting. Diabetes Educ 2007;33(Suppl. 6):S159–65
Poor methodological 
quality
Quantitative
Tobin and 
Dietrich (2006)
Tobin J, Dietrich A. A patient navigator approach boosts cancer screening 
in low-income women. Cancer J Clin 2006;56:190–2
Poor methodological 
quality
Quantitative
Toseland et al. 
(1979)
Toseland RW, Decker J, Bliesner J. A community outreach program for 
socially isolated older persons. J Gerontol Soc Work 1979;1:211–24
Poor methodological 
quality
Qualitative
Trickey et al. 
(2008)
Trickey R, Kelley-Gillespie N, Faley OW. A look at a community coming 
together to meet the needs of older adults: an evaluation of the neighbors 
Helping Neighbors program. J Gerontol Soc Work 2006;50:81–98
Poor methodological 
quality
Quantitative
Tudiver et al. 
(1992)
Tudiver F, Myers T, Kurtz RG, et al. The Talking Sex Project. Eval Health Prof 
1992;15:26–42
Poor methodological 
quality
Quantitative
Two Feathers et 
al. (2005)
Two Feathers J, Kieffer EC, Palmisano G, Anderson M, Sinco B, Janz 
N. Racial and Ethnic Approaches to Community Health (REACH) Detroit 
Partnership: improving diabetes-related outcomes among African 
American and Latino adults. Am J Public Health 2005;95:1552–60
Poor methodological 
quality
Quantitative
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Uccelli et al. 
(2004)
Uccelli MM, Mohr LM, Battaglia MA, Zagami P, Mohr DC. Peer support 
groups in multiple sclerosis: Current effectiveness and future directions. 
Multiple Scler 2004;10:80–4
Poor methodological 
quality
Quantitative
Ungar et al. 
(2004)
Ungar M, Manuel S, Mealey S, Thomas G, Campbell C. A study of 
community guides: lessons for professionals practicing with and in 
communities. Soc Work 2004;49:550–61
Poor methodological 
quality
Qualitative
Vari et al. (2000) Vari PM, Camburn J, Henly SJ. Professionally mediated peer support and 
early breastfeeding success. J Perinat Educ 2000;9:22–30
Poor methodological 
quality
Quantitative
Venne et al. 
(2007)
Venne VL, Hamann HA. Successful use of peer educators for sharing 
genetic information. J Genet Couns 2007;16:515–25
Poor methodological 
quality
Quantitative
Von Korff et al. 
(1998)
Von Korff M. Moore JE. Lorig K, Cherkin DC, Saunders K, Gonzalez VM, 
Laurent D, Rutter C, Comite F. A randomized trial of a lay person-led self-
management group intervention for back pain in primary health care. 
Spine 1998;23:2608–15
Poor methodological 
quality
Qualitative
Walls (2005) Walls, P. Kelso Lifestyle Adviser Service: 12 month evaluation. Melrose: 
NHS Borders; 2005
Poor methodological 
quality
Combined
Wan et al. (1980) Wan TTH, Weissert WG, Livieratos BB. geriatric day care and homemaker 
services: an experimental study. J Gerontol 1980;35:256–74
Poor methodological 
quality
Quantitative
Warrick et al. 
(1992)
Warrick LH, Wood AH, Meister JS, de Zapien JG. Evaluation of a peer 
health worker prenatal outreach and education program for Hispanic 
farmworker families. J Community Health 1992;17:13–26
Poor methodological 
quality
Qualitative
Wasserman et al. 
2006
Wasserman MR, Bender DE, Lee S, Morrissey JP, Mouw T, Norton 
EC. Social support among Latina immigrant women: bridge persons 
as mediators in cervical cancer screening. J Immigr Minor Health 
2006;8:67–84
Poor methodological 
quality
Combined
Weinberger et al. 
(1989)
Weinberger M, Tierney WM, Booher P, Katz BK. Can the Provision of 
Information to Patients with Osteoarthritis Improve Functional Status? A 
Randomised Controlled Trial. Arthritis Rheum 1989;32:1577–83
Poor methodological 
quality
Quantitative
Weinberger et al. 
(1991)
Weinberger M, Tierney WM, Booher P, Katz BP. The impact of increased 
contact on psychosocial outcomes in patients with osteoarthritis: a 
randomized controlled trial. J Rheum 1991;18:849–54
Poor methodological 
quality
Quantitative
Weinrich et al. 
1998
Weinrich SP, Boyd MD, Weinrich M, Green F, Reynolds WA, Metlin C. 
Increasing prostate cancer screening in African American men with 
peer-educator and client-navigator interventions. J Cancer Educ 
1998;13:213–19
Poor methodological 
quality
Quantitative
Welsh et al. 
(2005)
Welsh AL, Sauaia A, Jacobellis J. Min SJ, Byers T. The effect of two 
church-based interventions on breast cancer screening rates among 
Medicaid-insured Latinas. Prev Chronic Dis 2005;2:1–11
Poor methodological 
quality
Quantitative
Wertz et al. 
(1986)
Wertz R, Weiss DG. Aten JL, Brookshire RH, Garcia-Bunuel L, Holland AL, 
et al. Comparison of Clinic, Home, and Deferred Language Treatment for 
Aphasia. Arch Neurol 1986;43:653–8
Poor methodological 
quality
Quantitative
Whitehorse et al. 
(1999)
Whitehorse LE, Manzano R, Baezconde-Garbanati LA, Hahn G. 
Culturally tailoring a physical activity program for Hispanic women: 
recruitment success of La Vida Buena’s salsa aerobics. J Health Educ 
1999;30:S18–24
Poor methodological 
quality
Qualitative
Whitley et al. 
(2006)
Whitley EM, Everhart RM, Wright RA. Measuring Return on Investment of 
Outreach by Community Health Workers. J Health Care Poor Underserved 
2006;17:6–15
Not an evaluative design Quantitative
Williams et al. 
(2001)
Williams JH, Belle GA, Houston C, Haire-Joshu D, Auslander WF. Process 
evaluation methods of a peer-delivered health promotion program for 
African American women. Health Promot Pract 2001;2:135–42
Poor methodological 
quality
Quantitative
Williams (1996) Williams MP. Increasing participation in health promotion among older 
African-Americans. Am J Health Behav 1996;20:389–99
Poor methodological 
quality
Qualitative
Williamson et al. 
(2001)
Williamson LM, Hart GJ, Flowers P, Frankis JS, Der GJ. The Gay Men’s 
Task Force: the impact of peer education on the sexual health behaviour of 
homosexual men in Glasgow. Sex Transmi Infect 2001;77:427–32
Poor methodological 
quality
Quantitative
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Wolitski (1999) Wolitski RJ. Community-level HIV intervention in 5 cities: Final outcome 
data from the CDC AIDS community demonstration projects. Am J Public 
Health 1999;89:336–345.
Poor methodological 
quality
Quantitative
Wolitski et al. 
(2005)
Wolitski RJ, Gómez CA, Parsons JT, and the SUMIT Study Group. Effects of 
a peer-led behavioral intervention to reduce HIV transmission and promote 
serostatus disclosure among HIV-seropositive gay and bisexual men. AIDS 
2005;19(Suppl. 1):S99–109
Poor methodological 
quality
Quantitative
Young et al. 
(1996)
Young DR, Haskell WL, Taylor CB, Fortmann SP. Effect of community health 
education on physical activity knowledge, attitudes, and behavior: The 
Stanford Five-City Project. Am J Epidemiol 1996;144:264–74
Poor methodological 
quality
Quantitative
Zhu et al. (2002) Zhu K, Hunter S, Bernard L, Payne-Wilks K, Roland C, Elam L, et al. An 
intervention study on screening for breast cancer among single African 
American women aged 65 and older. Prev Med 2002;34:536–45.
Poor methodological 
quality
Quantitative
Ziersch et al. 
(2000)
Ziersch A, Gaffney J, Tomlinson DR. STI prevention and the male sex 
industry in London: Evaluating a pilot peer education programme. Sexually 
Transm Infect 2000;76:447–53
Poor methodological 
quality
Quantitative
Zuvekas et al. 
(1999)
Zuvekas A, Nolan L, Tumaylle C, Griffin L. Impact of community health 
workers on access, use of services, and patient knowledge and behaviour. 
J Ambul Care Manage 1999;22:33–44
Not an evaluative design Qualitative
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Appendix 13  
Use of ICERs in the analysis of cost-
effectiveness
The analysis of cost-effectiveness considers the marginal benefit and marginal cost of the programme under consideration in comparison with appropriate alternatives. Where 
data are available, the unit of effectiveness considered is the QALY,377 a measure that captures 
the impact of the intervention on both longevity and HRQoL. The use of a consistent unit for 
each analysis facilitates comparisons across interventions. Calculation of ICERs is undertaken 
according to the principles outlined by Karlsson and Johannesson.378 Alternative programmes 
are ranked according to cost. Any programme that is less effective and more expensive than an 
alternative programme is considered to be dominated. Clearly, it is inferior to the alternative. Any 
programme that produces a smaller effect than some combination of two other programmes is 
considered to be extendedly dominated. It would be better to implement the partial combination 
of the two alternatives than to implement this programme. We exclude all dominated and 
extendedly dominated programmes and rank the remaining programmes according to cost. The 
marginal cost (effectiveness) of each programme is calculated by subtracting, from the costs 
(effects) of the programme, the costs (effects) of the next lower ranking programme. The cheapest 
and least effective programme forms the baseline comparison. The ICER for the next most 
expensive programme is calculated by dividing the marginal cost by the marginal effectiveness. 
An ICER can be calculated for each of the remaining programmes.
The ICER provides a measure of the additional cost of gaining each additional unit of 
effectiveness delivered by that programme, over and above the next best alternative. Presentation 
of ICERs in this manner helps to guide decision-making. If the maximum threshold or maximum 
willingness to pay for a unit of effectiveness is established then the programme that should be 
implemented is the most effective programme with an ICER below that threshold. ICERs below 
the threshold indicate programmes with additional health gains that justify the additional cost; 
ICERs above the threshold indicate programmes whose additional health gains do not justify 
the additional resources required to implement them. Decision-making by NICE is not based 
on an arbitrary threshold, but interventions with an ICER > £25,000–35,000 per QALY require 
exceptional justifications to be considered good value for money.379
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We look forward to hearing from you.
